<SEC-DOCUMENT>0001564590-21-014204.txt : 20210318
<SEC-HEADER>0001564590-21-014204.hdr.sgml : 20210318
<ACCEPTANCE-DATETIME>20210318172454
ACCESSION NUMBER:		0001564590-21-014204
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20210427
FILED AS OF DATE:		20210318
DATE AS OF CHANGE:		20210318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adicet Bio, Inc.
		CENTRAL INDEX KEY:			0001720580
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813305277
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38359
		FILM NUMBER:		21755501

	BUSINESS ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		12TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-482-2333

	MAIL ADDRESS:	
		STREET 1:		500 BOYLSTON STREET
		STREET 2:		12TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	resTORbio, Inc.
		DATE OF NAME CHANGE:	20171024
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>acet-def14a_20210427.htm
<DESCRIPTION>DEF 14A
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
acet-def14a_20210427.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;border-top:Double 2.25pt;padding-top:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p>
<p style="text-align:center;border-top:none 0pt;padding-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SCHEDULE 14A INFORMATION</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Rule 14a-101)</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-align:center;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Proxy Statement Pursuant to Section 14(a) of the<br />Securities Exchange Act of 1934</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; )</p>
<p style="text-align:center;border-top:none 0pt;padding-top:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="text-align:center;border-top:none 0pt;padding-top:0pt;margin-bottom:0pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="border-top:none 0pt;padding-top:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  style="width:31.12%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed by the Registrant <font style="font-family:MS Mincho;">&#9746;</font></p></td>
<td valign="top"  style="width:35.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Filed by a Party other than the Registrant <font style="font-family:MS Mincho;">&#9744;</font></p></td>
<td valign="top"  style="width:33.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-family:Times New Roman;">Preliminary Proxy Statement</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-weight:bold;font-family:Times New Roman;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-top:3pt;margin-bottom:0pt;font-family:MS Mincho;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:MS Mincho;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</font></p></td>
<td valign="top">
<p style="margin-top:3pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:MS Mincho;font-size:10pt;"><font style="font-family:Times New Roman;">Definitive Proxy Statement</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-family:Times New Roman;">Definitive Additional Materials</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-family:Times New Roman;">Soliciting Material Pursuant to &#167;240.14a-12</font></p></td></tr></table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adicet Bio, Inc.</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Name of Registrant as Specified in its Charter)</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-align:center;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</p>
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment of Filing Fee (Check the appropriate box):</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:MS Mincho;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:MS Mincho;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9746;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-family:Times New Roman;">No fee required.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-family:Times New Roman;">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Title of each class of securities to which transaction applies:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Aggregate number of securities to which transaction applies:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Proposed maximum aggregate value of transaction:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Total fee paid:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-family:Times New Roman;">Fee paid previously with preliminary materials.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="margin-bottom:0pt;margin-top:3pt;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Segoe UI Symbol;font-size:10pt;"><font style="font-family:Times New Roman;">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Amount Previously Paid:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Form, Schedule or Registration Statement No.:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Filing Party:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:3pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Date Filed:</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-top:0pt;margin-left:6.67%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<p style="border-bottom:Double 2.25pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:3pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu3c32wcjg3v000001.jpg" title="" alt="" style="width:274px;height:56px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ADICET BIO, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Boston, Massachusetts 02116</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">NOTICE OF 2021 ANNUAL MEETING OF STOCKHOLDERS</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">To be held April 27, 2021</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notice is hereby given that the 2021 Annual Meeting of Stockholders, or Annual Meeting, of Adicet Bio, Inc., will be held online on April 27, 2021 at 3:00 p.m. Eastern Time. The safety of our stockholders is important to us, and given the current guidance by public health officials surrounding COVID-19 and group gatherings, this year&#8217;s Annual Meeting will be held virtually. You may attend the meeting virtually via the Internet at <font style="font-weight:bold;font-style:italic;color:#000000;letter-spacing:0.2pt;">www.virtualshareholdermeeting.com/ACET2021</font>, where you will be able to vote electronically and submit questions. You will need the 16-digit control number included with the Notice of Internet Availability of Proxy Materials being mailed to you separately in order to attend the Annual Meeting.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The purpose of the Annual Meeting is the following:&nbsp;&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">1.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">To elect two class III directors to our board of directors, to serve until the 2024 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal&#894; </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">2.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">To amend and restate the Company&#8217;s 2018 Employee Stock Purchase Plan as described herein;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">3.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">To amend and restate the Company&#8217;s 2018 Stock Option and Incentive Plan as described herein;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">4.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">5.</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">To transact any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The proposal for the election of directors relates solely to the election of class III directors nominated by the board of directors.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Only Adicet Bio, Inc. stockholders of record at the close of business on March 1, 2021, will be entitled to vote at the Annual Meeting and any adjournment or postponement thereof.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are pleased to take advantage of the Securities and Exchange Commission&#8217;s&nbsp;&nbsp;&#8220;Notice and Access&#8221; rules that allow companies to furnish their proxy materials over the Internet. We are mailing to our stockholders a Notice of Internet Availability of Proxy Materials, or Notice, instead of a paper copy of our proxy materials and our 2020 Annual Report to Stockholders, or 2020 Annual Report. We plan to mail the Notice on or about March 18, 2021, and it contains instructions on how to access those documents and to cast your vote via the Internet as well as instructions on how to request a paper copy of our proxy materials and our 2020 Annual Report. This process allows us to provide our stockholders with the information they need on a timelier basis, while reducing the environmental impact and lowering the costs of printing and distributing our proxy materials. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To be admitted to the Annual Meeting and vote your shares, you must provide the 16-digit control number as provided described in the Notice, or proxy card, or voting instruction form at <font style="font-style:italic;">www.proxyvote.com</font>. Please see the &#8220;General Information&#8221; section of the proxy statement that accompanies this notice for more details regarding the logistics of the virtual Annual Meeting, including the ability of stockholders to submit questions during the Annual Meeting, and technical details and support related to accessing the virtual platform.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Your vote is important. Whether or not you are able to attend the meeting in person, it is important that your shares be represented. To ensure that your vote is recorded promptly, please vote as soon as possible, even if you plan to attend the </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">meeting, by submitting your proxy via the Internet at the address listed on the proxy card or by signing, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">dating,</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and returning the proxy card. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:40%;">
<tr>
<td valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By order of the board of directors,</p></td>
</tr>
<tr>
<td valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;text-align:left;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="width:100%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Chen Schor</p></td>
</tr>
<tr>
<td valign="top"  style="width:100%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chen Schor</p></td>
</tr>
<tr>
<td valign="top"  style="width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">President, Chief Executive Officer and Secretary</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Boston, Massachusetts</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 18, 2021</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="TOC"></a><a name="TOC"></a>TABLE OF CONTENTS</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:-3.33%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:101.92%;">
<tr style="height:7.15pt;">
<td valign="top"  style="width:91.5%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&nbsp;</p></td>
<td valign="top"  style="width:1.26%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;">&nbsp;</p></td>
<td valign="top"  style="width:7.24%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Page</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PROXY_STATEMENT"><font style="text-decoration:none;">PROXY STATEMENT</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PROPOSAL_1"><font style="text-decoration:none;">PROPOSAL NO. 1 &#8211; ELECTION OF CLASS III DIRECTORS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p></td>
</tr>
<tr>
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PROPOSAL_2"><font style="text-decoration:none;">PROPOSAL NO. 2 &#8211; TO AMEND AND RESTATE THE COMPANY&#8217;S 2018 EMPLOYEE STOCK PURCHASE PLAN</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</p></td>
</tr>
<tr>
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PROPOSAL_3"><font style="text-decoration:none;">PROPOSAL NO. 3 &#8211; TO AMEND AND RESTATE THE COMPANY&#8217;S 2018 STOCK OPTION AND INCENTIVE PLAN</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td>
</tr>
<tr>
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PROPOSAL_4"><font style="text-decoration:none;">PROPOSAL NO. 4 &#8211; RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS ADICET BIO&#8217;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2021</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:18pt;;text-indent:-18pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CORPORATE_GOVERNANCE"><font style="text-decoration:none;">CORPORATE GOVERNANCE</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#CERTAIN_RELATIONSHIPS_RELATED_PARTY_TRAN"><font style="text-decoration:none;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#PRINCIPAL_STOCKHOLDERS"><font style="text-decoration:none;">PRINCIPAL STOCKHOLDERS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#DELINQUENT"><font style="text-decoration:none;">DELINQUENT SECTION 16(A) REPORTS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#REPORT__AUDIT_COMMITTEE"><font style="text-decoration:none;">REPORT OF THE AUDIT COMMITTEE</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#HOUSEHOLDING"><font style="text-decoration:none;">HOUSEHOLDING</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#STOCKHOLDER_PROPOSALS"><font style="text-decoration:none;">STOCKHOLDER PROPOSALS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#Other_Matters"><font style="text-decoration:none;">OTHER MATTERS</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ANNEXA"><font style="text-decoration:none;">ANNEX A &#8211; AMENDED AND RESTATED 2018 EMPLOYEE STOCK PURCHASE PLAN</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p></td>
</tr>
<tr style="height:14.4pt;">
<td valign="bottom"  style="width:91.5%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="#ANNEXB"><font style="text-decoration:none;">ANNEX B &#8211; AMENDED AND RESTATED 2018 STOCK OPTION AND INCENTIVE PLAN</font></a><font style="text-decoration:none;"></font></p></td>
<td valign="top"  style="width:1.26%;">
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  style="width:7.24%;">
<p style="text-align:center;margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu3c32wcjg3v000002.jpg" title="" alt="" style="width:274px;height:56px;"></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ADICET BIO, INC.</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Boston, Massachusetts 02116</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="PROXY_STATEMENT"></a><a name="PROXY_STATEMENT"></a>PROXY STATEMENT</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">FOR THE 2021 ANNUAL MEETING OF STOCKHOLDERS</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">to be held APRIL 27, 2021</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This proxy statement contains information about the 2021 Annual Meeting of Stockholders, or the Annual Meeting, of Adicet Bio, Inc., which will be held online on April 27, 2021 at 3:00 p.m. Eastern Time. You may attend the Annual Meeting virtually via the Internet at <font style="font-weight:bold;font-style:italic;color:#000000;letter-spacing:0.2pt;">www.virtualshareholdrmeeting.com/ACET2021</font>, where you will be able to vote electronically and submit questions. The board of directors of Adicet Bio, Inc. is using this proxy statement to solicit proxies for use at the Annual Meeting. In this proxy statement, the terms &#8220;Adicet Bio,&#8221; &#8220;Adicet,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Adicet Bio, Inc. The mailing address of our principal executive office is Adicet Bio, Inc., 500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor, Boston, Massachusetts 02116.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the proxies will be voted in accordance with the recommendation of our board of directors with respect to each of the matters set forth in the accompanying Notice of Meeting. You may revoke your proxy at any time before it is exercised at the meeting by giving our corporate secretary written notice to that effect.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This year&#8217;s Annual Meeting will be a virtual meeting of the shareholders conducted via live webcast. All shareholders of record on March 1, 2021 are invited to participate in the meeting. We have structured our virtual meeting to provide shareholders the same rights as if the meeting were held in person, including the ability to vote shares electronically during the meeting and ask questions in accordance with the rules of conduct for the meeting. We encourage you to vote your shares prior to the annual meeting.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We made this proxy statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 available to stockholders on or about March 18, 2021.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are an &#8220;emerging growth company&#8221; under applicable federal securities laws and therefore permitted to conform with certain reduced public company reporting requirements. As an emerging growth company, we provide in this proxy statement the scaled disclosure permitted under the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, including the compensation disclosures required of a &#8220;smaller reporting company,&#8221; as that term is defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended, or the Exchange Act. In addition, as an emerging growth company, we are not required to conduct votes seeking approval, on an advisory basis, of the compensation of our named executive officers or the frequency with which such votes must be conducted. We will remain an &#8220;emerging growth company&#8221; until the earliest of (i)&#160;the last day of the fiscal year following the fifth anniversary of our initial public offering in January 2018; (ii)&#160;the last day of the fiscal year in which our total annual gross revenue is equal to or more than $1.07&#160;billion; (iii)&#160;the date on which we have issued more than $1&#160;billion in nonconvertible debt during the previous three years; or (iv)&#160;the date on which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission. Even after we are no longer an &#8220;emerging growth company,&#8221; we may remain a &#8220;smaller reporting company.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Important Notice Regarding the Availability of Proxy Materials for<br />the Annual Meeting of Stockholders to be Held on April 27, 2021:</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">This proxy statement and our 2020 Annual Report to Stockholders are<br />available for viewing, printing, and downloading at <font style="font-style:italic;">www.proxyvote.com</font>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the Securities and Exchange Commission (SEC), except for exhibits, will be furnished without charge to any stockholder upon written request to Adicet Bio, Inc., 500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor, Boston, Massachusetts 02116, Attention:&nbsp;&nbsp;Corporate Secretary. This proxy statement and our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020 are also available on the SEC&#8217;s website at<font style="font-style:italic;"> www.sec.gov</font>.</p><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ADICET BIO, INC</font></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">PROXY STATEMENT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">FOR THE 2021 ANNUAL MEETING OF STOCKHOLDERS </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">GENERAL INFORMATION </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">When is this proxy statement and the accompanying materials scheduled to be sent to stockholders? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have elected to provide access to our proxy materials to our stockholders via the Internet. Accordingly, on or about March 18, 2021, we will begin mailing a Notice of Internet Availability of Proxy Materials, or Notice. Our proxy materials, including the Notice of the 2021 Annual Meeting of Stockholders, this proxy statement and the accompanying proxy card or, for shares held in street name (i.e., held for your account by a broker or other nominee), a voting instruction form, and the 2020 Annual Report to Stockholders, or 2020 Annual Report, will be mailed or made available to stockholders on the Internet on or about the same date. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Why did I receive a Notice of Internet Availability of Proxy Materials instead of a full set of proxy materials? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to rules adopted by the Securities and Exchange Commission, or SEC, for most stockholders, we are providing access to our proxy materials over the Internet rather than printing and mailing our proxy materials. We believe following this process will expedite the receipt of such materials and will help lower our costs and reduce the environmental impact of our annual meeting materials. Therefore, the Notice was mailed to holders of record and beneficial owners of our common stock starting on or about March 18, 2021. The Notice provides instructions as to how stockholders may access and review our proxy materials, including the Notice of the 2021 Annual Meeting of Stockholders, this proxy statement, the proxy card and our 2020 Annual Report, on the website referred to in the Notice or, alternatively, how to request that a copy of the proxy materials, including a proxy card, be sent to them by mail. The Notice also provides voting instructions. In addition, stockholders of record may request to receive the proxy materials in printed form by mail or electronically by e-mail on an ongoing basis for future stockholder meetings. Please note that, while our proxy materials are available at the website referenced in the Notice, and our Notice of the 2021 Annual Meeting of Stockholders, this proxy statement and our 2020 Annual Report are available on our website, no other information contained on either website is incorporated by reference in or considered to be a part of this proxy statement. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Why are you holding a virtual Annual Meeting?</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The safety of our stockholders is important to us and given the current guidance by public health officials surrounding COVID-19 and group gatherings, this year&#8217;s Annual Meeting will be a &#8220;virtual meeting&#8221; of stockholders. We have implemented the virtual format in order to facilitate stockholder attendance at our Annual Meeting. We have designed our virtual format to enhance, rather than constrain, stockholder access, participation and communication. For example, the virtual format allows stockholders to communicate with us in advance of, and during, the Annual Meeting so they can ask questions of our board of directors or management.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How do I attend and participate in the annual meeting online?</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To attend and participate in the Annual Meeting, stockholders will need to access the live audio webcast of the meeting. To do so, stockholders of record will need to visit <font style="font-weight:bold;font-style:italic;">www.virtualshareholdrmeeting.com/ACET2021</font> and use their control number found on the proxy card or Notice of Internet Availability of Proxy Materials, and beneficial owners of shares held in street name will need to follow the same instructions.&#8203;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk66814613"></a>You will need the 16-digit control number included on your proxy card or Notice of Internet Availability of Proxy Materials, as applicable. Instructions on how to connect to the Annual Meeting and participate via the Internet, including how to demonstrate proof of stock ownership, are posted at <font style="font-weight:bold;font-style:italic;text-decoration:none;color:#000000;">www.virtualshareholdrmeeting.com/ACET2021</font>. <font style="font-weight:bold;">If you do not have your 16-digit control number, you will be able to access and listen to the Annual Meeting but you will not be able to vote your shares or submit questions during the Annual Meeting</font>.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The live audio webcast of the Annual Meeting will begin promptly at 03:00 p.m. Eastern Time. We encourage stockholders to login to this website and access the webcast before the Annual Meeting&#8217;s start time. Online check-in will begin, and stockholders may begin submitting written questions, at 2:45&#160;p.m. Eastern Time, and you should allow ample time for the check-in procedures.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How can I get help if I have trouble checking in or listening to the meeting online?</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual meeting or submitting questions. If you encounter any difficulties accessing the virtual meeting during the check-in or meeting time, please call the technical support number that will be posted on the Virtual Shareholder Meeting log in page.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Who is soliciting my vote? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors is soliciting your vote for the Annual Meeting. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">When is the record date for the Annual Meeting? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The record date for determination of stockholders entitled to vote at the Annual Meeting is the close of business on March 1, 2021. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How many votes can be cast by all stockholders? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were 31,581,277 shares of our common stock, par value $0.0001 per share, outstanding on March 1, 2021, all of which are entitled to vote with respect to all matters to be acted upon at the Annual Meeting of the Stockholders on April 27, 2021, or the Annual Meeting. Each stockholder of record is entitled to one vote for each share of our common stock held by such stockholder. None of our shares of undesignated preferred stock were outstanding as of March 1, 2021. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How do I vote? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you are a stockholder of record, there are several ways for you to vote your shares.</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:9pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-style:italic;color:#000000;">By Internet</font><font style="color:#000000;">.&nbsp;&nbsp;You may vote at www.proxyvote.com, 24 hours a day, seven days a week, by following the instructions at that site for submitting your proxy electronically. You will be required to enter the 16-digit control number provided on your proxy card or voting instruction form. Votes submitted through the Internet prior to the commencement of the Annual Meeting.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:9pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-style:italic;color:#000000;">By Telephone</font><font style="color:#000000;">.&nbsp;&nbsp;You may vote using a touch-tone telephone by calling 1-800-690-6903, 24 hours a day, seven days a week. You will be required to enter the 16-digit control number provided on your proxy card or voting instruction form. Votes submitted by telephone prior to the commencement of the Annual Meeting. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:9pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-style:italic;color:#000000;">By Mail</font><font style="color:#000000;">.&nbsp;&nbsp;If you requested and received a printed copy of the proxy materials, you may vote by mail by completing, signing, and dating the enclosed proxy card and returning it in the enclosed prepaid envelope. Votes submitted through the mail must be received prior to April 26, 2021.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:9pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:9pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-style:italic;color:#000000;">During the Annual Meeting</font><font style="color:#000000;">.&#160; </font><font style="Background-color:#FFFFFF;color:#000000;">If you attend the Annual Meeting online, you may vote your shares online while virtually attending the Annual Meeting by visiting&#160;</font><font style="text-decoration:none;color:#000000;">www.virtualshareholdrmeeting.com/ACET2021</font><font style="color:#000000;">. </font><font style="Background-color:#FFFFFF;color:#000000;">You will need your control number provided on your proxy card or Notice of Internet Availability of Proxy Materials in order to be able to vote during the Annual Meeting.</font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you do not wish to vote in person or will not be attending the Annual Meeting, you may vote by proxy. You can vote by proxy over the Internet by following the instructions provided in the Notice, or, if you requested printed copies of the proxy materials by mail, you can vote by mailing your proxy as described in the proxy materials. In order to be counted, proxies submitted by Internet must be received by the cutoff time of 11:59 p.m. Eastern Time on April 26, 2021. Proxies submitted by mail must be received before the start of the Annual Meeting. If you complete and submit your proxy before the Annual Meeting, the persons named as proxies will vote the shares represented by your proxy in accordance with your instructions. If you submit a proxy without giving voting instructions, your shares will be voted in the manner recommended by the board of directors on all matters presented in this proxy statement, and as the persons named as proxies may determine in their discretion with respect to any other matters properly presented at the Annual Meeting. You may also authorize another person or persons to act for you as proxy in a writing, signed by you or your authorized representative, specifying the details of those proxies&#8217; authority. The original writing must be given to each of the named proxies, although it may be sent to them by electronic transmission if, from that transmission, it can be determined that the transmission was authorized by you. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Even if you plan to participate in our virtual Annual Meeting, we recommend that you also vote by proxy so that your vote will be counted if you later decide not to participate in the Annual Meeting. If you submit a proxy via the Internet, by telephone, or by mail, your voting instructions authorize the proxy holders in the same manner as if you signed, dated, and returned your proxy card.&#160;</font><font style="font-weight:bold;">If you submit a proxy via the Internet</font><font style="font-weight:bold;">,</font><font style="font-weight:bold;"> by telephone</font><font style="font-weight:bold;">, or by mail</font><font style="font-weight:bold;">, you do not need to return your proxy card.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If any other matters are properly presented for consideration at the Annual Meeting, including, among other things, consideration of a motion to adjourn the Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies), the persons named in your proxy and acting thereunder will have discretion to vote on those matters in accordance with their best judgment. We do not currently anticipate that any other matters will be raised at the Annual Meeting. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If you are a street name stockholder, you will receive voting instructions from your broker, bank, or other nominee. You must follow the voting instructions provided by your broker, bank or other nominee in order to instruct your broker, bank or other nominee on how to vote your shares. Street name stockholders should generally be able to vote by returning an instruction card, or by telephone or on the Internet. However, the availability of telephone and Internet voting will depend on the voting process of your broker, bank or other nominee. If you are a street name stockholder, you may not vote your shares on your own behalf at the Annual Meeting unless you obtain a legal proxy from your broker, bank, or other nominee.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How do I revoke my proxy? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may revoke your proxy by (1)&#160;following the instructions on the Notice and entering a new vote by mail that we receive before the start of the Annual Meeting or over the Internet by the cutoff time of 11:59 p.m. Eastern Time on April 26, 2021, (2)&#160;attending and voting at the Annual Meeting (although attendance at the Annual Meeting will not in and of itself revoke a proxy), or (3) by filing an instrument in writing revoking the proxy or another duly executed proxy bearing a later date with our Corporate Secretary. Any written notice of revocation or subsequent proxy card must be received by our Corporate Secretary prior to the taking of the vote at the Annual Meeting. Such written notice of revocation or subsequent proxy card should be hand delivered to our Corporate Secretary or sent to our principal executive offices at Adicet Bio, Inc., 500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor, Boston, Massachusetts 02116, Attention: Corporate Secretary. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a broker, bank, or other nominee holds your shares, you must contact such broker, bank, or nominee in order to find out how to change your vote. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How is a quorum reached? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Amended and Restated Bylaws, or bylaws, provide that a majority of the shares entitled to vote, present in person or represented by proxy, will constitute a quorum for the transaction of business at the Annual Meeting. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the General Corporation Law of the State of Delaware, shares that are voted &#8220;abstain&#8221; or &#8220;withheld&#8221; and broker &#8220;non-votes&#8221; are counted as present for purposes of determining whether a quorum is present at the Annual Meeting. If a quorum is not present, the meeting may be adjourned until a quorum is obtained.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How is the vote counted? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under our bylaws, any proposal other than an election of directors is decided by a majority of the votes properly cast for and against such proposal, except where a larger vote is required by law or by our Third Amended and Restated Certificate of Incorporation, or certificate of incorporation, or bylaws. Abstentions and broker &#8220;non-votes&#8221; are not included in the tabulation of the voting results on any such proposal and, therefore, do not have an impact on such proposals. A broker &#8220;non-vote&#8221; occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item, and has not received instructions from the beneficial owner. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If your shares are held in &#8220;street name&#8221; by a brokerage firm, your brokerage firm is required to vote your shares according to your instructions. If you do not give instructions to your brokerage firm, the brokerage firm will still be able to vote your shares with respect to certain &#8220;discretionary&#8221; items, but will not be allowed to vote your shares with respect to &#8220;non-discretionary&#8221; items. Proposal No. 1, 2 and 3 are &#8220;non-discretionary&#8221; items. If you do not instruct your broker how to vote with respect to these proposals, your broker may not vote for these proposals, and those votes will be counted as broker &#8220;non-votes.&#8221; Proposal No. 4 is considered to be a discretionary item, and your brokerage firm will be able to vote on this proposal even if it does not receive instructions from you.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To be elected, the directors nominated via Proposal No. 1 must receive a plurality of the votes cast and entitled to vote on the proposal, meaning that the director nominees receiving the most votes will be elected. Shares voting &#8220;withheld&#8221; have no effect on the outcome of Proposal No. 1.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To approve the Company&#8217;s Amended and Restated 2018 Employee Stock Purchase Plan (&#8220;2018 ESPP&#8221;) and the Company&#8217;s Amended and Restated 2018 Stock Option and Incentive Plan (&#8220;2018 Plan&#8221;, and together with the 2018 ESPP, the &#8220;2018 Plans&#8221;) via Proposals No. 2 and No. 3, the proposals must receive the affirmative vote of a majority of shares of common stock properly cast and entitled to vote on these proposals. Shares voting &#8220;withheld&#8221; have no effect on the outcome of Proposals No. 2 and No. 3.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;letter-spacing:0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The ratification of the appointment of&nbsp;&nbsp;KPMG LLP as our independent registered public accounting firm for the fiscal year ended December 31, 2021 via Proposal No. 4 requires the <font style="color:#000000;">affirmative vote of a majority of shares of common stock properly cast and entitled to vote on these proposals</font>. Shares voting &#8220;withheld&#8221; have no effect on the outcome of Proposal No. 4.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Who pays the cost for soliciting proxies? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are making this solicitation and will pay the entire cost of preparing and distributing the Notice and our proxy materials and soliciting votes. If you choose to access the proxy materials or vote over the Internet, you are responsible for any Internet access charges that you may incur. Our officers and employees may, without compensation other than their regular compensation, solicit proxies through further mailings, personal conversations, facsimile transmissions, e-mails, or otherwise. We have hired Broadridge Financial Solutions, Inc. to assist us in the distribution of proxy materials and the solicitation of votes described above. Proxy solicitation expenses that we will pay include those for preparation, mailing, returning, and tabulating the proxies. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How may stockholders submit matters for consideration at an annual meeting? </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The required notice must be in writing and received by our corporate secretary at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year&#8217;s annual meeting. However, in the event that the date of the annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding year&#8217;s annual meeting, or if no annual meeting were held in the preceding year, a stockholder&#8217;s notice must be so received no earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (A) the 90th day prior to such annual meeting and (B) the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, any stockholder proposal intended to be included in the proxy statement for the next annual meeting of our stockholders in 2021 must also satisfy the requirements of SEC Rule 14a-8 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and be received not later than November 18, 2021. If<font style="Background-color:#FFFFFF;color:#333333;font-family:Verdana;">&#160;</font>the date of the annual meeting is moved by more than 30 days from the date contemplated at the time of the previous year&#8217;s proxy statement, then notice must be received within a reasonable time before we begin to print and send proxy materials. If that happens, we will publicly announce the deadline for submitting a proposal in a press release or in a document filed with the SEC. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">How can I know the voting results?</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We plan to announce preliminary voting results at the Annual Meeting and will publish final results in a Current Report on Form 8-K to be filed with the SEC within four business days following the Annual Meeting.</p>
<p style="text-align:left;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;text-transform:none;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="PROPOSAL_1"></a><a name="PROPOSAL_1"></a>PROPOSAL NO. 1 &#8211; ELECTION OF CLASS III DIRECTORS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors currently consists of seven members. In accordance with the terms of our certificate of incorporation and bylaws, our board of directors is divided into three classes, class I, class II and class III, with members of each class serving staggered three-year terms. The members of the classes are divided as follows:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">the class I directors are Aya Jakobovits and Chen Schor, and their terms will expire at the annual meeting of stockholders to be held in 2022;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">the class II directors are Carl Gordon, Steve Dubin, and Jeffrey Chodakewitz, and their terms will expire at the annual meeting of stockholders to be held in 2023; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">the class III directors are Bastiano Sanna and Andrew Sinclair, and their terms will expire at the Annual Meeting annual meeting of stockholders to be held in 2021.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon the expiration of the term of a class of directors, directors in that class will be eligible to be elected for a new three-year term at the annual meeting of stockholders in the year in which their term expires.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our certificate of incorporation and bylaws provide that the authorized number of directors may be changed only by resolution of our board of directors. Our certificate of incorporation also provides that our directors may be removed only for cause by the affirmative vote of the holders of at least two-thirds (2/3) of the outstanding shares then entitled to vote in an annual election of directors, and that any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors has nominated Bastiano Sanna and Andrew Sinclair for election as the class III directors at the Annual Meeting. The nominees are presently directors, and have indicated a willingness to continue to serve as directors, if elected. If the nominees become unable or unwilling to serve, however, the proxies may be voted for a substitute nominee selected by our board of directors.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our Nominating and Corporate Governance Committee Policies and Procedures for Director Candidates, or the Director Guidelines, provide that the value of diversity should be considered in determining director candidates as well as other factors such as a candidate&#8217;s character, judgment, skills, education, expertise, and absence of conflicts of interest. Our priority in selection of board members is identification of members who will further the interests of our stockholders through their established records of professional accomplishment, their ability to contribute positively to the collaborative culture among board members, and their knowledge of our business and understanding of the competitive landscape in which we operate and adherence to high ethical standards. <font style="color:#000000;">The Nominating and Corporate Governance Committee does not have a formal&#160;diversity&#160;policy and does not follow any ratio or formula with respect to&#160;diversity&#160;in order to determine the appropriate composition of the Board, although the Nominating and Corporate Governance Committee and the full Board are committed to creating a board of directors with&#160;diversity, including&#160;diversity&#160;of expertise, experience, background and gender, and are committed to identifying, recruiting and advancing candidates offering such&#160;diversity&#160;in future searches</font>. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">In addition to the information presented below regarding each of the nominees and continuing directors&#8217; specific experience, qualifications, attributes and skills that our board of directors and our nominating and corporate governance committee considered in determining that he or she should serve as a director, we also believe that each of our directors has demonstrated business acumen, integrity and an ability to exercise sound judgment, as well as a commitment of service to Adicet Bio and our board of directors</font><font style="color:#000000;">.<sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup></font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Nominees for Election as Class III Directors</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table identifies our director nominees, and sets forth their principal occupation and business experience during the last five years and their ages as of March 15, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.48%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.18%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Positions Held</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">with Adicet Bio</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Director</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Since</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.18%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Age</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.48%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bastiano Sanna, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.82%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Director</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Andrew Sinclair, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Director</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.42%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.66%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><a name="_Hlk66816965"></a>Bastiano Sanna, Ph.D.<font style="font-weight:normal;font-style:normal;"> has served as a member of the Board since December 2020. Dr. Sanna joined Vertex Pharmaceuticals, Inc. (&#8220;Vertex&#8221;) in February 2020 and currently serves as the company&#8217;s Executive Vice President, Chief of Cell and Genetic Therapies. Dr. Sanna was previously the Chief Executive Officer of Semma Therapeutics, Inc. (&#8220;Semma&#8221;) from May 2018 until Semma was acquired by Vertex in February 2020. Prior to Semma, Dr. Sanna was Chief Operating Officer at Magenta Therapeutics, Inc. (&#8220;Magenta&#8221;) from May 2016 until April 2018, where he was responsible for operations, finance, clinical development, and program management. Prior to Magenta, Dr. Sanna served on the leadership team of Novartis International AG&#8217;s (&#8220;Novartis&#8221;) Cell and Gene Therapy Unit as the Global Program Head of Stem Cell Transplant and early programs from 2014 until April 2016, where he oversaw clinical, regulatory, CMC and commercial aspects of programs in bone marrow transplant and CAR-T cell therapies. He also served as Global Head of Strategic Planning and Portfolio Management at the Novartis Institutes for BioMedical Research from 2010 until 2014, where he was responsible for global portfolio management of all Novartis&#8217; research programs, from discovery through Phase II across all disease areas. Dr. Sanna received a Ph.D. in Biotechnology from the University of Sassari. We believe that Dr. Sanna is qualified to serve on our board of directors due to his extensive experience working for various pharmaceutical and biotechnology companies.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Andrew Sinclair, Ph.D.</font><font style="Background-color:#FFFFFF;font-weight:normal;font-style:normal;"> has served as a member of the Adicet Board since March 2021. </font><font style="font-weight:normal;font-style:normal;">Dr. Sinclair is currently a partner and portfolio manager at Abingworth LLP (&#8220;Abingworth&#8221;), a life sciences investment group. He has been at Abingworth since November 2008 where he has served in various positions focusing on investments in public and private biotech and pharmaceutical companies. Dr. Sinclair currently serves on the boards of directors of public companies Soleno Therapeutics Inc., Sierra Oncology, Inc. and Verona Pharma plc. Prior to joining Abingworth, he was senior equity analyst, director, at HSBC Global Markets, where he was responsible for investment research in the mid-cap pharmaceutical sector. Previously, Dr. Sinclair held biotechnology analyst positions at Credit Suisse and SG Cowen. Dr. Sinclair received his B.Sc. in Microbiology from King's College London and his Ph.D. in Chemistry and Genetic Engineering at the BBSRC Institute of Plant Science, Norwich. He is qualified as a chartered accountant with KPMG, LLC. We believe Dr. Sinclair is qualified to serve on our board of directors due to his background in strategic development within the life sciences industry.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Vote Required and Board of Directors&#8217; Recommendation</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The nominees for class III director who receive the most votes (also known as a plurality) will be elected. You may vote either FOR all the nominees, FOR any one of the nominees, WITHHOLD your vote from all the nominees or WITHHOLD your vote from any one of the nominees. Votes that are withheld will not be included in the vote tally for the election of directors. If your shares are held in &#8220;street name&#8221; by a broker, bank or other nominee, your broker, bank or other nominee does not have authority to vote your unvoted shares held by the firm for the election of directors. As a result, any shares not voted by you will be treated as a broker non-vote. Such broker non-votes will have no effect on the results of this vote.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The proxies will be voted in favor of the above nominees unless a contrary specification is made in the proxy. The nominees have consented to serve as our directors if elected. However, if the nominees are unable to serve or for good cause will not serve as a director, the proxies will be voted for the election of such substitute nominee as our board of directors may designate.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">THE BOARD OF DIRECTORS RECOMMENDS VOTING &#8220;FOR&#8221; THE ELECTION OF BASTIANO SANNA AND ANDREW SINCLAIR AS THE CLASS III DIRECTORS, TO SERVE FOR A THREE-YEAR TERM ENDING AT THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD IN 2024.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Directors Continuing in Office</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table identifies our continuing directors, and sets forth their principal occupation and business experience during the last five years and their ages as of March 16, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.16%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.3%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.58%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Position Held with Adicet Bio</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.78%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Position Held Since <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.6%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.62%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Class and Year in Which Term Expires</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Age</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.16%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chen Schor</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.58%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director, President and Chief Executive Officer</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.62%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class I &#8211; 2022</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aya Jakobovits, Ph.D.</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2014</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class I &#8211; 2022</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carl L. Gordon, Ph.D., CFA</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class II &#8211; 2023 </p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steve Dubin, J.D.</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class II &#8211; 2023 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jeffrey Chodakewitz, M.D.</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.3%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Director</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.78%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.62%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Class II &#8211; 2023 </p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.88%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:7pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1) The years set forth below reflect when the director joined the former Adicet Bio, Inc. (&#8220;Former Adicet&#8221;). </p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2) Mr. Schor, Mr. Dubin and Dr. Chodakewitz joined Adicet at the completion of the merger in September 2020.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Class I Directors (Term Expires at 2022 Annual Meeting)</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Chen Schor<font style="font-weight:normal;font-style:normal;"> has served as our President and Chief Executive Officer and as a member of our board of directors since the completion of the merger of resTORbio, Inc. (&#8220;resTORbio&#8221;) and Former Adicet in September 2020. Previously, he held the role of director, President and Chief Executive Officer at resTORbio since co-founding the company in 2016. Mr.&#160;Schor previously served as President, Chief Executive Officer and director of Synta Pharmaceuticals Corp. from May 2015 until its merger with Madrigal Pharmaceuticals in July 2016, and prior to that, from 2014 until 2016, Mr.&#160;Schor served as the company&#8217;s Executive Vice President and Chief Operation Officer. From September 2012 to December 2014, Mr.&#160;Schor served as President and Chief Executive Officer of Novalere FP, Inc., a pre-commercial stage allergy therapeutics company. From September 2011 to October 2012, Mr.&#160;Schor served as Chief Business Officer of Eleven Biotherapeutics, an emerging therapeutics company. From March 2009 until September 2011, Mr.&#160;Schor served as Vice President of Business Development, global branded products at Teva Pharmaceutical Industries Limited. Mr.&#160;Schor currently serves on the board of Karyopharm Therapeutics Inc., a public biotechnology company. Mr.&#160;Schor received his M.B.A. from Tel Aviv University, a B.A. in Economics and Accounting from Haifa University and a B.A. in Biology from Tel Aviv University. We believe that Mr.&#160;Schor is qualified to serve on our board of directors due to his service as our President and Chief Executive Officer and his extensive knowledge of our company and industry.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Aya Jakobovits, Ph.D.</font><font style="font-weight:normal;font-style:normal;color:#000000;"> has served as a member of our board of directors since the completion of the merger of resTORbio and Former Adicet in September 2020 and previously served as a member of the board of directors of Former Adicet since November 2014. Dr. Jakobovits founded Former Adicet and served as President and Chief Executive Officer from its incorporation until February 2018. From February 2018 until February 2019, Dr. Jakobovits served as a senior strategic advisor to Former Adicet. Prior to starting Former Adicet, Dr. Jakobovits served as a Venture Partner with OrbiMed Advisors from 2011 to 2016. From September 2010 to December 2013, she served as President and Founding Chief Executive Officer of Kite Pharma Inc. From December 2007 to June 2010, she served as Executive Vice President, Head of Research and Development at Agensys Inc., an affiliate of Astellas Pharma, Inc. Before Agensys&#8217; acquisition by Astellas, she served as Agensys&#8217; Senior Vice President, Technology and Corporate Development and Chief Scientific Officer and led its research, development, clinical and corporate development operations from January 1999 to December 2007. Before Agensys, from 1996 to 1999, Dr. Jakobovits served as Director, Discovery Research and Principal Scientist at Abgenix Inc. which was spun out of Cell Genesys, Inc. in 1996 based on the XenoMouse&#174; technology developed under her leadership. She joined Cell Genesys in 1989 and served ultimately as Director, Molecular Immunology. Dr. Jakobovits currently serves on the boards of directors of Dorian Therapeutics Inc., Yeda Research and Development Co. Ltd., and the UCLA Technology Development Corporation. Dr. Jakobovits previously served on the boards of directors of cCAM therapeutics Ltd. from 2013 to 2015 and the Alliance for Cancer Gene Therapy from 2015 to 2019. Dr. Jakobovits received her B.Sc. from the Hebrew University of Jerusalem, her M.Sc. in Chemistry and Ph.D. in Life Sciences from the Weizmann Institute of Sciences, Israel, and was a postdoctoral fellow at University of California, San Francisco and at Genentech, Inc. We believe Dr. Jakobovits is qualified to serve on the Board because of her expertise, experience, and track record in forming and growing successful companies and in developing immunotherapy platform technologies and oncology products.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Class I</font><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">I</font><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> Directors (Term Expires at 202</font><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">3</font><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> Annual Meeting)</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Carl L. Gordon, Ph.D, CFA.</font><font style="font-weight:normal;font-style:normal;color:#000000;"> has served as a member of our board of directors since the completion of the merger of resTORbio and Former Adicet in September 2020 and previously served as a member of the board of directors of Former Adicet since August 2015. Dr. Gordon is a founding member, Managing Partner, and Co-Head of Global Private Equity at OrbiMed Advisors LLC, an investment firm. Dr. Gordon currently serves on the boards of directors of Keros Therapeutics, Inc., ORIC Pharmaceuticals, Inc., and several private companies. Dr. Gordon previously served on the boards of directors of Alector, Inc., X4 Pharmaceuticals, Inc. (formerly Arsanis, Inc.), Acceleron Pharma Inc., ARMO Biosciences, Inc., Intellia Therapeutics, Inc. Selecta Biosciences, Inc., Passage Bio, Inc., and SpringWorks Therapeutics Inc. Dr. Gordon received a B.A. in Chemistry from Harvard College and a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology and was a Fellow at The Rockefeller University. We believe Dr. Gordon is qualified to serve as the initial Chairperson of the Board because of his venture capital experience, expertise in the scientific field of molecular biology and financial credentials.</font></p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Steve Dubin, J.D.</font><font style="font-weight:normal;font-style:normal;color:#000000;"> has served as a member of our board of directors since the completion of the merger of resTORbio and Former Adicet in September 2020. Since November 2011, Mr. Dubin has been a Principal in SDA Ventures LLC, a firm focused on assisting emerging growth and middle-market companies, primarily in the health &amp; wellness and nutritional products markets, on matters including corporate development, business acquisition, customer relations, growth strategies and corporate finance. In connection with SDA Ventures LLC, Mr. Dubin acts as a Senior Advisor to Paine Schwartz Partners, LLC, a global private equity investment firm located in New York, and San Mateo, for the purpose of identifying and executing investment opportunities in the global human and animal food and nutritional products industries. From 2006 until its acquisition by Royal DSM N.V. in February 2011, Mr. Dubin served as Chief Executive Officer and a member of the board of directors of Martek Biosciences Corporation. He later served as President of DSM&#8217;s Nutritional Lipids Division from February 2011 through October 2011 and as a Senior Advisor to DSM Nutritional Products from November 2011 through October 2012. After joining Martek in 1992 and serving in various management positions, including Chief Financial Officer, Treasurer, Secretary, General Counsel and Senior Vice President, Business Development, he served as President of Martek from 2003 to 2006. Mr. Dubin currently serves as a member of the board of directors of privately held companies Alcresta Therapeutics, Inc., The UCAN Company, Triton Algae Innovations, Ltd. and Phytolon LTD. From January 2014 to January 2018, Mr. Dubin served on the board of directors of Enzymotec Ltd. Mr. Dubin is a certified public accountant and a member of the Maryland Bar. He holds a bachelor&#8217;s degree in accounting from the University of Maryland and a J.D. from the National Law Center at George Washington University. We believe Mr. Dubin is qualified to serve on the Board because of his accounting experience and extensive experience working with emerging growth and middle-market companies.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Jeffrey Chodakewitz, M.D.<font style="font-weight:normal;font-style:normal;"> has served as a member of our board of directors since the completion of the merger of resTORbio and Former Adicet in September 2020 and previously served as a member of the board of directors of resTORbio since August 2018. From April 2018 through March 2019, Dr. Chodakewitz served as Executive Vice President, Clinical Medicine and External Innovation, at Vertex. Prior to that role, Dr. Chodakewitz held the roles of Chief Medical Officer and Executive Vice President, Global Medicines Development and Medical Affairs at Vertex from January 2014 to April 2018 and was a member of the Vertex Executive Committee. Prior to joining Vertex in January 2014, he spent over 20 years at Merck &amp; Co., where he served in a number of positions including Head of Infectious Diseases and Vaccines Global Development from August 2013 to December 2013, Senior Vice President of Global Scientific Strategy (Infectious Disease, Respiratory &amp; Immunology) from January 2013 to August 2013 and Senior Vice President of Late Stage Development from March 2011 to January 2013. Dr. Chodakewitz is a Diplomate of the National Board of Medical Examiners and the American Board of Internal Medicine (both Internal Medicine and Infectious Disease). Dr. Chodakewitz currently serves as a member of the board of directors of public companies Schrodinger, Inc. and Freeline Therapeutics Holdings plc., and previously served on the board of public company Tetraphase Pharmaceuticals Inc., which was acquired by La Jolla Pharmaceutical Company in July 2020. He holds a B.S in Biochemistry cum laude from Yale University and an M.D. from the Yale University School of Medicine. We believe Dr. Chodakewitz is qualified to serve on the Board because of his extensive experience working for various pharmaceutical and biotechnology companies.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no family relationships between or among any of our directors or executive officers. The principal occupation and employment during the past five years of each of our directors was carried on, in each case except as specifically identified in this proxy statement, with a corporation or organization that is not a parent, subsidiary or other affiliate of us. There is no arrangement or understanding between any of our directors and any other person or persons pursuant to which he or she is to be selected as a director.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no material legal proceedings to which any of our directors is a party adverse to us or any of our subsidiaries or in which any such person has a material interest adverse to us or our subsidiary.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Executive Officers Who Are Not Directors</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table identifies our executive officers who are not directors, and sets forth their current positions at Adicet Bio and their ages as of March 16, 2021.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:90%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.32%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Positions Held with Adicet Bio</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.74%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Officer Since</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.36%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Age</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stewart Abbot, Ph.D.</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.32%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Scientific and Operating Officer</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.74%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Francesco Galimi, M.D., Ph.D.</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Medical Officer</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.74%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrie Krehlik</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Human Resource Officer</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.74%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nick Harvey</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.74%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.9%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Don Healey, Ph.D.</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Technology Officer</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.74%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.36%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.9%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:8pt;">&nbsp;</p>
<p style="margin-top:2pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You should refer to &#8220;<font style="font-style:italic;">Class&#160;I Directors</font>&#8221; above for information about our Chief Executive Officer and President, Chen Schor. Biographical information for our other executive officers, as of March 15, 2021, is set forth below. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Stewart Abbot, Ph.D. </font><font style="font-weight:normal;font-style:normal;color:#000000;">has served as our Senior Vice President, Chief Scientific Officer and Chief Operating Officer since the completion of the merger of resTORbio and Former Adicet in September 2020 and previously served as Senior Vice President, Chief Scientific Officer and Chief Operating Officer of Former Adicet since July 2018. From July 2015 to June 2018, Dr. Abbot served as the Vice President of Translational Research and Chief Development Officer of Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company developing cellular immunotherapies for cancer and immune disorders. From June 2007 to July 2015, Dr. Abbot held multiple positions at Celgene Cellular Therapeutics, where he assisted with various cell therapy research and development programs. From October 2003 to June 2007, Dr. Abbot held various positions at GE Healthcare Biosciences and GE Global Research. Dr. Abbot received a B.Sc. in Biological Sciences from Edinburgh University, a M.Sc. in Biomedical Engineering from the University of Strathclyde, and a Ph.D. in Cell Biology and Pathology from the University of London.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><a name="_Hlk66817038"></a><font style="Background-color:#FFFFFF;">Francesco Galimi, M.D., Ph.D.</font><font style="font-weight:normal;font-style:normal;color:#000000;"> has served as our Chief Medical Officer since the completion of the merger of resTORbio and Former Adicet in September 2020 and previously served as Chief Medical Officer of Former Adicet since September 2019. Prior to Adicet, Dr. Galimi worked at Amgen Inc., where he served as Global Program General Manager, Early Development from August 2015 to September 2019. During his tenure at Amgen, he was responsible for the cross-functional strategy and execution of a portfolio of oncology programs, from pre-IND to late-stage. From November 2014 to August 2015, Dr. Galimi was the Head of Clinical Development at Onyx Pharmaceuticals Inc., where he led the Oncology Clinical Development Group. From 2011 to 2014 he served in leadership roles at the Genomics Institute of the Novartis Research Foundation, leading the early development of a portfolio of oncology programs. Dr. Galimi holds a M.D. from the University of Torino Medical School with a specialty certification in Medical Oncology, and a Ph.D. from the University of Torino Medical School.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Carrie Krehlik </font><font style="font-weight:normal;font-style:normal;color:#000000;">has served as our Chief Human Resource Officer since the completion of the merger of resTORbio and Former Adicet in September 2020 and previously served as Chief Human Resource Officer of Former Adicet since November 2017. From July 2016 to November 2017, Ms. Krehlik served as a consultant to Blue Beyond Consulting. From July 2015 to June 2016, Ms. Krehlik served as the Vice President of Human Resources of ZS Pharma, Inc., a biopharmaceutical company developing therapies for ion imbalances. From December 2012 to March 2015, Ms. Krehlik served as the Vice President of Human Resources at InterMune, a biopharmaceutical company developing and commercializing therapies in pulmonology and orphan fibrotic diseases. Ms. Krehlik received a B.Sc. in Organizational Behavior from Miami University, and an MBA in International Business from San Francisco State University.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Nick Harvey</font><font style="font-weight:normal;font-style:normal;color:#000000;"> has served as our Chief Financial Officer since the completion of the merger of resTORbio and Former Adicet in September 2020. Previously, he served as the Chief Financial Officer since July 2018 and the Executive Vice President and Treasurer since October 2018 of Centrexion Therapeutics Corporation until December 2019, then as Senior Advisor through January 2020. From June 2017 through June 2018, he served as an independent consultant to private and public life science companies. Prior to that, Mr. Harvey served as the Chief Financial Officer of Radius Health Inc. from December 2006 to May 2017. Mr. Harvey received a Bachelor of Economics degree and a Bachelor of Laws degree with first-class honors from the Australian National University and an M.B.A. from the Harvard Business School.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Don Healey, Ph.D.</font><font style="font-weight:normal;font-style:normal;color:#000000;"> has served as our Chief Technology Officer since October 2020. From February 2017 to October 2020, Dr. Healey served as the Senior Vice President, Operations and Site Head for KBI Biopharma, Inc., a biopharmaceutical contract services organization. From April 2010 to February 2017, Dr. Healey held multiple roles at Opexa Therapeutics, Inc. (&#8220;Opexa&#8221;) where he was responsible for all pre-clinical scientific development, closed-system process design and the scaling of Opexa&#8217;s autologous T-cell immunotherapy. From March 2001 to April 2010, Dr. Healey held various positions at Argos Therapeutics, Inc. and ML Laboratories, UK, (formerly Cobra Biotherapeutics). Dr. Healey received his Ph.D. from University of London, and holds a B.Sc. in Cellular Pathology from Bristol University.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The principal occupation and employment during the past five years of each of our executive officers was carried on, in each case except as specifically identified in this proxy statement, with a corporation or organization that is not a parent, subsidiary or other affiliate of us. There is no arrangement or understanding between any of our executive officers and any other person or persons pursuant to which he was or is to be selected as an executive officer.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no material legal proceedings to which any of our executive officers is a party adverse to us or our subsidiary or in which any such person has a material interest adverse to us or our subsidiary.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="PROPOSAL_2"></a>PROPOSAL NO. 2 &#8211;<a name="PROPOSAL_2"></a> To amend and restate the Company&#8217;s 2018 Employee Stock Purchase Plan</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Proposal</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 2, 2021, upon the recommendation of the compensation committee of our board of directors (referred to as the &#8220;compensation committee&#8221;), our board of directors approved the amendment and restatement of the 2018 Employee Stock Purchase Plan (as amended and restated, referred to as the &#8220;2018 ESPP&#8221;), subject to approval by our stockholders at the Annual Meeting.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 1, 2021 (the &#8220;Record Date&#8221;), a total of 31,581,277 shares of our common stock were outstanding. The 2018 ESPP share reserve will represent approximately 1.7% of the total number of shares of our common stock outstanding as of the Record Date.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 ESPP permits eligible employees to purchase shares of our common stock through payroll deductions at 85% of the fair market value of the common stock as of the applicable grant date or exercise date, whichever is lower. As of March 16, 2021, there were 209,135 shares available for future awards under the 2018 ESPP as in effect prior to its amendment and restatement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based solely on the closing price of our common stock as reported by NASDAQ on March 16, 2021, which was $15.78, a<font style="Background-color:#FFFFFF;color:#000000;">nd the maximum number of shares that would have been available for awards as of such date under the 2018 ESPP, as amended and restated, the maximum aggregate market value of the common stock that could potentially be issued under the 2018 ESPP, as amended and restated, is $</font>8,280,950.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors is submitting the 2018 ESPP for approval by our stockholders and has specifically conditioned its effectiveness on such approval. If our stockholders do not approve the 2018 ESPP, the 2018 ESPP as in effect prior to its amendment will remain in effect. In such event, our board of directors will consider whether to adopt alternative arrangements based on its assessment of our needs.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Our Board believes that the adoption of the 2018 ESPP is in the best interests of our company and our stockholders and recommends a vote &#8220;FOR&#8221; this proposal.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Summary of Material Features of the 2018 ESPP</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following description of certain provisions of the 2018 ESPP is intended to be a summary only. The summary is qualified in its entirety by the full text of the 2018 ESPP, a copy of which is attached hereto as Annex A<font style="font-weight:bold;"> </font>and is incorporated herein by reference.&nbsp;&nbsp;The 2018 ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423(b) of the Code.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Shares Subject to the Plan.&nbsp;&nbsp;<font style="font-style:normal;">If this Proposal 2 is approved by our stockholders, the 2018 ESPP reserves and authorizes the issuance of up to a total of 524,775 shares of common stock to participating employees. The 2018 ESPP provides that the number of shares reserved and available for issuance will automatically increase each January 1, beginning on January 1, 2022 and each January 1 thereafter through January 1, 2028, by the least of (i) 1% of the outstanding number of shares of our common stock on the immediately preceding December 31; (ii)&#160;1,262,560&#160;shares or (iii)&#160;such number of shares as determined by the compensation committee. The number of shares reserved under the 2018 ESPP is subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Plan Administration<font style="font-style:normal;">. The 2018 ESPP will be administered by the compensation committee, which will have full authority to make, administer and interpret such rules and regulations regarding the 2018 ESPP as it deems advisable. The compensation committee has authority at any time to: (i) adopt, alter and repeal such rules, guidelines and practices for the administration of the 2018 ESPP and for its own acts and proceedings as it shall deem advisable; (ii) interpret the terms and provisions of the 2018 ESPP; (iii) make all determinations it deems advisable for the administration of the 2018 ESPP; (iv) decide all disputes arising in connection with the 2018 ESPP; and (v) otherwise supervise the administration of the 2018 ESPP. All interpretations and decisions of the compensation committee shall be binding on all persons.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Eligibility.&nbsp;&nbsp;</font><font style="font-style:normal;">All employees who have completed at least three months of employment and whose customary employment is for more than 20 hours per week are eligible to participate in the 2018 ESPP. However, any employee who owns 5% or more of the total combined voting power or value of all classes of stock is not eligible to purchase shares under the 2018 ESPP.&nbsp;&nbsp;</font><font style="font-style:normal;">No person who owns or holds, or </font><font style="font-style:normal;">as a result of</font><font style="font-style:normal;"> participation in the 2018 ESPP would own or hold, common stock or options to purchase common stock, that together equal to 5% or more of total outstanding common stock is entitled to participate in the 2018 ESPP.&nbsp;&nbsp;As of</font><font style="font-style:normal;"> March 1</font><font style="font-style:normal;">6</font><font style="font-style:normal;">, 2021, there are approximately </font><font style="font-style:normal;">8</font><font style="font-style:normal;">1</font><font style="font-style:normal;"> employees who would be eligible to participate in the ESPP. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Offering Periods.&nbsp;&nbsp;<font style="font-style:normal;">We will make one or more offerings each year to our employees to purchase shares under the 2018 ESPP. Unless otherwise determined by the compensation committee, offerings will usually begin on each January 1 and July 1 and will continue for&#160;six-month&#160;periods, referred to as offering periods.&nbsp;&nbsp;The compensation committee may, in its discretion, designate a different period for any offering, provided that no offering period shall exceed one year in duration or overlap any other offering period.&nbsp;&nbsp;</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Participation; Payroll Deductions.&nbsp;&nbsp;<font style="font-style:normal;">Participation in the 2018 ESPP is voluntary. Each eligible employee may elect to participate in any offering by submitting an enrollment form at least 15 business days before the relevant offering date (or by such other deadline as specified by the compensation committee).&nbsp;&nbsp;Each eligible employee who is a participant in the 2018 ESPP may purchase shares by authorizing payroll deductions of up to 15% of his or her base compensation during an offering period. Unless the participating employee has previously withdrawn from the offering, his or her accumulated payroll deductions will be used to purchase shares on the last business day of the offering period, or the exercise date.&nbsp;&nbsp; The maximum number of shares of common stock a participant may purchase will equal the lowest of (a)&#160;a number of shares of common stock determined by dividing such participant&#8217;s accumulated payroll deductions on such date by the applicable exercise price, (b)&#160;</font><font style="color:#000000;font-style:normal;">a number of shares determined by dividing $25,000 by the fair market value of our common stock on the first day of the offering</font><font style="font-style:normal;">; or (c) such other lesser maximum number of shares as shall have been established by the compensation committee in advance of the offering period (subject to certain additional limitations).Under applicable tax rules, an employee may purchase no more than $25,000 worth of shares of common stock, valued at the start of the purchase period, under the 2018 ESPP in any calendar year.&nbsp;&nbsp;Any amount remaining in a participant&#8217;s account at the end of an offering period solely by reason of the inability to purchase a fractional share will be carried forward to the next offering period; any other balance remaining in a participant&#8217;s account at the end of an offering period will be refunded to the participant promptly. The accumulated payroll deductions of any employee who is not a participant on the last day of an offering period will be refunded. An employee&#8217;s rights under the 2018 ESPP terminate upon voluntary withdrawal from the plan or when the employee ceases employment with us for any reason.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Exercise Price.&nbsp;&nbsp;<font style="font-style:normal;">On the exercise date of each offering period, the participant is deemed to have exercised the option, at the exercise price, to the extent of accumulated payroll deductions.&nbsp;&nbsp;The option exercise price is equal to 85% of the fair market value of the shares on the first business day or the last business day of the offering period, whichever is lower.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Terms of Participation<font style="font-style:normal;">. Except as may be permitted by the compensation committee in advance of an offering, a participant may not increase or decrease the amount of his or her payroll deductions during any offering period but may increase or decrease his or her payroll deduction with respect to the next offering period by filing a new enrollment form </font><font style="color:#000000;font-style:normal;">at least 15 business days before the next offering (or by such other deadline as specified by the compensation committee)</font><font style="font-style:normal;">. A participant may withdraw from an offering period at any time without affecting his or her eligibility to participate in future offering periods. If a participant withdraws from an offering period, that participant may not again participate in the same offering period, but may enroll in subsequent offering periods. A participant&#8217;s withdrawal will be effective as of the business day following the participant&#8217;s delivery of written notice of withdrawal under the 2018 ESPP. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Amendments and Termination.&nbsp;&nbsp;<font style="font-style:normal;">The 2018 ESPP may be terminated or amended by our board of directors at any time. An amendment that increases the number of shares of common stock authorized under the ESPP and certain other amendments require the approval of our stockholders. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Rationale for Share Increase and Evergreen Provision</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Approval of the 2018 ESPP will allow us to provide our employees (which may include employees of our subsidiaries) with the opportunity to acquire an ownership interest in us through their participation in the ESPP, thereby encouraging them to remain in our service and more closely aligning their interests with those of our stockholders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">New Plan Benefits</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since<font style="color:#231F20;"> participation in the 2018 ESPP is voluntary, the benefits or amounts that will be received by or allocated to any individual or group of individuals under the 2018 ESPP in the future are not determinable.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#231F20;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;color:#231F20;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Summary of Federal Income Tax Consequences </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the principal federal tax consequences of certain transactions under the 2018 ESPP.&nbsp;&nbsp;It does not describe all federal tax consequences under the 2018 ESPP, nor does it describe state or local tax consequences.&nbsp;&nbsp;The 2018 ESPP, and the rights of participating employees to make purchases thereunder, qualify for treatment under the provisions of Sections 421 and 423 of the Internal Revenue Code. Under these provisions, a participant recognizes no taxable income either as a result of participation in the 2018 ESPP or upon exercise of an option to purchase shares of our common stock under the terms of the 2018 ESPP. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a participant disposes of shares purchased upon exercise of an option granted under the 2018 ESPP within two years from the first day of the applicable offering period or within one year from the exercise date, which we refer to as a &#8220;<font style="color:#000000;">disqualifying</font> disposition,&#8221; the participant will realize ordinary income in the year of that disposition equal to the amount by which the fair market value of the shares on the date the shares were purchased exceeds the purchase price. The amount of ordinary income will be added to the participant&#8217;s basis in the shares, and any additional gain or resulting loss recognized on the disposition of the shares will be a capital gain or loss. A capital gain or loss will be long-term if the participant&#8217;s holding period is more than 12 months, or short-term if the participant&#8217;s holding period is 12 months or less. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the <font style="color:#000000;">participant</font> disposes of shares purchased upon exercise of an option granted under the 2018 ESPP at least two years after the first day of the applicable offering period and at least one year after the exercise date, the participant will realize ordinary income in the year of disposition equal to the lesser of (1) 15% of the fair market value of the common stock on the first day of the offering period in which the shares were purchased and (2)&#160;the excess of the amount actually received for the common stock over the amount paid. The amount of any ordinary income will be added to the participant&#8217;s basis in the shares, and any additional gain recognized upon the disposition after that basis adjustment will be a long-term capital gain. If the fair market value of the shares on the date of disposition is less than the exercise price, there will be no ordinary income and any loss recognized will be a long-term capital loss. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Vote Required; Recommendation of the Adicet Bio Board</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<font style="color:#000000;"> affirmative vote of a majority of shares of common stock present in person or represented by proxy at the Annual Meeting and entitled to vote on this proposal is required for the approval of the Amended and Restated 2018 Employee Stock Purchase Plan.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;<font style="font-style:italic;">FOR</font>&#8221; THE APPROVAL OF THE AMENDED AND RESTATED 2018 EMPLOYEE STOCK PURCHASE PLAN</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="PROPOSAL_3"></a><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman Bold;text-transform:uppercase;"><a name="PROPOSAL_3"></a>PROPOSAL NO</font><font style="font-weight:bold;font-family:Times New Roman Bold;text-transform:uppercase;">. 3 &#8211; To amend and restate the Company&#8217;s 2018 Stock Incentive Plan</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors believes that stock-based incentive awards can play an important role in the success of the Company by encouraging and enabling the employees, officers, non-employee directors and consultants of Adicet Bio and its subsidiaries upon whose judgment, initiative and efforts we largely depend for the successful conduct of its business, to acquire a proprietary interest in the Company. Our board of directors believes that providing such persons with a direct stake in Adicet Bio assures a closer identification of the interests of such individuals with those of the Company and its stockholders, thereby stimulating their efforts on Adicet Bio&#8217;s behalf and strengthening their desire to remain with the Company.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 2, 2021, upon the recommendation of the compensation committee, the Board approved an amendment and restatement of the 2018 Stock Option and Incentive Plan (as amended and restated, referred to as the &#8220;2018 Plan&#8221;), subject to stockholder approval, to, among other things, increase the aggregate number of shares authorized for issuance under the 2018 Plan by 1,500,000 shares, plus on January 1, 2022 and each January 1, thereafter, the number of shares authorized for issuance shall be increased by the lesser of 5% of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31, or such lesser number as determined by the compensation committee. This amendment was designed to enhance the flexibility of the compensation committee in granting stock options and other awards to the Company&#8217;s employees, non-employee directors and other key persons and to ensure that Adicet Bio can continue to grant stock options and other awards to such persons at levels determined to be appropriate by the compensation committee. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of March 16, 2021, there were stock options to acquire 4,768,980 shares of common stock outstanding under Adicet Bio&#8217;s equity compensation plans, with a weighted average exercise price of $12.79. I<font style="Background-color:#FFFFFF;color:#000000;">n addition, as of March 16, 2021 there were no full value awards outstanding under Adicet Bio&#8217;s equity compensation plans. </font>As of March&#160;16, 2021, there were 1,072,657&#160;shares of common stock available for awards under Adicet Bio&#8217;s equity compensation plans.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Summary of Material Features of the Adicet Bio 2018 Plan</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If this Proposal 3 is approved by our stockholders, the material features of the 2018 Plan, as amended and restated, are:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The maximum number of shares of common stock to be issued under the 2018 Plan is 5,136,003; thereafter, such maximum number shall be increased on January 1, 2022 and on each January 1 thereafter by the lesser of an amount as determined by the Compensation Committee or 5% of the number of shares of stock issued and outstanding on the immediately preceding December 31 (the &#8220;Annual Increase&#8221;);</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The maximum number of shares of common stock that be issued under the 2018 Plan as incentive stock options is 5,136,003, as increased on January 1, 2022 and each January 1 thereafter by the lesser of the Annual Increase or 3,150,000 shares of common stock.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">All full-time and part-time officers, employees, non-employee directors and consultants are eligible to participate in the Adicet Bio 2018 Plan, subject to the discretion of the administrator</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The award of stock options (both incentive and non-qualified options), stock appreciation rights, restricted stock, restricted stock units, unrestricted stock, cash-based awards, and dividend equivalent rights is permitted;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Shares reacquired on the open market will not be added to the reserved pool under the 2018 Plan;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Stock options and stock appreciation rights will not be repriced in any manner without stockholder approval;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The value of all awards awarded under the 2018 Plan and all other cash compensation paid by Adicet Bio to any non-employee director in any calendar year may not exceed $1,000,000;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">To the extent required by NASDAQ, any material amendment to the 2018 Plan is subject to approval by Adicet Bio stockholders: and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The term of the 2018 Plan will expire on April 27, 2031.</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"></p></td></tr></table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based solely on the closing price of our common stock as reported by Nasdaq on March 16, 2021, which was $15.78, and the maximum number of shares that would have been available for awards as of such date under the 2018 Plan, as amended and restated, the maximum aggregate market value of the common stock that could potentially be issued under the 2018 Plan, as amended and restated, is $16,926,527. The shares of common stock underlying any awards that are forfeited, canceled, held back upon exercise of an option or settlement of an award to cover the exercise price or tax withholding, reacquired by Adicet Bio prior to vesting, satisfied without the issuance of common stock or otherwise terminated, other than by exercise, under the 2018 Plan and Adicet Bio&#8217;s 2015 Stock Incentive Plan referred to as the &#8220;2015 Plan&#8221;) will be added back to the shares of common stock available for issuance under the 2018 Plan and 2015 Plan, respectively. Shares of common stock repurchased on the open market will not be added back to the shares of common stock available for issuance under the 2018 Plan or 2015 Plan.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Rationale for Share Increase and Evergreen Provision</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan is critical to Adicet Bio&#8217;s ongoing effort to build stockholder value following the merger. Equity incentive awards are an important component of Adicet Bio&#8217;s executive and non-executive employees&#8217; compensation. Adicet Bio&#8217;s compensation committee and the board of directors believe that Adicet Bio must continue to offer a competitive equity compensation program in order to attract, retain and motivate the talented and qualified employees necessary for continued growth and success.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adicet Bio manages its long-term stockholder dilution by limiting the number of equity incentive awards granted annually. The compensation committee carefully monitors Adicet Bio&#8217;s annual net burn rate, total dilution and equity expense in order to maximize stockholder value by granting only the number of equity incentive awards that it believes are necessary and appropriate to attract, reward and retain Adicet Bio&#8217;s employees. Adicet Bio&#8217;s compensation philosophy reflects broad-based eligibility for equity incentive awards for high performing employees. By doing so, Adicet Bio links the interests of those employees with those of the Adicet Bio stockholders and motivate its employees to act as owners of the business.</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk46402660"></a>Summary of the 2018 Plan </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following description of certain provisions of the 2018 Plan is intended to be a summary only. The summary is qualified in its entirety by the full text of the 2018 Plan, a copy of which is attached hereto as Annex B<font style="font-weight:bold;"> </font>and is incorporated herein by reference.&nbsp;&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Administration</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan will be administered by the compensation committee. The compensation committee has full power to select from among the individuals eligible for awards, the individuals to whom awards will be granted, to make any combination of awards to participants, and to determine the specific terms and conditions of each award, subject to the provisions of the 2018 Plan. The compensation committee may delegate to the chief executive officer or one or more executive officers the authority to grant awards to employees who are not subject to the reporting and other provisions of Section&#160;16 of the Securities Exchange Act, subject to certain limitations and guidelines. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Eligibility; Plan Limits</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All full-time and part-time officers, employees, non-employee directors and consultants are eligible to participate in the 2018 Plan, subject to the discretion of the administrator. As of March 16, 2021, approximately 108 individuals were eligible to participate in the 2018 Plan, which includes 6 executive officers, 76 employees who are not executive officers, 6 non-employee directors and 20 consultants. There are certain limits on the number of awards that may be granted under the 2018 Plan. For example, no more than 5,136,003 shares of common stock (as increased each year by the Annual Increase and subject in each case to adjustment for stock splits and similar events) may be granted in the form of incentive stock options. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Director Compensation Limit</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan provides that the value of all awards awarded under the 2018 Plan and all other cash compensation paid by the Company to any non-employee director in any calendar year shall not exceed $1,000,000.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Options</font><font style="font-style:normal;"> </font></p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan permits the granting of (1)&#160;options to purchase common stock intended to qualify as incentive stock options under Section&#160;422 of the Code and (2)&#160;options that do not so qualify. Options granted under the 2018 Plan will be non-qualified options if they fail to qualify as incentive options or exceed the annual limit on incentive stock options. Incentive stock options may only be granted to employees of the Company and its subsidiaries. Non-qualified options may be granted to any persons eligible to receive incentive options and to non-employee directors and consultants. The option exercise price of each option will be determined by the Compensation Committee but may not be less than 100% of the fair market value of the common stock on the date of grant. Fair market value for this purpose will be determined by reference to the price of the shares of common stock on Nasdaq. The exercise price of an option may not be reduced after the date of the option grant without stockholder approval, other than to appropriately reflect changes in our capital structure. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term of each option will be fixed by the compensation committee and may not exceed ten years from the date of grant. The compensation committee will determine at what time or times each option may be exercised. Options may be made exercisable in installments and the exercisability of options may be accelerated by the compensation committee. In general, unless otherwise permitted by the compensation committee, no option granted under the 2018 Plan is transferable by the optionee other than by will or by the laws of descent and distribution or pursuant to a domestic relations order, and options may be exercised during the optionee&#8217;s lifetime only by the optionee, or by the optionee&#8217;s legal representative or guardian in the case of the optionee&#8217;s incapacity. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon exercise of options, the option exercise price must be paid in full either in cash, by certified or bank check or other instrument acceptable to the compensation committee or by delivery (or attestation to the ownership) of shares of common stock that are beneficially owned by the optionee and that are not subject to risk of forfeiture. Subject to applicable law, the exercise price may also be delivered to the Company by a broker pursuant to irrevocable instructions to the broker from the optionee. In addition, non-qualified options may be exercised using a net exercise feature which reduces the number of shares issued to the optionee by the number of shares with a fair market value equal to the exercise price. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To qualify as incentive options, options must meet additional federal tax requirements, including a $100,000 limit on the value of shares subject to incentive options that first become exercisable by a participant in any one calendar year. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Appreciation Rights</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation committee may award stock appreciation rights subject to such conditions and restrictions as the compensation committee may determine. Stock appreciation rights entitle the recipient to shares of common stock or cash equal to the value of the appreciation in the stock price over the exercise price. The exercise price may not be less than the fair market value of the common stock on the date of grant. The term of a stock appreciation right may not exceed ten years. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation committee may award shares of common stock to participants subject to such conditions and restrictions as the compensation committee may determine. These conditions and restrictions may include the achievement of certain performance goals and/or continued employment with us through a specified restricted period.&nbsp;&nbsp;During the vesting period, restricted stock awards may be credited with dividend equivalent rights (but dividend equivalents payable with respect to restricted stock awards with vesting tied to the attainment of performance criteria shall not be paid unless and until such performance conditions are attained).</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Units</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation committee may award restricted stock units to participants. Restricted stock units are ultimately payable in the form of shares of common stock or cash subject to such conditions and restrictions as the compensation committee may determine. These conditions and restrictions may include the achievement of certain performance goals and/or continued employment with the Company through a specified vesting period. In the compensation committee&#8217;s sole discretion, it may permit a participant to make an advance election to receive a portion of his or her future cash compensation otherwise due in the form of a restricted stock unit award, subject to the participant&#8217;s compliance with the procedures established by the compensation committee and requirements of Section&#160;409A of the Code. During the deferral period, the deferred stock awards may be credited with dividend equivalent rights. </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Unrestricted Stock Awards</font></p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation committee may also grant shares of common stock that are free from any restrictions under the 2018 Plan. Unrestricted stock may be granted to any participant in recognition of past services or other valid consideration and may be issued in lieu of cash compensation due to such participant. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Dividend Equivalent Rights</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation committee may grant dividend equivalent rights to participants, which entitle the recipient to receive credits for dividends that would be paid if the recipient had held specified shares of common stock. Dividend equivalent rights granted as a component of another award (other than a stock option or stock appreciation right) may be paid only if the related award becomes vested. Dividend equivalent rights may be settled in cash, shares of common stock or a combination thereof, in a single installment or installments, as specified in the award. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash-Based Awards</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation committee may grant cash bonuses under the 2018 Plan to participants. The cash bonuses may be subject to the achievement of certain performance goals.</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Performance Share Awards<font style="font-style:normal;"> </font></p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation committee may grant performance share awards to any participant which entitle the recipient to receive shares of common stock upon the achievement of certain performance goals and such other conditions as the compensation committee shall determine.&nbsp;&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Change of Control Provisions</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event of a &#8220;sale event,&#8221; as defined in the 2018 Plan, awards under the 2018 Plan may be assumed, continued or substituted.&nbsp;&nbsp;In the event that awards are not assumed, continued or substituted, except as otherwise provided by the compensation committee in the award agreement, upon the effective time of the sale event, all awards with time-based conditions will become vested and exercisable upon the sale event, and awards with conditions and restrictions relating to the attainment of performance goals may become vested and non-forfeitable in connection with a sale event in the compensation committee&#8217;s discretion or to the extent specified in the relevant award agreement. In addition, the Company may make or provide for payment, in cash or in kind, to participants holding options and stock appreciation rights equal to the difference between the per share cash consideration and the exercise price of the options or stock appreciation rights. The compensation committee shall also have the option to make or provide for a payment, in cash or in kind, to grantees holding other awards in an amount equal to the per share cash consideration multiplied by the number of vested shares under such awards. All awards will terminate in connection with a sale event unless they are assumed by the successor entity.</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Adjustments for Stock Dividends, Stock Splits, Etc.</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan requires the compensation committee to make appropriate adjustments to the number of shares of common stock that are subject to the 2018 Plan, to certain limits in the 2018 Plan, and to any outstanding awards to reflect stock dividends, stock splits, extraordinary cash dividends and similar events (including the reverse stock split to be effected in connection with the merger). </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Tax Withholding</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Participants in the 2018 Plan are responsible for the payment of any federal, state or local taxes that the Company is required by law to withhold upon the exercise of options or stock appreciation rights or vesting of other awards. The compensation committee may require that tax withholding obligations satisfied by withholding shares of common stock to be issued pursuant to exercise or vesting.&nbsp;&nbsp;The compensation committee may also require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by an arrangement whereby a certain number of shares issued pursuant to any award are immediately sold and proceeds from such sale are remitted to the Company in an amount that would satisfy the withholding amount due.&nbsp;&nbsp; </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Amendments and Termination</font></p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board of Directors may at any time amend or discontinue the 2018 Plan and the compensation committee may at any time amend or cancel any outstanding award for the purpose of satisfying changes in the law or for any other lawful purpose. However, no such action may adversely affect any rights under any outstanding award without the holder&#8217;s consent. To the extent required under the rules of Nasdaq, any amendments that materially change the terms of the 2018 Plan will be subject to approval by our stockholders. Amendments shall also be subject to approval by our stockholders if and to the extent determined by the compensation committee to be required by the Code to preserve the qualified status of incentive options. </p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Effective Date of Plan</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2018 Plan, as amended and restated, was approved by our board of directors on March 2, 2021.&nbsp;&nbsp;Awards of incentive options may be granted under the 2018 Plan until March 2, 2031. No other awards may be granted under the 2018 Plan after the date that is ten years from the 2018 Plan, as amended and restated is approved by our stockholders. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">New Plan Benefits </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All awards to executive officers in future periods are made at the discretion of the compensation committee and our board of directors. Therefore, the benefits and amounts that will be received or allocated under the 2018 Plan to such persons are not determinable at this time, and we have not included a table that reflects such awards.&#160;</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Tax Aspects Under the Code </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the principal federal income tax consequences of certain transactions under the 2018 Plan. It does not describe all federal tax consequences under the 2018 Plan, nor does it describe state or local tax consequences. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Incentive Options.<font style="font-style:normal;">&#160;&#160;&#160;&#160;No taxable income is generally realized by the optionee upon the grant or exercise of an incentive option. If shares of common stock issued to an optionee pursuant to the exercise of an incentive option are sold or transferred after two years from the date of grant and after one year from the date of exercise, then (i)&#160;upon sale of such shares, any amount realized in excess of the option exercise price (the amount paid for the shares) will be taxed to the optionee as a long-term capital gain, and any loss sustained will be a long-term capital loss, and (ii)&#160;the Company will not be entitled to any deduction for federal income tax purposes. The exercise of an incentive option will give rise to an item of tax preference that may result in alternative minimum tax liability for the optionee. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If shares of common stock acquired upon the exercise of an incentive option are disposed of prior to the expiration of the two-year and one-year holding periods described above (a &#8220;disqualifying disposition&#8221;), generally (i)&#160;the optionee will realize ordinary income in the year of disposition in an amount equal to the excess (if any) of the fair market value of the shares of common stock at exercise (or, if less, the amount realized on a sale of such shares of common stock) over the option price thereof, and (ii)&#160;we will be entitled to deduct such amount. Special rules will apply where all or a portion of the exercise price of the incentive option is paid by tendering shares of common stock. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an incentive option is exercised at a time when it no longer qualifies for the tax treatment described above, the option is treated as a non-qualified option. Generally, an incentive option will not be eligible for the tax treatment described above if it is exercised more than three months following termination of employment (or one year in the case of termination of employment by reason of disability). In the case of termination of employment by reason of death, the three-month rule does not apply. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Non-Qualified Options.<font style="font-style:normal;">&#160;&#160;&#160;&#160;No income is realized by the optionee at the time a non-qualified option is granted. Generally (i)&#160;at exercise, ordinary income is realized by the optionee in an amount equal to the difference between the option exercise price and the fair market value of the shares of common stock on the date of exercise, and we receive a tax deduction for the same amount, and (ii)&#160;at disposition, appreciation or depreciation after the date of exercise is treated as either short-term or long-term capital gain or loss depending on how long the shares of common stock have been held. Special rules will apply where all or a portion of the exercise price of the non-qualified option is paid by tendering shares of common stock. Upon exercise, the optionee will also be subject to Social Security taxes on the excess of the fair market value over the exercise price of the option. </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Other Awards.<font style="font-style:normal;">&#160;&#160;&#160;&#160;The Company generally will be entitled to a tax deduction in connection with other awards under the 2018 Plan in an amount equal to the ordinary income realized by the participant at the time the participant recognizes such income. Participants typically are subject to income tax and recognize such tax at the time that an award is exercised, vests or becomes non-forfeitable, unless the award provides for a further deferral. </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Parachute Payments.</font><font style="font-style:normal;">&#160;&#160;&#160;&#160;The vesting of any portion of an award that is accelerated due to the occurrence of a change in control (such as a sale event) may cause a portion of the payments with respect to such accelerated awards to be treated as &#8220;parachute payments&#8221; as defined in the Code. Any such parachute payments may be non-deductible to the Company, in whole or in part, and may subject the recipient to a non-deductible 20% federal excise tax on all or a portion of such payment (in addition to other taxes ordinarily payable). </font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Limitation on Deductions.<font style="font-style:normal;">&#160;&#160;&#160;&#160;Under Section&#160;162(m) of the Code, the Company&#8217;s deduction for awards under the 2018 Plan may be limited to the extent that any &#8220;covered employee&#8221; (as defined in Section 162(m) of the Code) receives compensation in excess of $1&#160;million a year. </font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Vote Required; Recommendation of the Adicet Bio Board</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The affirmative vote of a majority of shares of common stock present in person or represented by proxy at the Annual Meeting and entitled to vote on this proposal is required for the approval of the Amended and Restated 2018 Stock Option and Incentive Plan.</p>
<p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;<font style="font-style:italic;">FOR</font>&#8221; THE APPROVAL OF THE AMENDED AND RESTATED 2018 STOCK OPTION AND INCENTIVE PLAN.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p><a name="_AEIOULastRenderedPageBreakAEIOU3"></a>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="PROPOSAL_4"></a>PROPOSAL NO. 4<a name="PROPOSAL_4"></a> &#8211; RATIFICATION OF THE APPOINTMENT OF KPMG LLP<br />AS ADICET BIO&#8217;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE<br />FISCAL YEAR ENDING DECEMBER 31, 2021</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adicet Bio&#8217;s stockholders are being asked to ratify the appointment by the audit committee of the board of directors of KPMG LLP, or KPMG, as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2021. KPMG previously served as resTORbio&#8217;s independent registered public accounting Subsequent to the Merger in September 2020, KPMG has served as Adicet Bio&#8217;s independent registered public accounting firm since 2020.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 24, 2020, following the closing of the Merger, the Company dismissed PricewaterhouseCoopers LLP, or PWC, as the independent registered public accounting firm of Adicet Bio, Inc. and appointed KPMG, resTORbio&#8217;s independent registered public accounting firm, as our going-forward independent registered public accounting firm. The engagement of KPMG was approved by the Audit Committee of the Board of Directors. We filed a Current Report on Form 8-K with the SEC on October 1, 2020 announcing the change in auditors, which filing is incorporated by reference herein. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The audit committee is solely responsible for selecting Adicet Bio&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2021. Stockholder approval is not required to appoint KPMG as Adicet Bio&#8217;s independent registered public accounting firm. However, the board of directors believes that submitting the appointment of KPMG to the stockholders for ratification is good corporate governance. If the stockholders do not ratify this appointment, the audit committee will reconsider whether to retain KPMG. If the selection of KPMG is ratified, the audit committee, at its discretion, may direct the appointment of a different independent registered public accounting firm at any time it decides that such a change would be in the best interest of Adicet Bio and its stockholders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A representative of KPMG is expected to be present at the Annual Meeting and will have an opportunity to make a statement if he or she desires to do so and to respond to appropriate questions from our stockholders.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents fees for professional services rendered by PWC in fiscal year 2019 and 2020 and KPMG during fiscal 2020 for the Company&#8217;s audit of the consolidated financial statements and for other services.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-size:12pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.08%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fee Category</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fiscal Year</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fiscal Year</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.08%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Audit Fees<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.56%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">690,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.02%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">190,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Audit-Related Fees<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.56%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">968,200</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.02%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,601,894</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.08%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax Fees<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.56%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.64%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.02%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.08%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Other Fees<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.64%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.02%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.08%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total Fees</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,658,200</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.64%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,791,894</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Audit fees consisted of fees for the audit of our annual financial statements included in our annual report on Form 10-K, the review of our interim financial statements included in our quarterly reports on Form 10-Q. Of the audit fees during the year ended December 31, 2020 and 2019, $0.2 million and $0.2 million were incurred by PWC and $0.5 million and $0 were incurred by KPMG, respectively. During the fiscal 2020, Adicet had total audit fees of $0.6 million, of which $0.2 million and $0.4 million were incurred by PWC and KPMG, respectively. In 2020, resTORbio incurred $60,000 audit fees in connection with quarterly reviews performed by KPMG, prior to the Merger. These expenses were incurred and paid by resTORbio before the Merger and were not recognized by Adicet Bio under the Merger accounting. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Audit-related fees consisted of fees related to registration statements, comfort letters and consents. Of the audit-related fees, during the year ended December 31, 2020 and 2019, $0.6 million and $1.6 million were incurred by PWC and $0.4 million and $0 were incurred by KPMG, respectively. In 2020, Adicet paid total audit-related fees of $0.8 million, of which $0.6 million and $0.2 million were paid to PWC and KPMG, respectively. In 2020, resTORbio incurred $0.2 million audit-related fees for registration statements in connection to the Merger. These expenses were incurred and paid by resTORbio before the close of the Merger and were not recognized by Adicet Bio under the Merger accounting.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">There were no tax fees in fiscal years 2020 and 2019.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">There were no other fees for fiscal years 2020 and 2019. </font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Audit Committee Pre-approval Policy and Procedures</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our audit committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our independent registered public accounting firm. This policy provides that we will not engage our independent registered public accounting firm to render audit or non-audit services unless the service is specifically </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">approved in advance by our audit committee or the engagement is entered into pursuant to the pre-approval procedure described below.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, our audit committee may pre-approve specified types of services that are expected to be provided to us by our independent registered public accounting firm during the next 12 months. Any such pre-approval details the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During our 2019 and 2020 fiscal years, no services were provided to us by KPMG or PwC, as applicable, other than in accordance with the pre-approval policies and procedures described above.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">THE BOARD OF DIRECTORS RECOMMENDS VOTING <font style="font-style:italic;">&#8220;FOR&#8221;</font> THE PROPOSAL TO RATIFY THE APPOINTMENT OF KPMG LLP AS ADICET BIO&#8217;S<font style="font-weight:normal;"> </font>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2021.</p><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="CORPORATE_GOVERNANCE"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="CORPORATE_GOVERNANCE"></a>CORPORATE </font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">GOVERNANCE</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Management Following the Merger</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to September 15, 2020, we were a clinical-stage biopharmaceutical company known as resTORbio, Inc. (&#8220;resTORbio&#8221;). On September 15, 2020, we completed our business combination whereby a wholly-owned subsidiary of resTORbio merged with and into Adicet Bio, Inc. (&#8220;Former Adicet&#8221;), with Former Adicet surviving as a wholly-owned subsidiary of resTORbio and changing its name to Adicet Therapeutics, Inc. (such transactions, the &#8220;Merger&#8221;). In connection with the completion of the Merger, resTORbio was renamed Adicet Bio, Inc. (&#8220;Adicet Bio&#8221;).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the Merger, Former Adicet was led by Anil Singhal, Ph.D. as President and Chief Executive Officer and its board of directors was composed of: Erez Chimovits, Carl L. Gordon, Ph.D., Aya Jakobovits, Ph.D., Donald Santel, Yair Schindel, M.D., Michal Silverberg, Ph.D., and Asish Xavier, Ph.D. In connection with the Merger, the following Former Adicet and resTORbio officers joined Adicet Bio&#8217;s management team: Stewart Abbot, Ph.D., as Senior Vice President and Chief Operating and Scientific Officer, Francesco Galimi, M.D., Ph.D., as Senior Vice President and Chief Medical Officer, Lloyd Klickstein, M.D., Ph.D., as Chief Innovation Officer and Carrie Krehlik, as Senior Vice President and Chief Human Resource Officer. Dr. Klickstein resigned from the Company in February 2021 and will continue to serve the Company as a consultant. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Post-Merger, the combined company is led by Chen Schor as President and Chief Executive Officer. We have offices in Boston, Massachusetts, and Menlo Park, California. Our principal executive offices are located at 500 Boylston Street, 13th Floor, Boston, MA 02116. The Board of Directors (the &#8220;Board&#8221;) of Adicet was composed of Carl Gordon, Ph.D. (Chairman), Erez Chimovits, Aya Jakobovits, Ph.D., and Yair Schindel, M.D., who joined from Adicet&#8217;s board of directors, and Jeffery A. Chodakewitz, M.D. and Mr. Schor, who joined from resTORbio&#8217;s board of directors, and Steve Dubin, who joined the Board at the closing of the Merger. The Company appointed Dr. Bastiano Sanna and Dr. Andrew Sinclair to the Board effective as of December 1, 2020 and March 2, 2021, respectively. Dr. Schindel and Mr. Chimovits resigned from the Board on November 24, 2020 and March 2, 2021, respectively. The resignations were not the result of any disagreements with the Company or its Board or any matter relating to the Company&#8217;s operations, policies, or practices.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Director Nomination Process</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our nominating and corporate governance committee is responsible for identifying individuals qualified to serve as directors, consistent with criteria approved by our board, and recommending such persons to be nominated for election as directors, except where we are legally required by contract, law or otherwise to provide third parties with the right to nominate.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The process followed by our nominating and corporate governance committee to identify and evaluate director candidates includes requests to board members and others for recommendations, meetings from time to time to evaluate biographical information and background material relating to potential candidates, and interviews of selected candidates by management, recruiters, members of the committee and our board. The qualifications, qualities and skills that our nominating and corporate governance committee believes must be met by a committee recommended nominee for a position on our board of directors are as follows:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">nominees should demonstrate high standards of personal and professional ethics and integrity;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">nominees should have proven achievement and competence in the nominee&#8217;s field and the ability to exercise sound business judgment;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">nominees should have skills that are complementary to those of the existing board;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">nominees should have the ability to assist and support management and make significant contributions to the Company&#8217;s success; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">nominees should have an understanding of the fiduciary responsibilities that is required of a member of the board of directors and the commitment of time and energy necessary to diligently carry out those responsibilities.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stockholders may recommend individuals to the nominating and corporate governance committee for consideration as potential director candidates. Any such proposals should be submitted to our corporate secretary at our principal executive offices no later than the close of business on the 90th day nor earlier than the close of business on the 120th day prior to the one-year anniversary of the date of the preceding year&#8217;s annual meeting and should include appropriate biographical and background material to allow the nominating and corporate governance committee to properly evaluate the potential director </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">candidate and the number of shares of our stock beneficially owned by the stockholder proposing the candidate. Stockholder proposals should be addressed to </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adicet Bio</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, Inc., 500 Boylston Street, 13</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup></font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Floor, Boston, Massachusetts 02116, Attention: Corporate Secretary. Assuming that biographical and background material has been provided on a timely basis in accordance with our bylaws, any recommendations received from stockholders will be evaluated in the same manner as potential nominees proposed by the nominating and corporate governance committee. If our board of directors determines to nominate a stockholder recommended candidate and recommends his or her election, then his or her name will be included on our proxy card for the next annual meeting of stockholders. See &#8220;Stockholder Proposals&#8221; for a discussion of submitting stockholder proposals.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Director Independence</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Applicable Nasdaq Stock Market LLC, or Nasdaq, rules require a majority of a listed company&#8217;s board of directors to be comprised of independent directors within one year of listing. In addition, the Nasdaq rules require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act and that compensation committee members satisfy independence criteria set forth in Rule 10C-1 under the Exchange Act. Under applicable Nasdaq rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the listed company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In order to be considered independent for purposes of Rule 10A-3, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee, accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries. In addition, in affirmatively determining the independence of any director who will serve on a company&#8217;s compensation committee, Rule 10C-1 under the Exchange Act requires that a company&#8217;s board of directors must consider all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member, including:&nbsp;&nbsp;the source of compensation to the director, including any consulting, advisory or other compensatory fee paid by such company to the director, and whether the director is affiliated with the company or any of its subsidiaries or affiliates.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors has determined that all members of the board of directors, except Mr. Schor, are independent directors, including for purposes of the rules of Nasdaq and the SEC. In making such independence determination, our board of directors considered the relationships that each non-employee director has with us and all other facts and circumstances that our board of directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director. In considering the independence of the directors listed above, our board of directors considered the association of our directors with the holders of more than 5% of our common stock. There are no family relationships among any of our directors or executive officers. Mr. Schor is not an independent director under these rules because he is an executive officer of the Company.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Board Committees</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee. Each of the audit committee, compensation committee, and nominating and corporate governance committee operates under a charter that satisfies the applicable standards of the SEC and Nasdaq. Each such committee reviews its respective charter at least annually. A current copy of the charter for each of the audit committee, compensation committee, and nominating and corporate governance committee is posted on the corporate governance section of our website, <font style="font-weight:bold;font-style:italic;">investor.adicetbio.com/corporate-governance/governance-highlights</font>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Audit Committee</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the Merger, resTORbio&#8217;s audit committee was composed of Paul Fonteyne, Michael Grissinger and Lynne Sullivan and chaired by Ms. Sullivan. In connection with the Merger, Steve Dubin, Jeffrey Chodakewitz and Yair Schindel were appointed to our audit committee, with Mr. Dubin serving as chairperson. Currently, Steve Dubin, Bastiano Sanna, Ph.D., Jeffrey A. Chodakewitz, M.D. and Andrew Sinclair, Ph.D. serve on our audit committee, which is chaired by Mr. Dubin. Dr. Sanna and Dr. Sinclair were appointed to the audit committee in November 2020 and March 2021, respectively. Our board of directors has determined that each member of the audit committee is &#8220;independent&#8221; for audit committee purposes as that term is defined in the rules of the SEC and the applicable Nasdaq rules, and each has sufficient knowledge in financial and auditing matters to serve on the audit committee. Our board of directors has designated Steve Dubin as an &#8220;audit committee financial expert,&#8221; as defined under the applicable rules of the SEC. During the fiscal year ended </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31, 2020, the audit committee met </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> times. The report of the audit committee is included in this proxy statement under &#8220;Report of the Audit Committee.&#8221; The audit committee&#8217;s responsibilities include:</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">appointing, approving the compensation of, and assessing the independence of our independent registered public accounting firm;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">pre&#8209;approving auditing and permissible non&#8209;audit services, and the terms of such services, to be provided by our independent registered public accounting firm;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing the overall audit plan with our independent registered public accounting firm and members of management responsible for preparing our financial statements;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements and related disclosures as well as critical accounting policies and practices used by us;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">establishing policies and procedures for the receipt and retention of accounting&#8209;related complaints and concerns;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">recommending based upon the audit committee&#8217;s review and discussions with management and our independent registered public accounting firm whether our audited financial statements shall be included in our Annual Report on Form&#160;10&#8209;K;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they relate to our financial statements and accounting matters;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">preparing the audit committee report required by SEC rules to be included in our annual proxy statement;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing all related person transactions for potential conflict of interest situations and approving all such transactions; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing quarterly earnings releases.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All audit and non-audit services, other than <font style="font-style:italic;">de minimis </font>non-audit services, to be provided to us by our independent registered public accounting firm must be approved in advance by our audit committee.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Compensation Committee</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the Merger, resTORbio&#8217;s compensation committee was composed of Paul Fonteyne, Jonathan Silverstein and Jeffrey Chodakewitz, M.D. and chaired by Mr. Fonteyne. In connection with the Merger, Jeffrey Chodakewitz, M.D., Carl Gordon, Ph.D., and Aya Jakobovits, Ph.D. were appointed to serve on the compensation committee, which is chaired by Dr. Gordon. Our board of directors has determined that each member of the compensation committee is &#8220;independent&#8221; as defined in the applicable Nasdaq rules. During the fiscal year ended December 31, 2020, the compensation committee met six times. The compensation committee&#8217;s responsibilities include:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">annually reviewing and recommending to the board of directors corporate goals and objectives relevant to the compensation of our chief executive officer;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">evaluating the performance of our chief executive officer in light of such corporate goals and objectives and determine the compensation of our chief executive officer;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing and approving the compensation of our other executive officers;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing and establishing our overall management compensation, philosophy, and policy;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing and making recommendations to the board regarding our compensation and similar plans;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">evaluating and assessing potential and current compensation advisors in accordance with the independence standards identified in the applicable Nasdaq rules;</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="text-decoration:none;Background-color:#auto;font-family:'Times New Roman';"></font><font style="color:#000000;"></font><font style="color:#000000;">retaining and approving the compensation of any compensation advisors;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing and making recommendations to our board of directors about our policies and procedures for the grant of equity&#8209;based awards;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">evaluating and making recommendations to the board of directors about director compensation;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">preparing the compensation committee report required by SEC rules, if and when required, to be included in our annual proxy statement;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing and approving the retention or termination of any consulting firm or outside advisor to assist in the evaluation of compensation matters; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing and discussing with the board of directors corporate succession plans for our chief executive officers and our other key officers.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Nominating and Corporate Governance Committee</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to the Merger, resTORbio&#8217;s nominating and corporate governance committee was composed of Paul Fonteyne, Jonathan Silverstein and Jeffrey Chodakewitz, M.D. and chaired by Mr. Silverstein. In connection with the Merger, Erez Chimovits, Aya Jakobovits and Steve Dubin were appointed to our nominating and corporate governance committee, with Mr. Chimovits serving as the chairperson. Mr. Chimovits resigned from our Board and related committees on March 2, 2021. Currently, Steve Dubin, Aya Jakobovits, Ph.D., and Andrew Sinclair, Ph.D. serve on the nominating and corporate governance committee, which is chaired by Dr. Sinclair. Our board of directors has determined that each member of the nominating and corporate governance committee is &#8220;independent&#8221; as defined in the applicable Nasdaq rules. During the fiscal year ended December 31, 2020, the nominating and corporate governance committee met two times. The nominating and corporate governance committee&#8217;s responsibilities include:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">developing and recommending to the board of directors criteria for board and committee membership;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">establishing procedures for identifying and evaluating board of director candidates, including nominees recommended by stockholders;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">reviewing the size and composition of the board of directors to ensure that it is composed of members containing the appropriate skills and expertise to advise us;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">identifying individuals qualified to become members of the board of directors;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">recommending to the board of directors the persons to be nominated for election as directors and to each of the board of directors&#8217; committees;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">developing and recommending to the board of directors a code of business conduct and ethics and a set of corporate governance guidelines; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">overseeing the annual evaluation of our board of directors and management.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The nominating and corporate governance committee considers candidates for Board of Director membership suggested by its members and the Chief Executive Officer. Additionally, in selecting nominees for directors, the nominating and corporate governance committee will review candidates recommended by stockholders in the same manner and using the same general criteria as candidates recruited by the committee and/or recommended by our board of directors. Any stockholder who wishes to recommend a candidate for consideration by the committee as a nominee for director should follow the procedures described later in this proxy statement under the heading &#8220;Stockholder Proposals.&#8221; The nominating and corporate governance committee will also consider whether to nominate any person proposed by a stockholder in accordance with the provisions of our bylaws relating to stockholder nominations as described later in this proxy statement under the heading &#8220;Stockholder Proposals.&#8221; </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Identifying and Evaluating Director Nominees.<font style="font-style:normal;"> Our board of directors is responsible for filling vacancies on our board of directors and for nominating candidates for election by our stockholders each year in the class of directors whose term expires at the relevant annual meeting. The board of directors delegates the selection and nomination process to the nominating and corporate governance committee, with the expectation that other members of the board of directors, and of management, will be requested to take part in the process as appropriate. </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Generally, the nominating and corporate governance committee identifies candidates for director nominees in consultation with management, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">through the use of</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> search firms or other advisors, through the recommendations submitted by stockholders or through such other methods as the nominating and corporate governance committee deems to be helpful to identify candidates. Once candidates have been identified, the nominating and corporate governance committee confirms that the candidates meet </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">all of</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the minimum qualifications for director nominees established by the nominating and corporate governance committee. The nominating and corporate governance committee may gather information about the candidates through interviews, detailed questionnaires, comprehensive background checks or any other means that the nominating and corporate governance committee deems to be appropriate in the evaluation process. The nominating and corporate governance committee then meets as a group to discuss and evaluate the qualities and skills of each candidate, both on an individual basis and </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">taking into account</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the overall composition and needs of our board of directors. based on the results of the evaluation process, the nominating and corporate governance committee recommends candidates for the board of directors&#8217; approval to fill a vacancy or as director nominees for election to the board of directors by our stockholders each year in the class of directors whose term expires at the relevant annual meeting.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Board and Committee Meetings Attendance</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The full board of directors met 23 times during 2020. During 2020, each member of the board of directors attended in person or participated in 75% or more of the aggregate of (i) the total number of meetings of the board of directors (held during the period for which such person has been a director), and (ii) the total number of meetings held by all committees of the board of directors on which such person served (during the periods that such person served).</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Director Attendance at Annual Meeting of Stockholders</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Directors are responsible for attending the annual meeting of stockholders to the extent practicable. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Policy on Trading, Pledging and Hedging of Company Stock</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain transactions in our securities (such as purchases and sales of publicly traded put and call options, and short sales) create a heightened compliance risk or could create the appearance of misalignment between management and stockholders. In addition, securities held in a margin account or pledged as collateral may be sold without consent if the owner fails to meet a margin call or defaults on the loan, thus creating the risk that a sale may occur at a time when an officer or director is aware of material, non-public information or otherwise is not permitted to trade in Company securities. Our insider trading policy expressly prohibits derivative transactions of our stock by our executive officers, directors and employees. Our insider trading policy expressly prohibits purchases of any derivative securities that provide the economic equivalent of ownership. </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Code of Business Conduct and Ethics</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A current copy of the code is posted on the corporate governance section of our website, which is located at <font style="font-weight:bold;font-style:italic;">investor.adicetbio.com/corporate-governance/governance-highlights</font>. If we make any substantive amendments to, or grant any waivers from, the code of business conduct and ethics for any officer or director, we will disclose the nature of such amendment or waiver on our website or in a current report on Form 8-K.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Board Leadership Structure and Board&#8217;s Role in Risk Oversight</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently, the role of chairman of the board is separated from the role of chief executive officer, and we plan to keep these roles separate. We believe that separating these positions allows our chief executive officer to focus on our day&#8209;to&#8209;day business, while allowing the chairman of the board to lead the board of directors in its fundamental role of providing advice to and independent oversight of management. Our board of directors recognizes the time, effort, and energy that the chief executive officer is required to devote to his position in the current business environment, as well as the commitment required to serve as our chairman, particularly as the board of directors&#8217; oversight responsibilities continue to grow. While our bylaws and our corporate governance guidelines do not require that our chairman and chief executive officer positions be separate, our board of directors believes that having separate positions is the appropriate leadership structure for us at this time and demonstrates our commitment to good corporate governance.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk is inherent to every business, and how well a business manages risk can ultimately determine its success. We face a number of risks, including risks relating to our financial condition, development and commercialization activities, operations, strategic direction, and intellectual property. Management is responsible for the day&#8209;to&#8209;day management of risks we face, while our board of directors, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, our board of directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The role of the board of directors in overseeing the management of our risks is conducted primarily through committees of the board of directors, as disclosed in the descriptions of each of the committees above and in the charters of each of the committees. The full board of directors (or the appropriate board committee in the case of risks that are under the purview of a particular </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">committee</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) discusses with management our major risk exposures, their potential impact on us, and the steps we take to manage them. When a board committee is responsible for evaluating and overseeing the management of a particular risk or risks, the chairman of the relevant committee reports on the discussion to the full board of directors during the committee reports portion of the next board meeting. This enables the board of directors and its committees to coordinate the risk oversight role, particularly with respect to risk interrelationships.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Communication with the Directors of Adicet Bio</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any interested party with concerns about our company may report such concerns to the board of directors or the chairman of our board of directors and nominating and corporate governance committee, by submitting a written communication to the attention of such director at the following address:</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">c/o Adicet Bio, Inc.<br />500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Boston, Massachusetts 02116<br />United States</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a stockholder, customer, supplier, or other interested party.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A copy of any such written communication may also be forwarded to Adicet Bio&#8217;s legal counsel and a copy of such communication may be retained for a reasonable period of time. The director may discuss the matter with Adicet Bio&#8217;s legal counsel, with independent advisors, with non-management directors, or with Adicet Bio&#8217;s management, or may take other action or no action as the director determines in good faith, using reasonable judgment, and applying his or her own discretion.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Communications may be forwarded to other directors if they relate to important substantive matters and include suggestions or comments that may be important for other directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances, and matters as to which we tend to receive repetitive or duplicative communications.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The audit committee oversees the procedures for the receipt, retention, and treatment of complaints received by Adicet Bio regarding accounting, internal accounting controls, or audit matters, and the confidential, anonymous submission by employees of concerns regarding questionable accounting, internal accounting controls or auditing matters. Adicet Bio has also established a toll-free telephone number for the reporting of such activity, which is 1-866-207-4643.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Director Compensation</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below shows all compensation earned by or paid to our non-employee directors during 2020. Mr. Schor, our chief executive officer, does not receive any compensation for his services as director and, consequently, is not included in this table. The compensation received by Mr. Schor during 2020 is set forth in the section of this Proxy Statement captioned &#8220;Executive Compensation&#8212;Summary Compensation Table.&#8221;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fees Earned <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.32%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Option Awards <sup style="font-size:85%;line-height:120%;vertical-align:top">(2)(3)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Erez Chimovits<sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,542</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,201</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">327,743</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jeffrey Chodakewitz, M.D. <sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45,021</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,201</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">360,222</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steve Dubin</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,750</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,201</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">330,951</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Paul Fonteyne <sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,021</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,021</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carl Gordon, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,875</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,201</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">337,076</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Michael Grissinger <sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,104</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,104</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aya Jakobovits, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,833</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">315,201</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">328,035</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bastiano Sanna, Ph.D.<sup style="font-size:85%;line-height:120%;vertical-align:top">(6)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,542</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229,636</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">233,178</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yair Schindel<sup style="font-size:85%;line-height:120%;vertical-align:top">(7)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,107</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,107</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jonathan Silverstein <sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,458</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,458</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">David Steinberg<sup style="font-size:85%;line-height:120%;vertical-align:top"> (5)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,792</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,792</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lynne Sullivan<sup style="font-size:85%;line-height:120%;vertical-align:top"> (5)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,417</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.38%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,417</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Amounts represent cash compensation for services rendered by each member of the board of directors.</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Amounts shown reflect the grant date fair value of stock option awards granted during 2020. The grant date fair value was computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or ASC Topic 718, </font><font style="font-style:italic;color:#000000;">Compensation &#8212; Stock Compensation</font><font style="color:#000000;">, disregarding the effect of estimated forfeitures related to service-based vesting. These amounts reflect the accounting cost for the stock options and do not correspond to the actual economic value that may be received by the director upon exercise of the stock options. See note 18 to the financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 regarding assumptions we made in determining the fair value of option awards.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">The following table shows the number of outstanding stock options held by our directors as of December 31, 2020: </font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Underlying</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Erez Chimovits</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.54%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jeffrey Chodakewitz, M.D.</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steve Dubin</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carl Gordon, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aya Jakobovits, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bastiano Sanna, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,828</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Yair Schindel</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.54%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Mr. Chimovits resigned from the Board on March 2, 2021. Mr. Chimovits&#8217; resignation was not the result of any disagreement with the Company or its Board of Directors or any matter relating to the Company&#8217;s operations, policies, or practices.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Each of Messrs. Chodakewitz, Fonteyne, Grissinger, Silverstein and Steinberg and Ms. Sullivan were members of the board of directors of resTORbio and resigned </font><font style="color:#000000;">upon completion of the Merger. All fees were earned prior to the completion of the Merger. Mr. Chodakewitz was reappointed to the Board upon completion of the Merger and remains a member of the Board of the Company. In fiscal year 2020, Mr. Chodakewitz earned $45,021 in fees, of which $31,167 were paid by resTORbio and $13,854 were paid by Adicet Bio.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(6)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Dr. Sanna was appointed to the Board effective as of December 1, 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(7)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Dr. Schindel resigned from the Board on November 24, 2020. Dr. Schindel&#8217;s resignation was not the result of any disagreement with the Company or its Board of Directors or any matter relating to the Company&#8217;s operations, policies, or practices.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under our director compensation program, we pay our non-employee directors a cash retainer for service on the board of directors and for service on each committee on which the director is a member. The chairman of each committee receives a higher retainer for such service. These fees are payable in arrears in four equal quarterly installments on the last day of each quarter, provided that the amount of such payment is prorated for any portion of such quarter that the director is not serving on our board of directors. The fees paid to non-employee directors for service on the board of directors and for service on each committee of the board of directors on which the director is a member are as follows:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80.34%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.52%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Member</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual Fee</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.86%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.02%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:21.54%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Chairperson</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual Fee</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Board of Directors</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.86%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Audit Committee</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,500</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.86%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,500</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation Committee</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.86%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nominating and Corporate Governance Committee</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.42%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.1%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.86%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.02%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.12%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:2pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We also reimburse our non-employee directors for reasonable travel and out-of-pocket expenses incurred by our non-employee directors in connection with attending our meetings of the board of directors and committees thereof.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">In connection with the merger, the existing non-employee directors elected to our board of directors were granted an option to purchase 30,000 shares of our common stock on the date of such director&#8217;s election or appointment to the board of directors. These options vest monthly over three years. Post-merger, any new non-employee directors elected to our board of directors were granted an option to purchase 30,000 shares of our common stock on the date of such director&#8217;s election or appointment to the board of directors. These options vest monthly over the following three years. In February 2021, the board </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">of directors approved an updated non-employee director compensation policy to provide that any new non-employee directors elected to our board of directors will be granted an option to purchase 37,000 shares of our common</font><font style="Background-color:#FFFFFF;"> </font><font style="Background-color:#FFFFFF;">stock on the date of such </font><font style="Background-color:#FFFFFF;">director&#8217;s </font><font style="Background-color:#FFFFFF;">election or appointment to the board of directors. These options </font><font style="Background-color:#FFFFFF;">vest monthly over the following three years. On the date of each annual meeting of stockholders of our company, each</font><font style="Background-color:#FFFFFF;"> </font><font style="Background-color:#FFFFFF;">non-employee</font><font style="Background-color:#FFFFFF;"> </font><font style="Background-color:#FFFFFF;">director will be granted an additional option to purchase 18,500</font><font style="Background-color:#FFFFFF;"> shares of our common stock</font><font style="Background-color:#FFFFFF;">, which </font><font style="Background-color:#FFFFFF;">will vest full</font><font style="Background-color:#FFFFFF;">y upon the earlier to occur of the first anniversary of the date of grant or the date of the next annual meeting</font><font style="color:#000000;">.</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This program is intended to provide a total compensation package that enables us to attract and retain qualified and experienced individuals to serve as directors and to align our directors&#8217; interests with those of our stockholders.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Executive Compensation</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Summary Compensation Table</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides information concerning the total compensation awarded to, paid to, or earned by our principal executive officer(s) and two other persons serving as named executive officers during 2020 who were the most highly compensated officers for the years ended December 31, 2020 and 2019. Mr. Singhal served as Chief Executive Officer from January 1, 2020 to September 15, 2020 and Mr. Schor served as Chief Executive Officer from September 15, 2020 to the present. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100.06%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name and Principal Position</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Salary<sup style="font-size:85%;line-height:120%;vertical-align:top"> (1)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.3%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Bonus<sup style="font-size:85%;line-height:120%;vertical-align:top"> (2)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Awards <sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.78%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Option</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Awards<sup style="font-size:85%;line-height:120%;vertical-align:top"> (4)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.22%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Non-Equity</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Incentive Plan</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Compensation<sup style="font-size:85%;line-height:120%;vertical-align:top"> (5)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">All Other</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Compensation<sup style="font-size:85%;line-height:120%;vertical-align:top"> (6)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.48%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.36%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:7pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr style="height:12.5pt;">
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chen Schor<sup style="font-size:85%;line-height:120%;vertical-align:top"> (7)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">499,216</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">815,280</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,710,925</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212,167</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,700</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,276,287</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">479,167</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">436,880</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,664,646</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">189,150</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,400</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,778,243</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anil Singhal, Ph.D. <sup style="font-size:85%;line-height:120%;vertical-align:top">(</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">8)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">338,038</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,982</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">211,500</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&nbsp;</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">754,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,404,520</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">307,992</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,215,879</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,877</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&nbsp;</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,183</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,703,931</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lloyd Klickstein, M.D., Ph.D.<sup style="font-size:85%;line-height:120%;vertical-align:top">(</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">9</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">397,608</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280,186</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202,885</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,671</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,897,351</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Innovation Officer</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248,182</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,142</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,933,455</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77,675</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,869</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,415,323</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Francesco Galimi, M.D., Ph.D.<sup style="font-size:85%;line-height:120%;vertical-align:top">(1</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">0</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">389,212</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,500</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">821,610</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115,790</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&nbsp;</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,677</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,527,789</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:7pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Medical Officer</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.84%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:5.32%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162,500</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.76%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">347,480</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.22%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,400</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">&nbsp;</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,370</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.48%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">659,750</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.36%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">The amounts reported in the &#8220;Salary&#8221; column set forth the base salary earned during each fiscal year.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">The amounts reported in the &#8220;Bonus&#8221; column set forth the discretionary bonuses.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">The amounts reported in the &#8220;Stock Awards&#8221; column for 2020 set forth the expense recognized upon the acceleration and settlement of restricted stock units at the close of the Merger.&nbsp;&nbsp;The amounts reported for 2019 represent the grant date fair value of such awards, computed in accordance with the provisions of ASC, Topic 718.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">The amounts reported in the &#8220;Option Awards&#8221; column set forth the grant date fair value of options to purchase shares of the Company&#8217;s common stock granted during each fiscal year. The amounts are computed in accordance with the provisions of ASC, Topic 718 disregarding the effect of estimated forfeitures related to service-based vesting. These amounts reflect the accounting cost for the stock options and do not correspond to the actual economic value that may be received by the named executive officer upon exercise of the stock options. See Note 18 to our consolidated financial statements appearing at the end of our Annual Report on Form 10-K regarding certain assumptions underlying the valuation of equity awards.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">The amounts reported in the &#8220;Non-Equity Incentive Plan Compensation&#8221; column set forth the amount of compensation earned by the executive officers&nbsp;&nbsp;under the Company&#8217;s annual performance-based bonus program during each fiscal year. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(6)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">The amounts reported in the &#8220;All Other Compensation&#8221; column set forth all of the compensation for each fiscal year that we could not properly report in any other column of the table, including the incremental cost to the Company of perquisites and other personnel benefits; </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(7)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">Mr. Schor was Chief Executive Officer of resTORbio prior to the Merger. For disclosure purposes, Mr. Schor&#8217;s full-year salary was disclosed including salary he earned at resTORbio of $353,216 between January 1, 2020 and September 15, 2020, as well as salary he earned at the Company of $146,000 from September 16, 2020 to December 31, 2020. Salary paid by resTORbio were expenses incurred by resTORbio pre-merger and were not recognized as expense by Adicet under merger accounting. Mr. Schor&#8217;s annual base salary was $520,000 as of September 16, 2020 and was $536,000 effective January 1, 2021, for fiscal year 2021. The amount in All Other Compensation in 2020 includes a payout of $31,212 related to earned paid time off at resTORbio at the close of Merger, 401(k) match contributions of $6,413 and other employee benefits of $1,075 prior to the Merger. These expenses were incurred by resTORbio and were not recognized as expenses by Adicet under the Merger accounting. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(8)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">On April 28, 2020, the Company entered into a transition agreement with Dr. Anil Singhal providing for the following compensation: (1) cash payments of (i) $470,000 within 60 days. following the closing of the Merger, (ii) an amount equal to his pro-rated bonus of $211,500 for the 2020 calendar year payable within 60 days following the closing of the Merger, (iii) $250,000 payable in one lump sum on January 1, 2021 and (iv) $24,000 payable within 60 days following the closing of the Merger, (2) 12 months&#8217; of accelerated vesting of his unvested options to purchase the Company&#8217;s common stock upon completion of the Merger, and (3) a 12-month post-termination exercise period following termination of his independent contractor services agreement, dated April 28, 2020 (the ICSA), subject to any earlier expiration of the options to purchase the Company&#8217;s common stock by their terms. Pursuant to the ICSA, Dr. Singhal provided certain advisory services to the Company for a term of up to 12 months following the closing of the Merger and is entitled to payments of $12,500 per month for such services. In addition, Dr. Singhal is entitled to reimbursement of up to $15,000 of his reasonable and documented legal expenses incurred in connection with such transition agreement. Upon completion of the Merger, Dr. Singhal&#8217;s continued service for purposes of vesting of his options to purchase the Company&#8217;s common stock until termination of the ICSA without cause in February 2021. Upon termination, Dr. Singhal was entitled to accelerated vesting of unvested options that would have vested from the date of such termination through May 7, 2021. The amount in All Other Compensation for Dr. Singhal in 2020 includes separation payment of $494,000, consulting fees of $37,500 in 2020, $146,900 of stock-based compensation related to his service as an advisor to the Company in 2020, a commuting allowance of $67,050, and 401(k) match contribution of $8,550 in 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(9)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">Dr. Klickstein was the Chief Scientific Officer of resTORbio prior to the Merger. Dr. Klickstein&#8217;s full-year salary as set forth above includes his salary at resTORbio of $284,262 between January 1, 2020 and September 15, 2020, as well as his salary at the Company </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="font-size:9pt;color:#000000;">of $113,347 between September 16, 2020 and December 31, 2020. Salary paid by resTORbio were expenses incurred by resTORbio pre-merger</font><font style="color:#000000;"> </font><font style="font-size:9pt;color:#000000;">and are not recognized as expense by Adicet under merger accounting.</font><font style="font-size:9pt;color:#000000;"> Dr. </font><font style="font-size:9pt;color:#000000;">Klickstein&#8217;s</font><font style="font-size:9pt;color:#000000;"> annual base salary was $403,700 effective September 16, 2020 and $413,000 effective January 1, 2021. Dr. Klickstein </font><font style="font-size:9pt;color:#000000;">resigned from the Company as of February 19, 2021. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(10)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:9pt;color:#000000;">Dr. Galimi was appointed the Chief Medical Officer on September 23, 2019 and received a signing bonus of $325,000 paid in two tranches of $162,500 in 2019 and 2020. The amount in All Other Compensation for Dr. Galimi in 2020 includes commuting allowance and relocation expenses of $30,127 and 401(k) match contribution of $8,550.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Narrative to Summary Compensation Table</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors and compensation committee review compensation annually for our executives. In setting executive base salaries and bonuses and granting equity incentive awards, we consider compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders, and a long-term commitment to our company. We target a general competitive position, based on independent third-party benchmark analytics to inform the mix of compensation of base salary, bonus or long-term incentives.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors has historically determined our executives&#8217; compensation. Our compensation committee typically reviews and discusses management&#8217;s proposed compensation with the chief executive officer for all executives other than the chief executive officer. Based on those discussions and its discretion, taking into account the factors noted above, the compensation committee then recommends the compensation for each executive officer. Our board of directors discusses the compensation committee&#8217;s recommendations and ultimately approves the compensation of our executive officers without members of management present. In 2020, prior to the Merger, the compensation committee retained the services of Pearl Meyer, as its external compensation consultant. The board of directors and the compensation committee considered Pearl Meyer&#8217;s input on certain compensation matters as they deemed appropriate. In connection to the Merger, the Compensation Committee retained Radford to provide executive compensation consulting services. Both firms served at the discretion of the compensation committee and did not provide any other services to the Company during fiscal year 2020 other than those for which they were engaged by the compensation committee. In addition, in 2020, the compensation committee retained the services of Radford to provide compensation consulting services following the Merger.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our compensation committee requires that its compensation consultants be independent of Company management and performs an annual assessment of the compensation consultants&#8217; independence to determine whether the consultants are independent. Our compensation committee has determined that both Pearl Meyer and Radford are independent and that neither of their work has raised any conflict of interests.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Annual base salary</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each named executive officer&#8217;s base salary is a fixed component of annual compensation for performing specific duties and functions, and has been established by our board of directors taking into account each individual&#8217;s role, responsibilities, skills, and experience. Base salaries for our named executive officers are reviewed annually by our compensation committee, typically in connection with our annual performance review process, and adjusted from time to time, based on the recommendation of the compensation committee, to realign salaries with market levels after considering individual responsibilities, performance, and experience.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below lists our NEOs&#8217; annual base salary for fiscal 2020 and 2021: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.32%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.7%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Annual Salary</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.32%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.7%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.32%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chen Schor<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.7%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">520,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">536,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anil Singhal, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">470,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.04%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lloyd Klickstein, M.D., Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">403,700</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">413,000</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Francesco Galimi, M.D., Ph.D.<sup style="font-size:85%;line-height:120%;vertical-align:top">(</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.7%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.7%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">400,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">413,000</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">In August 2020, our Compensation Committee recommended, and our Board approved, an increase to Mr. Schor&#8217;s salary from $502,000 to $520,000 effective September 16, 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:6pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:6pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">In August 2020, our Compensation Committee recommended, and our Board approved, an increase to Dr. Galimi&#8217;s salary from $385,000 to $400,000 effective September 16, 2020.</font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Cash bonus</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our named executive officers, as well as other executive officers, are eligible to participate in our Cash Incentive Bonus Plan, or the Bonus Plan, which is an annual bonus program intended to reward our named executive officers for meeting objective or subjective performance goals for a fiscal year. The Bonus Plan provides for cash payments based upon the attainment of performance targets established by the Compensation Committee, which may relate to financial and operational measures or objectives with respect to the Company. Each executive officer who is selected to participate in the Bonus Plan will have a target bonus opportunity set for each performance period. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below lists cash bonus target percentages for fiscal 2020 for our NEOs: </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.28%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="4" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Bonus</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.28%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.7%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.28%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chen Schor</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.7%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50%</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.04%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50%</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anil Singhal, Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45%</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.04%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">N/A</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lloyd Klickstein, M.D., Ph.D.<sup style="font-size:85%;line-height:120%;vertical-align:top"> (1)</sup></p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40%</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.04%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40%</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.28%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Francesco Galimi, M.D., Ph.D.<sup style="font-size:85%;line-height:120%;vertical-align:top"> (2)</sup></p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.7%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35%</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.04%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40%</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:10pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:10pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Dr. Klickstein resigned in February 2021. Accordingly, he was not entitled to receive an incentive bonus for 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">In April 2020, Dr. Singhal entered into a transition agreement with us, pursuant to which he agreed to receive a prorated target incentive bonus for 2020, payable within 60 days following the Merger. </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The corporate goals used in our 2020 Cash Incentive Bonus Plan were proposed by management, and reviewed and approved by our Compensation Committee and our Board. The Board considered and assigned a relative weight to each corporate goal to appropriately focus efforts on achievements that were intended to enhance stockholder value. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the Company&#8217;s achievement of certain performance goals and metrics related to our 2020 corporate objectives, the Compensation Committee determined that the bonuses would be paid at 85% of target for each named executive officer and paid in the amounts as set forth above in the Summary Compensation Table.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Long&#8209;term equity incentives</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our equity grant program is intended to align the interests of our named executive officers with those of our stockholders and to motivate them to make important contributions to our performance. In addition, the vesting requirements of our equity awards contribute to executive retention by providing an incentive to our executive officers to remain employed by us during the vesting period. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant equity awards are granted at the time an executive officer commences employment. Thereafter, equity awards may be granted at varying times and in varying amounts in the discretion of our Compensation Committee or, if awards are being granted to the Chief Executive Officer, in the discretion of the Board, but are generally made once a year. None of our executive officers is currently party to an employment agreement that provides for an automatic grant of long-term equity incentives.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the fiscal year ended December&#160;31, 2020, we granted stock options to each of our named executive officers, as shown in more detail in the &#8220;Outstanding Equity Awards at Fiscal Year End&#8221; table below.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">401(k) Savings Plan</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We maintain a 401(k) retirement savings plan for the benefit of our employees, including our named executive officers, who satisfy certain eligibility requirements. Under the 401(k) plan, eligible employees may elect to defer a portion of their compensation, within the limits prescribed by the Code, on a pre-tax or after-tax (Roth) basis, through contributions to the 401(k) plan. The 401(k) plan is intended to qualify under Sections 401(a) and 501(a) of the Code. As a tax-qualified retirement plan, pre-tax contributions to the 401(k) plan and earnings on those pre-tax contributions are not taxable to the employees until distributed from the 401(k) plan, and earnings on Roth contributions are not taxable when distributed from the 401(k) plan. The 401(k) plan authorizes employer discretionary match contributions. We match 50% of the contributions that eligible participants make to the 401(k) plan up to 6.00% of the participant&#8217;s eligible compensation. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Health and Welfare Benefits</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All of our full-time employees, including our executive officers, are eligible to participate in our health and welfare benefits, including medical, dental and vision insurance, medical and dependent care flexible spending accounts, group life </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and disability insurance, and 401(k)</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> plan</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Named executive officers are eligible to participate in all our employee benefit plans, in each case on the same basis as other employees. </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We do not offer any defined benefit pension plans or nonqualified defined compensation arrangements for our employees, including our named executive officers.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Outstanding Equity Awards at 2020 Fiscal Year End Table</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents information regarding all outstanding stock options and stock awards held by each of our named executive officers on December 31, 2020. All equity awards in the table below were granted under our equity compensation plans.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="17" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.82%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Option Awards</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:32.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td rowspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.56%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of Securities</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Underlaying Unexercised Options</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td rowspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Vesting</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Type</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td rowspan="2" colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.86%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Option</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td rowspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.16%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Option</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Expiration</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.98%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unexercisable</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chen Schor</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/15/2020</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,857</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%; border-top:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.89</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%; border-top:solid 0.75pt #000000;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12/5/2029</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/17/2020</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,506</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">817,605</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.11</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/17/2030</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anil Singhal, Ph.D.</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/22/2019</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">250,503</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,405</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.76</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/10/2022</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Executive Officer</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2019</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">225,414</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,359</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.97</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/10/2022</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/17/2020</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,578</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,353</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4)</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.11</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2/10/2022</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lloyd Klickstein, M.D., Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/15/2020</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,666</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1)</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.89</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/19/2021</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Innovation Officer</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/17/2020</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,064</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">180,963</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.11</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5/19/2021</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Francesco Galimi, M.D., Ph.D.</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2019</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,132</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88,292</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2)</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.97</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10/15/2029</p></td>
</tr>
<tr>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.04%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Chief Medical Officer</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.34%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/17/2020</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.98%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,829</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,440</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.34%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3)</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.8%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.11</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="middle"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.16%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9/17/2030</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:8%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Fully vested on the date of grant.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">25% of the Shares subject to the Option shall vest twelve (12) months after the Vesting Commencement Date, and 1/36th of the remaining unvested Shares subject to the Option shall vest on each of the next thirty-six (36) monthly anniversaries of the Vesting Commencement Date thereafter, provided that the Optionee remains in Continuous Service as of the applicable vesting date.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">1/48th of the Shares subject to the Option shall vest on each of the next forty-eight (48) monthly anniversaries of the Vesting Commencement Date, provided that the Optionee remains in Continuous Service as of the applicable vesting date.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">One-third (1/3) of the Shares shall vest on the first anniversary of the Vesting Commencement Date, one-third (1/3) of the Shares shall vest in 12 equal monthly installments following such first anniversary of the Vesting Commencement Date in accordance with, and subject to the terms of, Section 5 of the Transition Agreement and one-third (1/3) of the Shares shall vest in accordance with, and subject to the terms of, Section 6(e) of the Transition Agreement.</font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Employment Arrangements with Our Named Executive Officers</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Chen Schor</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2017, we entered into an offer letter with Mr. Schor, as amended in January 2018 and September 2020. Under his amended offer letter, Mr.&#160;Schor is entitled to receive an annual base salary of $520,000 and an annual target bonus equal to 50% of his annual base salary. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event Mr.&#160;Schor&#8217;s employment is terminated by us without cause or by him for good reason, Mr.&#160;Schor shall be entitled to receive, subject to his execution and non-revocation of a release in favor of the Company (i) an amount equal to twelve (12) months of the Executive&#8217;s Base Salary (the &#8220;Severance Amount&#8221;);, (ii) any unpaid bonus earned for the year preceding the date of Executive&#8217;s employment termination, payable at the time it otherwise would have been paid had the Executive&#8217;s employment with the Company not terminated;&nbsp;&nbsp;and (iii) a monthly cash payment (including a gross up payment to account for applicable taxes and withholdings) equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive and covered dependents if the Executive had remained employed by the Company until the earliest of (A) the twelve (12) month anniversary of the Date of Termination; (B) the date that the Executive becomes eligible for group medical plan benefits under any other employer&#8217;s group medical plan; or (C) the cessation of the Executive&#8217;s health continuation rights under COBRA. The amounts payable under (i) and (iii), to the extent taxable, shall be paid out in substantially equal installments in accordance with the Company&#8217;s payroll practice over twelve (12) months commencing within 60 days after the Date of Termination.<font style="font-size:11.5pt;"> </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mr.&#160;Schor&#8217;s amended offer letter further provides that, in the event that his employment is terminated by us without cause or by him for good reason, and such termination occurs </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 months prior to or within</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the 12-month period following a change of control, then in lieu of the payments and benefits described above, Mr.&#160;Schor shall be entitled to receive, subject to his execution and non-revocation of a release in favor of the Company, (</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) a lump sum cash payment equal to 1.5 times the sum of his then current base salary and target annual incentive compensation </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for the then-current year (or the target annual incentive compensation in effect immediately prior to the Change in Control, if higher),</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (ii)&nbsp;&nbsp;</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a lump sum cash payment of any unpaid bonus earned for the year preceding the date of Mr. Schor&#8217;s employment termination, payable at the time it otherwise would have been paid had Mr. Schor&#8217;s employment with the Company not terminated,</font><font style="font-size:11.5pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii) </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">a monthly cash payment (including a gross up payment to account for applicable taxes and withholdings) equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive and covered dependents if the Executive had remained employed by the Company until the earliest of (A) the eighteen (18) month anniversary of the Date of Termination; (B) the date that the Executive becomes eligible for group medical plan benefits under any other employer&#8217;s group medical plan; or (C) the cessation of the Executive&#8217;s health continuation rights under COBRA</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, and (iv) full acceleration of all time-based stock options and other time-based stock-based awards held by Mr.&#160;Schor. All references to &#8220;cause,&#8221; &#8220;good reason&#8221; and &#8220;change in control&#8221; are as defined in his amended offer letter.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mr. Schor holds options to purchase 36,857 shares of the Company&#8217;s common stock at an exercise price of $8.89. These options were carried over from resTORbio and fully vested at the close of the Merger. The Board also granted Mr. Schor options on September 17, 2020 to purchase 872,111 shares of the Company&#8217;s common stock under the 2018 Plan at an exercise price of $16.11. These options will vest monthly, subject to his continued employment through each such vesting date. As of December 31, 2020, Mr. Schor holds 908,968 shares of stock options of which 91,363 shares are vested and 817,605 shares unvested. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Anil Singhal, Ph.D.</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 28, 2020, the Company entered into a transition agreement with Dr. Singhal providing for the following compensation: (1) cash payments of (i) $470,000 within 60 days following the closing of the Merger, (ii) an amount equal to his pro-rated bonus of $212,000 for the 2020 calendar year payable within 60 days following the closing of the Merger, (iii) $250,000 payable in one lump sum on January 1, 2021 and (iv) $24,000 payable within 60 days following the closing of the Merger, (2) 12 months&#8217; of accelerated vesting of his unvested options to purchase the Company&#8217;s common stock upon completion of the Merger, and (3) a 12-month post-termination exercise period following termination of his independent contractor services agreement, dated April 28, 2020 (the &#8220;ICSA&#8221;), subject to any earlier expiration of the options to purchase the Company&#8217;s common stock by their terms. Pursuant to the ICSA, Dr. Singhal provided certain advisory services to the Company for a term of up to 12 months following the closing of the Merger and is entitled to payments of $12,500 per month for such services. In addition, Dr. Singhal is entitled to reimbursement of up to $15,000 of his reasonable and documented legal expenses incurred in connection with such transition agreement. Upon completion of the Merger, Dr. Singhal&#8217;s continued service for purposes of vesting of his options to purchase the Company&#8217;s common stock continued until termination of the ICSA without cause in February 2021. Upon termination, Dr. Singhal was entitled to accelerated vesting of unvested options that would have vested from the date of such termination through May 7, 2021.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Francesco Galimi, M.D., Ph.D.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2019, we entered into an employment agreement with Dr. Galimi, as amended in April 2020 and September 2020. Under his amended agreement, Dr. Galimi is entitled to receive an annual base salary of $400,000 In addition, he will be eligible to receive an annual performance bonus targeted at up to 35% of his annual base salary, and 40% commencing in calendar year 2021. The company provided Dr. Galimi with a signing bonus upon his hire of $325,000 paid in two tranches of $162,500 in 2019 and 2020. The company also provides Dr. Galimi with a fully taxable commuter reimbursement for reasonable travel and lodging expense of up to $6,000 per month (for up to two years from his start date), less all required deductions and withholdings. If during the term of Dr. Galimi&#8217;s employment, he chooses to relocate, the Company will make a fully taxable lump sum payment to cover reasonable moving expenses, up to a maximum of $60,000, as amended April 2020.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event Dr. </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Galimi&#8217;s</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> employment is terminated by us without cause or by him for good reason, Dr. Galimi will be eligible to receive, subject to his execution and non-revocation of a release in favor of the Company, </font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) an amount equal to nine (9) months of the Executive&#8217;s Base Salary (the &#8220;Severance Amount&#8221;);, (ii) any unpaid bonus earned for the year preceding the date of Executive&#8217;s employment termination, payable at the time it otherwise would have been paid had the Executive&#8217;s employment with the Company not terminated;&nbsp;&nbsp;and (iii) a monthly cash payment (including a gross up payment to account for applicable taxes and withholdings) equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive and covered dependents if the Executive had remained employed by the Company until the earliest of (A) the nine (9) month anniversary of the Date of Termination; (B) the date that the Executive becomes eligible for group medical plan benefits under any other employer&#8217;s group medical plan; or (C) the cessation of the Executive&#8217;s health continuation rights under COBRA. The amounts payable under (</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) and (iii), to the extent taxable, shall be paid out in substantially equal installments in accordance with the Company&#8217;s payroll practice over nine (9) months commencing within 60 days after the Date of Termination.</font><font style="font-size:11.5pt;"> </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dr. Galimi&#8217;s employment agreement further provides that, in the event that his employment is terminated by us without cause or by him for good reason, and such termination occurs within the 12-month period following a change of control, then in lieu of the payments and benefits described above, Dr. Galimi shall be entitled to receive, subject to his execution and non-revocation of a release in favor of the Company, (i)&#160;a lump sum in cash in an amount equal to one (1) times the sum of (A) the Executive&#8217;s then-current Base Salary (or the Executive&#8217;s Base Salary in effect immediately prior to the Change in Control, if <font style="color:#auto;">higher) plus (B) the Executive&#8217;s Target Bonus for the then-current year (or the Executive&#8217;s Target Bonus in effect immediately prior to the Change in Control, if higher)</font>, (ii) any unpaid bonus earned for the year preceding the date of Executive&#8217;s employment termination, payable at the time it otherwise would have been paid had the Executive&#8217;s employment with the Company not terminated,<font style="font-size:11.5pt;"> </font> (iii)&#160;100% acceleration of all time-based equity awards held as of the date of termination and (iv)&#160;subject to his election of COBRA health continuation coverage, for up to twelve (12) months or his COBRA health continuation period, whichever ends earlier, a monthly cash payment equal to the monthly employer contribution that the Company would have made to provide health insurance to him if he has remained employed by the Company. All references to &#8220;cause,&#8221; &#8220;good reason&#8221; and &#8220;change in control&#8221; are as defined in his employment agreement.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dr. Galimi was granted a stock option to purchase 128,424 shares of the Company&#8217;s common stock under the Company&#8217;s 2015 Stock Option and Incentive Plan with an exercise price of $5.97. On September 17, 2020, the Board granted Dr. Galimi 63,751 shares of options under the 2018 Plan with an exercise price of $16.11. The options will vest 25% on the first anniversary of the effective date of his employment agreement, and the remainder shall vest ratably each month over the remaining terms, subject to his continued employment with the Company through each such vesting date. As of December 31, 2020, Dr. Galimi holds total 205,693 shares of stock options of which 44,961 shares are vested and 160,732 are unvested. </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Lloyd Klickstein, M.D., Ph.D.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with his resignation, Dr.&#160;Klickstein and the Company entered into a Consulting Agreement, dated February&#160;19, 2021 (the &#8220;Consulting Agreement&#8221;), pursuant to which Dr.&#160;Klickstein has agreed to serve as a member of the Company&#8217;s Scientific Advisory Board and provide strategic advice and services related to scientific and innovation matters as the Company and Dr.&#160;Klickstein may mutually agree to from time to time. As compensation for his services under the Consulting Agreement, a portion of the equity awards held by Dr.&#160;Klickstein as of February&#160;19, 2021 will continue to vest during the term of the Consulting Agreement.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Compensation Risk Assessment&#160;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We believe that although a portion of the compensation provided to our executive officers and other employees is performance-based, our executive compensation program does not encourage excessive or unnecessary risk taking. Our compensation programs are designed to encourage our executive officers and other employees to remain focused on both short-term and long-term strategic goals, in particular in connection with our pay-for-performance compensation philosophy. As a result, we do not believe that our compensation programs are reasonably likely to have a material adverse effect on us.</p><a name="_AEIOULastRenderedPageBreakAEIOU5"></a>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Equity Compensation Plan Information</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table provides information as of December 31, 2020 with respect to the shares of our common stock that may be issued under our existing equity compensation plans. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.04%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk66917906"></a>Plan Category</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.1%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number&#160;of&#160;securities</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">To Be&#160;Issued&#160;Upon</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding&#160;Options</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.18%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted&#160;Average</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise&#160;Price&#160;of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding&#160;Options</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.12%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of Securities</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining Available</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Future Issuance</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">under Equity Compensation Plans</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Excluding Securities in First Column)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.04%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity compensation plans approved by security holders <sup style="font-size:85%;line-height:120%;vertical-align:top">(1)(2)(3)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,317,892</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.84%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.62</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.12%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,587,924</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.04%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity compensation plans not approved by security holders<sup style="font-size:85%;line-height:120%;vertical-align:top"> (4)(5)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,389,053</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.84%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:16.82%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.29</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.86%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">283,129</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:34.04%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,706,945</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.84%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:16.82%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.86%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,871,053</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">Includes the following plans: our 2017 Stock Incentive Plan (the &#8220;2017 Plan&#8221;), 2018 Stock Option and Incentive Plan (the &#8220;2018 Plan&#8221;), and 2018 Employee Stock Purchase Plan (the &#8220;2018 ESPP&#8221;).</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:uppercase;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:uppercase;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:uppercase;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><a name="_Hlk66918533"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="text-transform:none;color:#000000;"></font><font style="font-size:10pt;text-transform:none;color:#000000;">As of December&#160;31, 2020, a total of 1,456,492 shares of our common stock have been reserved for issuance pursuant to the 2018 Plan, which number excludes the 787,089, shares that were added to the 2018 Plan as a result of the automatic annual increase of 4% on January 1, 2021. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:10pt;color:#000000;">On January 1, 2020, as a result of the foregoing evergreen provision, the number of shares of common stock available for issuance under the 2018 ESPP automatically increased from 79,369 to 131,432 shares. No shares have been issued under the 2018 ESPP during the year ended December 31, 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><a name="_Hlk66917810"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:10pt;">As of December 31, 2020, an aggregate of 1,957,536 shares of common stock were issuable upon the exercise of outstanding stock options under the </font><font style="font-size:10pt;color:#000000;">2015 Stock Incentive Plan (the 2015 Plan) </font><font style="Background-color:#FFFFFF;font-size:10pt;">at a weighted average exercise price of $7.43 per share and an aggregate of 69,014 shares of common stock were issuable upon the exercise of outstanding stock options under the </font><font style="font-size:10pt;color:#000000;">2014 Share Option Plan (the 2014 Plan) </font><font style="Background-color:#FFFFFF;font-size:10pt;">at a weighted average exercise price of $1.27 per share. </font><font style="font-size:10pt;color:#000000;">Since the date of effectiveness of the Merger, the Company has not and will not grant any further awards under the 2014 Plan.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;font-size:10pt;">Includes the following plans and outstanding awards under the </font><font style="font-size:10pt;color:#000000;">2014 Plan and the 2015 Plan that were assumed in the Merger</font><font style="Background-color:#FFFFFF;font-size:10pt;">. Descriptions of the 2014 Plan and the 2015 Plan are contained in Note 18 of the notes to our consolidated financial statements contained in our Annual Report on Form&#160;10-K&#160;for the year ended December&#160;31, 2020, filed with the SEC on March&#160;12, 2021</font><font style="color:#000000;">.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:-3.33%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:-3.33%;font-weight:bold;;font-size:6pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="CERTAIN_RELATIONSHIPS_RELATED_PARTY_TRAN"></a><a name="CERTAIN_RELATIONSHIPS_RELATED_PARTY_TRAN"></a>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Certain Relationships and Transactions</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other than the compensation agreements and other arrangements described under &#8220;Executive Compensation&#8221; and &#8220;Director Compensation&#8221; in this proxy statement and the transactions described below, since January 1, 2020, there has not been and there is not currently proposed, any transaction or series of similar transactions to which we were, or will be, a party in which the amount involved exceeded, or will exceed, $120,000 (or, if less, 1% of the average of our total assets amounts at December 31, 2020 and 2019) and in which any director, executive officer, holder of five percent or more of any class of our capital stock or any member of the immediate family of, or entities affiliated with, any of the foregoing persons, had, or will have, a direct or indirect material interest.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Funding Agreement and Concurrent Private Placement</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Merger between resTORbio and Former Adicet, <font style="Background-color:#FFFFFF;">in April 2020, we entered into a Funding Agreement with certain of our investors, including entities affiliated with OrbiMed Advisors LLC and Regeneron Pharmaceuticals, Inc., pursuant to which the investors agreed to fund a certain amount into an escrow account to be used to subscribe for shares of our common stock in a future concurrent private placement.</font> </p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">In February 2021, in connection with our February 2021 follow-on public offering and pursuant to the Funding Agreement and an additional non-escrow funding agreement with certain investors executed in September 2020, we entered into a stock purchase agreement (the &#8220;Purchase Agreement&#8221;) with certain of our investors, including entities affiliated with OrbiMed Advisors LLC, for the sale of $15.0 million of shares of our common stock at a price per share equal to the public offering price of $13.00 per share, resulting in the issuance of an aggregate of 1,153,840 shares of our common stock. </font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The following table summarizes the purchases on February 12, 2021 of our common stock by our 5% stockholders at such date and prior to such purchases:</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:84.3%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.68%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of Purchaser</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Purchased</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.56%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.76%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate Purchase Price</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OrbiMed Private Investments V, LP<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">420,299</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$5,463,897</p></td>
</tr>
<tr>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OrbiMed Israel Partners II, L.P.<sup style="font-size:85%;line-height:120%;vertical-align:top"> (</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">2)</sup></p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,050</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
<td valign="bottom"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
<td valign="top"  style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,352,652</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">aMoon 2 Fund Limited Partnership<sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,447</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.56%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.04%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.72%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,435,812</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">OrbiMed Capital GP V LLC ("GP V") is the general partner of OrbiMed Private Investments V, LP ("OPI V"), and OrbiMed Advisors is the managing member of GP V. By virtue of such relationships, GP V and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI V noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Exchange Act. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of the Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the Shares held by OPI V. Dr. Gordon is a member of our board of directors. As detailed in the section of this proxy statement entitled &#8220;Principal Stockholders&#8221;, entities affiliated with OrbiMed hold greater than 5% of our outstanding common stock.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">OrbiMed Israel Partners Limited Partnership ("OIP") is the holder of record. OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP, and OrbiMed Israel GP Ltd. ("OrbiMed Israel GP") is the general partner of OrbiMed BioFund. By virtue of such relationships, OrbiMed BioFund and OrbiMed Israel GP may be deemed to have voting and investment power with respect to the shares held directly by OIP noted above and, as a result, may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Exchange Act. OrbiMed Israel GP exercises this investment and voting power through a management committee comprised of the Carl L. Gordon, Jonathan T. Silverstein, Nissim Darvish, Anat Naschitz, and Erez Chimovits, each of whom disclaims beneficial ownership of the shares held by OIP. Dr. Gordon is a member of our board of directors. Mr. Chimovits was a former member of our Board and resigned on March 2, 2021. As detailed in the section of this proxy statement entitled &#8220;Principal Stockholders&#8221;, entities affiliated with OrbiMed hold greater than 5% of our outstanding common stock.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Yair Schindel, a former member of our Board who resigned on November 24, 2020, is the sole shareholder of aMoon General Partner Ltd., which is the sole general partner of aMoon 2 Fund G.P. Limited Partnership, which is the sole general partner of aMoon 2 Fund Limited Partnership, which directly holds the shares purchased in the February 2021 private placement.</font><font style="Background-color:#FFFFFF;color:#008000;"> </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> connection with the Purchase Agreement, </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we entered</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> into a Registration Rights Agreement (the &#8220;Registration Rights Agreement&#8221;) </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">requiring us to</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> prepare and file a registration statement with the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SEC</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> within 90 calendar days following the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">closing of the private placement on February 12, 2021</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (the &#8220;Filing Deadline&#8221;). </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are required to use our</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> reasonable best efforts to cause this registration statement to be declared effective by the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SEC</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> within 30 calendar days of the Filing Deadline (or within 60 calendar days if the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SEC</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> reviews the registration statement); provided that if </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> receive notice from the </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SEC</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> that the registration statement will not be reviewed, </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">we </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">must seek effectiveness within five trading days.</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Follow-On Offering</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain of our greater-than-five percent holders, including stockholders affiliated with certain of our directors, purchased an aggregate of approximately $42&#160;million in shares of our common stock in our follow-on public offering in February 2021 at the public offering price. The underwriting discount for the shares sold to such stockholders in the follow-on public offering was the same as the underwriting discount for the shares sold to the public.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Merger Voting Agreements and Support Agreements</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the Merger, Former Adicet entered into voting agreements with certain holders of Adicet capital stock and resTORbio capital stock, including OrbiMed Private Investments V, LP, OrbiMed Israel Affiliates, aMoon 2 Fund Limited Partnership, Novartis Bioventures Ltd., Regeneron Pharmaceuticals, Inc., Johnson&#160;&amp; Johnson Innovation&#8212;JJDC, Inc. and certain trusts affiliated with Aya Jakobovits, a member of the Adicet Board. The parties to the voting agreement have agreed, subject to certain conditions, to vote the shares of Adicet capital stock held by them so as to elect the following individuals as directors: (1)&#160;two nominees designated by OrbiMed Private Investments V, LP and its permitted transferees, currently Carl Gordon and one vacancy, (2)&#160;one nominee designated by OrbiMed Israel Affiliates and its permitted transferees, currently Erez Chimovits, (3)&#160;one nominee designated by Novartis Bioventures Ltd. and its permitted transferees, currently Michal Silverberg, (4)&#160;one nominee designated by the holders of a majority the outstanding shares of Adicet&#8217;s common stock held by the major common stockholders party to the voting agreement, currently Dr.&#160;Aya Jakobovits, (5)&#160;one nominee who is not an officer or employee of Adicet or its subsidiaries and is not an affiliate of any investor and who is designated by the holders of a majority of the then outstanding shares of common stock and preferred stock, voting together as a single class on an&#160;as-converted&#160;basis, currently Donald Santel, (6)&#160;one nominee designated by Johnson&#160;&amp; Johnson Innovation&#8212;JJDC, Inc. and its permitted transferees, currently Asish K. Xavier, (7)&#160;one nominee designated by aMoon 2 Fund Limited Partnership and its permitted transferees, currently Yair Schindel, and (8)&#160;one individual who was the then current Chief Executive Officer of Former Adicet, currently Dr. Anil Singhal. Upon the completion of the Merger, the obligations of the parties to the voting agreement to vote their shares so as to elect these nominees, as well as the other rights and obligations under this agreement, terminated and none of Former Adicet&#8217;s stockholders have any special rights regarding the nomination, election or designation of members of the Adicet&#8217;s board of directors.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concurrently with the execution of the merger agreement, resTORbio and Former Adicet also entered into a support agreement with Former Adicet&#8217;s directors and officers and certain stockholders (the &#8220;Former Adicet Support Agreement&#8221;). The Former Adicet Support Agreement provided, among other things, that the stockholders of Former Adicet subject to the agreement would vote their shares in favor of the approval of the merger agreement and the contemplated transactions. resTORbio and Former Adicet also entered into a support agreement with resTORbio&#8217;s directors and officers and OrbiMed Private Investments VI, LP (the &#8220;resTORbio Support Agreement&#8221;). The resTORbio Support Agreement provided that the stockholders of resTORbio subject to the agreement would vote (i) in favor of adoption and approval of (A) the issuance of the shares of resTORbio common stock by virtue of the Merger and (B) the adoption of the merger agreement and approval of the Merger; (ii) against any action or agreement that, to the knowledge of the stockholder, would reasonably be expected to result in a breach in any material respect of any covenant, representation or warranty or any other obligation or agreement of resTORbio or any of its subsidiaries or affiliates under the merger agreement or that would reasonably be expect to result in any of the conditions to resTORbio&#8217;s or any of its subsidiaries&#8217; or affiliates&#8217; obligations under the merger agreement not being fulfilled; and (iii) against any resTORbio acquisition proposal, or any agreement, transaction, or other matter that is intended to, or would reasonably be expected to, impede, interfere with, delay, postpone, discourage or materially and adversely affect the consummation of the merger and all other contemplated transactions. Upon the completion of the Merger, the obligations of the parties to the vote their shares as set forth in the resTORbio Support Agreement and Former Adicet Support Agreement terminated and none of the parties have any remaining rights or obligations under the agreements.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Limitation of Liability and Indemnification of Officers and Directors</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for the following:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">any breach of their duty of loyalty to our company or our stockholders&#894;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law&#894;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law&#894; or</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">any transaction from which they derived an improper personal benefit.</font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of our directors will be further limited to the greatest extent permitted by the Delaware General Corporation Law.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, we adopted bylaws which provide that we will indemnify, to the fullest extent permitted by law, any person who is or was a party or is threatened to be made a party to any action, suit or proceeding by reason of the fact that he or she is or was one of our directors or officers or is or was serving at our request as a director or officer of another corporation, partnership, joint venture, trust, or other enterprise. Our bylaws provide that we may indemnify to the fullest extent permitted by law any person who is or was a party or is threatened to be made a party to any action, suit, or proceeding by reason of the fact that he or she is or was one of our employees or agents or is or was serving at our request as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise. Our bylaws also provide that we must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to very limited exceptions.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We have entered into and in the future plan to enter into agreements to indemnify our directors and executive officers. These agreements, among other things, require us to indemnify these individuals for certain expenses (including attorneys&#8217; fees), judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in our right, on account of any services undertaken by such person on behalf of our company or that person&#8217;s status as a member of our board of directors to the maximum extent allowed under Delaware law.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Related Person Transaction Policy</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors adopted a written related person transactions policy providing that transactions with our directors, officers and holders of five percent or more of our voting securities and their affiliates, each a related person, must be approved by our audit committee. This policy became effective on January 25, 2018, the date our registration statement for our initial public offering became effective. Pursuant to this policy, the audit committee has the primary responsibility for reviewing and approving or disapproving &#8220;related person transactions,&#8221; which are transactions between us and related persons in which a related person has or will have a direct or indirect material interest. For purposes of this policy, a related person is defined as a director, executive officer, nominee for director, or greater than 5% beneficial owner of our common stock, in each case since the beginning of the most recently completed year, and their immediate family members.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As appropriate for the circumstances, the audit committee will review and consider:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">the related person&#8217;s interest in the related person transaction;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">whether the transaction was undertaken in the ordinary course of our business; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">whether the terms of the transaction are no less favorable to us than terms that could have been reached with an unrelated third party;</font></p></td></tr></table></div><a name="_AEIOULastRenderedPageBreakAEIOU6"></a>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="PRINCIPAL_STOCKHOLDERS"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="PRINCIPAL_STOCKHOLDERS"></a>PRINCIPAL S</font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">TOCKHOLDERS</font></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth information, to the extent known by us or ascertainable from public filings, with respect to the beneficial ownership of our common stock as of March 16, 2021 by:</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">each of our directors&#894;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">each of our named executive officers&#894;</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">all of our directors and executive officers as a group&#894; and</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:3.33%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:12pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">each person, or group of affiliated persons, who is known by us to beneficially owner of greater-than-5.0% of our common stock.</font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The column entitled &#8220;Shares Beneficially Owned&#8221; is based on a total of 31,800,426 shares of our common stock outstanding as of March 16, 2021.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to our common stock. Shares of our common stock subject to options that are currently exercisable or exercisable within 60 days of March 16, 2021 are considered outstanding and beneficially owned by the person holding the options for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person. Except as otherwise noted, the persons and entities in this table have sole voting and investing power with respect to all of the shares of our common stock beneficially owned by them, subject to community property laws, where applicable. Except as otherwise indicated in the table below, addresses of named beneficial owners are in care of Adicet Bio, Inc., 500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor, Boston, Massachusetts 02116.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of Beneficial Owner<sup style="font-size:85%;line-height:120%;vertical-align:top">(1)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Percentage of</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">5% Stockholders</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">OrbiMed Entities<sup style="font-size:85%;line-height:120%;vertical-align:top">(2)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,242,855</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.8</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Avidity Partners Management LP <sup style="font-size:85%;line-height:120%;vertical-align:top">(3)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,860,000</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.8</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Abingworth Bioventures 8 LP <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,615,385</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Directors and Named Executive Officers</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chen Schor <sup style="font-size:85%;line-height:120%;vertical-align:top">(5)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">506,796</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.6</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Anil Singhal <sup style="font-size:85%;line-height:120%;vertical-align:top">(6)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">569,612 </p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.8</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">% </p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lloyd Klickstein<sup style="font-size:85%;line-height:120%;vertical-align:top"> (7)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,369 </p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Francesco Galimi, M.D., Ph.D.<sup style="font-size:85%;line-height:120%;vertical-align:top"> (8)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70,543</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jeffrey Chodakewitz, M.D. <sup style="font-size:85%;line-height:120%;vertical-align:top">(9)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,833</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steve Dubin <sup style="font-size:85%;line-height:120%;vertical-align:top">(10)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,833</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carl Gordon, Ph.D. <sup style="font-size:85%;line-height:120%;vertical-align:top">(</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,242,855</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.8</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Aya Jakobovits, Ph.D. <sup style="font-size:85%;line-height:120%;vertical-align:top">(1</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">1</sup><sup style="font-size:85%;line-height:120%;vertical-align:top">)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">924,444</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.9</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bastiano Sanna, Ph.D.</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.14%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Andrew Sinclair, Ph.D. <sup style="font-size:85%;line-height:120%;vertical-align:top">(4)</sup></p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,615,385</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.1</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
<tr>
<td valign="top"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All Executive Officers and Directors as a Group (14 persons) <sup style="font-size:85%;line-height:120%;vertical-align:top">(12)</sup></p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,123,406</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.14%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33.9</p></td>
<td valign="bottom"  BGCOLOR="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td>
</tr>
</table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</font></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Represents beneficial ownership of less than one percent.</p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(1)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Unless otherwise indicated, the address for each beneficial owner is c/o Adicet Bio, Inc., 500 Boylston Street, 13th Floor, Boston, Massachusetts 02116.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(2)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Consists of (i) 7,232,856 shares of common stock reported on a Schedule 13D filed by OrbiMed Advisors LLC on February 19, 2021 and (ii) 9,999 shares of common stock issuable upon exercise of options exercisable within 60 days of March 16, 2021 held by Erez Chimovits and Carl Gordon, members of OrbiMed Advisors. All shares and options are held by OrbiMed Capital GP V LLC (&#8220;GP V&#8221;), OrbiMed Capital GP VI LLC (&#8220;GP VI&#8221;), OrbiMed Israel BioFund GP Limited Partnership (&#8220;BioFund&#8221;), OrbiMed Israel GP Ltd. (&#8220;Israel GP Ltd.&#8221;), OrbiMed Israel GP II, L.P. (&#8220;Israel GP II&#8221;), OrbiMed Advisors Israel II Limited (&#8220;Israel II Limited&#8221;) and Erez Chimovits and Carl Gordon (collectively, the &#8220;Reporting Persons&#8221;). Carl Gordon, Ph.D. is a member of our board of directors. Erez Chimovits was a former member of our Board and resigned on March 2, 2021. Mr. Chimovits and Dr. Gordon disclaims beneficial ownership </font></p></td></tr></table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap"></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="color:#000000;">of the shares</font><font style="color:#000000;"> and options</font><font style="color:#000000;"> held by Reporting Persons, except to the extent of its or his pecuniary interest therein if any.</font><font style="color:#000000;"> </font><font style="color:#000000;">OrbiMed Advisors</font><font style="color:#000000;"> has its principal offices at 601 Lexington Avenue, 54th Floor, New York, New York 10022</font><font style="color:#000000;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(3)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Consists of 1,860,000 shares of common stock reported on a Schedule 13G by Avidity Partners Management LP filed on February 12, 2021. Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC , (collectively, the &#8220;Avidity Funds&#8221;), David Witzke and Michael Gregory share power to vote, dispose, direct the vote or disposition of 1,860,000 shares of common stock while Avidity Master Fund LP has the shared power to vote, dispose, direct the vote or disposition of 1,650,208 shares of common stock.  Avidity Partners Management has its principal offices at 2828 N Harwood Street, Suite 1220, Dallas, Texas 75201.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(4)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Consists of 1,615,385 shares of common stock reported on a Schedule 13D/A filed by Abingworth LLP on March 16, 2021. All shares are held by Abingworth Bioventures 8 LP (&#8220;ABV 8&#8221;). Abingworth Bioventures 8 GP LP (&#8220;Abingworth GP&#8221;) serves as the general partner of ABV 8. Abingworth General Partner 8 LLP serves as the general partner of Abingworth GP. ABV 8 (acting by its general partner Abingworth GP, acting by its general partner Abingworth General Partner 8 LLP) has delegated to Abingworth, all investment and dispositive power over the securities held by ABV 8. Andrew Sinclair, a member of Abingworth LLP, is a member of our board of directors. Dr Sinclair disclaims beneficial ownership of the shares held by ABV 8, except to the extent of its or his pecuniary interest therein if any. Abingworth LLP has its principal office at Princes House, 38 Jermyn Street, London, England SW1Y 6DN. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(5)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Consists of 85,623 shares of common stock held directly by an irrevocable family trust having an independent trustee, 3,571 shares held by a revocable family trust of which Mr. Schor is the trustee, 91,857 shares held directly by an irrevocable family trust having an independent trustee, 3,571 shares held directly by a revocable trust of which Mr. Schor&#8217;s spouse is the trustee and 39,286 shares held directly by a grantor retained annuity trust of Mr. Schor&#8217;s spouse, and 210,389 shares of common stock issuable upon the exercise of options exercisable within 60 days of March 16, 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(6)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;color:#000000;">Consists of 569,612 shares of common stock issuable upon exercise of options exercisable within 60 days of </font><font style="color:#000000;">March&#160;16, 2020</font><font style="Background-color:#FFFFFF;color:#000000;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(7)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;color:#000000;">Consists of 11,931 shares of common stock and 46,369 shares of common stock issuable upon exercise of options exercisable within 60 days of </font><font style="color:#000000;">March 16, 2020</font><font style="Background-color:#FFFFFF;color:#000000;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(8)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;color:#000000;">Consists of 70,543 shares of common stock issuable upon exercise of options exercisable within 60 days of </font><font style="color:#000000;">March 16, 2020</font><font style="Background-color:#FFFFFF;color:#000000;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(9)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;color:#000000;">Consists of 5,833 shares of common stock issuable upon exercise of options exercisable within 60 days of </font><font style="color:#000000;">March 16, 2020</font><font style="Background-color:#FFFFFF;color:#000000;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(10)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="Background-color:#FFFFFF;color:#000000;">Consists of 5,833 shares of common stock issuable upon exercise of options exercisable within 60 days of </font><font style="color:#000000;">March 16, 2020</font><font style="Background-color:#FFFFFF;color:#000000;">.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(11)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;">Consists of (i) 918,611 shares of common stock held in a grantor retained annuity trust ("GRAT") and other trusts of which Dr. Jakobovits's spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary or Dr. Jakobovits's child is the beneficiary, and (ii) 5,833 shares of common stock issuable upon the exercise of options exercisable within 60 days </font><font style="Background-color:#FFFFFF;color:#000000;">of </font><font style="color:#000000;">March 16, 2020.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4.54%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;">(12)</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="color:#000000;">Includes the shares described in notes (2), (4), (5) and notes (8)&#160;through (11) above, 135,736 shares of common stock issuable upon exercise of options exercisable within 60 days of March 16, 2020 for other executive officers Stewart Abbot, Ph.D, our Chief Scientific and Operating Officer, Carrie Krehlik, our Chief Human Resource Officer, Nick Harvey, our Chief Financial Officer, and Don Healey, PhD., our Chief Technology Officer.  </font></p></td></tr></table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="DELINQUENT"></a><a name="DELINQUENT"></a>Delinquent Section 16(a) Reports</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Section 16(a) of the Exchange Act requires the Company&#8217;s directors and executive officers, and persons who own more than ten percent of a registered class of the Company&#8217;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than ten percent stockholders are required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the Company&#8217;s knowledge, based solely on a review of the copies of such reports furnished to the Company and written representations that no other reports were required, during the fiscal year ended December 31, 2020, all Section 16(a) filing requirements applicable to its officers, directors and greater than ten percent beneficial owners were complied with, other than the following late filings: one late Form 4 filing for Lloyd Klickstein and one late Form 3 filing for Steve Dubin.</p><a name="_AEIOULastRenderedPageBreakAEIOU8"></a>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="REPORT__AUDIT_COMMITTEE"></a><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="REPORT__AUDIT_COMMITTEE"></a>REPORT OF THE A</font><font style="font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;">UDIT COMMITTEE</font></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The audit committee is appointed by the board of directors to assist the board of directors in fulfilling its oversight responsibilities with respect to (1) the integrity of Adicet Bio&#8217;s financial statements and financial reporting process and systems of internal controls regarding finance, accounting, and compliance with legal and regulatory requirements, (2) the qualifications, independence, and performance of Adicet Bio&#8217;s independent registered public accounting firm, (3) the performance of Adicet Bio&#8217;s internal audit function, if any, and (4) other matters as set forth in the charter of the audit committee approved by the board of directors.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Management is responsible for the preparation of Adicet Bio&#8217;s financial statements and the financial reporting process, including its system of internal control over financial reporting and its disclosure controls and procedures. The independent registered public accounting firm is responsible for performing an audit of Adicet Bio&#8217;s financial statements in accordance with the standards of the Public Company Accounting Oversight Board (PCAOB) and issuing a report thereon. The audit committee&#8217;s responsibility is to monitor and oversee these processes.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with these responsibilities, the audit committee reviewed and discussed with management and the independent registered public accounting firm the audited consolidated financial statements of Adicet Bio for the fiscal year ended December 31, 2020. The audit committee also discussed with the independent registered public accounting firm the matters required to be discussed by the PCAOB&#8217;s Auditing Standard No. 1301, <font style="font-style:italic;">Communication with Audit Committees</font>. In addition, the audit committee received written communications from the independent registered public accounting firm confirming their independence as required by the applicable requirements of the PCAOB and has discussed with the independent registered public accounting firm their independence.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the reviews and discussions referred to above, the audit committee recommended to the board of directors that the audited consolidated financial statements of Adicet Bio be included in Adicet Bio&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, that was filed with the SEC. The information contained in this report shall not be deemed to be (1) &#8220;soliciting material,&#8221; (2) &#8220;filed&#8221; with the SEC, (3) subject to Regulations 14A or 14C of the Exchange Act, or (4) subject to the liabilities of Section 18 of the Exchange Act. This report shall not be deemed incorporated by reference into any of our other filings under the Exchange Act or the Securities Act, except to the extent that we specifically incorporate it by reference into such filing. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:53.33%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THE AUDIT COMMITTEE OF THE BOARD OF</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:53.33%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DIRECTORS OF ADICET BIO, INC.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:53.33%;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:53.33%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steve Dubin, Chairperson </p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:53.33%;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jeffrey Chodakewitz, M.D.</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:53.33%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bastiano Sanna, Ph.D</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-left:53.33%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Andrew Sinclair, Ph.D.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">March 18, 2021</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="HOUSEHOLDING"></a><a name="HOUSEHOLDING"></a>HOUSEHOLDING</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statements and annual reports. This means that only one copy of our documents, including the annual report to stockholders and proxy statement, may have been sent to multiple stockholders in your household. We will promptly deliver a separate copy of either document to you upon written or oral request to Adicet Bio, Inc., 500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor, Boston, Massachusetts 02116, Attention: Corporate Secretary, telephone:&nbsp;&nbsp;857-315-5528. If you want to receive separate copies of the proxy statement or annual report to stockholders in the future, or if you are receiving multiple copies and would like to receive only one copy per household, you should contact your bank, broker, or other nominee record holder or you may contact us at the above address and phone number.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="STOCKHOLDER_PROPOSALS"></a><a name="STOCKHOLDER_PROPOSALS"></a>STOCKHOLDER PROPOSALS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A stockholder who would like to have a proposal considered for inclusion in our 2022 proxy statement must submit the proposal in accordance with the procedures outlined in Rule 14a-8 of the Exchange Act so that it is received by us no later than November 18, 2021. However, if the date of the 2022 Annual Meeting of Stockholders is changed by more than 30 days from the date of the previous year&#8217;s meeting, then the deadline is a reasonable time before we begin to print and send our proxy statement for the 2022 Annual Meeting of Stockholders. SEC rules set standards for eligibility and specify the types of stockholder proposals that may be excluded from a proxy statement. Stockholder proposals should be addressed to Adicet Bio, Inc., 500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor, Boston, Massachusetts 02116, Attention: Corporate Secretary.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If a stockholder wishes to propose a nomination of persons for election to our board of directors or present a proposal at an annual meeting but does not wish to have the proposal considered for inclusion in our proxy statement and proxy card, our bylaws establish an advance notice procedure for such nominations and proposals. Stockholders at an annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors or by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered timely notice in proper form to our corporate secretary of the stockholder&#8217;s intention to bring such business before the meeting.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The required notice must be in writing and received by our corporate secretary at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year&#8217;s annual meeting. However, in the event that the date of the annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding year&#8217;s annual meeting, a stockholder&#8217;s notice must be so received no earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (A) the 90th day prior to such annual meeting and (B) the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs. For stockholder proposals to be brought before the 2022 Annual Meeting of Stockholders, the required notice must be received by our corporate secretary at our principal executive offices no earlier than December 28, 2021 and no later than January 27, 2022. Stockholder proposals and the required notice should be addressed to Adicet Bio, Inc., 500 Boylston Street, 13<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> Floor, Boston, Massachusetts 02116, Attention:&nbsp;&nbsp;Investor Relations / Corporate Secretary.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-align:center;text-indent:0%;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-size:10pt;font-style:normal;font-variant: normal;"><a name="Other_Matters"></a><a name="Other_Matters"></a>OTHER MATTERS</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our board of directors does not know of any other matters to be brought before the Annual Meeting. If any other matters not mentioned in this proxy statement are properly brought before the meeting, the individuals named in the enclosed proxy intend to use their discretionary voting authority under the proxy to vote the proxy in accordance with their best judgment on those matters.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:6pt;"><a name="_AEIOULastRenderedPageBreakAEIOU9"></a>&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:6pt;margin-bottom:0pt;text-indent:4.86%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU10"></a><a name="ANNEXA"></a><a name="ANNEXA"></a>ANNEX A</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ADICET BIO, INC.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AMENDED AND RESTATED 2018 EMPLOYEE STOCK PURCHASE PLAN </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU11"></a>The purpose of the Adicet Bio, Inc. Amended and Restated 2018 Employee Stock Purchase Plan (&#8220;the Plan&#8221;) is to provide eligible employees of Adicet Bio, Inc. (the &#8220;Company&#8221;) and each Designated Subsidiary (as defined in Section&#160;11) with opportunities to purchase shares of the Company&#8217;s common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;). 524,775 shares of Common Stock have been approved and reserved for this purpose, plus on January&#160;1, 2022, and each January&#160;1 thereafter through January&#160;1, 2031, the number of shares of Common Stock reserved and available for issuance under the Plan shall be cumulatively increased by the least of (i) 1,262,560 shares of Common Stock, (ii)&#160;one percent (1%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31st, or (iii)&#160;such lesser number of shares of Common Stock as determined by the Administrator. The Plan is intended to constitute an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423(b) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), and shall be interpreted in accordance with that intent.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Administration</font>. The Plan will be administered by the person or persons (the &#8220;Administrator&#8221;) appointed by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) for such purpose. The Administrator has authority at any time to: (i)&#160;adopt, alter and repeal such rules, guidelines and practices for the administration of the Plan and for its own acts and proceedings as it shall deem advisable; (ii)&#160;interpret the terms and provisions of the Plan; (iii)&#160;make all determinations it deems advisable for the administration of the Plan; (iv)&#160;decide all disputes arising in connection with the Plan; and (v)&#160;otherwise supervise the administration of the Plan. All interpretations and decisions of the Administrator shall be binding on all persons, including the Company and the Participants. No member of the Board or individual exercising administrative authority with respect to the Plan shall be liable for any action or determination made in good faith with respect to the Plan or any option granted hereunder.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Offerings</font>. The Company will make one or more offerings to eligible employees to purchase Common Stock under the Plan (&#8220;Offerings&#8221;). Unless otherwise determined by the Administrator, an Offering will begin on the first business day occurring on or after each January&#160;1 and July&#160;1 and will end on the last business day occurring on or before the following June&#160;30 and December&#160;31, respectively. The Administrator may, in its discretion, designate a different period for any Offering, provided that no Offering shall exceed one year in duration or overlap any other Offering.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Eligibility</font>. All individuals classified as employees on the payroll records of the Company and each Designated Subsidiary are eligible to participate in any one or more of the Offerings under the Plan, provided that as of the first day of the applicable Offering (the &#8220;Offering Date&#8221;) they are customarily employed by the Company or a Designated Subsidiary for more than 20 hours a week and have completed at least three months of employment. Notwithstanding any other provision herein, individuals who are not contemporaneously classified as employees of the Company or a Designated Subsidiary for purposes of the Company&#8217;s or applicable Designated Subsidiary&#8217;s payroll system are not considered to be eligible employees of the Company or any Designated Subsidiary and shall not be eligible to participate in the Plan. In the event any such individuals are reclassified as employees of the Company or a Designated Subsidiary for any purpose, including, without limitation, common law or statutory employees, by any action of any third party, including, without limitation, any government agency, or as a result of any private lawsuit, action or administrative proceeding, such individuals shall, notwithstanding such reclassification, remain ineligible for participation. Notwithstanding the foregoing, the exclusive means for individuals who are not contemporaneously classified as employees of the Company or a Designated Subsidiary on the Company&#8217;s or Designated Subsidiary&#8217;s payroll system to become eligible to participate in this Plan is through an amendment to this Plan, duly executed by the Company, which specifically renders such individuals eligible to participate herein.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Participation</font>.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Participants</font>. An eligible employee who is not a Participant in any prior Offering may participate in a subsequent Offering by submitting an enrollment form to his or her appropriate payroll location at least 15 business days before the Offering Date (or by such other deadline as shall be established by the Administrator for the Offering).</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Enrollment</font>. The enrollment form will (a)&#160;state a whole percentage to be deducted from an eligible employee&#8217;s Compensation (as defined in Section&#160;11) per pay period, (b)&#160;authorize the purchase of Common Stock in each Offering in accordance with the terms of the Plan and (c)&#160;specify the exact name or names in which shares of Common Stock purchased for such individual are to be issued pursuant to Section&#160;10. An employee who does not enroll in accordance with </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">these procedures will be deemed to have waived the right to participate. Unless a Participant files a new </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">enrollment</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> form or withdraws from the Plan, such Participant&#8217;s deductions and purchases will continue at the same percentage of Compensation for future Offerings, provided he or she remains eligible.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, participation in the Plan will neither be permitted nor be denied contrary to the requirements of the Code.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Employee Contributions</font>. Each eligible employee may authorize payroll deductions up to a maximum of fifteen&#160;percent of such employee&#8217;s Compensation for each pay period. The Company will maintain book accounts showing the amount of payroll deductions made by each Participant for each Offering. No interest will accrue or be paid on payroll deductions.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Deduction Changes</font>. Except as may be determined by the Administrator in advance of an Offering, a Participant may not increase or decrease his or her payroll deduction during any Offering, but may increase or decrease his or her payroll deduction with respect to the next Offering (subject to the limitations of Section&#160;5) by filing a new enrollment form at least 15 business days before the next Offering Date (or by such other deadline as shall be established by the Administrator for the Offering). The Administrator may, in advance of any Offering, establish rules permitting a Participant to increase, decrease or terminate his or her payroll deduction during an Offering.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Withdrawal</font>. A Participant may withdraw from participation in the Plan by delivering a written notice of withdrawal to his or her appropriate payroll location. The Participant&#8217;s withdrawal will be effective as of the next business day. Following a Participant&#8217;s withdrawal, the Company will promptly refund such individual&#8217;s entire account balance under the Plan to him or her (after payment for any Common Stock purchased before the effective date of withdrawal). Partial withdrawals are not permitted. Such an employee may not begin participation again during the remainder of the Offering, but may enroll in a subsequent Offering in accordance with Section&#160;4.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Grant of Options</font>. On each Offering Date, the Company will grant to each eligible employee who is then a Participant in the Plan an option (&#8220;Option&#8221;) to purchase on the last day of such Offering (the &#8220;Exercise Date&#8221;), at the Option Price hereinafter provided for, the lowest of (a)&#160;a number of shares of Common Stock determined by dividing such Participant&#8217;s accumulated payroll deductions on such Exercise Date by the lower of (i)&#160;85&#160;percent of the Fair Market Value of the Common Stock on the Offering Date, or (ii)&#160;85&#160;percent of the Fair Market Value of the Common Stock on the Exercise Date, (b)&#160;a number of shares determined by dividing $25,000 by the Fair Market of the Common Stock on the Offering Date of such Offering ; or (c)&#160;such other lesser maximum number of shares as shall have been established by the Administrator in advance of the Offering; provided, however, that such Option shall be subject to the limitations set forth below. Each Participant&#8217;s Option shall be exercisable only to the extent of such Participant&#8217;s accumulated payroll deductions on the Exercise Date. The purchase price for each share purchased under each Option (the &#8220;Option Price&#8221;) will be 85&#160;percent of the Fair Market Value of the Common Stock on the Offering Date or the Exercise Date, whichever is less.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing, no Participant may be granted an option hereunder if such Participant, immediately after the option was granted, would be treated as owning stock possessing 5&#160;percent or more of the total combined voting power or value of all classes of stock of the Company or any Parent or Subsidiary (as defined in Section&#160;11). For purposes of the preceding sentence, the attribution rules of Section&#160;424(d) of the Code shall apply in determining the stock ownership of a Participant, and all stock which the Participant has a contractual right to purchase shall be treated as stock owned by the Participant. In addition, no Participant may be granted an Option which permits his or her rights to purchase stock under the Plan, and any other employee stock purchase plan of the Company and its Parents and Subsidiaries, to accrue at a rate which exceeds $25,000 of the fair market value of such stock (determined on the option grant date or dates) for each calendar year in which the Option is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply with Section&#160;423(b)(8) of the Code and shall be applied taking Options into account in the order in which they were granted.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Exercise of Option and Purchase of Shares</font>. Each employee who continues to be a Participant in the Plan on the Exercise Date shall be deemed to have exercised his or her Option on such date and shall acquire from the Company such number of whole shares of Common Stock reserved for the purpose of the Plan as his or her accumulated payroll deductions on such date will purchase at the Option Price, subject to any other limitations contained in the Plan. Any amount remaining in a Participant&#8217;s account at the end of an Offering solely by reason of the inability to purchase a fractional share will be carried forward to the next Offering; any other balance remaining in a Participant&#8217;s account at the end of an Offering will be refunded to the Participant promptly.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.&#160;&#160;&#160;&#160;</font><font style="text-decoration:underline;">Issuance of Certificates</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Certificates representing shares of Common Stock purchased under the Plan may be issued only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights of survivorship, or in the name of a broker authorized by the employee to be his, her or their, nominee for such purpose.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Definitions</font>.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;Compensation&#8221; means the amount of base pay, prior to salary reduction pursuant to Sections&#160;125, 132(f) or 401(k) of the Code, but excluding overtime, commissions, incentive or bonus awards, allowances and reimbursements for expenses such as relocation allowances or travel expenses, income or gains on the exercise of Company stock options, and similar items</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;Designated Subsidiary&#8221; means any present or future Subsidiary (as defined below) that has been designated by the Board to participate in the Plan. The Board may so designate any Subsidiary, or revoke any such designation, at any time and from time to time, either before or after the Plan is approved by the stockholders.&nbsp;&nbsp;<font style="color:#000000;">The current list of Designated Companies is attached hereto as </font><font style="text-decoration:underline;color:#000000;">Appendix A</font><font style="color:#000000;">.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;Fair Market Value of the Common Stock&#8221; on any given date means the fair market value of the Common Stock determined in good faith by the Administrator; provided, however, that if the Common Stock is admitted to quotation on the National Association of Securities Dealers Automated Quotation System (&#8220;Nasdaq&#8221;), Nasdaq Global Market or another national securities exchange, the determination shall be made by reference to the closing price on such date. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date for which there is a closing price.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;Initial Public Offering&#8221; means the first underwritten, firm commitment public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale by the Company of its Common Stock.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;Parent&#8221; means a &#8220;parent corporation&#8221; with respect to the Company, as defined in Section&#160;424(e) of the Code.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;Participant&#8221; means an individual who is eligible as determined in Section&#160;3 and who has complied with the provisions of Section&#160;4.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The term &#8220;Subsidiary&#8221; means a &#8220;subsidiary corporation&#8221; with respect to the Company, as defined in Section&#160;424(f) of the Code.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Rights on Termination of Employment</font>. If a Participant&#8217;s employment terminates for any reason before the Exercise Date for any Offering, no payroll deduction will be taken from any pay due and owing to the Participant and the balance in the Participant&#8217;s account will be paid to such Participant or, in the case of such Participant&#8217;s death, to his or her designated beneficiary as if such Participant had withdrawn from the Plan under Section&#160;7. An employee will be deemed to have terminated employment, for this purpose, if the corporation that employs him or her, having been a Designated Subsidiary, ceases to be a Subsidiary, or if the employee is transferred to any corporation other than the Company or a Designated Subsidiary. An employee will not be deemed to have terminated employment for this purpose, if the employee is on an approved leave of absence for military service or sickness or for any other purpose approved by the Company, if the employee&#8217;s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise provides in writing.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Special Rules</font>. Notwithstanding anything herein to the contrary, the Administrator may adopt special rules applicable to the employees of a particular Designated Subsidiary, whenever the Administrator determines that such rules are necessary or appropriate for the implementation of the Plan in a jurisdiction where such Designated Subsidiary has employees; provided that such rules are consistent with the requirements of Section&#160;423(b) of the Code. Any special rules established pursuant to this Section&#160;13 shall, to the extent possible, result in the employees subject to such rules having substantially the same rights as other Participants in the Plan.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Optionees Not Stockholders</font>. Neither the granting of an Option to a Participant nor the deductions from his or her pay shall constitute such Participant a holder of the shares of Common Stock covered by an Option under the Plan until such shares have been purchased by and issued to him or her.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15.&#160;&#160;&#160;&#160;</font><font style="text-decoration:underline;">Rights Not Transferable</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Rights under the Plan are not transferable by a Participant other than by will or the laws of descent and distribution, and are exercisable during the Participant&#8217;s lifetime only by the Participant.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Application of Funds</font>. All funds received or held by the Company under the Plan may be combined with other corporate funds and may be used for any corporate purpose.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Adjustment in Case of Changes Affecting Common Stock</font>. In the event of a subdivision of outstanding shares of Common Stock, the payment of a dividend in Common Stock or any other change affecting the Common Stock, the number of shares approved for the Plan and the share limitation set forth in Section&#160;8 shall be equitably or proportionately adjusted to give proper effect to such event.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Amendment of the Plan</font>. The Board may at any time and from time to time amend the Plan in any respect, except that without the approval within 12 months of such Board action by the stockholders, no amendment shall be made increasing the number of shares approved for the Plan or making any other change that would require stockholder approval in order for the Plan, as amended, to qualify as an &#8220;employee stock purchase plan&#8221; under Section&#160;423(b) of the Code.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Insufficient Shares</font>. If the total number of shares of Common Stock that would otherwise be purchased on any Exercise Date plus the number of shares purchased under previous Offerings under the Plan exceeds the maximum number of shares issuable under the Plan, the shares then available shall be apportioned among Participants in proportion to the amount of payroll deductions accumulated on behalf of each Participant that would otherwise be used to purchase Common Stock on such Exercise Date.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Termination of the Plan</font>. The Plan may be terminated at any time by the Board. Upon termination of the Plan, all amounts in the accounts of Participants shall be promptly refunded.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Governmental Regulations</font>. The Company&#8217;s obligation to sell and deliver Common Stock under the Plan is subject to obtaining all governmental approvals required in connection with the authorization, issuance, or sale of such stock.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Governing Law</font>. This Plan and all Options and actions taken thereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware, applied without regard to conflict of law principles.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Issuance of Shares</font>. Shares may be issued upon exercise of an Option from authorized but unissued Common Stock, from shares held in the treasury of the Company, or from any other proper source.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Tax Withholding</font>. Participation in the Plan is subject to any minimum required tax withholding on income of the Participant in connection with the Plan. Each Participant agrees, by entering the Plan, that the Company and its Subsidiaries shall have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant, including shares issuable under the Plan.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Notification Upon Sale of Shares</font>. Each Participant agrees, by entering the Plan, to give the Company prompt notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased or within one year after the date such shares were purchased.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26.&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Effective Date and Approval of Shareholders</font>. The Plan shall take effect on the date immediately preceding the date on which the Company&#8217;s registration statement on Form&#160;S-1&#160;becomes effective following approval by the holders of a majority of the votes cast at a meeting of stockholders at which a quorum is present or by written consent of the stockholders.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="ANNEXB"></a><a name="ANNEXB"></a>ANNEX B</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ADICET BIO, INC.</p>
<p style="text-align:center;Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">AMENDED AND RESTATED 2018 STOCK OPTION AND INCENTIVE PLAN</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;1.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">GENERAL PURPOSE OF THE PLAN; DEFINITIONS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The name of the plan is the Adicet Bio, Inc. Amended and Restated 2018 Stock Option and Incentive Plan (the &#8220;Plan&#8221;). The purpose of the Plan is to encourage and enable the officers, employees,&#160;Non-Employee&#160;Directors and Consultants of Adicet Bio, Inc. (the &#8220;Company&#8221;) and its Affiliates upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its businesses to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company&#8217;s welfare will assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company&#8217;s behalf and strengthening their desire to remain with the Company.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following terms shall be defined as set forth below:</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;2017 Plan&#8221;<font style="font-style:normal;">&#160;means the Adicet Bio, Inc. 2017 Stock Incentive Plan, as amended.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Act&#8221;<font style="font-style:normal;">&#160;means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Administrator&#8221;<font style="font-style:normal;">&#160;means either the Board or the compensation committee of the Board or a similar committee performing the functions of the compensation committee and which is comprised of not less than two&#160;Non-Employee&#160;Directors who are independent.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Affiliates&#8221;<font style="font-style:normal;"> means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 of the Act.&nbsp;&nbsp;The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition. </font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Award&#8221;<font style="font-style:normal;">&#160;or&#160;</font>&#8220;Awards,&#8221;<font style="font-style:normal;">&#160;except where referring to a particular category of grant under the Plan, shall include Incentive Stock Options,&#160;Non-Qualified&#160;Stock Options, Stock Appreciation Rights, Restricted Stock Units, Restricted Stock Awards, Unrestricted Stock Awards, Cash-Based Awards and Dividend Equivalent Rights.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Award Certificate&#8221;<font style="font-style:normal;">&#160;means a written or electronic document setting forth the terms and provisions applicable to an Award granted under the Plan. Each Award Certificate is subject to the terms and conditions of the Plan.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Board&#8221;<font style="font-style:normal;">&#160;means the Board of Directors of the Company.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Cash-Based Award&#8221;<font style="font-style:normal;">&#160;means an Award entitling the recipient to receive a cash-denominated payment.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Code&#8221;<font style="font-style:normal;">&#160;means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Consultant&#8221;<font style="font-style:normal;">&#160;means a consultant or adviser who provides bona fide services to the Company or an Affiliate as an independent contractor and who qualifies as a consultant or advisor under Instruction A.1.(a)(1) of Form S-8 under the Act.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Continuous Service&#8221;<font style="font-style:normal;"> means </font><font style="Background-color:#FFFFFF;font-style:normal;">that a Service Relationship is not interrupted or terminated.&nbsp;&nbsp;For this purpose, a Service Relationship shall be deemed to continue without interruption in the event an individual&#8217;s status changes from full-time employee to part-time employee or Consultant.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Dividend Equivalent Right&#8221;<font style="font-style:normal;">&#160;means an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other award to which it relates) if such shares had been issued to and held by the grantee.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Effective Date&#8221;<font style="font-style:normal;">&#160;means the date on which the Plan becomes effective as set forth in Section&#160;19.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Exchange Act&#8221;<font style="font-style:normal;">&#160;means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Fair Market Value&#8221;</font><font style="font-style:normal;">&#160;of the Stock on any given date means the fair market value of the Stock determined in good faith by the Administrator; provided, however, that if the Stock is admitted to quotation on the National Association of Securities Dealers Automated Quotation System (&#8220;Nasdaq&#8221;), Nasdaq Global Market or another national securities exchange, the determination shall be made by reference to market quotations. If there are no market quotations for such date, the determination shall be made by reference to the last date preceding such date for which there are market quotations.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Incentive Stock Option&#8221;<font style="font-style:normal;">&#160;means any Stock Option designated and qualified as an &#8220;incentive stock option&#8221; as defined in Section&#160;422 of the Code.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Non-Employee&#160;Director&#8221;<font style="font-style:normal;">&#160;means a member of the Board who is not also an employee of the Company or any Subsidiary.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Non-Qualified&#160;Stock Option&#8221;<font style="font-style:normal;">&#160;means any Stock Option that is not an Incentive Stock Option.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Option&#8221;<font style="font-style:normal;">&#160;or&#160;</font>&#8220;Stock Option&#8221;<font style="font-style:normal;">&#160;means any option to purchase shares of Stock granted pursuant to Section&#160;5.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Restricted Shares&#8221;<font style="font-style:normal;">&#160;means the shares of Stock underlying a Restricted Stock Award that remain subject to a risk of forfeiture or the Company&#8217;s right of repurchase.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Restricted Stock Award&#8221;<font style="font-style:normal;">&#160;means an Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Restricted Stock Units&#8221;<font style="font-style:normal;">&#160;means an Award of stock units subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Sale Event&#8221;<font style="font-style:normal;">&#160;shall mean (i)&#160;the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (ii)&#160;a merger, reorganization or consolidation pursuant to which the holders of the Company&#8217;s outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction, (iii)&#160;the sale of all of the Stock of the Company to an unrelated person, entity or group thereof acting in concert, or (iv)&#160;any other transaction in which the owners of the Company&#8217;s outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;<font style="font-style:italic;">Sale Price</font>&#8221; means the value as determined by the Administrator of the consideration payable, or otherwise to be received by stockholders, per share of Stock pursuant to a Sale Event.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Section&#160;409A&#8221;<font style="font-style:normal;">&#160;means Section&#160;409A of the Code and the regulations and other guidance promulgated thereunder.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Service Relationship&#8221;<font style="font-style:normal;"> means any relationship as an employee, Non-Employee Director or Consultant of the Company or any Affiliate.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Stock&#8221;<font style="font-style:normal;">&#160;means the Common Stock, par value $0.0001 per share, of the Company, subject to adjustments pursuant to Section&#160;3.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Stock Appreciation Right&#8221;<font style="font-style:normal;">&#160;means an Award entitling the recipient to receive shares of Stock (or cash, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of the Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock Appreciation Right shall have been exercised.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Subsidiary&#8221;<font style="font-style:normal;">&#160;means any corporation or other entity (other than the Company) in which the Company has at least a 50&#160;percent interest, either directly or indirectly.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Ten Percent Owner&#8221;</font><font style="font-style:normal;">&#160;means an employee who owns or is deemed to own (by reason of the attribution rules of Section&#160;424(d) of the Code) more than 10&#160;percent of the combined voting power of all classes of stock of the Company or any parent or subsidiary corporation.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">&#8220;Unrestricted Stock Award&#8221;<font style="font-style:normal;">&#160;means an Award of shares of Stock free of any restrictions.</font></p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;2.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">ADMINISTRATION OF PLAN; ADMINISTRATOR AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Administration of Plan</font>. The Plan shall be administered by the Administrator.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Powers of Administrator</font>. The Administrator shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority:</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)&#160;&#160;&#160;&#160;to select the individuals to whom Awards may from time to time be granted;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)&#160;&#160;&#160;&#160;to determine the time or times of grant, and the extent, if any, of Incentive Stock Options,&#160;Non-Qualified&#160;Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Units, Unrestricted Stock Awards, Cash-Based Awards and Dividend Equivalent Rights, or any combination of the foregoing, granted to any one or more grantees;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)&#160;&#160;&#160;&#160;to determine the number of shares of Stock to be covered by any Award;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)&#160;&#160;&#160;&#160;to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the forms of Award Certificates;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(v)&#160;&#160;&#160;&#160;to accelerate at any time the exercisability or vesting of all or any portion of any Award;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vi)&#160;&#160;&#160;&#160;subject to the provisions of Section&#160;5(c), to extend at any time the period in which Stock Options may be exercised; and</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(vii)&#160;&#160;&#160;&#160;at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including related written instruments); to make all determinations it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and to otherwise supervise the administration of the Plan.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">All decisions and interpretations of the Administrator shall be binding on all persons, including the Company and Plan grantees.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Delegation of Authority to Grant Awards</font>. Subject to applicable law, the Administrator, in its discretion, may delegate to a committee consisting of one or more officers of the Company, including the Chief Executive Officer of the Company, all or part of the Administrator&#8217;s authority and duties with respect to the granting of Awards to individuals who are (i) not subject to the reporting and other provisions of Section&#160;16 of the Exchange Act and (ii) not members of the delegated committee. Any such delegation by the Administrator shall include a limitation as to the amount of Stock underlying Awards that may be granted during the period of the delegation and shall contain guidelines as to the determination of the exercise price and the vesting criteria. The Administrator may revoke or amend the terms of a delegation at any time but such action shall not invalidate any prior actions of the Administrator&#8217;s delegate or delegates that were consistent with the terms of the Plan.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Award Certificate</font>. Awards under the Plan shall be evidenced by Award Certificates that set forth the terms, conditions and limitations for each Award which may include, without limitation, the term of an Award and the provisions applicable in the event employment or service terminates.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Indemnification</font>. Neither the Board nor the Administrator, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Administrator (and any delegate thereof) shall be entitled in all cases to indemnification </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys&#8217; fees) arising or resulting therefrom to the fullest extent permitted by law and/or under the Company&#8217;s articles or bylaws or any directors&#8217; and officers&#8217; liability insurance coverage which may be in effect from time to time and/or any indemnification agreement between such individual and the Company.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Foreign Award Recipients</font>. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company and its Subsidiaries operate or have employees or other individuals eligible for Awards, the Administrator, in its sole discretion, shall have the power and authority to: (i)&#160;determine which Subsidiaries shall be covered by the Plan; (ii)&#160;determine which individuals outside the United States are eligible to participate in the Plan; (iii)&#160;modify the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws; (iv)&#160;establish subplans and modify exercise procedures and other terms and procedures, to the extent the Administrator determines such actions to be necessary or advisable (and such subplans and/or modifications shall be attached to this Plan as appendices); provided, however, that no such subplans and/or modifications shall increase the share limitations contained in Section&#160;3(a) hereof; and (v)&#160;take any action, before or after<font style="font-weight:bold;">&#160;</font>an Award is made, that the Administrator determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, the Administrator may not take any actions hereunder, and no Awards shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or any other applicable United States governing statute or law.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;3.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">STOCK ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Stock Issuable</font>. The maximum number of shares of Stock reserved and available for issuance under the Plan shall be 5,136,003 shares of Stock (the &#8220;Initial Limit&#8221;), subject to adjustment as provided in Section&#160;3(c), plus on January&#160;1, 2022 and each January&#160;1 thereafter, the number of shares of Stock reserved and available for issuance under the Plan shall be cumulatively increased by 5% of the number of shares of Stock issued and outstanding on the immediately preceding December&#160;31 (the &#8220;Annual Increase&#8221;). Subject to such overall limitation, the maximum aggregate number of shares of Stock that may be issued in the form of Incentive Stock Options shall not exceed the Initial Limit cumulatively increased on January&#160;1, 2022 and on each January&#160;1 thereafter by the lesser of the Annual Increase for such year or 3,150,000 shares of Stock, subject in all cases to adjustment as provided in Section&#160;3(c). For purposes of this limitation, the shares of Stock underlying any Awards that are forfeited, canceled, held back upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) under each of the Plan and the 2017 Plan shall be added back to the shares of Stock available for issuance under the Plan. In the event the Company repurchases shares of Stock on the open market, such shares shall not be added to the shares of Stock available for issuance under the Plan. Subject to such overall limitations, shares of Stock may be issued up to such maximum number pursuant to any type or types of Award. The shares available for issuance under the Plan may be authorized but unissued shares of Stock or shares of Stock reacquired by the Company.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Maximum Awards to&#160;Non-Employee&#160;Directors</font>. Notwithstanding anything to the contrary in this Plan, the value of all Awards awarded under this Plan and all other cash compensation paid by the Company to any&#160;Non-Employee&#160;Director in any calendar year shall not exceed $1,000,000. For the purpose of this limitation, the value of any Award shall be its grant date fair value, as determined in accordance with ASC 718 or successor provision but excluding the impact of estimated forfeitures related to service-based vesting provisions.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Changes in Stock</font>. Subject to Section&#160;3(d) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in the Company&#8217;s capital stock, the outstanding shares of Stock are increased or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new or different shares or other securities of the Company or other&#160;non-cash&#160;assets are distributed with respect to such shares of Stock or other securities, or, if, as a result of any merger or consolidation, sale of all or substantially all of the assets of the Company, the outstanding shares of Stock are converted into or exchanged for securities of the Company or any successor entity (or a parent or subsidiary thereof), the Administrator shall make an appropriate or proportionate adjustment in (i)&#160;the maximum number of shares reserved for issuance under the Plan, including the maximum number of shares that may be issued in the form of Incentive Stock Options, (ii)&#160;the number and kind of shares or other securities subject to any then outstanding Awards under the Plan, (iii)&#160;the repurchase price, if any, per share subject to each outstanding Restricted Stock Award, and (iv)&#160;the exercise price for each share subject to any then outstanding Stock Options and Stock Appreciation Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of shares subject to Stock Options and Stock Appreciation Rights) as to which such Stock Options and Stock Appreciation Rights remain exercisable. The Administrator shall also make equitable or proportionate adjustments in the number of shares subject to outstanding Awards and the exercise price and the terms of outstanding Awards </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">to take into consideration cash dividends paid other than in the ordinary course or any other extraordinary corporate event. The adjustment by the Administrator shall be final, </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">binding</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and conclusive. No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Administrator in its discretion may make a cash payment in lieu of fractional shares.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Mergers and Other Transactions</font>. In the case of and subject to the consummation of a Sale Event, the parties thereto may cause the assumption or continuation of Awards theretofore granted by the successor entity, or the substitution of such Awards with new Awards of the successor entity or parent thereof, with appropriate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as such parties shall agree. To the extent the parties to such Sale Event do not provide for the assumption, continuation or substitution of Awards, upon the effective time of the Sale Event, the Plan and all outstanding Awards granted hereunder shall terminate. In such case, except as may be otherwise provided in the relevant Award Certificate, all Options and Stock Appreciation Rights with time-based vesting conditions or restrictions that are not vested and/or exercisable immediately prior to the effective time of the Sale Event shall become fully vested and exercisable as of the effective time of the Sale Event, all other Awards with time-based vesting, conditions or restrictions shall become fully vested and nonforfeitable as of the effective time of the Sale Event, and all Awards with conditions and restrictions relating to the attainment of performance goals may become vested and nonforfeitable in connection with a Sale Event in the Administrator&#8217;s discretion or to the extent specified in the relevant Award Certificate. In the event of such termination, (i)&#160;the Company shall have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding Options and Stock Appreciation Rights, in exchange for the cancellation thereof, in an amount equal to the difference between (A)&#160;the Sale Price multiplied by the number of shares of Stock subject to outstanding Options and Stock Appreciation Rights (to the extent then exercisable at prices not in excess of the Sale Price) and (B)&#160;the aggregate exercise price of all such outstanding Options and Stock Appreciation Rights (provided that, in the case of an Option or Stock Appreciation Right with an exercise price equal to or greater than the Sale Price, such Option or Stock Appreciation Right shall be cancelled for no consideration); or (ii)&#160;each grantee shall be permitted, within a specified period of time prior to the consummation of the Sale Event as determined by the Administrator, to exercise all outstanding Options and Stock Appreciation Rights (to the extent then exercisable) held by such grantee. The Company shall also have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding other Awards in an amount equal to the Sale Price multiplied by the number of vested shares of Stock under such Awards.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;4.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">ELIGIBILITY</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Grantees under the Plan will be such employees,&#160;Non-Employee&#160;Directors or Consultants of the Company and its Affiliates as are selected from time to time by the Administrator in its sole discretion; provided that Awards may not be granted to employees, Non-Employee Directors or Consultants who are providing services only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405 of the Act, unless (i) the stock underlying the Awards is treated as &#8220;service recipient stock&#8221; under Section 409A or (ii) the Company has determined that such Awards are exempt from or otherwise comply with Section 409A.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;5.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">STOCK OPTIONS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Award of Stock Options</font>. The Administrator may grant Stock Options under the Plan. Any Stock Option granted under the Plan shall be in such form as the Administrator may from time to time approve.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options granted under the Plan may be either Incentive Stock Options or&#160;Non-Qualified&#160;Stock Options. Incentive Stock Options may be granted only to employees of the Company or any Subsidiary that is a &#8220;subsidiary corporation&#8221; within the meaning of Section&#160;424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a&#160;Non-Qualified&#160;Stock Option.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options granted pursuant to this Section&#160;5 shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Administrator shall deem desirable. If the Administrator so determines, Stock Options may be granted in lieu of cash compensation at the optionee&#8217;s election, subject to such terms and conditions as the Administrator may establish.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Exercise Price</font>. The exercise price per share for the Stock covered by a Stock Option granted pursuant to this Section&#160;5 shall be determined by the Administrator at the time of grant but shall not be less than 100&#160;percent of the Fair Market Value on the date of grant. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the exercise price of such Incentive Stock Option shall be not less than 110&#160;percent of the Fair Market Value on the grant date.&nbsp;&nbsp;Notwithstanding </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the foregoing, Stock Options may be granted with an exercise price per share that is less than 100 percent of the Fair Market Value on the date of grant (</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">i</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">) pursuant to a transaction described in, and in a manner consistent with, Section 424(a) of the Code, (ii) to individuals who are not subject to U.S. income tax on the date of grant or (iii) the Stock Option is otherwise compliant with Section 409A.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Option Term</font>. The term of each Stock Option shall be fixed by the Administrator, but no Stock Option shall be exercisable more than ten years after the date the Stock Option is granted. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option shall be no more than five years from the date of grant.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Exercisability; Rights of a Stockholder</font>. Stock Options shall become exercisable at such time or times, whether or not in installments, as shall be determined by the Administrator at or after the grant date. The Administrator may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have the rights of a stockholder only as to shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Method of Exercise</font>. Stock Options may be exercised in whole or in part, by giving written or electronic notice of exercise to the Company, specifying the number of shares to be purchased. Payment of the purchase price may be made by one or more of the following methods except to the extent otherwise provided in the Award Certificate:</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)&#160;&#160;&#160;&#160;In cash, by certified or bank check or other instrument acceptable to the Administrator;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)&#160;&#160;&#160;&#160;Through the delivery (or attestation to the ownership following such procedures as the Company may prescribe) of shares of Stock that are not then subject to restrictions under any Company plan. Such surrendered shares shall be valued at Fair Market Value on the exercise date;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)&#160;&#160;&#160;&#160;By the optionee delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price; provided that in the event the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Company shall prescribe as a condition of such payment procedure; or</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iv)&#160;&#160;&#160;&#160;With respect to Stock Options that are not Incentive Stock Options, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Payment instruments will be received subject to collection. The transfer to the optionee on the records of the Company or of the transfer agent of the shares of Stock to be purchased pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser acting in his stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such shares and the fulfillment of any other requirements contained in the Award Certificate or applicable provisions of laws (including the satisfaction of any withholding taxes that the Company is obligated to withhold with respect to the optionee). In the event an optionee chooses to pay the purchase price by previously-owned shares of Stock through the attestation method, the number of shares of Stock transferred to the optionee upon the exercise of the Stock Option shall be net of the number of attested shares. In the event that the Company establishes, for itself or using the services of a third party, an automated system for the exercise of Stock Options, such as a system using an internet website or interactive voice response, then the paperless exercise of Stock Options may be permitted through the use of such an automated system.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Annual Limit on Incentive Stock Options</font>. To the extent required for &#8220;incentive stock option&#8221; treatment under Section&#160;422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options granted under this Plan and any other plan of the Company or its parent and subsidiary corporations become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this limit, it shall constitute a&#160;Non-Qualified&#160;Stock Option.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;6.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">STOCK APPRECIATION RIGHTS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Award of Stock Appreciation Rights</font>. The Administrator may grant Stock Appreciation Rights under the Plan. A Stock Appreciation Right is an Award entitling the recipient to receive shares of Stock (or csh, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of a share of Stock on the </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">55</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock Appreciation Right shall have been exercised.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Exercise Price of Stock Appreciation Rights</font>. The exercise price of a Stock Appreciation Right shall not be less than 100&#160;percent of the Fair Market Value of the Stock on the date of grant.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Grant and Exercise of Stock Appreciation Rights</font>. Stock Appreciation Rights may be granted by the Administrator independently of any Stock Option granted pursuant to Section&#160;5 of the Plan.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Terms and Conditions of Stock Appreciation Rights</font>. Stock Appreciation Rights shall be subject to such terms and conditions as shall be determined on the date of grant by the Administrator. The term of a Stock Appreciation Right may not exceed ten years. The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;7.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">RESTRICTED STOCK AWARDS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Nature of Restricted Stock Awards</font>. The Administrator may grant Restricted Stock Awards under the Plan. A Restricted Stock Award is any Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant. Conditions may be based on continuing employment (or other Service Relationship) and/or achievement of&#160;pre-established&#160;performance goals and objectives.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Rights as a Stockholder</font>. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee shall have the rights of a stockholder with respect to the voting of the Restricted Shares and receipt of dividends; provided that if the lapse of restrictions with respect to the Restricted Stock Award is tied to the attainment of performance goals, any dividends paid by the Company during the performance period shall accrue and shall not be paid to the grantee until and to the extent the performance goals are met with respect to the Restricted Stock Award. Unless the Administrator shall otherwise determine, (i)&#160;uncertificated Restricted Shares shall be accompanied by a notation on the records of the Company or the transfer agent to the effect that they are subject to forfeiture until such Restricted Shares are vested as provided in Section&#160;7(d) below, and (ii)&#160;certificated Restricted Shares shall remain in the possession of the Company until such Restricted Shares are vested as provided in Section&#160;7(d) below, and the grantee shall be required, as a condition of the grant, to deliver to the Company such instruments of transfer as the Administrator may prescribe.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Restrictions</font>. Restricted Shares may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or in the Restricted Stock Award Certificate. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;16 below, in writing after the Award is issued, if a grantee&#8217;s employment (or other Service Relationship) with the Company and its Subsidiaries terminates for any reason, any Restricted Shares that have not vested at the time of termination shall automatically and without any requirement of notice to such grantee from or other action by or on behalf of, the Company be deemed to have been reacquired by the Company at its original purchase price (if any) from such grantee or such grantee&#8217;s legal representative simultaneously with such termination of employment (or other Service Relationship), and thereafter shall cease to represent any ownership of the Company by the grantee or rights of the grantee as a stockholder. Following such deemed reacquisition of Restricted Shares that are represented by physical certificates, a grantee shall surrender such certificates to the Company upon request without consideration.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Vesting of Restricted Shares</font>. The Administrator at the time of grant shall specify the date or dates and/or the attainment of&#160;pre-established&#160;performance goals, objectives and other conditions on which the&#160;non-transferability&#160;of the Restricted Shares and the Company&#8217;s right of repurchase or forfeiture shall lapse. Subsequent to such date or dates and/or the attainment of such&#160;pre-established&#160;performance goals, objectives and other conditions, the shares on which all restrictions have lapsed shall no longer be Restricted Shares and shall be deemed &#8220;vested.&#8221;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;8.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">RESTRICTED STOCK UNITS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Nature of Restricted Stock Units</font>. The Administrator may grant Restricted Stock Units under the Plan. A Restricted Stock Unit is an Award of stock units that may be settled in shares of Stock (or cash, to the extent explicitly provided for in the applicable Award Certificate) upon the satisfaction of such restrictions and conditions at the time of grant. Conditions may be based on continuing employment (or other Service Relationship) and/or achievement of&#160;pre-established&#160;performance goals and objectives. The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees. Except in the case of Restricted Stock Units with a deferred </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">settlement date that complies with Section&#160;409A, at the end of the vesting period, the Restricted Stock Units, to the extent vested, shall be settled in the form of shares of Stock. Restricted Stock Units with deferred settlement dates are subject to Section&#160;409A and shall contain such additional terms and conditions as the Administrator shall determine in its sole discretion </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in order to</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> comply with the requirements of Section&#160;409A.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Election to Receive Restricted Stock Units in Lieu of Compensation</font>. The Administrator may, in its sole discretion, permit a grantee to elect to receive a portion of future cash compensation otherwise due to such grantee in the form of an award of Restricted Stock Units. Any such election shall be made in writing and shall be delivered to the Company no later than the date specified by the Administrator and in accordance with Section&#160;409A and such other rules and procedures established by the Administrator. Any such future cash compensation that the grantee elects to defer shall be converted to a fixed number of Restricted Stock Units based on the Fair Market Value of Stock on the date the compensation would otherwise have been paid to the grantee if such payment had not been deferred as provided herein. The Administrator shall have the sole right to determine whether and under what circumstances to permit such elections and to impose such limitations and other terms and conditions thereon as the Administrator deems appropriate. Any Restricted Stock Units that are elected to be received in lieu of cash compensation shall be fully vested, unless otherwise provided in the Award Certificate.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Rights as a Stockholder</font>. A grantee shall have the rights as a stockholder only as to shares of Stock acquired by the grantee upon settlement of Restricted Stock Units; provided, however, that the grantee may be credited with Dividend Equivalent Rights with respect to the stock units underlying his Restricted Stock Units, subject to the provisions of Section&#160;11 and such terms and conditions as the Administrator may determine.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Termination</font>. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;18 below, in writing after the Award is issued, a grantee&#8217;s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;9.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">UNRESTRICTED STOCK AWARDS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Grant or Sale of Unrestricted Stock</font>. The Administrator may grant (or sell at par value or such higher purchase price determined by the Administrator) an Unrestricted Stock Award under the Plan. An Unrestricted Stock Award is an Award pursuant to which the grantee may receive shares of Stock free of any restrictions under the Plan. Unrestricted Stock Awards may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;10.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">CASH-BASED AWARDS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Grant of Cash-Based Awards</font>. The Administrator may grant Cash-Based Awards under the Plan. A Cash-Based Award is an Award that entitles the grantee to a payment in cash upon the attainment of specified performance goals. The Administrator shall determine the maximum duration of the Cash-Based Award, the amount of cash to which the Cash-Based Award pertains, the conditions upon which the Cash-Based Award shall become vested or payable, and such other provisions as the Administrator shall determine. Each Cash-Based Award shall specify a cash-denominated payment amount, formula or payment ranges as determined by the Administrator. Payment, if any, with respect to a Cash-Based Award shall be made in accordance with the terms of the Award and may be made in cash.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;11.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">DIVIDEND EQUIVALENT RIGHTS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Dividend Equivalent Rights</font>. The Administrator may grant Dividend Equivalent Rights under the Plan. A Dividend Equivalent Right is an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other Award to which it relates) if such shares had been issued to the grantee. A Dividend Equivalent Right may be granted hereunder to any grantee as a component of an award of Restricted Stock Units or as a freestanding award. The terms and conditions of Dividend Equivalent Rights shall be specified in the Award Certificate. Dividend equivalents credited to the holder of a Dividend Equivalent Right may be paid currently or may be deemed to be reinvested in additional shares of Stock, which may thereafter accrue additional equivalents. Any such reinvestment shall be at Fair Market Value on the date of reinvestment or such other price as may then apply under a dividend reinvestment plan sponsored by the Company, if any. Dividend Equivalent Rights may be settled in cash or shares of Stock or a combination thereof, in a single installment or installments. A Dividend Equivalent Right granted as a component of an Award of Restricted Stock Units shall provide that such Dividend Equivalent Right shall be settled only upon settlement or payment </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of, or lapse of restrictions on, such other Award, and that such Dividend Equivalent Right shall expire or be forfeited or annulled under the same conditions as such other Award.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Termination</font>. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section&#160;16 below, in writing after the Award is issued, a grantee&#8217;s rights in all Dividend Equivalent Rights shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;12.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">TRANSFERABILITY OF AWARDS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Transferability</font>. Except as provided in Section&#160;12(b) below, during a grantee&#8217;s lifetime, his or her Awards shall be exercisable only by the grantee, or by the grantee&#8217;s legal representative or guardian in the event of the grantee&#8217;s incapacity. No Awards shall be sold, assigned, transferred or otherwise encumbered or disposed of by a grantee other than by will or by the laws of descent and distribution or pursuant to a domestic relations order. No Awards shall be subject, in whole or in part, to attachment, execution, or levy of any kind, and any purported transfer in violation hereof shall be null and void.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Administrator Action</font>. Notwithstanding Section&#160;12(a), the Administrator, in its discretion, may provide either in the Award Certificate regarding a given Award or by subsequent written approval that the grantee (who is an employee or director) may transfer his or her&#160;Non-Qualified&#160;Stock Options to his or her immediate family members, to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award. In no event may an Award be transferred by a grantee for value.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Family Member</font>. For purposes of Section&#160;12(b), &#8220;family member&#8221; shall mean a grantee&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew,&#160;mother-in-law,&#160;father-in-law,&#160;son-in-law,&#160;daughter-in-law,&#160;brother-in-law,&#160;or&#160;sister-in-law,&#160;including adoptive relationships, any person sharing the grantee&#8217;s household (other than a tenant of the grantee), a trust in which these persons (or the grantee) have more than 50&#160;percent of the beneficial interest, a foundation in which these persons (or the grantee) control the management of assets, and any other entity in which these persons (or the grantee) own more than 50&#160;percent of the voting interests.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Designation of Beneficiary</font>. To the extent permitted by the Company, each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise any Award or receive any payment under any Award payable on or after the grantee&#8217;s death. Any such designation shall be on a form provided for that purpose by the Administrator and shall not be effective until received by the Administrator. If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee&#8217;s estate.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;13.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">TAX WITHHOLDING</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Payment by Grantee</font>. Each grantee shall, no later than the date as of which the value of an Award or of any Stock or other amounts received thereunder first becomes includable in the gross income of the grantee for Federal income tax purposes, pay to the Company, or make arrangements satisfactory to the Administrator regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by the Company with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company&#8217;s obligation to deliver evidence of book entry (or stock certificates) to any grantee is subject to and conditioned on tax withholding obligations being satisfied by the grantee.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Payment in Stock</font>. The Administrator may require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by the Company withholding from shares of Stock to be issued pursuant to any Award a number of shares with an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding amount due; provided, however, that the amount withheld does not exceed the maximum statutory tax rate or such lesser amount as is necessary to avoid liability accounting treatment. For purposes of share withholding, the Fair Market Value of withheld shares shall be determined in the same manner as the value of Stock includible in income of the grantees.&nbsp;&nbsp;The Administrator may also require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by an arrangement whereby a certain number of shares of Stock issued pursuant to any Award are immediately sold and proceeds from such sale are remitted to the Company in an amount that would satisfy the withholding amount due.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;14.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">SECTION&#160;409A AWARDS</font></p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Awards are intended to be exempt from Section 409A to the greatest extent possible and to otherwise comply with Section 409A.&nbsp;&nbsp;The Plan and all Awards shall be interpreted in accordance with such intent.&nbsp;&nbsp;To the extent that any Award is determined to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section&#160;409A (a &#8220;409A Award&#8221;), the Award shall be subject to such additional rules and requirements as specified by the Administrator from time to time in order to comply with Section&#160;409A. In this regard, if any amount under a 409A Award is payable upon a &#8220;separation from service&#8221; (within the meaning of Section&#160;409A) to a grantee who is then considered a &#8220;specified employee&#8221; (within the meaning of Section&#160;409A), then no such payment shall be made prior to the date that is the earlier of (i)&#160;six months and one day after the grantee&#8217;s separation from service, or (ii)&#160;the grantee&#8217;s death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties and/or additional tax imposed pursuant to Section&#160;409A. Further, the settlement of any such Award may not be accelerated except to the extent permitted by Section&#160;409A.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;15.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">TERMINATION OF SERVICE RELATIONSHIP, TRANSFER, LEAVE OF ABSENCE, ETC.</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Termination of Service Relationship</font>. If the grantee&#8217;s Service Relationship is with an Affiliate and such Affiliate ceases to be an Affiliate, the grantee shall be deemed to have terminated his or her Service Relationship for purposes of the Plan.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;For purposes of the Plan, the following events shall not be deemed a termination of a Service Relationship:</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)&#160;&#160;&#160;&#160;a transfer to the employment of the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another; or</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:9.58%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)&#160;&#160;&#160;&#160;an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the employee&#8217;s right to&#160;re-employment&#160;is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise so provides in writing.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;16.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">AMENDMENTS AND TERMINATION</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board may, at any time, amend or discontinue the Plan and the Administrator may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall materially and adversely affect rights under any outstanding Award without the holder&#8217;s consent. Except as provided in Section&#160;3(c) or 3(d), without prior stockholder approval, in no event may the Administrator exercise its discretion to reduce the exercise price of outstanding Stock Options or Stock Appreciation Rights or effect repricing through cancellation and&#160;re-grants&#160;or cancellation of Stock Options or Stock Appreciation Rights in exchange for cash or other Awards. To the extent required under the rules of any securities exchange or market system on which the Stock is listed, to the extent determined by the Administrator to be required by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section&#160;422 of the Code, Plan amendments shall be subject to approval by the Company&#8217;s stockholders. Nothing in this Section&#160;16 shall limit the Administrator&#8217;s authority to take any action permitted pursuant to Section&#160;3(c) or 3(d).</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;17.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">STATUS OF PLAN</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise expressly determine in connection with any Award or Awards. In its sole discretion, the Administrator may authorize the creation of trusts or other arrangements to meet the Company&#8217;s obligations to deliver Stock or make payments with respect to Awards hereunder, provided that the existence of such trusts or other arrangements is consistent with the foregoing sentence.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;18.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">GENERAL PROVISIONS</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(a)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">No Distribution</font>. The Administrator may require each person acquiring Stock pursuant to an Award to represent to and agree with the Company in writing that such person is acquiring the shares without a view to distribution thereof.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(b)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Issuance</font>. To the extent certificated, stock certificates to grantees under this Plan shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company. Uncertificated Stock shall be </p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">deemed delivered for all purposes when the Company or a Stock transfer agent of the Company shall have given to the grantee by electronic mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic &#8220;book entry&#8221; records). Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any evidence of book entry or certificates evidencing shares of Stock pursuant to the exercise or settlement of any Award, unless and until the Administrator has determined, with advice of counsel (to the extent the Administrator deems such advice necessary or advisable), that the issuance and delivery is in compliance with all applicable laws, regulations of governmental authorities and, if applicable, the requirements of any exchange on which the shares of Stock are listed, quoted or traded. Any Stock issued pursuant to the Plan shall be subject to any stop-transfer orders and other restrictions as the Administrator deems necessary or advisable to comply with federal, </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">state</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or foreign jurisdiction, securities or other laws, rules and quotation system on which the Stock is listed, quoted or traded. The Administrator may place legends on any Stock certificate or notations on any book entry to reference restrictions applicable to the Stock. In addition to the terms and conditions provided herein, the Administrator may require that an individual make such reasonable covenants, agreements, and representations as the Administrator, in its discretion, deems necessary or advisable </font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">in order to</font><font style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> comply with any such laws, regulations, or requirements. The Administrator shall have the right to require any individual to comply with any timing or other restrictions with respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Administrator.</font></p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(c)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Stockholder Rights</font>. Until Stock is deemed delivered in accordance with Section&#160;18(b), no right to vote or receive dividends or any other rights of a stockholder will exist with respect to shares of Stock to be issued in connection with an Award, notwithstanding the exercise of a Stock Option or any other action by the grantee with respect to an Award.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Other Compensation Arrangements; No Employment Rights</font>. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases. The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued employment with the Company or any Subsidiary.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(e)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Trading Policy Restrictions</font>. Option exercises and other Awards under the Plan shall be subject to the Company&#8217;s insider trading policies and procedures, as in effect from time to time.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(f)&#160;&#160;&#160;&#160;<font style="text-decoration:underline;">Clawback Policy</font>. Awards under the Plan shall be subject to the Company&#8217;s clawback policy, as in effect from time to time.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:18pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;19.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">EFFECTIVE DATE OF PLAN</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Plan, as amended and restated, shall become effective upon approval by the holders of a majority of the votes cast at a meeting of stockholders at which a quorum is present.&nbsp;&nbsp;No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the Effective Date and no grants of Incentive Stock Options may be made hereunder after the tenth anniversary of the date the Plan, as amended and restated, is approved by the Board.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:18pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:13%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">SECTION&#160;20.</p></td>
<td valign="top"  BGCOLOR="#FFFFFF" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">GOVERNING LAW</font></p></td>
</tr>
</table></div>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:4.79%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Plan and all Awards and actions taken thereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware, applied without regard to conflict of law principles.</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DATE APPROVED BY BOARD OF DIRECTORS: December&#160;21, 2017</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DATE APPROVED BY STOCKHOLDERS: January 12, 2018</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">AMENDED AND RESTATED BY THE BOARD OF DIRECTORS: March 2, 2021</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">DATE STOCKHOLDERS APPROVED AMENDED AND RESTATED PLAN:</p>
<p style="Background-color:#FFFFFF;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60</a></p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu3c32wcjg3v000003.jpg" title="" alt="" style="width:672px;height:870px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FFFFFF;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ADICET BIO, INC. 500 BOYLSTON STREET, 13TH FLOOR BOSTON, MASSACHUSETTS 02116&nbsp;&nbsp;VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com&nbsp;&nbsp;Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 p.m. Eastern Time on April 26, 2021. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.&nbsp;&nbsp; During The Meeting -Go to www.virtualshareholdermeeting.com/ACET2021&nbsp;&nbsp;You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.&nbsp;&nbsp; VOTE BY PHONE - 1-800-690-6903&nbsp;&nbsp;Use any touch-tone telephone to transmit your voting instructions. Vote by&nbsp;&nbsp;11:59 p.m. Eastern Time on April 26, 2021. Have your proxy card in hand when you call and then follow the instructions.&nbsp;&nbsp; VOTE BY MAIL&nbsp;&nbsp;Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.&nbsp;&nbsp;D40630-P50112&nbsp;&nbsp; ADICET BIO, INC. For Withhold For All&nbsp;&nbsp;To withhold authority to vote for any individual All All Except nominee(s), mark "For All Except" and write theThe Board of Directors recommends you vote FOR number(s) of the nominee(s) on the line below. the following:&nbsp;&nbsp;1. To elect two class III directors, to serve for a three-year !!! term ending at the Annual Meeting of Stockholders to be held in 2024.&nbsp;&nbsp; Nominees:&nbsp;&nbsp;01) Bastiano Sanna&nbsp;&nbsp;02) Andrew Sinclair&nbsp;&nbsp; The Board of Directors recommends you vote FOR proposals 2, 3 and 4. For Against Abstain&nbsp;&nbsp;2. To approve the Amendment and Restatement of the Company's 2018 Employee Stock Purchase Plan.&nbsp;&nbsp;!!!&nbsp;&nbsp;3.&nbsp;&nbsp;To approve the Amendment and Restatement of the Company's 2018 Stock Option and Incentive Plan. !!!&nbsp;&nbsp; 4.&nbsp;&nbsp;To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021.&nbsp;&nbsp;&nbsp;&nbsp;!!!&nbsp;&nbsp;NOTE: Such other business as may properly come before the meeting or any adjournment thereof.&nbsp;&nbsp;Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gu3c32wcjg3v000004.jpg" title="" alt="" style="width:672px;height:870px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#FFFFFF;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:&nbsp;&nbsp;The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com.&nbsp;&nbsp;D40631-P50112&nbsp;&nbsp;&nbsp;&nbsp;ADICET BIO, INC. ANNUAL MEETING OF STOCKHOLDERS APRIL 27, 2021, 3:00 PM EDT This proxy is solicited by the Board of Directors&nbsp;&nbsp;The stockholder(s) hereby appoint(s) Chen Schor and Nick Harvey, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of ADICET BIO, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held in a virtual format only at 3:00 PM, EDT on April 27, 2021, and any adjournment or postponement thereof.&nbsp;&nbsp;&nbsp;&nbsp;All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the proxies will be voted in accordance with the recommendation of our Board of Directors with respect to each of the matters set forth in the accompanying Notice of Meeting.&nbsp;&nbsp;Continued and to be signed on reverse side</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>gu3c32wcjg3v000002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu3c32wcjg3v000002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "O UD# 2(  A$! Q$!_\0
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MUI]U;26DQ0@\>U1I\Y]Z\R<VI6/LZ4*7LSN_ ^K2W-^8-YPO:O4HSE!FO(?
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M%<DG<HDR<THZT=:45  :.U!H[4!T&2_ZE_\ =-?/WQ%_X^6_WJ^@)?\ 4O\
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M_CY/^]6U+<&<$3Z5?T4/_;%J1_?J@14]G<&VNXI <;3FNQZHD^HM 8FP3/\
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MEB9K='^M:.TYZTX4DV%C#;PII+')LHZGC\.:5%REG&,5JXI<55V!6BLH(O\
M5QA?I4I4[^#Q3L&E I,!<T=:4TF: %IO6G44 ,]<U3GTVVN#^\B5OK5_B@T(
M#*_L#3>]JE._L+3,?\>B5I4M%V!EC0M-(_X]$H_L'3<_\>J5J<>E%%V!EG0=
M-'/V5*D33+&,82W45H4TBB[ CBACC^ZH%.[T_% QGI1<!K L.#BDP?6GFE%(
M"&2"*9<2(&^M4?[#TYB2UJAK4XHIH#*&AZ>L@9+9!BM".-(UVHN!4F.:6AW
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4I-M.HI@)B@BEHH 0"C%+10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gu3c32wcjg3v000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu3c32wcjg3v000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "O UD# 2(  A$! Q$!_\0
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MUI]U;26DQ0@\>U1I\Y]Z\R<VI6/LZ4*7LSN_ ^K2W-^8-YPO:O4HSE!FO(?
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M%<DG<HDR<THZT=:45  :.U!H[4!T&2_ZE_\ =-?/WQ%_X^6_WJ^@)?\ 4O\
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M_CY/^]6U+<&<$3Z5?T4/_;%J1_?J@14]G<&VNXI <;3FNQZHD^HM 8FP3/\
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MEB9K='^M:.TYZTX4DV%C#;PII+')LHZGC\.:5%REG&,5JXI<55V!6BLH(O\
M5QA?I4I4[^#Q3L&E I,!<T=:4TF: %IO6G44 ,]<U3GTVVN#^\B5OK5_B@T(
M#*_L#3>]JE._L+3,?\>B5I4M%V!EC0M-(_X]$H_L'3<_\>J5J<>E%%V!EG0=
M-'/V5*D33+&,82W45H4TBB[ CBACC^ZH%.[T_% QGI1<!K L.#BDP?6GFE%(
M"&2"*9<2(&^M4?[#TYB2UJAK4XHIH#*&AZ>L@9+9!BM".-(UVHN!4F.:6AW
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4I-M.HI@)B@BEHH 0"C%+10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gu3c32wcjg3v000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu3c32wcjg3v000003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" J?"#0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ J*YF^S6TLYCDD\M2VR-<LV.P'<U+2'D$4
M8'ACQCI7BZVN)M+>0FVD\N6.5=KH?<?@?RI=0\7Z=I_B6R\/LEQ-J%XN]$AC
MW!5SR6.> .OTKS7P9$_A+XP:WH+LMKIMW$;F(2NI+X/R_,3G."_'^%3>!8V\
M4_%7Q!XID@C$5JQM;66*3*;E&SGUR@SZ<\4 =WXC^('A_P +RF"_NB]UE?\
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M0^$.K>'=;C^SZKI$L$)1D()B#J 3V]O?KWK.\7OY?@WX=R[2VRWE?:G5L,G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4'I110!Y%\5?#6L2ZWI7B7P[IJWEW
M)(9E4%F;(POR@] "_P"8KI/A;X8N/#'@NUM[RT6&^E+2W(!))))VY]PNT8]J
M[FB@#QEO#/BGX?>,K_6/#M@-0T.]D!DL(<[^<].I^7GG_:Z4V_T/Q;\3?$=E
M-K&E?V3X?LIE)M+G)>4CDGC!.[D9&,9[XKVBD8XYH Y7QYIUS??#_5=/TZW:
M65[;RXH8QEB1C %4?A1IM[HWP_LK+4+5[:X1Y6>)Q@KER:[9>. 0>_2GT >
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M4]A5R+7-/UC28)+75XE%S*($GMW',H&XJN003@'\*R]8@G:V\-Z--+YU^]Q
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M#41:?P[;-*L,;_.GW]N W0@J3]>M 'J%KXFT>]TF;5;?4[:73X21)<(_R)@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6WGGEOWF),TMWAC+QCE0 N,8&  ./6LU/![)/C^W=3-ANR+ NGE@#D+NV[\
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MO[.?*%+@J-L6,",% ORC\_>MRB@#F$\%6Q817=[>WNGQN&M[*>0>7"5(*X(
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M93Q\QKTVB@#RSQ!X0U+Q+H&EZ->>'YX[?3D58GCU2+<V%V\Y3TI?$WA/5/%
MTH7>@3Q?V9_JC%J<66^[][*'^Z.E>I44 16YE:"-IH_+D* M'N#;3CD9[U+1
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% #%<L6&W&TXY[^]&\^9LV]1D'^E8?AFZ
MGNI-:\^0OY6IRQ(3_"@"X'ZTW[9-_P )ZUGYC&W73!($[;_,(S^7% '0T5B#
MQ;H?]H_8!?#S]VS_ %;[,_[^-OZU9U37]-T;R_M]QY9D.%549R??"@\>] &D
M>E1[SC.![9-06.I6FIV2W=G*)8&X# $?F#R/QKGO&7BN/PW96^)@EU)<0 (T
M3,/*,JJYR!C(4F@#J2^"H^7DX/-.!R,UQ_B34[2>QT#4(I\6K:G"QE8%/EP_
M4'!Q6]I>OZ9JZO\ 8+CS3']Y2C(1^# ''O0!ITA. 367JGB/2M&>-+ZZ\MY!
ME46-G./4A0<#ZU<L[ZVU&SCNK202PR#*L./T/(^AH F,A&WY3R?RI]8'B:YN
M+0:28)"GFZG!$_\ M(2<BKFH^(=+TJ80WMTL<IC\U4VDLR[@N0!R>2* - L0
MV /QI58MGIC/%9J:[ITVF2:I#<;[2-27=4;(QU&W&<^V*R?"7BZW\027\/G;
MYH;J98P(64>2K84DD=>1QUH ZJBL1_%VAQZ@;%KX"</L/[MMN?\ >QM_6KNH
M:Q8:4D3WURD*S/Y<9;^)L%L#WP#^5 %ZBLO_ (2'2QIT.H/=".TFD$:2R*4!
M8G:!R,C)]:73?$.EZO(\=C<^:\?WE*,AQZX8#(^E &G36)49&*R=2\4:/I-S
M]GO;O9+C.U8G?'UV@X_&L[Q?XNMM"T+[3!<I]HEVF#]VSJXWJ&Y P.#WH Z;
M><XQGTQ06;L,\XJI9:A;ZE9I=VDAEMWSL?85R1QT.#UK!\3>,+30K_3;7[0%
MEFND6<-"YQ$RN<@@8SE1Q0!UE%5O[0M1:)=/.B0.H97<[1@].O2J6G^)=(U2
M5HK2\5G4XVNI0L?;<!GH>E &JQVJ3Z4U7)/08SC@U'<7,4%M)/*2J1H68XS@
M 9/ KFO"_B^VUR^U"T-P'FANI%A A=<Q!4P22,9RQXH ZRBLFX\3:/:WQLI;
MU1<B1(C$%9F#, 5S@< Y'/2J\WC/0;>[>VDO3YJ'!VPNR_\ ?07'ZT ;U%4K
MO5["PL1>W-S'':ED42D_+EB%7GT)(YJ#3O$6E:K</;V=T'F09*%&4X]L@9Z=
MJ -2BL?4_%&CZ/.L%[=F.1AG:L3N1]=H./QI]UXDTBRA@EGO46.XC:2$X)\P
M+C=@#DD9''6@#5I"?P ZYK'7Q3HS:<U^+T"W5MI)1@V?]W&[]*GM=6T_5K<O
M:7*2QXRV.&4>ZGD?B* +Y?\ NC-*&)."*XW6O%MCH/A2SN+34'N&F$1@FG5W
M,L9=59B0.N">M=18W]MJ%K%=VLA>&4$JQ0KG!QT.".10!<HJLE_;/=R6HE'G
MQJ&>,CD ]#[_ (4AU&T%Q+ 9T$D*>9+D\(ON>@H M45CP^*=$GO7LTOX_.3K
MN!"GZ,1M/X&M"6_M8+FWMI9E6:X+")?[VT9/Y"@"Q155]1M8]0AL'E"W4T;2
MQQ'JRJ0&/X%A^=4Y?$VD0WYL7O%^UB583"%8L'8 @' XX(YZ4 :U%5[J]@LK
M9[BX?9$@RQVDX[=OK3;C4;6ULVO)IE6W5=YDZC'MCK^'6@"U2,2,8&<U2N]7
ML;"U%Q=7"Q1LNY<_>8>R]3U[53_X2G1FTYK];P&W0@.?+;<O..4QNZ^U &NL
MF>N.F>#FEW9Y'(KFO!?B6/Q+HB7#3"2Z4'S52)E"_,P&,CG@5:AU;2M/TZ6]
M?4R]J+MH7GG8G;(9-FS..@8[1VH W:*RM.\1Z5JUP\%C=>;+'RRE&7CU&X#/
MX9J34]=TW1D1K^X\K><* C.3[X4$X]Z -&D)P,UG:;K^EZO*\5A=K-(D:R.@
M!!56) )!'&=IX]JLZ@T2:=<O/*T,2Q,SRH<% !RP]QUH F#DG Q3ZRYM3TZQ
MTVTN;B]"V\I2..64G]X6'&3ZFC2_$.EZRSKI]SYI3E@49"!ZX8 D?2@#4II;
M# <<^]9&H>*]&TNZ-M=W928#)58G?'UV@X/M6+-X[T__ (3*WTR.[5[5[:0L
M5A=LS!T"@$#I@MST]Z .Q!)ZC'I3JSK_ %FPTIHEOKE(/,#% <DMM&3C'?VI
MUOK6GW4UO#%< R7$)GB4J060$ GD>K#KZT 7Z*K?;K8W[6(D!NEB$QC[["2
M?S!%4-0\4:-IDZPW5Z!(<_*B-(1CUV@X_&@#69R"1M)XS]:%;)_K7&P>.M/O
M?%ZZ;!=%K:2U4Q_Z/(&,QD(QR.F,=>/>NC>:T37+>%[MUNF@D9(-WRNH*Y8C
MU!(_,T :-%9%SXHT6TNTM9;]/.<XPH+ './F(&%_$BK=SJMC::>]_/=1K:H
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M+'4WG6SG\[R2%<A2!D^A/!_"I;W4+73K1[J\F$4*#+,03^0')/L* +-,WG+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***0D $GH.M '-^%?W=YX@MW^68:E)+Y9X;8P&UL>AVG![X-)&5E^(<
M[QG,<.G+%*5Z*YD+8)[':0<>AJQJ/AJROK[^T$\^TOM@0W-H^R1D'\.?[O.?
MPJUIFCV&BI(EE$(VF8//(>6E?&"S'N30!SRPR^$-*6TO(O[3T%.3/+L#P MT
M9<?.,D8P,]<]JA']N+XYUT6#Z<A*Q-$+Y)"Q3RU!V;2/DW9SVSFM"'P/IL42
MP3S7U]:#YDM;N??&C9R"!CJ*TM2\/V6J3QW$AE@OHDV1W=N^V5%/4!O0\]J
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M+$?VNV?9+L!)V[O3GTJ?3-*BTQ)-DMQ-+(=TDL[[W;'0$^PZ4 4/%Q&W1/\
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MB7;LT:-_Q*Y)>5'WQ(BAOJ%)&?0D5#'%%#\1=7:.-$9])@9RJ@%F\R49/<G
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MJP>[N/.FST+[%7C\%% &)X*@@;PS!/+ GVV\!?4LJ-S7!_UBN/4$GCMTK O
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MVJ9=9BO8%E49QCFNTCM+'13JFI.[(MTXNKEFRV,(J\ #IA16)HD-KK'C*_\
M$5O$#$MO';07 4KYH/+A@1DE2JXZ=30!UH#>F>QJ0=*6B@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MSVZURH74?$>KZA$NI36>EV<@@7[.-L[3K]X[N1LP1@8YYZ8Y .I/'?\ ^O2
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M>9&2KHQ2:)^&B<?PL/U]P0>AJ6_U"#3K1KBX;"@@!1RS,> %'<UR.H07VC>
M?$.J%FAU:[26ZD*'[K!=J >AV*N??- &M_PE%Q=RL-%T:YU&!>L^]8D/H4+X
M#@^JY%;=A=&^M4G,4L.X$-'*N"".".??\ZYJRU#68+.W32O#$<.FQ(%6.YN?
M*F  YVQA6'T^;GVKHM.OXM1LH[RW):.7(''((.""/4$$'Z4 73TK!O-8U"*\
MDM]-T&>^6(@22><D(#$ X&_&[@CD?3M6Z7Y'?/I52YO(;&UDNKF18H8P6>1N
MN/I0!5T[5DOXIFFC^RW%MQ<P2,-T7<'(X*G!P>AQQ5#_ (2AT(NI--FCT<G
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M>[E5"[W.6;'<^]2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%)D4 +129%+D4 %%)D>M&01G- "T4FX9Q
MFC<,9S0 M%)D>M&1G&: %HI,C&<T9'K0 M%)D>M&1ZT +12%@.I]J,C.,\T
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ .0LHM=TFTFTR+1UF>61V.I-/&$D9B2&9<[S@87U^7TI;?P_?\ _"L;'0Y
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M)FR.-ZJ%X[\@UM#O@=:;L'RGDXZ<]*:70OLRNXC)7=SB@#*O[.XN?$VBWD2
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MO;:4DR_ZR&!TC8A3T!#2,1D'DUU5[IMEI6BSS6MG;;K6!F3S(@W*C()/4]*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC7+<D\9Z'L:XG18XQ\%X,1*N=%W\+QN\K.?KGFNLT<EM!T]B22;:,DGO\HH
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M('RD@E<9YY..]9Z^.=#,YBCN)I=LKQ22);NT<+*Q5A(X&$P03\Q''/2DOO\
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M>R2+&0005!.%(QU';(KI-^%)(Y':HI[ZWM3 L\JQM/((H@Q^\Y!( ]\ _E0
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M;H?M4K3" _\ 3,,3L[=,=!6WNXY'..F:@M;ZWO85FM9%FB8D!T.1D'!_4$4
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M"@).-W=B2>0!Q@8XR<_5;?7H?&EOJEAI,-W:06<EOEKP1DL[(V<%3TV8]\T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\WRWRWF;EZ#.4Y.>AQCFI/"=O<IJFO7,NE'3[:YEA:"+:!E1&!G@<'U'8\4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9T'_ * FF_\ @*G^%'_",Z%_T!M.QZ?94_PH YCPGJNO13W!\4:]X>F@VKY
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MH+#,"!RACD)'/3E1[T ;U%1!\$ DG-8]OK1U'PJ=7@1XO,MGDC4X)4@'\.U
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M@R9P1D9Z=\9J0L02#G([C_"@"6BH2Q& H)XR<'I1\S  G((ZB@":BHCNP,G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %!Z444 <5XKLY8M3LI+*\>T&HR?8
M)UC7[Q;YQ(?<!&7'_30\\5O:C<P^'?#MW<6]LIAL;9Y$@4[00BDXS[XZT[5]
M)DU*73'254^QWJW+[A]X!'7 _P"^A^57I88YHGAEC1TD!5D900RGJ"#U% '*
M67A"VN--CN;R]NKC5I(]PU$MB6//("CH ,_SK+NM3EO_  )82.[^=#K-O:/(
M3S*8[M8RQ]-VTDCWK:@T3Q%:V/\ 9EKK$+6+*5%U,A-S&#V7C:<=LU?;PO9M
MX<AT?) AV.LP #&92&$I[%MPW'/4YS0!6\32;9M!V9&[5H@2#C/RO735R<NB
M>(M0O].EO[ZP6"RNDG\N!&S+@,,DGH1D8QQR<]JZR@#SWPUX<L;GPA!JLQG?
M4565X[HR'?%AVP%[8']335TR&\\$-XG=YTUN733>_;4?#(QCW;5[!1TQCIWK
MJ]&T:73/#$>E22H\BI(N]0<?,S'^M5XM!EA\"+X?:=/-73OL9F&0N?+VY]<4
M 9.I1Z7<VFG3ZK:WFKW,EJA2SA^8CC+.!D8SD9)/88JGHMN-1M_$^D6-E<V,
M,(B^QVUS\IAD,>X-P3QOPW7M6L- U6QU%=1TBXLGN)+*&TF6ZW[ (MVTKM[G
M>V<^@J[H.B:AI^H:I?:C>17$U\\;@1IM$6U<;1ZCT)YQUH R)M2.NZ7X=L(Y
M)&>^DS<;^!)'"=LP)'J>GK[5UTR;H'7S7C!0@NIQM]P>V*Y'PQI:KXP\0WD<
M[FUBG6WBMG/RP2;0SF,=%5@RY ZD'-=;?68O].N;-VVI/"\1*]0&!''YT >9
M:^-&L-'OKW2M"U+[5#&SP:K&H*AQ_'DN.^><5M3^'M'G^)5M+)9JTTNGRW#/
MD\R"6/!Z^YJ;4/#?B;4O#LNAM>Z9;VQ@\E)(D=G90, -NXY Y(Y]*V;W1KS^
MV[/5=/DMQ-'";:5)PVWRV96)7'\65&,\=: ,+7_#>DWGCC19+FR25KI;DS$D
MY<JBXXSVJ'5[B+4/$]_INHZ1J&I6=E'$8HK5 4#."2S?,#GC ]B:Z76M(O+F
M[LM0T^6$7MH7"+<;O+8. #G;R.!QBF:GHE\^J1:MI5ZEO>)$8Y(9%S#< D8W
MXYR,<$<]NA- &;X6>XAU*[M(-,OK#1TA5HH[Q0-LF3N"88_+C!P>Y-9'A[P_
M9+\/[36F:9]4CLS-'=-(=Z$ D*.VWC&/0FNQTVVUC=+)JL]H<KM2*U0[!W+$
MMSGG&.G J'3="EL?!<6A-,C2I:&W\P [<D$9^G- &5<W<VJP>%[.Y;%OJMNT
MMX$XWXB#[?\ =)."/2JFK>'=.TG6/#<VGPO:AM4 >*-SL<^5)RP/<=OJ:W'\
M/SKI6DK;SQKJ.EP*D$K E&.P*P(_NL!CU';FJLNB^(M3U+3+K4[VPCCL;H3^
M1:HVV3Y&7)+<@C=QVZ^U &_?Z;::K9M:7T(G@8@E&)&<'CI7&>#M-L++X;F>
MU@6.:YLW>1@3\V P'\Z[[%<[I&@WNFZ)<Z.TMLUJL1BM'4-OP0<E^V>1TH Y
MNWT2TTGX<P:_;&4ZK;:4MRETSDL<1!@A[;/X<>G>KOB75)6OM#TZ>RN[VRO+
M66>XM[-07<KY> <D?)\YSSZ5M3Z%+)X#/A\2H)CIOV/S<';N\O9GZ4[4_#[Z
MA96 ANVM+VQ*F.XC49.!@H<_P-QD>P]* ,+1M]IKUG'HV@ZCIUC*'^V+<H%C
M^X2I'S$[MV!]*U?';N?!&J[9&C)C4!D.&!W#H:MZ?;^(FNT?5+FP6! ?W=HK
M$R9& &+= .O'I4OB+29-:T"ZTZ*1(Y)E"AV' Y!_I0!SOB#1[;PWIZ:AI32V
M]Y-<P6TTX<EI5ED5&+?[7S%@?[P!]J75-$M/#UUHTVE-+;&?4(X+A$<XN%8'
M._/7IVQU-=!XCTB36M-CM8I4C9+J"<E@<8CE5R/Q"XHU?2)-1;3O+E5!:WL=
MRV[)R%!X'YT <5'<VNM7E_+J_AW5=6DAO9[>*6&)?*1$<J OS@YP.?4U//JN
ML67AK9+:ZC%'+JB6D$3(OVHV[*.GS8W9R!ST%;\VAZM8:G=7VAWEMLNF#/9W
MBGRD;'+IMY#$\GL<FI[C0KO5=!GL]4O0+J8[UFMEQ]F;L8R>>.3D\\F@#E=L
M5C)!-X>\*ZQ8WGG(K%XU$;1[@K[_ )SP%)(QW JU8>'=(3XF7\D5BBO'8V\Z
M')^60R2Y8<]>!^5;D%EXG$D=O/?V!M$89G6,F=U'J"-F3T.!QDXJ>71KJ/Q0
M-7LY8=LT*6]S'*#D(C,P*8[_ #GKZ"@"#1R?^$Q\3#)P/LN!G@?NS6#X7\-6
M-[X934;E[B2^\VX:*X,IWP8E? 3T'&><]376V6ER6NNZMJ#2*R7OD[5 Y78I
M4YIFA:1)I/A]-.DE1W5I3O4''SNS#_T*@#F1K-[JGAOP@)G"?VU(J7C1?*=O
MDNY"^F2H'T)HUSPYIFDR:/<Z; ]FQU6V5UB<[9 6'W@>N.U:$?AY+#PWH.FS
M7L4>I:<%%G-V:8(0< ]05+#'H2>U9VN+XAENM$74I[':-2@=;>R5B9 K99CN
MYPHYX_&@#KM7L/[0TF[M4 WR1MY>6P _53GV.#7*R:@VN:!H6FB21Y[V4173
M-PLJPMMN 3UYVMCU]J[<GKQQ7.:+X5?2M:NKQ[KS;<$K8VY&1 K$LYR?XF=G
MY],#M0 RP8'Q=XCC:5TC$%JJX.-GRR<BN1\1?V+9:)J%[I>B:C)=00R/!JR+
ME!*H)\S<6'1NIV]0>*[I=#;^U-<N))1Y6I010@*#N3:KJ3S_ +U8M[X;\37W
MAN?0!?Z;!:-:FV25$=I-H7: P/'(QG'OB@#JXAYUC&)@'$D8W9[@CFN/\*>'
M]*L_%_B.2VLDC>VNXTB()^56@0D#GN2:[:&$QV\<1(.U0I]\"LFTTB[L/$-Y
M=P20-97K+),D@/F(RH$&S'&/E!.?>@# T3PYI^KWOB":_629AJLHB#.<18"\
MKCH3QZ]!5:?Q#J*>!?M1DF>X&I'3R\0!E:,7)A!&2!YA49SZ\UU^BZ5)ICZD
M9)%?[7>R7*[1]T,!P??BLZU\* >&KS2+J<'SY[F998QDQF21G5AGHR[@0>Q'
M% ',31Q62?:- \*ZS::FK@+,\:A7Y&X2?.<J>IQW KTA5Q@;LCO7.Q6'BB+R
M[1M1LI+9 $^U-$?M!7U(QLW?A72*O>@#S:"V^T^!/"MOYTT2RZFJ,T3;6QNE
MZ&MYK"V\-^(]&MM*B^SV^H2RQW$0)*G;$SAAGH<J!]*FMO"]Q!HFAV!N(R^G
M7@N78 X< OP/?YJT]1TF2]UG1[Y9%5+"621U(Y8-&R<?BU ')Z;X<TF#XE:M
M-%91QM#96TT1W'*.SS;CU[X%54N;76;R_DU?PYJFJ20WD]O#)!&IB1$8J OS
M@YP.?>NMDT6ZB\5'6+.6$I<Q1P7:2YR$C+%2F._SG.?056GT75M/U2ZO=#N[
M;9<D,]G=H?)1L<NNWG<3R?7)/6@#"OY=1;X;^(A=17EJD19+,7 "S"+"X)()
M[E@/8"MZ]T:TT;PGK1M1)YTMI*\T[N2\K;#\S'U^F*??:+J>K>%=0TZ]NX3>
M7BD!D7]W%TX'<CC///-:^IV;7^CWMDC!6N+=X@QZ LI&?UH XF?1[70O X\0
MV?F?VK;V:3_:9'+-(=HX?L5Q@8] *N>)[TS>(+/2+FQO;ZPDM'N)+:S4$NP=
M5&_)'R#=G [@5LZGH4U]X*ET-)D69[06XD(.T$ #/TXI=9T&74)+.[M+UK2^
MLW+I(J@B08(,;^J$G./4 ]0* .4M],@O+Y-/@\-W]KHTBN]W%> +'O4?(RX8
MG/8^P%:WPWTZTL/ VDRVMOY3W-K&\F#G+;>IK6L;?Q!+<[]5N;!(50KY5FC'
M?G^\7Y&/;\:3PUI%YHFF+IDTL$EK;(L5J\8(<H!U?MGITXH B\1PZ=):Q'4U
MFGB5_DM(CS.QZ#'&2#TY KG_  ]+;6WC>&RT[2+[2;6;3Y9I8;A0HD=9(PK#
MYFY 8C\:Z76M'O+J\T_4-/EA%Y8EQ&MQN\M@X ;.WG/'%5+#0]9;Q1%K>K7E
MH^RTDMQ;6Z$(I9D;<">3]WG/X4 9.F^'M/UOQ3XJ;4XWN8H[Z-4A=SL7]Q$2
MP [G-.DU>^M?!^LNDY,UA?-90S2<L8Q(B@MZMACSZXKI-)T>33M5UJ[>5'74
M+E9T50<H!$B8/XJ3^-5(O#2/I^JV5ZRR1WMZ]RICR"H)!7/N"![4 8'C'P?H
MUGX,UB[M8GAO5LI6-RLAWR?*<[CT.[OQWKL[<)+I\<17*M" PQUR*YK5]#\4
MZWHE]I$U_ID4$\#P^<D3>8X((&X$8&>^.G:NM@A,,$<9(.Q0,_A0!PHU2ZTW
MPIJFD&>0:I;W!L()4.5C:8_Z/@^BJZ G'&#UJR-._M36AH4DLL6FZ7:1-<6R
M/\MT9<XW=\*4;Z[NV*TI/"OF^+5U8W&+3B62TQD2SA=JN<_W5"XQT(S4VJ:%
M=S:K;ZMIEXMK=PQ-&\17]U<@XP)._&#@CD9/J: ,N33K?1?$%GIL#2MI.JQR
MP&R+_NX"J%RR]_FQ@CWS4/@G0=+L-0UNXM+-$ECU&6%6!.53:AV]>E;.G:/?
M_P!L#5=7NH9K@1>7%;PI^ZA]60GYLD<$GUQTIVF:;>Z;JEXT<D#:?=S-<MN4
M^:)6 &!VVX7ZT <?!<6VO7%W/K'A[4]4>.\G@CD@C7R41)&4!?G!S@<^^:ZS
MPM-?MILZWT%S#''<,ELMTH$OE +MW8)!.2PS["HI=$U6RU*ZN]$N;41W3!GM
M+M"(HVQAF3;SECDG/!))K8TV"_BM&_M&XCEN7<L?)7"1CCY5[D<=3SS0!S[6
M5OXE\0ZM:ZK"9[?3S$L$))"@O&&+''\63CZ5FZ;IL6E>,_$=M;"7R1I5LT<;
M-D)\T_RJ>P[X]S70WFD:E;:C/?Z)+:B6[VBZCNPQ1MHPK KR#@ 8Z?C4&E>'
M]3BUW4M4U2\@F:]M8H/*A3 CVE\@'J1\_?GK[4 9^G/(_P '()'9B_\ 8FX-
MGYL^3G.?6FZ[&U[X:\-P^?-%YMY:(TD3X?E>>:GNO#NN)H\V@:=?VD.F&!H(
M9'C+31)M(5.FT@<#)YQ[UIW.ARW.G:/;K*@:QN()G8@X81C! ^M &?XGTVTT
M;P=]FTZ$6\*W=MA4)XS<1YJ"\TBUUKXAWL%^9);6+3+=_L^\A&8R2\D#N,<5
MT/B'2I-9T@V<4BQL9H9-S#C"2*Y'Y+38M(DC\4W>K&53'/9Q6X3!R"C.Q/T^
M<?E0!AV]U-I \36%NQ^SZ7 LMH).0F8V?;[J"  /2EM/#.EZAI5OJ=Q'*=2G
M@65KQ'(D5V4'(/08S@<= *T?[(2/4-;NKRX3[)J$2(58E2J*A5\GMP<Y[5GR
M1:]I^EF*'5-+CTB.+"7LN?-2+'!Y^0X&,$\''- %SP*SOX#T1F=G8VD9+.>3
MQ63;>&]&3XE32K8HLL>GQ7"')^60S2?-UZ\"MCP-;SV_@?1H+E'25+.-721,
M%6QW%37&CW:^(HM4M)8"'A6VN(Y\G$89FRF/XLL>OM0!AC0K#6O'6O\ V]&G
MBCBM?W#,0F=K_,0.I[=>YJ/^U[W2-#\6I!+O.B,PL_.&<#R5D 8]P"Q'T 'O
M73V.DO::[J>H-(C)>)"JC'S+L# Y_.HK+01%>:Y)>>3<6^I3JXB*Y 3RD0JP
M/!^Z?SH XWR;7[+]JM_"WB :J5\Q+UD3>9,<$G?CD\=.F:] TMKB;2;.6]3R
M[MH4,R@8VO@;A^>:P[;2/$NE6J6%EJ5I=6J# GO0QG4'M\O!QVS^-=)!&\5O
M'')*9750ID8 %CCJ<4 <3HGAS3]9N]=N=166XD759DA#R'$/"_<],\>O04[0
M='M_$.G2:EJ3S3WT=Q/;PS^80T2Q2,BE?0_*&)Y^8D^U=)HNE2:7_:'F2*_V
MJ]DN5VC[H;'!]^*;X>T>31M+>TEE61FN9YMR9'$DK.!^ ;% '"+K%S=:9X:L
M-0BOM3@O+2>:Z2W4-+.8W4#<21\OS<XZG%:NBYM=?LX=(\/:EINGS;_MGVI%
M$?"$J1\Y.[.!]*T(?!TT?A_2[1+_ .SZAIS;H[J) <C))3YA]TY&1_LCTK2L
M;?Q#)=JVJ3Z<MN@/R6J,3(2,88OT Z\4 <1I\]IKEBFI:MX8UB_O92?])BC7
M8 &('E_.,*,=QU-)KU@VI^#;.\UZQ<7L6J001&XXD\@W2JN[!P6*$9]R:ZQ-
M$UG2)[@Z)>6KVUQ*9/LUXI"6_3B/9T!]#QZ=ZFU+0KK4_#HLKV\$ET)X[D.%
MP@D202*O'.S( ]<>] %37K:"PM_#MK9+Y,":M"NQ2>!A^*BU32K?6/'T-M>-
M*]L-+=W@#X23]Z,!AW Z_A6G=Z5?ZE:Z3]JDM4N;2\CN9O*!V':&&%SSW'6K
M/]E2?\)0NK>8OEBR-MLQSDN&S].* .2OM3G\,MXBT[3&"VMA8075NCY81-(S
MJP'^S\@('J35O7_!^DV_AS4KJ%9UOH[25Q>K*?.9MA))/3)[\=STK0U+08)M
M2U>]U&XB73KVRAM74ML*;&<DEO\ @8_*LOQ!%XDB\,ZA!+J.FK:BV>-;@(1/
M)E2%&#\FYC@8 _BXYQ0!U.BR%M$L6)S_ */&"2>?NBKY)/&?P%9FGQ7,>C:8
ML:QJZ1P^<)01A=HW8'8UHJ,G&<9Y&* .$TR[U^#7_$JZ9IEG=0?VER\UX8B#
MY,7  1N/?-6-.N=7G^(D)U>PMK1AI<PC6WN3-N'FQ\G*KBN@TC1Y=.OM8N))
M5<7UY]HC 'W%\M$P?Q0G\:63299/%,.K>:GE1V;V_EXY)9T8'/IA3^= '*ZA
M9^'3>7&[0M1UJX#DRW4*[\-UVDEEY QT'3%,L[NZ/A/PIXDEGE,D2QB]<_?D
MBD!7;CI]\QD_2M>VT/Q%IUH^EV%[8)8%Y"EQ(K-.@=BQ.#\A(+'&1C %6+7P
MLT7@>WT">99)H;9(_-&0"ZX*MC_> - &-KFK7*W'B/6+4@_V'8M%%'+T6XV[
MRV.X*,@_"J!CM/LK75OX7\0#5PFY+UHTWM(1G)._&"1SQTKL=(T!-.T+[%?N
MM]+*&-Y+(@/GLV2=PQR.<#/8 5G6>D>)M*MDTZSU2UNK5!M6>]#-.!^'!QVS
M^- '0:;-=2Z;:/>HL=TT2-,H[-M&X>W.:N#I4<,31P(DDGFN$"L[ #><<G X
MY]JD' H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/S9 YZ8.1WH Z"[G6VM)YW+;(D9VQR< 9./RHT^ZBO=.MKN#=Y4\2RINZX8
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MC=XXFE;:650<$D#@<],US&H:KXDTK3IM4O[;2S8VZ^=+%&[F8(.2 ?N[OTH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_#;;K^DV1U+4':U,4;%XHP<D,,DY8 9'/!Q7#'0YOA7J'AK5X[Q;RVU J;F
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MV>!Z4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_L8((95ENMQD#N7#+E@#MPJX&.YJ/0M/U'6TU"[FUZ_B:'4;J.VCB;"JJR,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MPI<:(MI&I_>3M.KAAWPJG(/3&:Z"B@ KFGTZ^LO&-QJD5M]HMKZ"&WD*N%,
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MUU9ZQK]Q/&JQWEVLT)4YW*(47GWRIK=HH Y:V\.RS:3K=G>QA?ME[-/$0^<
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MQM9(IVW [6,:*,>O(-2Z'97VF7VHV\UIOMKBYENX[I9!U=L[-O4$>O2NCHH
MC^; ^7GZUQ'B'39;KQQIUI;R+]FOD\W4K<CF9(2-C;NVUBO P3GVKNCT-8NE
M^'X+"]:\-W=WDS*566ZEWL@)!(7@8!P,_04 )KNE7E\+:YTYX(K^UDW0O<*6
M3:>'4@=B.*S+BUUSQ&+>UOM/BT[3DE5[J)Y!(]R!D@*5/R@,%/KQ]:Z^B@#G
M-3L;VUUE=:T^T%Y,;<6TEL7"$KN+!E8\ @DYSVJ/0++5E\0:QJ6IVR0+=QVZ
MPHCAB F_(8CN-PZ<5T]% &#X5TVZTK2&MKJ-4E:[N)?E.1M>9V7\<$5O444
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MBX?=(X'0$]\9/YT :U%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)'KJ[K:)MJW"@#Y!P/EZ5#H5U!H/AK6Y;AI;J.#5)UW2G<SL9%4;C_O$<XH
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M/M6WXN58_!+!%"B,VY0J,%3YJ#CTX)H ZVBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5'R%TX(;ENHSZUTI5B?0G\J-K9 [>_4T 96J>%M+U:7SIHY89R?FFM)G@D<
M8 9D(+#V)J_9:=;:;;B"R@B@B!W%8T"Y/<G'?WJW10!SEWX(T2^N;F:>"4I<
M*PDMQ<.("6&"WE [ W.=V,YYZ\UJS:3:7$=E'+&2EE(DL #$;64$ ^_4]:O4
M4 %<1<^&H=8\>ZG+?6]Q';BPME@N(9&A8,'E+*KJ0>ZY&>>*[>HSN.01]#0!
M0TK1;72+=H;,2'><R232-))(?]IV)8X[9-36&F6VFV*V5M&%MT+80DGAB2>O
MN35P9[^M+0!SI\#Z#]K$PM&6(#_CS25A:GW,(/ED]^5Z\U?;0K%]7M]3*/\
M:+>$PPJ)&\M%/7"9VY]\=A6G10!S>H?V7H.IRZY)#?R3W@6"06J2S [1P3&F
M0.!UQ_.CP?I']GZ1)/) (+J]N'NIE5=H))PIVCA?D"9'KG/.:W]F>Q]ZD48&
M.?QH ;L]>?2L"[\%Z1=3"54N+0DDNMC<R6RN<YW,L9 9O<\UT5% '/7G@S2[
MZ^>ZD:\1G(+1P7DL4;GU9%8*Q/?(Y[U:3PSI<?AZ70H[?9ITJ2(T2N1\LA)8
M ]N6/3IVK7HH JSV$%S9&SEC5X"NTHWIV_&L2+P+HL<L<KK=W+Q2)-$;N[EF
M\MU;<"N]CCGKCJ.*Z6B@!@4CO6:GA[3TTBYTL1$6=UYOG)O/S>:Q9^>HR6-:
MM% %"\TFUO\ 3FT^Y0M:LJJ4#$9"D$<_@*NE3G(./:G44 4K'3+?3FN6MEV&
MYF,\N6)W.0 3S]!5=/#VGIIL]AY(:">5YG5B3AW<N6!Z@ACD$=#C%:M% '-V
MW@C1[:ZAN-MU/+!(LL,ES=RS-&PS]TNQP.>0.O&>@K7ATVWM[ZZO(E*SW3*T
MK9/.U=HX^E7:* *5OIEO:-<M FUKJ8S39).YB I//LHXK%?P%H4LDOF1W3P2
M!E-JUY*8 "","+=L &> !Q@8QBNGHH A@MUM[>*"(;8XE"*.O &!52_T2QU2
M6SEO8%F:SF\^$-RJOM*YQT. 3C/U[5HT4 9^IZ-9:S;QV^H6Z3P1RK*(V'RE
MEY&1W^G2I+_3;?4[-K2Z4M"S*VT,5Y5@PZ>X%7** *=[IMO?B 7 9O(F2=,,
M1\ZG(Z=1[5!JF@Z?J\:BZMP9%&(YHR4EB'?8ZX9>G8BM.B@# A\'Z3%IMY8N
MD\\=Y&8IGN+F261D/\(=B6 ]@>I)K2O-+MK^P:QN5+VS;<KN(/RD$<_4"KM%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ_V=/:*J,%8A3N9=Y5@ =R^I Z5JW-I<'QUI]Z()&MXM/GC:4GY0[21$ ^Y
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MC[P)/<<<].>M1Z5\3[J+Q%'H/BS17TF^N'5861_,C.X?+DCN20.,@9YQ7/?
MQ?-UCQ3-."\_G1[9).7 )?(R>>P_2IOV@0D>B:/<)\EPMT0K+P_W3C!Z]: .
M@\4^,O&/A^34+B/PI!+I5H25O'NE&Z/CG&<]:I^&?'WC3Q)'97=MX0MFTZ>8
M(]PMT!L3=AFP3VY./:MGQP2?A+JC%LYT]>O7^&J_P44#X8Z>!_STF_\ 1C4
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MUV?3[C3(;6)+4SJZREB2&48Q_P "KDM4\2CQIX)\*>&HKJR2]OYTAO%C!9H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHI P(HW#N<4 +13=P-*&!&0>* %HIN]<9SQ2[AC- "T4W>O/.,>M+N&,Y]Z
M%HI@D4C(.03@'UJ.YO+>S@:>YF2*%2 SN< $D <_4B@">BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM>74;VJ _-M1@SL#_"-@89[YQWJWK0:/Q;X=NGRMNOVB-G(X#NJA5SZD@XH
MTFU*%->ATDI)]H>V:X# #;M5E4CKURPK-3Q1#<ZW=:3;Z?>W,MM<+%<.BKLB
M!56#$DCCYN@R>#QTJO\ :H9OBC;P++&TT.DR^:BGE<RQXS]:E\+?\A[Q;_V%
M%_\ 2>&@#HQG'0XSUK,US7+3P_8Q7EV)!"T\<!\M"Q!<X!P.?RR:USTKD_'5
MQ!9:=IEU=.L5O'JEJ\DCMA5 D&2?0"@"Q:^)VEN5BO='U#3(93A)[GR]C/\
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MF&HR9MI3PQME^XI7M@E^O/-=,<$ B@#+U;7K72G@@DCEGN[@,;:UB7+R%<9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% $$%G;6OF^1 D?G2&63:/O.>I/N<46ME:V4)BM8$BC9F<J@P"6.
M2?Q)-2[\]/7%)N8C@#.._2@"&'3[.WLA9PV\:6P4J(@ORX],?C69;>#O#EH<
MV^C6D9RC<)W5@RG\" ?PK8\SY2>"1U -!E"XR>#T/:@!CV5M)>17;PH;B)66
M.0CE0V-P'UP/RI9;6":>">6)'E@):)R.4)!!Q^!(IZR9[8/I07P1GH: *5QI
M]K<7D%TRLD\#%EE0X.#U4^QP,CV%5[#2A97U_?22&2>]D#R/M"X51A% YZ#
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MSU.T>TOK:.>W?&Z.09!P<C]:F\S'4''KCBJVH7XL+"YNBF\00M,R \D*,XH
MK6'AK1=+=7L=-M[=D+%2B8(+  _F *OQVEO#<37$<*+--M\QP.7V\#/TS4=G
M>B\L;>Z5=J31+* >HR,XJ?S.2,9/M0!'!96UM)<200)&]R_F3,HP7; 7)]\
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MC-2ER" !UH ?C-4[?2;"UOI[Z"TBCNKC EE5<%\=,U9W\<\>O/2@N01P.N*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK:WI4#/JR6,SS2)!:168=6>1L\$L< >],?5=<T5TN=;6PDT^218B]D'W1,Q
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M(Z9I<&F>/3'&SR2R:9OFG<_/*_G<EC_(= .!@4 =A<S1V]M)--(L<:*69V.
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MN4T3.J^(=3UF0?)#)]BL^<QLB@$NI]2S,IQQ\@':NKH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"IJ%C:ZC:M:WD"30O]
MY'JEI7A[2-(N7FTZPBMY'&UF0$DCKWZ=:V,#.<<T4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 9>JZ)IFL%/[1LHK@1@[=^<CUZ5+I6E
MV.DVQ@L+9+>%COV(.Y]ZO8'I2T %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2'.#CK2T=J .9;Q
MEHD0:*>:2"<$H;9XFWAO[IP",GZU+X1L+K3M#\J\&R62XGF5,YV*\C.JD=B
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MV ]^:0J6;+8X/% #Z*!THH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ***0D#K0 M%)N'K1D'O0 M%)D
M>M&X$D9Z4 +129'K1D>M "T4@=23@].M 8'H: %HI-RYQFDWKC.: '44FX8S
MFESSB@ HHI,CUH 6BDW+C.:,CUH 6BD+ #)-!8 \F@!:*3(QUI: "BD!![T9
M% "T4F11N7UH 6BBDR#T- "T4F0.]&1ZT +12;@>]&1C- "T4F1ZT @]#0 M
M%&:;O7GGIUH =129%&Y?7OB@!:*3<,9SQ1N!Z&@!:**0L ,DT +12;AG&:-P
MSC- "T49H)P,F@ HI-PQG-&X>M "T4F1ZT!E/0T +11FDW+ZT +12;E'<4;A
MZ^U "T4F1G&:7- !12;@3C/2C(]: %HHI,CCGK0 M%)D>M&]?7I0 M%)D8SF
MEH ***0,IZ&@!:*3<N>M&X>M "T4F1C-&0>] "T4F1ZT9'K0 M%(&!Z'I06
MZF@!:*0$'H:,CUH 6BDR#06 ZF@!:*;O7UI<CUZ4 +12;ACK1N&<9YZT +12
M;E(SGBC<..>M "T4FX>M&X>M "T444 %%)N &<T;AG&>: %HI-P]:"P R30
MM%)D8S06 ZF@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@TQ9+>4#<$<2GJO\2^HX]B.M;NA:['JK7=JX2/4+)Q'<P _<)Z$'N#C@^QH
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M0<9H EHH[44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %2+3K:'4+J^16$]
MTJ+*VX\A,[>.WWC2WVFV6IVK6M_:0W-NQ!,4R!E)'0X-6J* .>B\%Z0LXDG%
MU>JO*0WMR\\:$="J,2 1V(Z5T&T4M% $4UO'/#)$X^212C8.,@\&J^EZ38Z-
MIMOI^GVZ06T"[8T4=/?ZGN>]7:* ,W4]"T_5TC%W!NEBSY4ZG;+%GJ4<<J>.
MHJ#3O"^F:==+=*DUS=)D1W%W,TTD8/4*S$E0?05LT4 5-2TZVU73YK&[4M!,
M,.H8@GG/7\*M8YS2T4 <M'X&TVU*BVO=7AC#EA%'J,P09.2 H; &35K5=!CU
MS5=+FNQ"]G8RFX2-UW%Y=I4<'@ 9SZY K>89'I2!,$')XH  B@8 [YJG:Z19
M6EM<V\<68;F6265'.X,7)+=>QR>*O44 4+#1K'3+-[6UBV1NQ9R3EG)XY/4\
M  >P [5#'X=TZ+3+#3EC?[)8[?*B,A(.T84-_>QUY[@'M6K10 @4 8Q5$:-9
M!+]%C*QWP/GHK$*200Q [$YY(ZU?HH J#3+/^RUTUX$DM!"(#'(-P9 ,8.>O
M%00:%96]U:W2K(T]M;M;QR22%FV$@G)/4_*.:TJ* ,^[T:TO+^WO7,T=Q P(
M>&5DW@'(5L?>7/8\<U>VC.>I]^U.HH Y^\\':==ZA<7WVC4K>:Y(:7[+?21*
MQ"A02%(&< 5KII]K%I_V".%4MO+,81. %(Q5FB@#F[+P5IU@]NT%YJP6W*[(
MVU&4I@= 5+8([8J[J7AK3-4G%S)$\-V %^U6LAAFVC^'>N#M]LXK7HH S-+\
M/Z?I#/+;1,]S(-LEU,YDFD'8,[?,0.V3QBEU30M/UA8_M<&Z6+/E3H=LL1/4
MHXY4\=16E10!B:=X6L-.O%NEFOKF9,^6;R[>?RR>"5W$[202,CL<5?CTNTBU
M6?4DC(NIXTBD;/54+$<?\"-7** ,YM$LSK"ZHOG)< 8<1RLJ2\8!=1PQ Z$]
M*SI/!>FO*[QW.IV\;$GR+>^ECB7/7"*< ?XUT5% $5O;06D$<%O$D44:A41%
MP% Z "L[6/#MGK<MM+<RWD4MMN\N2VN7A8;L9&5(]!6M10!GZ7HUII$<BV_F
MN\C;I)IY3)(_IEFY.!P/2LRX\%Z;/?W=XMSJ=O+=R"686U]+$K, !G"D#H!^
M5='10!EW6@V=[H7]D7#W,EOM12YG;S3M(()?.[.0.<U#IOAFUTRZ6XBO=3E9
M00$N+Z25.?\ 98D5M44 85YX1TNZG:=/M5G(Y+2M97#P>:3W?81N/N:OZ=H^
MGZ3 8;&UC@5CN?8N#(V,;F/\1..2:O44 9UQH>G7>KVFJ7%LLMY:(R0._.P-
MC)'OQU^M3:AIEKJ=FUK=(60D,K*<,C#HRD<JP/((Y%6Z* (;:UAL[=(+>-8X
M8U"JBC  'H*9J%C!JFG7-A=*6M[F-HI%!P2K#!YJS10!1_LFS_M*UO\ 8WVB
MU@>WB;<<!&*DC'?[BTS4]#T_6!;"]MUE-M.EQ"W='4@@@_4<^M:-% "8P,5C
M:KX8L-7OTO9I;V&X2+R0]K=/"2N<X.TC/-;5% %/3M,MM+M!;VRMMW%F>1BS
MNQZLS'ECP.3Z5B_\(-IBRSR17>K0>=(\KI#J,J+N9BQ( ; Y)KIJ* ,S4?#^
MG:K!$EW 7DA!$-QN(FB)QDH_WE)P.0:;I?AW3M(=I;>)GNG78]U.YDF=>P:1
MOF(';)K5HH P=1\(Z=J6IMJ,D^H07+Q+$S6MY)"&522,A2,_>/YUI:=IL6F6
M8MHI;F502=]Q,TKG/JS$FKE% $%S9V]Y:R6UU"DT$B[7CD7<K#T(/6L3_A"=
M&,HWI<R6PX%E)<.UL!V'E$[<#L,<8%=%10!1O]'LM1TN73;B+_198_*9$.W"
M^@(Z5+>6-O?V4EI<Q[X7 !'?@Y!!]00"#ZBK-% $<,*P1+&I8[5"[G;<QQZD
M\DUE:MX9L=8O(+N>:]AN(4,:O:W3PG:2"0=I&1D#\JV:* *&F:/9Z3;M#;*Y
M+L7DEE<O)(V,99CRQP ,GL .U8]IX$TNQ6%+:\U>*.$@I$NHRA!CMMW8Q[5T
M]% %2QTVVTY91;JVZ60R2.S%F=CZD\G P!Z  =J+[3K;48ECN%8['$B,K%61
MAW4CD'J..Q-6Z* ,_4M%L-7A6.]MUD,9+12?QQ,?XD;JK>A'-4;+PEI]E>1W
M)GU"Z>,[HUO+R294;^\ Q(#8R,]>3ZUO44 5/[-M?[5.I;#]J,(@WY_@!SC'
MUJ&?1;2?5(=1S-'<1'DQ2L@D Z!P.& R< ],FM&B@! H!SSGWK,_X1_3O[!_
ML7RF^P[=NS><XW;NO7K6I10!%+;PW$,D,T:R12*5=&&0P/!!'I6:GAG2X_#O
M]@I 5T\+L\L.<XSG&>O6M>B@"K>Z?;:A9R6ES'NBDZX."#U!![$'D'L1FELK
M*.PLXK:-YG2(8#32%V/U8\FK-% %2STRVLI+F6)6,ES(9)7=BS,3VR>PZ =
M.*+[3;74;7[/<1G:#N1D.UD8="I'(/N*MT4 8VI>&;'4[O[4\U[;S$ .UI=/
M#YF.F[:1NQVS5O3-)M-)MC!;*YW-ODDE<N\C>K,>6. !D]@*O44 4]0TRUU2
MS:UND+1,Z.0&(.58,.?J!5O:,TM% &-J?AC3-4N/M3I+;W9 #7-I*T,K*/X2
MZX)7VSC@5-I6@:=H^][6#-Q(,2W,K%YI?3>Y^9L=LFM.B@# O_".G:AJDFHO
M/J$%Q*BHYMKR2)6"],A2 >M%UX0TZ\M+*WEN-1S9L[0S+>R"4%NN7!R?Q-;]
M% &;I6B6^D+,L-Q>S"7&?M-R\V,9Z;B<=>U4;GP=I,\K20_:[$N29%L;E[=9
M&/5F"$;F]SS7044 5+#2['2[;[/8VL5O#G<4B4*"3U)QW]ZBDT73Y=:CU>2W
M5[Z*$P1RMR44DDX]#R>:T** *6HZ59ZK:BWNXMZ*P="#AD8=P>H."1QV)HN=
M)LKO3OL$D"BV"J$1?E\O;]TKC[I& 01T(%7:* ,&R\):?97<=P;C4+IXSE!=
MWLDRJ?[P#$@'WK8-LANQ<;I-P39M#G;C.<[>F?>IJ* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MZ#- !130X)P*029 X(R>* 'T4A;! QUI XQF@!U%-+@#/\Z"^.HH =13-_7C
M@=Z"Y R #SZT /HIN\?KBD\P8&.] #Z*:7P<$4Z@ HII8@XQ].: X..N?2@!
MU%-W@<'@^E&_T&<=>: '44W<<X S^-&[UXQUH =13=WKT]:0R '!'- #Z*9Y
M@_'WHWGC:,_C0 ^BCM10 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!$P8KR<8Y]<&N+T!/$^LZ#9:J?$6UKB(2^1]CC*_[I;KCWKMFZ-7.^ ^? NB
MX'_+LO>@"SHVK37TMY8:A"D%]:.%D$;'8ZE0P9,X)7G!..H-9'B_Q)>:4GV;
M3%0W019I9'Y2%/,1<$?WFW<9Z@-Z4ZXU&"R\7:KJS@R65CI2QW$D8W;7#LY3
M'][:0<>]<GJ7B+0CX/O[B?5[*36+\P-.L<F1A9 0J^R@GWZ\T >B:MJ;V1MK
M>W037UVQ2WB8X4D#))/90.3W],U0>?5_#RBZU:_2_L&8+*XB$;6^3@' ^\N3
M@]^G'6H+^^M=3\1>%;VSG66V:2Y"S(?E/[LC'Y\5<\=?\B;?#N3& /7]XM "
MZAJ-_-JQT?1U@CD2(27%Q+DK$&.,* #E_P"+!P,5/IUEK%G<'[=JL=_ ZG+-
M (FC;MC;P0><D^@KG[>QU2_\7^)8K;4OL-HT\)D:%!]H+"!,%6;*@=B"I^M:
M5C<7>C>(8=#N;R?48KR"2XAGN OF1E"H93M # [QC@8P>N> "6>P\123RSIK
M,%OM8F.T2 ,C*#\H9R-PR,9P.,G%0P>)C?Z;IYL(,7^I*[PQ2<! AP[L?0$C
MCKR..M3ZOX>NM2>>2'6]0M]Z;1;)L\DG&.?EWX/?# ]<$5AZ7?PZAX@\*7<,
M"P1R6%X!&IX4AHAQ]<4 ;'VK4O#SQ'6;\7]G/(L(N/)6,Q.QVH"J]020,\\G
MTYKI=ZC&<_E7,^/>?#]NHY)U*RP/^WB.K=UJ'B"*]>.VT*&>W5L+*U^$+#UV
M[3CZ4 4M7FU>Z\6Q:9IVJ"PB%BT[$6ZR%F#A?XNW-9^J>(=3TG2=<L99UDU/
M3[1+F.[6, 2*[,%RO0,"K9'3&/>GZTFK/X_MSI%S:6\PTIS(;F!I5*^:O PR
MX.<<U>;PJ+_3M0BU6Y:6^U*%8;BZ@78%09*J@.< $D\Y.6//2@":'1]>CN$>
M;Q.TB!@63[%&N1GID<U)J5]<3WW]CZ;(J7WEB6:=U!%O&20&P?O$D-@=.#G%
M9MW%>^&(DU%M8O=1A\^.*6&[V'(D<*-I55P0S \YX!'O4UKD?$G4BX^]I5L
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M%6DZ7<FWN)9VE49806TDVSV;8IP>^#S@BL^XY^(]EC##^R9\'_MK%5:PNO\
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MYMG+$,?5U []*UP0>E9^G:C8ZQ9BZL;E)XMQ&4;@'T-7DSG!.>^>U #Z***
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M_P"%Y^"O^>][_P" QH ])HKS;_A>?@K_ )[WO_@,:/\ A>G@K_GO>_\ @,:
M/2:*Y_POXQTKQA;3W&DM,T<$@C?S8]A!(S_*MF640Q/*S':BEC@9XH GHKS4
M?'3P4?\ EO>?^ QI?^%Y^"O^>][_ . QH ])HKS;_A>?@K_GO>_^ QH_X7GX
M*_Y^+W_P&- 'I-%<YX5\::3XRM[J;2'G=+9EC<R1[#DC(Q6\6*JS-D #Z]*
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M04'S[T9_Z=C0?CGX)/6>]_\  8_XT =U?6%MJ5DUM=1NT;8=6!PT;#D%3U#
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M/%OA]XXR50W&YPF0N8^,FN8/QP\&)(R&XNSM.,"V)YH_X7CX(_Y[7G_@,?\
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MKTBB@#S?_A1O@G_GUN__  ):D/P,\%$C%O>#V^TM7I-% &;H>AV?A[1[?2K
M.MK;J1&';<>22<GOR31K6B6GB#2+C2[_ 'M:W"A9 C;6."#U[<BM*B@#S?\
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M_P"GEJ/^%&^"?^?6[_\  EJ](HH \W_X4;X)_P"?6[_\"6H_X4;X)_Y];O\
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M?^?6[_\  EJ]&#@C/.*7<,XH \X_X4;X)_Y];O\ \"6H_P"%&^"?^?6[_P#
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M&^"?^?6[_P# EJ]') ZT%@!G^5 'G!^!O@DC'V6[_P# EJZ[PWX7T[PII?\
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M?_A1O@G_ )];O_P):C_A1O@G_GUN_P#P):O2*3=['\J /./^%&^"?^?6[_\
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MN.G^D'BO1RZ@\FN-\6>(+ZPO)ULG5(M-MTU&[^7+3Q;F'E+_ '2=IR>>O&*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$6)KPB*6V V1%<A,X7&?O9YSR!5?XM:;'KGQ9\/Z5)*4CNK>.%RGWAND<=Z
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M+O2[N0YEEM2")!_N.&0'/)( /O4VF:#;:9-]I>6>\OG&V2ZN'RS?0#Y5]/E
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M:WNA=2,8W1F.TXQT!KT+Q!JEAK?PSUJ^TZX2YLY+"?RY%! .%88Y'J,5M_\
M",:"#QHFF\]?]$C_ ,*N1Z?:0VAM(K:%+4@CR%C 3!ZC;TYH \6^$WCKP[X>
M\!M::KJ:6]TL\DGDE6)*X7&,#'-+HD&I?$[XBV_B*]T^2TT;3"#;;\HS$'<G
MU^;!/;'>O6_^$8T'OHVGGG(_T5./TK22%(HUCC4(B@*JJ,  = !VH YB^\=Z
M9IWC*T\*RQ7)O[H!E=4'E@'/4YSV]*ZA&9N2./ZU7;3+&2\2\DM+=[I!A9VB
M4N/HV,U: P>M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >1@
MTF!QQTI:* $P/2C I:* #%%%% !28![4M% "8'I2T44 %%%% ";1Z"EP***
M$P",8HVCT[8I:* $VCT]Z7 HHH 3 ]*6BB@ I,#TI:* $P/2EP*** $*@C!%
M+110 8%(5!ZBEHH 3:,8QUH(!ZBEHH 3 QBEQ110 F!2X%%% "8&<T8 &,4M
M% "!5!) QGK1@4M% "8'I2T44 %)M&<XI:* $P,YQS1@4M% !2!0,X'6EHH
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MTC_H!7G_ ']2C_AH?2/^@%>?]_4H ]FS1FO&?^&A](_Z 5Y_W]2C_AH?2/\
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MTC_H!7G_ ']2C_AH?2/^@%>?]_4H ]FS1FO&?^&A](_Z 5Y_W]2C_AH?2/\
MH!7G_?U* /9LT9KQG_AH?2/^@%>?]_4H_P"&A](_Z 5Y_P!_4H ]FS1FO&?^
M&A](_P"@%>?]_4H_X:'TC_H!7G_?U* /9LT9KQG_ (:'TC_H!7G_ ']2C_AH
M?2/^@%>?]_4H ]FS1FO&?^&A](_Z 5Y_W]2C_AH?2/\ H!7G_?U* /9LT9KQ
MG_AH?2/^@%>?]_4H_P"&A](_Z 5Y_P!_4H ]FS2;Q7C?_#0VD\_\2&]XZ_O4
MKH?"GQ>T#Q7>K8;9;"^D;9#%/@B3@8PW3))P!UXH ]$!STI:8G (/44_(H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L_6]4MM%TBYU*[)$%M&TC!<
M;C@9P,]36A7F?QTFCC^'<L;2*'DN(MJD\MAAG% '@'BOQ/>>*?$5SJ$QE*3R
M'RH&?<J#^%?U-=;X4^#7B#7MDVH_\2RQ8<-(NZ0@J""%XXY[D?2LGX6>'(O$
MWCJW@N&0V]NINI$&1N"D  8Z')!_"OJ]2&PP'&<<C% 'B?\ PSK%_P!#,_\
MX!#_ .+H_P"&=8O^AF?_ , A_P#%U[C4>26_'IGF@#Q+_AG6+_H9G_\  (?_
M !='_#.L7_0S/_X!#_XNO;0=HW9R#^-)NP"5.: /$_\ AG6+_H9G_P# (?\
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M *&9_P#P"'_Q=>XT4 >'?\,ZQ?\ 0S/_ . 0_P#BZ/\ AG6+_H9G_P# (?\
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MX9UB_P"AF?\ \ A_\77N-% 'AW_#.L7_ $,S_P#@$/\ XNC_ (9UB_Z&9_\
MP"'_ ,77N-% 'AW_  SK%_T,S_\ @$/_ (NC_AG6+_H9G_\  (?_ !=>XT4
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M7N-% 'AW_#.L7_0S/_X!#_XNC_AG6+_H9G_\ A_\77N-% 'AW_#.L7_0S/\
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M_P!#,_\ X!#_ .+H_P"&=8O^AF?_ , A_P#%U[<<\C./QII8KSG(^E 'B?\
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M8D1=S.QP%'J:<&+*IW#L>.] 'B7_  SK%_T,S_\ @$/_ (NC_AG6+_H9G_\
M (?_ !=>XT4 >'?\,ZQ?]#,__@$/_BZ/^&=8O^AF?_P"'_Q=>XTC$A<@9H \
M/_X9UB_Z&9__  "'_P 71_PSK%_T,S_^ 0_^+KVB:XC@M7N)91'&BEF=N H'
M4FI%D$@#(P*D<$<Y]Z /$_\ AG6+_H9G_P# (?\ Q='_  SK%_T,S_\ @$/_
M (NO<!TYI: /#O\ AG6+_H9G_P# (?\ Q='_  SK%_T,S_\ @$/_ (NO;VSC
MBF$D')./>@#Q/_AG6+_H9G_\ A_\71_PSK%_T,S_ /@$/_BZ]LW9 Z],\\5+
M0!X=_P ,ZQ?]#,__ (!#_P"+H_X9UB_Z&9__  "'_P 77N--=@N,G&: /$/^
M&=8O^AF?_P  A_\ %T?\,ZQ?]#,__@$/_BZ]M0DGD$8X(J2@#P[_ (9UB_Z&
M9_\ P"'_ ,71_P ,ZQ?]#,__ (!#_P"+KW&B@#P[_AG6+_H9G_\  (?_ !='
M_#.L7_0S/_X!#_XNO<:1LXXH \/_ .&=8O\ H9G_ / (?_%T?\,ZQ?\ 0S/_
M . 0_P#BZ]LW].21TZ8R:EH \._X9UB_Z&9__ (?_%T?\,ZQ?]#,_P#X!#_X
MNO<::QPV>>!0!XA_PSK%_P!#,_\ X!#_ .+H_P"&=8O^AF?_ , A_P#%U[+%
MJ%FVH-IXNHOM:H)#!Y@+A?7;UQ[U<H \._X9UB_Z&9__  "'_P 71_PSK%_T
M,S_^ 0_^+KW&B@#P[_AG6+_H9G_\ A_\71_PSK%_T,S_ /@$/_BZ]QHH \._
MX9UB_P"AF?\ \ A_\71_PSK%_P!#,_\ X!#_ .+KW&B@#P[_ (9UB_Z&9_\
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M71_PSK%_T,S_ /@$/_BZ]QHH \._X9UB_P"AF?\ \ A_\71_PSK%_P!#,_\
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M_ (?_%T?\,ZQ?]#,_P#X!#_XNO<:* /#O^&=8O\ H9G_ / (?_%T?\,ZQ?\
M0S/_ . 0_P#BZ]QHH \._P"&=8O^AF?_ , A_P#%T?\ #.L7_0S/_P" 0_\
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M.L7_ $,S_P#@$/\ XNO<:* /#O\ AG6+_H9G_P# (?\ Q='_  SK%_T,S_\
M@$/_ (NO<:* /#O^&=8O^AF?_P  A_\ %T?\,ZQ?]#,__@$/_BZ]QHH \._X
M9UB_Z&9__ (?_%T?\,ZQ?]#,_P#X!#_XNO<:* / [S]GJ2&RE>QUP3W:#]VD
MT&Q6.1U(8X&,]J\JUKPYK7A>^$.JVLEG+AFBD/(?DC(([<<5]H8'I7G?QC\.
M0Z[X(N;EV"3::&N(F;., ?,,#KD"@#GO@GXW&I6!\-7DDIN[9#)!)(P(9,@;
M?J,C YXS7L2<$#T'7UKY,^% '_"SM"&W:5F<8/\ US:OK8=: %HHHH ****
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M,9'7H#QCD$GGGB@#3^#FM#3/AMK6J:A-++':7+R,<[F"B-#QG\:I^#O#U_\
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M@Y!IU5;"\AO[."\MV+07$2S1,5QE6 (X[<&K5 !1110 4444 %%%% !1110
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MEJ-Q=:T^H7TXA$H=8T,84-M^5,=<GKZ5O8&XXSGITH XSP3J)NK_ %@-I=[
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MBC)(_,54U'Q/9Z5J$.GR0W5Q>30F6&*",,T@! ('(YYSSV!J+Q]_R(NKCCF
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M]_2@#9\/@?\ "4>*O^OR#C_MWCKIJYGP\<^*/%0[_;(<\]/]'CKIJ "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *YCXAJ/^%=^(3_TXRG_ ,=KIZYGXA_\DZ\0_P#7A+_Z": /
MF[X4?\E.T(=O-?\ ]%M7UL.M?)/PH_Y*?H7_ %U?_P!%M7UL.M "T444 %%%
M% !1110 4444 %%%% !1110 4444 %>+_M#_ /(&T3_KXD_]!%>T5XO^T/\
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MPSX@GF?6;*;S6^T3B0E6 ^5222VW&3CCYA6%\7@O_"Q?!Y*X'FH,YZ_O5[4
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MC;2:C%?&$&XBC>-)2>55BI8?CM'Y5%J>CZ?JT30W]JLZ8R">#P<]1@]:Q_\
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M@ KQ?]H?_D#:)_U\2?\ H(KVBO%_VA_^0-HG_7Q)_P"@B@#D_@#_ ,C[<_\
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M'GCD9[BN^GM+>Y55GA20*ZR+O&<,IR"/<'G-17^E:?JL @U"S@NH0P<),@<
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M)+>2,H=/O'4+!Q@!=W&W/(]R:S=%^'GB:U^(^B^(YM,L+2U)9I;>RVJ+9=I
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M![@@D'@FJGCGP5X@U?X8>&-(L; RW]D(_/B\U5V$1$'DG!Y]*['Q+X0?Q1X
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MD$5X]X5^'^K77CV+Q+J6BVV@068#16=NRL)'(()^7@=>?PKV#! ;Y"23U]:
M/)_C#XHUWP]JWA^#1KXVWVHR!EP-KL"@4-QTY-2^(?$?B3X>>$'O=5U*'4M8
MOKD&VC\@B* 8!9.&R0.<'-.^*WA#6_$>N>';C2K'[1%:.QN")%4#+(1]XC/
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M=,M])C*RB*/<]Y*N"<Y^ZN"OKR36_?>.=2U+X(3^)[5OL&H*%4M%R PE568
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M#+&Q!W/P<?6NWJO?_P#(.N?^N3?R- 'P\!QR>G0#IUK[<T?_ ) EA_U[1_\
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M'_A[H_A[5[C54>ZO+V7A9KN3>8AU(7CC_P"M77T4 (.@I:** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>__P"0=<_]
M<F_D:L57O_\ D'7/_7)OY&@#X?\ 6OMO1_\ D"6'_7M'_P"@BOB3UK[;T?\
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M>/7@BL[X?>"=2N/!7BS2=5LKJR^WLAB\Q=A8KDC&1TR!^=>X;.<YHV\DYZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=7<[_-$5!^5B"3D$=N,8 KU;XE?\DYU[_KU/\ZR/@D1_PK&QY_Y;3?\ H9H
MQ#^S[X>52$U/5,GU>/!^OR_RJ'X.ZAJ>G^)=<\'75T+FTTS?Y3$'*E7"X&?X
M>>AKV/N*\7^&O_):_&GUF_\ 1PH ]IHHHH **** "BBB@ HHHH \<^,.HZIJ
M'B70_!EG=_9+;4]AEE ))+.5 /\ L\=.]2I^S[X>"D-JFIMD#)W1\?\ CM5/
MB1_R6WP9[^3_ .CC7M Z4 ?/_C7X:1?#W1T\3>']7O4NK69?]<5)&X@#& /Q
M!R#7L7@_4I]<\):;JESL$MW;K(ZH,*&]JYGXV'_BV-[_ -=H?_0Q6S\-B/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZO\ ^BVKZV'6@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "O%_VA_\
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MG:V-5%MHPU22S>Y&LV^#;(ZIMY[,2<U+/.WASQ->WTUO.^GW\2-+=1KN%NR
M*%('S'<.X'!_.FZOJ-KK=GHUQIS23PKJ\ 8^4RX(SG(8 XYZT :>H/XB:\,>
MFC3X8% _>7BNYE)'. K#&/>L:Z\9S:?I-T]]]DANK:_73WG;(MP[*K!\$YV
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MTKG(K3P1Y$<%SX:$6J, &T\VS,P<_P  ;[ASV.['/.*Z:>+/Q!TR01OM&EW
MSCY1^\BX/OQ^E %G0]3GU!]1M+]8UNM/F$,SP@K&Y**X*@DD<,!R>H-4K7Q1
M)-X>LM2,$9GU.7R[& 9 &02 Y/H%8D\=*S/&6G74^MFVMX'=-<L?[-:2+_E@
M-S%Y6^BMQZD8K1\7Z&-0T&U"V9U Z?.DRV:@ 3X4ICD@#AB?PH F75-9TN>
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M#G/.?:HO$,,DGB7PNRJS(M[*7."=H^SR#\*DU.+?XU\/OL<A8;H;@.%XCZT
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M!&D$:PJI554* .P% %GM12#H*6@ HHHH **** "JU^";&; SB-CU]JLTQ^U
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MCGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH
M=13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?
M:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH
M =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>?:CGVH =13>
M?:CGVH =13>?:D)(QTZ^M #Z*:/O]3]#3J "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ JO?_P#(.N?^N3?R-6*KW_\ R#KG
M_KDW\C0!\/\ K7VWH_\ R!+#_KVC_P#017Q)ZU]MZ/\ \@2P_P"O:/\ ]!%
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MLFDVMA+;6CWCWETENL:-@C<K,&Y_W?R--T[5]0%_'8ZY:6]I=S FW^SS&5)
M!EER54[L GIC'>@#<&,=3D]212-@ X!/'R]3VK,M=7:[U_4-+,6S[)!#)O#<
MMYF_MVQL_6FP:T\M[K5L+5G.FE @B.6F+1!\ ' !R<=: -?  SCDXZFJ8U"W
M;5?[-R1=& SE<<;-VWZ=:P+C7_$>FP-?ZGI%A'I\9!E,5ZS2A"<<(8P"W(XS
M^-6CD_$4 CII)/7_ *;"@#H <]L>Q&*B@N;>XC:2VD21$=D<JV<,IP1GU!%3
MG)P, <=?2O-_"KG3-?GN6/E6FH:A>P,%.0TZS,0S9X'R@J/<@4 >B%T5 2V
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M_MXI(+D!71A<(#D G\/6MO5=8NX;L:?I%K%=ZD(Q*T<TQBC2,D@,S $\D$#
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M !1110 4444 %%%% !1110 A -)L IU% #=O?)S1L!X/>G44 %%%% !1110
M4444 %(RAA@TM% #=O.<YI<"EHH 9L&,$G%/HHH **** "BBB@ HHHH 1NG7
M&*YOQGHM]XB\.2Z;IVI&PN9'1DN5)& ""1\OK72,"1@'%-"8)XZT >)_\*>\
M9?\ 0]S?]_9O_BJ/^%/>,O\ H>YO^_LW_P 57MVT4;10!XC_ ,*>\9?]#W-_
MW]F_^*H_X4]XR_Z'N;_O[-_\57MVT4;10!XC_P *>\9?]#W-_P!_9O\ XJC_
M (4]XR_Z'N;_ +^S?_%5[=M%&T4 >(_\*>\9?]#W-_W]F_\ BJ/^%/>,O^A[
MF_[^S?\ Q5>W;11M% 'B/_"GO&7_ $/<W_?V;_XJC_A3WC+_ *'N;_O[-_\
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MT4;10!XC_P *>\9?]#W-_P!_9O\ XJC_ (4]XR_Z'N;_ +^S?_%5[=M%&T4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5>__P"0=<_]<F_D:L5!>*TEC<(HRS1L /?% 'P]ZU]M
MZ/\ \@2P_P"O:/\ ]!%?*0^%WC8C/_"/7//3YD_QKZOTR-X=)LXI%*R) BLI
M[$*,B@"W1110 4444 %<S\0_^2=>(?\ KPE_]!-=-7,_$/\ Y)UXA_Z\)?\
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M"[#_ *8UV/EC<Y 4LPP>.H]_6@1KY/ED*01@KC@CTQ0!S.NKNB\*$G(_M*(
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MPPR+B/(R*ZE(TC 2- %'8# %-$,(C*+"%3.=@4 ?E0!@ZUSXV\.#_IG==/\
M<6J.N6TESXO^S1#=-/H5VB_-CDO&._OBNNV+O4[1D=&(Y&>U,DC8[VB*"0H0
MK%<[2?Z>U ',Z=XHT?3="M[&ZO84O[:W2&2S!S.750-HC^\2<<8'((QUJWX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !2-]TTM% $>#TZY]:D[444 %%%% !1110 5S/Q#_Y)UXA_Z\)?
M_03735S/Q#_Y)UXA_P"O"7_T$T ?-WPH_P"2GZ%_UU?_ -%M7UL.M?)/PH_Y
M*?H7_75__1;5];#K0 M%%% !1110 4444 %%%% !1110 4444 %%%% !7B_[
M0_\ R!M$_P"OB3_T$5[17B_[0_\ R!M$_P"OB3_T$4 <G\ ?^1]N?^P>_P#Z
M&E?2E?-?P!_Y'VY_[![_ /H:5]*4 %%%% !1110 4444 %%%% !1110 4444
M %<9K>H2V'Q!L?L]I-=SRZ7,D<40ZGS8SRQX48!Y.!T'4BNSKDM3O;2S^(^G
M?:YEB\W3)DC+< MYB'&?H#^5 &AI^N23W7V._L9-.O"I=(I)%<2+W*LN02.X
MZCCU%5F\2W<KM-IVBW%]8*2INDE10^.I52<N,9P1G/:HK^5;_P 7:0;5EF2V
MAN#*T9RJ!U 7)[9(/'M7.^%-,MDT=-.G\3:K:WEA_H\T"W*I&KKQ\FY>5]#0
M!Z#97L=_:QW%LPDA<<-G&#Z$=B.A';%<IKFH2V'Q TN2WLIKN633+A(X8QC)
M\R(\L>%& >3QV[UO>'K:RL-#@M].FDGMD+E7D.YF8NQ8DX&?F)[51N4 ^)&F
MG=R=+N>,<_ZR+F@"_IFK_;VEMY[62TU"$ 2VTA!*J>C CAE]QWR.H-4Y/$EZ
M[O)I^B37]DAQ]JBF158#J54G+#W'7M3-F?B-.0P!_LB/'M^^?FN;\,:9!%IG
M]GS^)-5M;JP8P3PK<K'&K#NF5Y7TYH V[N]@U'Q%X5N;659(W>Z(; R,1$%2
M.Q'0CJ,<U?O==NENGM=*TF;4FAXF:.9(UC;LNYCACUR!TXSU%8EG9Z?I^K>%
M8-.N)+BW$]\WFR-N9W*L7).!_$36EX?GATZZUNUO+B.WF?4);A4D8+NC;&UN
M?7!H K>#[M;_ %KQ+,;>>!FNXEDCE0JRL($!'N,CKT/4<5NZ_?6^G:'<W=W;
MBX@BV[XL ALL!T/'?]*Q_"UW;WWB'Q1<6L@>/[9$@=>A(@0''XBI_'7_ ")F
MHG;GB/O_ +:T .U3Q')8ZW'I$&F7%[=RV_VE%B(5=H;!W,W"XQGDC/0<UH:5
MJRZDKI+ ]K>0G$UM(063/0Y'# ]B.#@^E9RJ/^%BX(Q_Q* >/^NM)IZ@_$/7
MFW9/V*T^7'3F:@#=N(1<0R6YWJKH4.URIVD8R".0?<5SVL:)X=TK1;J\;3+6
MW,,>X7$, $RMV(91NSGOFNE+!%)9@J@9R>-H]ZY6QO[/Q%(FJ7=[ MBC$VMJ
M9%!R#CS'YZ\<#MUR<\ #$?4-2NM,T366(<::MY>K$1^^D#!2A(_AW'.!UQ@Y
M!(J:_MX?#M_I]QI426T=Y=QVD]JB[8F#9(<*.%88/(QGOG Q+?O'8>*K769R
MOV"2R^R^<G(1V<,I/HIZ9]2/K3=7ECUC4-*LK!DGDMKR.\G9#E(XUW#EO4]A
M['I0!>;PSH4LLEQ<:5:W4LKL[R740E;DYQELG [#H!TXJMX1:233;HJS-8?:
MG%AO.6\D #'KP^_&>V.V*KW^J0:MJUQHJWL=M:VP47C&0*TNX9$:^@Q]X_48
MYR-.\\R3P[<P:!);?:$B,=ON;,:MCN10!R?C*:;59)S%+(MCIMS;+A6(62=I
MX\G(^\%&Y2IZ$CC(KT51A1FO+=<B\1Z9X+M]._L2RCM+>6U02'4C)(V)H\;O
MW0R2<9/XUZ-:7%T;2%M0CAMKASAHTDWJISP Q SGZ4 7:3 ]*%.??WI: "DP
M/2EHH *,#THHH *,444 )@#M2X'I110 F!Z"EZ444 )@>@I:** "C ]*** "
MBBB@ HP,]*** "C ]*** $P/2C ]*6B@!,#TI:** "C ]*** "BBB@ HHHH
M,#THP/2BB@ P/2C ]*** "DP/3K2T4 )@>E&!Z4M% !@>E! /49HHH ,#TI,
M ]12T4 %&!GI110 48!ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "N9^(?_).O$/_ %X2_P#H)KIJYGXA
M_P#).O$/_7A+_P"@F@#YN^%'_)3]"_ZZO_Z+:OK8=:^2?A1_R4_0O^NK_P#H
MMJ^MAUH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ?]H?_D#:)_U\
M2?\ H(KVBO%_VA_^0-HG_7Q)_P"@B@#D_@#_ ,C[<_\ 8/?_ -#2OI2OFOX
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M9K6*XV>=&D@C<2)N4':PZ$>XJ:B@! H'0"EHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9^(?\ R3KQ
M#_UX2_\ H)KIJYGXA_\ ).O$/_7A+_Z": /F[X4?\E/T+_KJ_P#Z+:OK8=:^
M2?A1_P E/T+_ *ZO_P"BVKZV'6@!:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "O%_P!H?_D#:)_U\2?^@BO:*\7_ &A_^0-HG_7Q)_Z"* .3^ /_ "/M
MS_V#W_\ 0TKZ4KYK^ /_ "/MS_V#W_\ 0TKZ4H **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<S\0_^2=>(?^O"
M7_T$UTU<S\0_^2=>(?\ KPE_]!- 'S=\*/\ DI^A?]=7_P#1;5];#K7R3\*/
M^2GZ%_UU?_T6U?6PZT +1110 4444 %%%% !1110 4444 %%%% !1110 5XO
M^T/_ ,@;1/\ KXD_]!%>T5XO^T/_ ,@;1/\ KXD_]!% ')_ '_D?;G_L'O\
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MO;+E3UW8SCMTS79?#G1?#R:EJ7B+2(=:D2WMS")M0=<3D\NN-N<C:O.?XNE
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M@ KQ?]H?_D#:)_U\2?\ H(KVBO%_VA_^0-HG_7Q)_P"@B@#D_@#_ ,C[<_\
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M"\O$O;I+2>.YF+@%LX=<_=Q@\=\CTIDF@WZ_#_1]*"(]W:FR\P$@C$;QEC^
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M00N,YPO':@#7\'ZE/J_A/3-0N6#37$ =V P":W*P_".G7&D>%]-T^\V?:K:
M))L.1FMR@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KF?B'_R3KQ#_ ->$O_H)KIJYGXA_\DZ\
M0_\ 7A+_ .@F@#YN^%'_ "4_0O\ KJ__ *+:OK8=:^2?A1_R4_0O^NK_ /HM
MJ^MAUH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ?]H?_ ) VB?\
M7Q)_Z"*]HKQ?]H?_ ) VB?\ 7Q)_Z"* .3^ /_(^W/\ V#W_ /0TKZ4KYK^
M/_(^W/\ V#W_ /0TKZ4H **** "BBB@ HHHH **** "BBB@ HHHH :5).0<?
MA7/7EK=Z3JLVKV5L]TMWM6\MXR/,PHPK1YP"1T()'!)SQ@]'3&!)[_2@#GK*
MWNM4U.'6+RV>T2V#K:6SX\T;AAFDP<9.,!03P <\X&+IVJW_ /:=WJ%_X8UJ
M2;S72V*)%M2#/RX!?ACQGZ5W.PD''RD]P*7:3R1SVP: .>UK6KF#PK-?VMM)
M;7\RF.UMKE!O,S$A%(!(Y.._>MC1]/BTG1[2P@#"*"((NXY/'K27.GP75Q;S
MW$?F&W8O&,G&<#DCH2,<'MVJZ.@XQ0 M%%% $5S,;>UEF$,DQC0L(X@"SX[#
M) S^-<EI7@?39--BDUG3[>YU-QONICDF1SW)]<5V)&1CUJ/9@Y /'04 <WIV
MA+X?\1XTVT$6EW-OMD6'H)@?OL#_ +.%!&:L>';.XM6U@W4)B674I98O]M"%
MP?IP:WB#G@#-&#DY!- '$6?AR^N/"$]G*@@N8]6EOH4?@/MN6E0$C. V!SVS
MT[4WQ)J&L:YX?N=-L_#FH13R;=[W)14VAAG:0Q)/H"!GGD5W"IM7;@D'L>U&
M"0/;U% &%JUG/<>(_#MS%$3%:S3-*W]P-"ZC/XD"JFL:?=V7B!=;LK&.]CEA
M$-]$Q'F%4)*&($8)!9\@D9R/2NH . < \9.100<]/TH Y^T8ZU!>6D^BW&GV
M,UNT,C7 5)6+<8 4L,8/7/7M6=X3T34@]UJ6K!8+B>U2Q6%/FQ%&S[&)[,0_
M3V'//'8#<3R.V<&E(.,8^N.,T <AX*T._L)G?45 %C#_ &=9-N^:2!2,NP[;
MBH(&3@&NR;.T[0"V. :8%P^>1@\5)0!RQ\1:BJF&7PSJ#W1RC%-C0;^F0Y8'
M9GOMSCMVJO-H-U9:!H=C$#<26VI17$I4_=7>S-U[#=C\*ZT@@\  8_*EP<#I
M^5 &'IUG<1^*==N98F6WG%OY4G9]J$-CZ5GVN@->KXML[^&1;/4;OY-I +H8
M8U)!^H(_"NLP<Y(/2FA" Q7/7(!H YC3]:UNSB@LM8T.ZFNEPKW%AM> ]LY9
ME(]Q@_C55=(U81^-%LB;:YO[@O9S,<9/V>-0P(S@!E/Y5V?_  'I2$'!( &!
MD8% 'GNJ_;K_ ,/KI&E>$[JW*M#NDN5C10JR*3LPS$MQT..,\]JZ9;2X7QS-
M>M$QM3IJ0B4]-PD<D?D16[@]P?PI,'(XX/:@#$\,6<]E_:_GQE//U*>9,_Q*
MV,'\:WZ:N1V'X4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *YGXA_\DZ\0_\ 7A+_ .@FNFKF?B'_ ,DZ\0_]>$O_ *": /F[
MX4?\E/T+_KJ__HMJ^MAUKY)^%'_)3]"_ZZO_ .BVKZV'6@!:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "O%_VA_^0-HG_7Q)_P"@BO:*\7_:'_Y VB?]
M?$G_ *"* .3^ /\ R/MS_P!@]_\ T-*^E*^:_@#_ ,C[<_\ 8/?_ -#2OI2@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGXA_\DZ\0_\
M7A+_ .@FNFKF?B'_ ,DZ\0_]>$O_ *": /F[X4?\E/T+_KJ__HMJ^MAUKY)^
M%'_)3]"_ZZO_ .BVKZV'6@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"O%_VA_^0-HG_7Q)_P"@BO:*\7_:'_Y VB?]?$G_ *"* .3^ /\ R/MS_P!@
M]_\ T-*^E*^:_@#_ ,C[<_\ 8/?_ -#2OI2@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *YGXA_\DZ\0_\ 7A+_ .@FNFKF?B'_ ,DZ\0_]
M>$O_ *": /F[X4?\E/T+_KJ__HMJ^MAUKY)^%'_)3]"_ZZO_ .BVKZV'6@!:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "O%_VA_^0-HG_7Q)_P"@BO:*
M\7_:'_Y VB?]?$G_ *"* .3^ /\ R/MS_P!@]_\ T-*^E*^:_@#_ ,C[<_\
M8/?_ -#2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y
MGXA_\DZ\0_\ 7A+_ .@FNFKF?B'_ ,DZ\0_]>$O_ *": /F[X4?\E/T+_KJ_
M_HMJ^MAUKY)^%'_)3]"_ZZO_ .BVKZV'6@!:*** "BBB@ HHHH **** "BBB
M@ HHHH **** "O%_VA_^0-HG_7Q)_P"@BO:*\7_:'_Y VB?]?$G_ *"* .3^
M /\ R/MS_P!@]_\ T-*^E*^:_@#_ ,C[<_\ 8/?_ -#2OI2@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HIA;&%SR>^*0R8P>HSC.* )**09QSU]J6@ HHHH ***0YSUQ0 M
M%(,YI: "BBB@ HII)W@ X'>A6R* '4444 %%,#9X/!S@9I [$'(PWH: )**0
M9[T'..#B@!:*86R2 2,=\4!LY&>1WQ0 ^BJ5OJEE=W<MK;WEO--$#YB1R!BF
M#CD#I5P4 +12,=HS358G'3!H ?113-QR>>!0 ^BHPS$9/&.M.4Y]: '4444
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M[KNNKB$8/'W-H!Y[Y]L4 >X[P!DU6U&^&GZ;=WACWBWA>4KG&[:"<9_"O.?
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MH **** "BBB@ HHHH *0C((I:#TH Y'XEO+#\.=;EAD:.1+?*LI((.X5YO\
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M2I;6:Y5.7B .(N-@)] =W';TKIM1\9ZI=^,-4T30SIF@3VP5I;[4UV_: GR
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MDF&U%(+DC<?3<,_A0!WVI_%;PUI1MEN#>&2X@2<1QP%FC# $!AV.#TJ_X?\
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M &=N ,,?KZUZ]10!X]K/P_DT3X,W.CZ392W.I7!AEN5C^=I)-ZEL>P&<>PK
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** #&>M)M [=:6B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HP*** "BBB@ HHHH , 4444 %%%% !1110 4444 %%
M%% !1@444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/Q#_Y)UXA_P"O
M"7_T$UTU<S\0_P#DG7B'_KPE_P#030!\W?"C_DI^A?\ 75__ $6U?6PZU\D_
M"C_DI^A?]=7_ /1;5];#K0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M!7B_[0__ "!M$_Z^)/\ T$5[17B_[0__ "!M$_Z^)/\ T$4 <G\ ?^1]N?\
ML'O_ .AI7TI7S7\ ?^1]N?\ L'O_ .AI7TI0 4444 %%%% !1110 449HH *
M*** "BBB@ HHHS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111F@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHR/6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **,T9% !1110 4444 %%%% !7,_$/_ ))UXA_Z\)?_ $$UTU<S\0_^
M2=>(?^O"7_T$T ?-WPH_Y*?H7_75_P#T6U?6PZU\D_"C_DI^A?\ 75__ $6U
M?6PZT +1110 4444 %%%% !1110 4444 %%%% !1110 5XO^T/\ \@;1/^OB
M3_T$5[17B_[0_P#R!M$_Z^)/_010!R?P!_Y'VY_[![_^AI7TI7S7\ ?^1]N?
M^P>__H:5]*4 %%%% !1110 AZ5&6 7:6'IN],]*D;[IX)^E9FIZ3::LL4%]&
MTMLK;C%GY'XXW#N!U'OB@"]@!MJGG_/6I1TKC9]*L?#^K:7#H-O';37<Y$\$
M8P)( /G8CU4E>?\ :KLEQM&.E "T444 %%%% #&.UL[NW2FY!).XX/!'& :D
MVC.<<UPOCOPMHG]AW6H+IMNMX]Q!NFV_,=TZ!OS!(_&@#MU.7QD=,XJ2N<%M
MX<\&0O?1VT-A'.5C=XHR=[?PKQD_I2V/BN":]AL[ZTN].N;EMMM'=H!YW!)P
M4+ 8 [D4 =%146[!!)Z]>]<V_BUOFDCT35Y+,9(N@D81E_O\N&QWY&?:@#J:
M*P-3\4V>F+IV4GN?[2!^S"W7<9#M! &<8SD8S@>N*=I_B);R[^S75C>Z;.PS
M%'>*@\T#KM*L1QQP<']: -VBN9N?&$2:G>:=:Z9J-]=VC*)8[:-3@%0P.68#
MOZYJ_::Y#=Z?+=A98S I,\$B@21D#)!&<?D<4 :]%<YI_BVUU"QDU%8;F'3H
MK?[0;N9 L;+C) YW97G/&..":B_X32S3$MU;7MOI[D"+4)(AY4A/W< $L,^Z
MCI0!U%%9T>I1R:O-IN'2>)!(-X&)$/\ $N#T!XYQR*CAUFVFFODW,L-B=LUP
MV F_J5'.<@8SQ_$,9H U:*YN/Q=&TRF?2M3MK%R M]-&@B(/W3PQ8 \=5&,\
MXK>\T&-G7+C&1MQS]* ',,MR>*9;W$$[S"&5)&B?9(%;.UL X/H<$?G7(^'_
M !%?:AXKU>TGTS4HH0\10S"/9;CRP2#ASC<>1C/6JNCZ\-/U+Q%!%IM]>2C5
M7DE6V53Y:F*/!)8@<X/ STH [^BL^/5[*33/[0%TGV4)N,G(Q^'4'/&.M9L'
MBI)+A$NM)U*QMY#M2[N501$GIT8D9]P/?% '15&^1DXS^/2I*Y/Q+$=;U2'P
M^DLHMW@>:]$+;'"GB/GT9@PQ[4 =2F<'C@=#ZT^L3PSJ5SJ&@6LMYM^VJOE7
MBJ,>7,O#K^!JG-XPB&I7FGVFG:A>W%G*(YQ;QK\F5# Y9@".>W/!XZ4 =/17
M.2>+;?Y6LK*^U"(J'EDMD&(0?[VX@],\ $\58;Q+ISZ5%J=M,UU%.2MO'"IW
MS,"5VJ#CG(QS@#O0!MT5AZ?XA^W77V>XT^]TZ8KNC2\"@RXZ[=K,#CT)!_6J
M<_C.%=4OM/M-,U*^N;)U2:.WC3Y<J&!RS $?-CUR.E '45%=7$-K:RW%Q*L4
M,2%W=S@*HZDFJ<6KVD^FF_CG7R-N2[9&WU!'4'VKC_%_B;[3X-UJ.72=1MK6
M>QE2.[GC7RF+(0I^5BP!XZKWYQ0!WD961%=2"N,@@\'WJ0=!6!?:Y:Z%I.G7
M%VLA6=D@01KN^<J2/Y&HX_%<2Q/]KL+ZSN ,Q6LZ+YDV>!MVL0<GCDC'?CF@
M#I**P;#Q1:WUY]@GAN-/U QM*+:[0!S&, ME25QR.^:@D\6HKN;;2]2NK1#@
MWL2(8@!]X\L&('/(4].,T =+16+JGB2QTBRM;N<R2PW,RPQM"N_)8$C^5167
MB3[69$ETZ]L[I4:1+:X5 \P _@PQ!.>Q(H WZ*XWPCX@U#4[_5K>YT[48PM[
M)LDN-FR%0J8C.&)SR3P".>M=3+/]FMY)I"PCC!9FQG@<DX'M0!9HKEF\8F$^
M=<Z)JMM9#E[N98_+1?[Q <MC\,U>USQ#;>'S9BY6X=KR7R85B3<=X4L!^.,?
M4\X'- &W16-I>OQZC*T$MI=6-TOS?9[M5#LO]X%201U'7/'TJ&]\2&"Y>WM-
M,O\ 49(S^\-HJ$1'L&+,O/TSB@#5BN8+B:XCAF21X7\N4(V2C8!P?3@C\ZF.
M!QD #K7*>";N*_NO$EU$&"R:IG#+@@B&($$>H(Q4_CV-'\'7$3KF)YK=''J#
M/&"* .DC(Z9S4E<;?:39>&;O39]"MX[6:>ZB@E2,<21,WS$COM'(],ULZEK\
M=A*L,-K=7]T1N-O:A2RI_>.X@ =.^>>E &S16);>);.73[F\N5ELOL@+7,-P
M )(AUR0,@C'.02/QR*I?\)?)LS)X?UF+?_JB\<9\UO[HPYYQD\X''6@#J**Y
M#P+K=YJNCL;RUOT99IO](N2F&'FN HPQ.5&!^'>K!\72#]Y'H.JRV8Y^U!(P
MA3NPRX;'?D9H Z>BN%UKQ7=Q>(]%2QTW5+FRE\QPUN(]MVIBW+MRXZ9R<XKI
MM1UB/3K>*1XY9;B7B*UB ,DA] "0./4D#WH U**Q=-U[^T+AH9K&[T^<+N2&
MZ"AI!W*[6(/YY]JH/XT@:[N[:TTS4;MK.<PW)AC7$6 #D[F&0>>F3P>.F0#J
M:*YN7Q;;(ZO:6E]?VN TUQ;Q@I ",_-D@\#D@ D=.O%67\2V0TN"_M6>]2Y'
M^CQP+^\F/^R&Q^N!0!MT5B:;X@%]<&UGLKNPNB-Z0W:J#(OJI5B/US6;;>.;
M:\A2[AT_4&L=Q22Z$2^7"02#N^;<<<= >OUP =;17&>.?$%YINEVS:=:WLPF
MN+?%U:E"@4S("N2P/S D<#'/6NGLKR2ZLXYWMIK=F&3%, &7ZX)'ZT 7**S-
M6UNRT9(3>S,KSOY4$:*6:5\$A1COQWX]ZIZ?XFBN[M;&XMKFRU!U9TM;E '=
M!U8%25Q^.?:@"]-JMA;7UM83WL*7ER"8("X#R@==H[XK0'2N#\/:O-<^-]9$
MV@ZC"93!\\JQX@Q$?O8<XS[9KL9[F2VLYKB.":X\L$B&,#>_LN2!^9% %F3[
MO. !W-16D\%U"LUM*DL9R Z-D'!(/Y$$5RW@W7[[59=2AN[#4(U2]G*2W 3:
MJA\"+AB<KGTQQUK-\*>)X;'0(X4L+^>""XN!<7440,4!\YR0<D,< @_*#UH
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M.SWP>:YGP$I3PG;1N9'*SW"@NVYCB>3DGUK/O+32;G5[W_A+H8'92\EH\_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *YCQ3XXT+P>81J]TR27!^2-%+-CIG [?UKIZ\!\':5:>
M,_BOXG;Q!$VH):2RK%',<@@2% "/0#I]!0!VJ_&SP2#C[7=%F];9JZ+PSXYT
M'Q:9QI%RTKP_ZQ'4HP'J >2/>HF^'7@[&?\ A'+#UXB&:\L\9Z19^#_BSX:D
M\/1'3UO)8A*D)VJ<R!& 'H1G/UH ][3)()QQT/K4E-  / IU !1110 4444
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M\*V.EZOH-DNGW8N=N8/E!P"V?J"*]PTN1YM(LI9&+.\",S'J25'- %NBBB@
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M[BT@BBLX$A?<BQJ%?@[AC@_C67/X4T:YOUOYM,MGN@RMYA'0C&/RQ6X!@8%
M',Z+A?%_B@#IYEL>G_3$4>%1_I7B,E@<ZL__ **BK8ETJSFU:'4GMHVNX5*I
M-_$H(P14MM90VAF:&-5:>0RRD#&YB ,_7 'Y4 >>W5E-=> M<6WG$9BUJ>X:
M5<918[K>Q /!(52<'J15R;1CK/AQKJX\;7LNCW$6YY&CMPA0GNP3C\Z[6WL8
M;2&2.")%621Y7'8LQRQ_$FLX^%-%.I#4/[,MS=[PYEQSGZ=* -C<Q/ '!YKA
MM)3Q!JEY=>(M/FTM4O"88UNXY"\<<;,H3Y2 1NWMG&?F]J[:2W6:%X90'CD0
MHZGH01@TL%O';P)#$@2-%"JJC  % ')Z -0TOQ#=Z5J#VSM?(]^@M%8(AW@/
MG<2<L6!ZX&*F\+9.N>*P>G]J+CC_ *=XN]=%/8V]Q<03RPH\ENQ>)F'*,01D
M'Z$C\:2WL+>UFGFAA2.6XD\R9E_C; &3[X 'X4 8GA%?DUAO,##^UKK@=OG_
M )UQ)1H-!\/Z@^J/I=K;WU[$]XFQBAEF=5SN!&"<@GM7J5O90VGG""-4$LC2
MOCNS<D_G3(-,M;6T^RP6\:0 LPCQQEB6)_$DF@#FF\/R+J>F7>I>*;RY6&XW
MV]O*D*+))L8 ?*@).TL<9[5/X84?\)%XJ/( U"/J?^G>*M+3_"^C:5=?:;'3
MX()2""R@YYK0@LH+>6XEBB5)+AQ),RCEV "@G\ !^% '!W,$LWA+Q.(LR/\
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M>I/J[Z3:[)K,W,:QDF60HR*=X( (C;GU ]:ZV[T/3KZPCTZYLX9+*-55(B.
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M;AN]=^X]<UZ'G<,G:=O8&N;TB"ZU7Q/<:W=64]K;I;);VL5T%$L;Y8R, I(
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M  R?P 'X5:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/7H">?IWKT0?%+P3C/\ PD%O@]/E;G]* .._:# 'A?2SC.+TXY_V&KU71_\
MD!Z?_P!>T?\ Z"*\.^,7B[1O%MCI.D:#<_;[E[H.#$N%Y!4+DXY)(KW/3(GA
MTFSBD4K(D"*RGL0HS0!;HHHH **** "N9^(?_).O$/\ UX2_^@FNFKF?B'_R
M3KQ#_P!>$O\ Z": /F[X4?\ )3]"_P"NK_\ HMJ^MAUKY)^%'_)3]"_ZZO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 8RY/?GTH488G!Y]Z?10 444
M4 %1L&WYQD&I** &KUYIU%% !1110 4444 %%%% !1110 4444 %%%% !4;+
MEL\GM]*DHH 8H(/0@4^BB@ J/:<].O?N:DHH :O3J?RIU%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7-^(/!7A[Q.X;5-+CFE5L^:N8W/&.67!(QZUTE% ' ?\*;\$94_V,1@
M\?Z3+_\ %5N:#X(\/^&I&DTK2XHIF.3*Y,CCC'#-D@8["NCHH C12,;N2#UJ
M2BB@ HHHH **** "BBB@"&XACN87@GA26&0;71U#*P]"#U%<;<_"7P5>W4MU
M-HJ^9,Y=@DKHH)]%! 'T%=Q10!P1^#?@8C']C$9_Z>)?_BJ[*QLK73[<6]C:
MQ6\ YV1QA%SZX'>K=% !1110 4444 %%%% !3&'4XSQQBGT4 8FN>%M(\26O
MV?6+"*Z7@"0C:XP0>&&".?0US9^#G@DON.CDMC_GYE_^*KOZ* .1T;X<^$_#
M]V;FQT:,2X #2EI=O.00&)P<CJ*Z[M110 4444 %%%% !7,_$/\ Y)UXA_Z\
M)?\ T$UTU<S\0_\ DG7B'_KPE_\ 030!\W?"C_DI^A?]=7_]%M7UL.M?)/PH
M_P"2GZ%_UU?_ -%M7UL.M "T444 %%%% !1110 4444 %%%% !1110 4444
M%>+_ +0__(&T3_KXD_\ 017M%>+_ +0__(&T3_KXD_\ 010!R?P!_P"1]N?^
MP>__ *&E?2E?-?P!_P"1]N?^P>__ *&E?2E !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5S/Q#_ .2=>(?^O"7_ -!-=-7,_$/_ ))UXA_Z
M\)?_ $$T ?-WPH_Y*?H7_75__1;5];#K7R3\*/\ DI^A?]=7_P#1;5];#K0
MM%%% !1110 4444 %%%% !1110 4444 %%%% !7B_P"T/_R!M$_Z^)/_ $$5
M[17B_P"T/_R!M$_Z^)/_ $$4 <G\ ?\ D?;G_L'O_P"AI7TI7S7\ ?\ D?;G
M_L'O_P"AI7TI0 4444 %%%% !11TI,C'6@!:*3(]:6@ HHHH **** "B@D#K
M2%@,<]>E "T4F03C-+0 4444 %%%% !1110 4444 %%%% !1110 44A( Y-+
MG- !1110 444A('4T +1110 4444 %%%% !1110 44F1GK2T %%%% !1110
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M+2;?PYJ&BRZ4]S;B[U!+>Y02EEF4HY^8-GH1VQU-$&BV>N>+?$9U(SW$$,T
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M;6>\FD8,[#I\JD #T&.G7/6L6?49X/B;JFFVA1;N]TZV*2N/EC56EW'W/S#
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M]6Q#97WW*HY[$TS1]'ET[4M9N9)$87]X+A%7/R@1(F#[Y0UMD9(I"N1UY]:
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MB_[63G\34$47BCSDMYKC3OLZD;KI5;SF [["-@)Z<=,\5T13)SDYI=N1SUH
M;U(P3Q^M9FA:2^F1WRRR))]HO9KE=O\ "';('UK4V<YR<TY1C/.<F@#)US27
MU..Q$3HAM[V&X8L.JHV2*S$TK7M/GO(M*ET[[+<W3W!><N)$+G+8 &#CMG\:
MZDC(INSCECGU% '(IX8O!\/+SP\]U&UW/%<1BX8$*QD=F!..GWJUM=TJ75?#
M[:=%-&CL8SN?I\KJQ_E6UC--*9_BQ]* (9/M*W$7E^7Y'S>;NSN''&W\>N:G
M4DDYQQZ4@3YLD\TJIMZ=* '4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?B'_ ,DZ\0_]>$O_ *":
MZ:N9^(?_ "3KQ#_UX2_^@F@#YN^%'_)3]"_ZZO\ ^BVKZV'6ODGX4?\ )3]"
M_P"NK_\ HMJ^MAUH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQ?\
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M%'<1E)#ABQ<K_#R2,'TS4_B..?[()#KAT:QA!>>Y0)O[!1EP5"\G/&>G(YH
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MC (P, 9SS5(^*;%%.I_\+ MWN /-.G[HO(/'W -N_P#\>SF@#TH/Q[T%R,G
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M5,KK@@8XPHZ<UIQ-?^'-3T^SN=3N-5BU&9H$:Y5 \+JC/D;%4%2%(P1G)'-
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MB3!SM^H!J;PG8W.GZ"MO>0F.7[3</MR#PTSL#^1!K?HH Y;1=,O+;X=PZ;-
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M0):F5]NR;:N-R8.=O'< ^U='10!PMKHFI)X8T&V>W=9[;5!/,FX?*GFN=Q_
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M6&WO9;5I.DT04LG/;<"/S%5=&T5-)CG8S27-S<2>9<7$N-TK8"@D* H^4*.
M.GK0!FZG87]CXA?6+"R2\MIX0E[!D>:Y7B,QYXX!;()'7VJI?/JNM:3*L>AS
MVENDD9EMYV02W2!LR1@*2I#+QRPY]!S7:*,* :6@#AKEM6UC4M%-OX=FL+2T
MOEDG:Z*!\>6X&T*6!'/.2.HZ]MH65T/&LE]L;[+_ &<L(<XQO$A;&/H:WZ*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *3 _*EHH **** "BBB@ HHHH **** #%%%% !11
M10 4444 %%%% !1110 4444 %%%% "%03DCG&*-HP1CK2T4 %%%% !1110 4
M444 %%%% !1@444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% "8'IUI0,=*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*B8-C"9Z<\\TNX\8YX]: )**B)'<GKC -&XE2#U[\]J ):*CRW3.,#I2%C@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVL=G806L:X1$  !R./>N7N])CN/B=:21R%8X+/[3<6[ >7,Y8JCX[R*5')Z
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MY!P20,5Z8Z[T*YQGBN,B\-^(K;03X?M;S3HM/6W-O'<[&,^W& 2"-N3W^O%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 -<97&,_A6%)X-\/M=F[;3%,Q;?D.V,YSTSC'MBM
M^B@"()A<!0O8!>.*EHHH **** "BBB@ J,H0Y;J#U]:DHH RK/0-.TZ[FO+6
MS5;F8DN^XDG)SW)Q^%:2*1R<D].:?10 4444 %4)-)L7U4:FULK7@3RQ(23@
M?3I^-7Z* &(#DDKCW]:?110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5S/Q#_Y)UXA_Z\)?_03735S/Q#_Y)UXA_P"O"7_T$T ?
M-WPH_P"2GZ%_UU?_ -%M7UL.M?)/PH_Y*?H7_75__1;5];#K0 M%%% !1110
M 4444 %%%% !1110 4444 %%%% !7B_[0_\ R!M$_P"OB3_T$5[17B_[0_\
MR!M$_P"OB3_T$4 <G\ ?^1]N?^P>_P#Z&E?2E?-?P!_Y'VY_[![_ /H:5]*4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$/_DG7B'_K
MPE_]!-=-7,_$/_DG7B'_ *\)?_030!\W?"C_ )*?H7_75_\ T6U?6PZU\D_"
MC_DI^A?]=7_]%M7UL.M "T444 %%%% !1110 4444 %%%% !1110 4444 %>
M+_M#_P#(&T3_ *^)/_017M%>+_M#_P#(&T3_ *^)/_010!R?P!_Y'VY_[![_
M /H:5]*5\U_ '_D?;G_L'O\ ^AI7TI0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %<S\0_^2=>(?^O"7_T$UTU<S\0_^2=>(?\ KPE_]!-
M'S=\*/\ DI^A?]=7_P#1;5];#K7R3\*/^2GZ%_UU?_T6U?6PZT +1110 444
M4 %%%% !1110 4444 %%%% !1110 5XO^T/_ ,@;1/\ KXD_]!%>T5XO^T/_
M ,@;1/\ KXD_]!% ')_ '_D?;G_L'O\ ^AI7TI7S7\ ?^1]N?^P>_P#Z&E?2
ME !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/Q#_Y)UXA_
MZ\)?_03735S/Q#_Y)UXA_P"O"7_T$T ?-WPH_P"2GZ%_UU?_ -%M7UL.M?)/
MPH_Y*?H7_75__1;5];#K0 M%%% !1110 4444 %%%% !1110 4444 %%%% !
M7B_[0_\ R!M$_P"OB3_T$5[17B_[0_\ R!M$_P"OB3_T$4 <G\ ?^1]N?^P>
M_P#Z&E?2E?-?P!_Y'VY_[![_ /H:5]*4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7,_$/_DG7B'_KPE_]!-=-7,_$/_DG7B'_ *\)?_03
M0!\W?"C_ )*?H7_75_\ T6U?6PZU\D_"C_DI^A?]=7_]%M7UL.M "T444 %%
M%% !1110 4444 %%%% !1110 4444 %>+_M#_P#(&T3_ *^)/_017M%>+_M#
M_P#(&T3_ *^)/_010!R?P!_Y'VY_[![_ /H:5]*5\U_ '_D?;G_L'O\ ^AI7
MTI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<S\0_^2=>(
M?^O"7_T$UTU<S\0_^2=>(?\ KPE_]!- 'S=\*/\ DI^A?]=7_P#1;5];#K7R
M3\*/^2GZ%_UU?_T6U?6PZT +1110 4444 %%%% !1110 4444 %%%% !1110
M 5XO^T/_ ,@;1/\ KXD_]!%>T5XO^T/_ ,@;1/\ KXD_]!% ')_ '_D?;G_L
M'O\ ^AI7TI7S7\ ?^1]N?^P>_P#Z&E?2E !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5S/Q#_Y)UXA_Z\)?_03735S/Q#_Y)UXA_P"O"7_T
M$T ?-WPH_P"2GZ%_UU?_ -%M7UL.M?)/PH_Y*?H7_75__1;5];#K0 M%%% !
M1110 4444 %%%% !1110 4444 %%%% !7B_[0_\ R!M$_P"OB3_T$5[17B_[
M0_\ R!M$_P"OB3_T$4 <G\ ?^1]N?^P>_P#Z&E?2E?-?P!_Y'VY_[![_ /H:
M5]*4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$/_DG7
MB'_KPE_]!-=-7,_$/_DG7B'_ *\)?_030!\W?"C_ )*?H7_75_\ T6U?6PZU
M\D_"C_DI^A?]=7_]%M7UL.M "T444 %%%% !1110 4444 %%%% !1110 444
M4 %>+_M#_P#(&T3_ *^)/_017M%>+_M#_P#(&T3_ *^)/_010!R?P!_Y'VY_
M[![_ /H:5]*5\U_ '_D?;G_L'O\ ^AI7TI0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<S\0_^2=>(?^O"7_T$UTU<S\0_^2=>(?\ KPE_
M]!- 'S=\*/\ DI^A?]=7_P#1;5];#K7R3\*/^2GZ%_UU?_T6U?6PZT +1110
M 4444 %%%% !1110 4444 %%%% !1110 5XO^T/_ ,@;1/\ KXD_]!%>T5XO
M^T/_ ,@;1/\ KXD_]!% ')_ '_D?;G_L'O\ ^AI7TI7S7\ ?^1]N?^P>_P#Z
M&E?2E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/Q#_Y)
MUXA_Z\)?_03735S/Q#_Y)UXA_P"O"7_T$T ?-WPH_P"2GZ%_UU?_ -%M7UL.
MM?)/PH_Y*?H7_75__1;5];#K0 M%%% !1110 4444 %%%% !1110 4444 %%
M%% !7B_[0_\ R!M$_P"OB3_T$5[17B_[0_\ R!M$_P"OB3_T$4 <G\ ?^1]N
M?^P>_P#Z&E?2E?-?P!_Y'VY_[![_ /H:5]*4 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7,_$/_DG7B'_KPE_]!-=-7,_$/_DG7B'_ *\)
M?_030!\W?"C_ )*?H7_75_\ T6U?6PZU\D_"C_DI^A?]=7_]%M7UL.M "T44
M4 %%%% !1110 4444 %%%% !1110 4444 %>+_M#_P#(&T3_ *^)/_017M%>
M+_M#_P#(&T3_ *^)/_010!R?P!_Y'VY_[![_ /H:5]*5\U_ '_D?;G_L'O\
M^AI7TI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<S\0_^
M2=>(?^O"7_T$UTU<S\0_^2=>(?\ KPE_]!- 'S=\*/\ DI^A?]=7_P#1;5];
M#K7R3\*/^2GZ%_UU?_T6U?6PZT +1110 4444 %%%% !1110 4444 %%%% !
M1110 5XO^T/_ ,@;1/\ KXD_]!%>T5XO^T/_ ,@;1/\ KXD_]!% ')_ '_D?
M;G_L'O\ ^AI7TI7S7\ ?^1]N?^P>_P#Z&E?2E !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5S/Q#_Y)UXA_Z\)?_03735S/Q#_Y)UXA_P"O
M"7_T$T ?-WPH_P"2GZ%_UU?_ -%M7UL.M?)/PH_Y*?H7_75__1;5];#K0 M%
M%% !1110 4444 %%%% !1110 4444 %%%% !7B_[0_\ R!M$_P"OB3_T$5[1
M7B_[0_\ R!M$_P"OB3_T$4 <G\ ?^1]N?^P>_P#Z&E?2E?-?P!_Y'VY_[![_
M /H:5]*4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$/
M_DG7B'_KPE_]!-=-7,_$/_DG7B'_ *\)?_030!\W?"C_ )*?H7_75_\ T6U?
M6PZU\D_"C_DI^A?]=7_]%M7UL.M "T444 %%%% !1110 4444 %%%% !1110
M 4444 %>+_M#_P#(&T3_ *^)/_017M%>+_M#_P#(&T3_ *^)/_010!R?P!_Y
M'VY_[![_ /H:5]*5\U_ '_D?;G_L'O\ ^AI7TI0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %<S\0_^2=>(?^O"7_T$UTU<S\0_^2=>(?\
MKPE_]!- 'S=\*/\ DI^A?]=7_P#1;5];#K7R3\*/^2GZ%_UU?_T6U?6PZT +
M1110 4444 %%%% !1110 4444 %%%% !1110 5XO^T/_ ,@;1/\ KXD_]!%>
MT5XO^T/_ ,@;1/\ KXD_]!% ')_ '_D?;G_L'O\ ^AI7TI7S7\ ?^1]N?^P>
M_P#Z&E?2E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/Q
M#_Y)UXA_Z\)?_03735S/Q#_Y)UXA_P"O"7_T$T ?-WPH_P"2GZ%_UU?_ -%M
M7UL.M?)/PH_Y*?H7_75__1;5];#K0 M%%% !1110 4444 %%%% !1110 444
M4 %%%% !7B_[0_\ R!M$_P"OB3_T$5[17B_[0_\ R!M$_P"OB3_T$4 <G\ ?
M^1]N?^P>_P#Z&E?2E?-?P!_Y'VY_[![_ /H:5]*4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7,_$/_DG7B'_KPE_]!-=-7,_$/_DG7B'_
M *\)?_030!\W?"C_ )*?H7_75_\ T6U?6PZU\D_"C_DI^A?]=7_]%M7UL.M
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^DMH>AV^G/<FY:+<6E*;=Q9BW3)QU]:HZWI^J#5K?5M)AM;J>.![<V]S,8E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P DZ\0_]>$O_H)H ^;O
MA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:OK8=: %HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\ :'_Y
M VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#2OI2
M@ HHHH **** $.<<5CZ[#YED&?59=/MDR\\T/#LH' 5NW..QST[UL-G:<5S_
M (BLKNXDTVZMK3[8EE,9'LMZJ)<J0OWOERK$,,]-O'- &%HNM6O_  EUIINF
MZW>:C;SV\TD_VLEC&4V;=N57&=QSUZ"K]G%<^*3=WLNJ7MA%#<RVT4%E*%&(
MV*%F)!W$D9[8Z<]:+>'7-2\5Z9JEYIB65E;6\\95YE>568IR<'!!V\8Z8.>H
MI8H-5\-/<6UCI+:G:W%S)<HZ3I&T9=BS*VXC/)XQVQ0!A)/?Z5X,\:2K>%KV
M#4)-EPB[3GRXL''//-:NIQ:KX;L1J:ZK<W<[21PS13 &',CA,QK_  [2P.,G
M(&.^:A_L+6[CPCXEMKJWA%[J-T\T21O\I!6,#KW^4_E6]XKT^YU+1!;6:;Y!
M<V\A!8#Y5F1F.3[ T 95Y#J?A^[TN:+6+FZCN[V*WN([K#@ALYV8QL_7MZ5I
MM>SCQS;V?F,+=M-DE,8/REQ(@!^N":?K]A<7_P#90MHPWD:A#<29(&$7.3SU
MI6L;@^-8]1"@VR:>\#-D??,BL!CKT!H Y_0++5M3T./59O$%X+E7F\I  (MJ
MR. '7^+IUR.,>E6K[7KF^^'=KK=N6M);H6LGR-DH'EC!&>_!(K3\-:=<Z?X8
M2QNTV3@S$KN!^]([#GZ$5E)H.I#X9Z?I'DH+Z"*U#H7& 4D1FY^BF@"&;[5>
M^);^VU;4M3TJ!7 L'AE6.&>,*"<D@_,&+9SCC%5_$^BW,VL>&7NM9O1(]\(V
M^SL(UW""7+*O."<>IXS6KJ4FLZA+>6$WANTNK1I +:XN)$:(#:,,Z$[CAB>@
M[5#/H6JV^B^'<L-1O]'E6:4>9M,Y\IXSM+'_ &\\^E $FOK?'6= TRSU.>VA
MG$ZSN#F1U5!T/9N^>Q[58UFT^RZ;;B[U^]M+*W7$DJ-^^E;L2^.>^0%YX/:K
M%YI]U>:]H-^;<*MLLQE!<?NRZ  >_.>E0:U::BFN66JVMG_:,=O"\7V02A"K
ML5(D^8XR &&>OS?6@##T:[BU?5[S1+#7M2N;5+6.X-R92)ED+L"NXJ/EP!QC
MN:N> 84TSP):WTMW=3H;02E)'#! H/W!@8S5O2;?6I_%=SJVHV<5K;O8I!#$
MLH9U(=B0^#@]<\<8(J7PYI]Q9^'QH5_:%8K>(0+,L@*W"G.2 .5_'UH IZ;8
M:UK6GQZO=Z[-;2S S6<5JN(EB)W1^:I^^<$9Y'I[U7OM9U%OA_J,QN!%JMG(
M+>:6),*)0Z@E1GE?FJW9KXET>V72X["WOHP2EK<I*$2",'"+("0QVC&=O7'K
M4=UX:OQX,N]/!2XU&[D$]PZ':LDI=2S#/087H* .ATJPFL+<K<7T]Y,YWN\A
M& QZA1V7/0<XJS-)';6TD\@)CB0LQZD@<\5E?VI=R>+!ID$<!L8;?S;F4YWA
MR<*@QP#C!P><&M::-);=HW7,;J58+W!X(H Y33+/6=<T]-7NM7EMFF)FLX[0
M;8UB8[H_-4_?.TKN ([CWJO>ZWJ1^'NJ3/<B#5;)S;RS1)A1*&7E1GIAA^M7
M+ >)-#M4TN.QM[^&,E+6XCE6-8(LX19%)!;:N,D<D#UJ.\\.W_\ PA%_I^8K
MC4[US-<.AVK)*67)&>@POZ4 =!I>G3:?#(;B_N+N:0[V,A^53CD(/X5]LFLG
M4[B^U3Q(-#TZ]-I!;VXFOY%3]YM<D1B-L\'Y'R2...N:Z;^'(YQZUSNI:?J%
MMK2ZWI$44KM%Y5Y;NQ5YU4Y0(3PI!9^O!S0!61;[2-9@TFYU2XNM-U"-XK:5
MSFXCF"ECE^A&T'!QP<#WJIX)TAK34]=F;4K^?R]2>/9-*&1_W<?S$8^]VS["
MM&UL]4U77+75-3M8[2WM48VUIOW2I*05+NRG!!4L .V?6I='M-0TS6]3@>T+
MVE[<->"[$BX0E4785ZD_)G/3F@#"\/Z/>WT>JW,>LW5L5U6[$$5N J@B5OOC
M^,9^G'%6[WQ9)#X.L]2D,=NUW<"V:;:6$7S,I?:.6^Z3CWK7\.:=<:;:WJS1
MB-I=0N9U^;=E7D+ \>H/2LNT\.W?_"$VVG!DM]2MIGFMW<[UCE\QF1B!U&&Z
M>] &.?$%AI5Q#<:5X@O]4F>:.*2SO SAU=@N5.T;2,[L\\ COFM>]BU#4_'M
MSIZ:M<V=A%I\,S1VY"LSEY!D,?N_=&>#G Z5?BU'Q&\J6LNBQ(P(5[SSU,1
M^\P0'?@]@1W&>]2Q:=<KXSO-2:-3!)80P(VX9+J\A(Q]&'YT :=W;_:K5H/M
M$\/FX EA;:ZXYX/X5S'P\L1:>'EN#>WLRR23#RYI R)MFDY48X)[UUY.5Y4G
M\*QO"MC<Z9X>AM;M-DRRS,0#GAI78?H10!@1ZYJ&#9"8F6]URXL8YSR;>-0[
M9 [G"8'/&<]L4S7]%N-/?1Y8]9OKR$ZK:B2&\829_>#!4\;>?8YJU'X=O$22
M?"K>6VKSZC;QEALD5MR@$CIE7./?&:-2'B+79].4Z&+&"VOX)YFFN4=F57S\
MNT]NO/X4 :<US<)X[L+3S6-N^G3NZ#H6#Q@'\B?SIRW<_P#PG4]F)6-LNFQR
M^23P&,C L/P 'X4:OI]RFLVFMV,7VFXMX'MVM]P7?&Y4DACP&!0=>,9]JJ:5
M:ZQ)XKN=8OK".VA>P2"&(3!Y 5D8D,0<$\YR.,$=\T 5],M]0\4VK:G/J]W:
MV,SEK*.R81,(NQD/.YOIT]\UH7T]Q::_X=M([B4QRF9)=[9WA8\@MZG/-4K.
M/7?#43V%KI<>IZ<KD6HAF6-X(^R/O(W'W'XUHWME=WFOZ!?"WV1VPE:<,X^0
MM'@#WYXXH YO6+BRTN2Y%[XNU-=16-I/+B8B+<.0 H4X';&ZKVLZKJ3^"-%O
M[:Z^S7MY+8AG5,J#(Z;AC/3YB,9Z5#;P>(;'0)M%AT=99&C=&U"6X3RY6.?G
M89WG/3UJY=Z-J$G@_0=/2$&ZM)+$S#=P!&R%_P @#0 L$=YX>\16%O/J-W=V
M-^LB22W;A@LXVE$3 ^7(\SCG[M7]$O9M4UK5KE9F:PAD%M;;3\C%0/,./[P<
M,N?:J_CA=OAB:\AF%O=V;K/;3,I<1R\JI*]_O$<^M46FOO"OA&P@M+>)M8NY
MH]\$C%@9I7!F<!>2H+.QQP /2@#M#P*XP6^H:SXIURWDUJ\MK&UDA$,=HX1@
MQB4GYB#D9).,=:Z\%PH,A7=@ @=,]ZXJ"\U6R\7^(_L6F+?0"2W#I'*L;*WD
MJ<Y<@;<?CF@"Y:7ES#=ZQH,\LERMI:).ES*?WC+)O&UO4C8?F[YZ<5SUKKUO
M:>'?#6D76H2Z=;S:/%</<P@F1L!1L4@';ZYP>!COFNHL=,NI;C4]8NXQ!=:A
M;+ MKN#;%3?MRPX)RYS@XZ50L= U;3M+\/W%FL":C8V26EU!(Y(DC"<HI' .
MX @^WI0!'X?UZW.M1:3IVKW.JV]Q%)(TURC%[=EQU8@9#9X';:>N>*&M7EEH
M\%X\_BS4VU2WC:801L1"T@!(7:%.%)XV[N!QFNJM+S6M0DDCN=*73H5C8;I;
MA)&8D<;=A.,=\^HQ7.K:^)+;P?+X=@T=7F:T>"2_EN$"3.4(9R,[LN<\GN>>
M] %[6[Z^FLM%D>2^M[">$RWMS8 !H3M4KDG.%R6S@&JNK:H_ARRLK?\ MF2>
MUU"Z\A+Z;][) -C,W*_>)VX' VY[XK8GDUC3=/TF"RTD7P6WV7*K.B,A"J%Q
MN(!'7/TK'@\*:B8[F]CCL]/N1<1W&GVD8/E6I"E6#*ORDLK,"1QDYH ALM?L
MK#5+&/3-=OM6%U<+;S0789BH;^-6VC&._K[5VFH71L-,NKS:'\F%Y=F<9VJ3
MC/X5F6>HZ_-<Q0S:*+9%;]]</<(Z$#KM53N!/;/XUK7UJ+VPN+.4[5GC:,LH
MR0&!']: .=M]+O\ 4--AU9==OHKR>$3)&K#[.I(R 4ZD 8!Y&>>E41JU^/A7
M8:@+N1KQX[8M< \L6E0'\P2/QJ]%/XBT^Q73(=&CD$$7DI>FX01$ 8#%<[L
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M1I +:>>2-XONCYW0G=PV>@SQ6MH5C<Z9H-C9WL_VFY@A6.64$_.P')R>?SH
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M4ZE<ZI 04MI7+1.^1D$!<8Y_O5U;2:YK-AJ%O)9C2=]J\43M,'D$C @-E"0
M,_7-8>IVOB*^\+RZ%9^'DM (E0S27$>QP",[0IR">3S[YH V]9N]1N=;L]&T
MVY6V>2-I[J1TW,L/W?DYX?<1]!SSC%6+?2&TNUO&.IW]YOB(_P!+F#XP#T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@ HHHH **** "BBB@ HHHH *\7_:'_ .0-HG_7Q)_Z"*]HKQ?]H?\
MY VB?]?$G_H(H Y/X _\C[<_]@]__0TKZ4KYK^ /_(^W/_8/?_T-*^E* "BB
MB@ HHHH 1N5(SBH2RJO<<X]1[5,>G-<UXRU*_P!+T%;C37BCNFO+>%3(/E(>
M95(/L0<<<^E '0>K GGL>E/X)(/YXKD[Y]:\.6,FK7>L-?P0 -/;&W1!M)Q\
MC* <CMD_6HM7\11R:S=:6/$5IH@L@F^29HC),67<,"3C: >O7- '7D##+@DG
MK0.PR,CK7!3^,;B/1->M[+4K:^OM,M4GCOHMC(X<D ,%XW#:<XXP16MJ<^N:
M'X;O+^:X-]=/)'^Z@MMP@5G ;8%&Y]H)(SD\<T =1G@ 'GUHW YP>G7-8&CQ
MZA&JWCZR-3L9$+L9($C92.FW8!GN#GIBJ=A<:[X@M5U6UU*&RL'8O91QPJXN
M(CRC2;AE<C' P1GUH ZDD>O/?CM2\!0H^@[UQ-YXDUA]$MUA6VMM975([&Z0
MJ6B4L<X!ZD%2IR.F:T1<:AH>J:=::C?MJ*:C,8(Y#$D;Q.$9^B@ KA"/7)'O
M0!TORY!VY[?2JU_<BQL+JZ S]GA:38#C=@$X_2L36WO(+HRW'BNVT:V;Y849
M(OG '))D'7GH.,8JM9ZH^K^"M8>2>.Z\A;F!;E",3!%(#_+QS[<4 :4?B#=<
M:#%]FQ_:L+2D[_\ 5X0-CISUQVK98@OY?J<\]ZXZW5OM_@4A^?L,OT_U*UHV
M.N7$>CZI)?/&UUITLD89P$,H'W&([;NV.#VH Z,*KKQD#-#* ._TJEHDES)H
M]I)>.SW,T8D?*!2I;YMN!TVYV\\\<U)JEZMAI=S>$J/)C++N; +8X'XG _&@
M"I;Z]87>N7&D03%KF",-+\OR GL#W/J!TIVN:FVD:3/?^09?)*?(&P6W,%/Y
M9S7*)9G2-"\/ZN=PDAN3-/'(NQ8A<MF4MZ! Y.3Z<UM>.6#>"[YL@H?*(YZC
MS%H T4OE3Q(VEK;A<VHN6FS]X[B@'Z=:37M5.B:-<:AY F\@+\F[;G+ =<>_
MZ514_P#%R&!_Z!*X]OWIIOCU7/@G4]NTL%3;GIG>O6@#HCTVXQZ8HSE2<@CU
MKEKJ?6/#PAO=0U'[=!<W$5O);I"J>2TC!048 $@,W\78>M6-0O\ 4[O71HND
M311-'#YMY=.NYK=6.(]BGAB=K]<@8Y[4 =&P[XX[^U9FEZF-2?446/R_L=XU
MM][.["J=WM][]*SK.\U33=>MM,U.[BNK>Z5OLUR4"R/( 6965>   2"!V%95
MIJ,FG_VQY"*UQ>:^UM$2.$9HT^9O4#% '2:]JG]CZ>MX8Q+NN(8-N[;CS)%3
M.?;=FM,<\$_A7G_BW3=9L=*MY+G6_P"T+9M0LQ)'-;I&5_?H05V 9.<=>V:T
M]<\10KKCZ'_;5MHS16Z7#W4[1[I Y8*J!^#C8<_44 ==NY)'(II.>  <'FN9
M\/ZZLVL2:.NJ6VK;(#<+=0,F57< 58)P#D\8[5F6&J>(V\)S^(9;D73I'-Y5
ME!;C]YM=@"<#=NXZ#C@4 =UD%<X_.C  )//;@=:YO0O[4N%M[Q==;4;.48D2
M>V6)TX[;0"&!P"&Z<]ZN^++^[TKPGJE]9N([F"W9XV90V".G!ZT :X+<G^'K
MS0N  .U<GJ$VOZ%9-JUUJ,5VC%$DL_*"I&SL%4HP&XX9AG<>F>^*==SZ]H5Q
MI\]SJ4=_#>WD5M+$\(3R=[8RA4 G'^UZ"@#J0ZJN2N-Q^8'M1CG(/;CBLC3]
M0NKGQ/K5B[C[/:K 80%'5U8MSWZ5E'Q!J<47C"2.(7D^F3;;2 )RX\B-]O')
M)9C^= '6_>)!Q@=O6H(;RVNI[FW@F22:V<1RH.L;%0V#^!!_&N>T9-7NX8KR
M'Q UY;R@I)'/:)&\/![!00X./E;WS6?X-T_4(/%7B1YM8DN$6\02HT,:^:WD
M1X;Y1QC@8''% '<A@20,<4AQDD >M8/BW4[K3+*U-L9$6>Y6&:>*#S6MT*L2
M^W![@#GCFK&CV^HVN6N-274K5T#QS&)4?)] @ *XYSUYH T+6<W-JDODR1%N
M3'*H#+]1GK4W4@-GKD$5Q>FZ_J.J6&AV*2B*_P!2MI;F2\$:D(J,H.%QC<=Z
M]1C -6E?7=(\3:-83ZJ+VRO&F\QI(%1P5C+ ?*,;<@>] &KJ.@0ZI=>;<WEX
M8< -9K(!"^#GD8SUQW["M4*'979067E21R,URLTVN:GXMU32[/4TLK.VM[>4
M.L*O(&;?D#<""#MYSTP,=ZU-#U*YGFO["^99+K3Y%BDF0860,H96QV.",]LY
MQQ0!LE1CI6(/L.E:\O$WVK6I<'C*DQ1?H-J^];>X'CFN8\0I*WB3PW%',8G>
M:Y42!0Q7_1WP1GN.M %RSUB>_P!9O((+5!86DAMY+AI<.)@ 2 F.5PPYS^%;
M&/FR?7/TKCO!-CJ<.I:[)<ZP]S$FHR(T1@C4.VR/YR0,Y[8Z5U-^EW):.EA+
M%%<' #N,A03R<=SC.,\9QF@"?(SL QWYI%'S$'/ YYZUQ2ZW)I^K6$:^+K;6
M#<W26KV@$ *YSEODYR,?3FNQN;F*TLYKJY(6""-I'(!.% R>GL* )L@'TS[<
M4Y1RS=CR.:Y.QB\1ZS9Q:A/JRZ8),F.VMK=)04)^4L7!.XCL.*LWU[JFH:]-
MI6EW,5O#;QJUW<E=TD3-R@13P<CKGC\: .@W+C![^W6DECCFBDBD0LC*0P/<
M'@U@6-]JMAK\>D:M-%<)/ 7M+H+M><KRX=1PI4%>@ .?K4&@7&MZIJ=]<7.H
MQI9VNH7$$=ND2YD16(&XD9&.,$=>] %C_A$H694DU;5);4<?97G'EE?[I^7.
MW''6M]$2-%2-0L:C"A1@"N-T1?$NO:6+^77A9YFE1$AM8VW*LC*"VY>O&..,
M =\U9D\37;:1B.WA?6&O6T^*)B?*>53ECD=%VJQ&?3'>@#JL#) XXSUI6./Y
M5R=]+KWAVV.J7FH17UFC![U'A5/(B_B,>T9; SP<DX'>G:Q>ZM<>+-/TG3+V
M*WM[BQFGE<QJ[J5>,*5!!Y^8C!XY]<4 =0N1@')[<]Z1Y8X89)9"%CC7<Q/0
M <DUS6J&^MG5KOQ9;Z3%A4B+)%F4@#)/F#KG/"\8Q5*.^O->\&:J;?6%W6DL
M\/VR"-)/M"(O7&"HSGMZ4 =6+V,Z:+^W5[B%H_.181EI%(R-N<=15C*G:VU@
M3S@]L^M<5:SZGHGPIDU :B;FYBTG[1;N\"+Y>(LJN ,$#WK5U/6;U/[-TW3_
M "'U*]3S29P0D<*@;WXX)#,F![^U '0X8KSC<.0,THP<XXXZBN5:YU;P_>69
MO]0CU"PNI1#+<O$J21.WRQ@!!@J6(&>V?2H[%_$6LWFKF/5TM+>SOWA@5;=6
M,@ 4X?<.G/!'/)]J .M/)Z#Z9]Z08Y.XD9K,\/ZM_;&E&[:/9(L\MO(HY!>-
MRC$>Q*DCVJOKNHW=O=V6G:8D#W]VS%?/SL2)<;VX[@LO'?- &YU8C.,<<&@$
M'('('!KEI;C5_#ES9OJ5^E_IL\PAGGDB5)(G<[8\*@P07*@GMG/2ET:36]3U
MO5&?4DBT^QOVA2)(E+RJ$4[6)' &>".>3GM0!U(&U<<<>E,QDY/"]?>J6MW4
MUCX?U.YMV"SV]K+)&< X8(2./K6):VWB6338=6EUQ/-:!96M!;IY)XR1NQNY
MH ZK..H-'., X)SR:Y>35+C6-!L-7M=731=/GMTN&ED5&9=^"%;?\H&#UZYQ
M1X;UM[O7+[2_[9@U>*W@BG%U$8\@N6!0A..-@/KS0!U!Y'7%0V=U;WD"S6TJ
M2PN2%=>AP<']0:Y;3AX@UV6_D&N"RAMK^>" 0VT;ED5R!NW XP/3\:/AS9W<
M7AQ))M2>XA9YE2$Q(HC(E?)R!DYZ\T =B,!L?C3 5QDG(/8=ZY#3F\1:W+J4
ML>L1VT-KJ$\$$:0(WF!&( <D<#ME><59G\6+%X5MM7*0PR7$_P!D5IWQ'')O
M*;F/]S*D^N* .HP% _I2'[V6' '%<&?$R:04NCXOL=:C:1(WM5\A7^=@H*;.
M202.O&,]\5HZ=<:YJWBG6(3J20:?IMZD:(D*EY 8HV*DD<#YCR.>?I0!UF
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MRG[J;5 7:<'GV.>U '3' *Y'.>#0&4$J/R%<M%<ZSJ7BW5+2/4A;6%C)!@+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7,_$/\ Y)UXA_Z\)?\ T$UTU<S\0_\ DG7B
M'_KPE_\ 030!\W?"C_DI^A?]=7_]%M7UL.M?)/PH_P"2GZ%_UU?_ -%M7UL.
MM "T444 %%%% !1110 4444 %%%% !1110 4444 %>+_ +0__(&T3_KXD_\
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M+I]S#-+J$>R)@5_UA613N7U&._M79D8&>1COU[5 ]W$E[':'S/-D1G7]VVW
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M?O=36RNK^WU!8T9;507B* @?*3R""><C'IS5#1&UFPC\5ZK-HLOVB6[\^UM
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M5./Q!%;#NJ(SL6*J-QPI/&/;K26DZ7,$<\8;RY$#+O4JV".X/(/L: $M93/
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M9[A[K$<S/&=\85>1MW 9.>F1[UH^&K2XM3K)G@:(3:E++'N_B0A<-^AK>HH
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MQ[UV4"/]GC\R,1/L&40Y"''(![U/10 @Z"EHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?B'_
M ,DZ\0_]>$O_ *":Z:N9^(?_ "3KQ#_UX2_^@F@#YN^%'_)3]"_ZZO\ ^BVK
MZV'6ODGX4?\ )3]"_P"NK_\ HMJ^MAUH 6BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *,#THHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHV>AQ3Z* &;3SR.1W%/HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N9^(?\ R3KQ#_UX2_\ H)KIJYGXA_\
M).O$/_7A+_Z": /F[X4?\E/T+_KJ_P#Z+:OK8=:^2?A1_P E/T+_ *ZO_P"B
MVKZV'6@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "O%_P!H?_D#:)_U
M\2?^@BO:*\7_ &A_^0-HG_7Q)_Z"* .3^ /_ "/MS_V#W_\ 0TKZ4KYK^ /_
M "/MS_V#W_\ 0TKZ4H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N9^(?\ R3KQ#_UX2_\ H)KIJYGXA_\ ).O$/_7A+_Z": /F[X4?\E/T
M+_KJ_P#Z+:OK8=:^2?A1_P E/T+_ *ZO_P"BVKZV'6@!:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "O%_P!H?_D#:)_U\2?^@BO:*\7_ &A_^0-HG_7Q
M)_Z"* .3^ /_ "/MS_V#W_\ 0TKZ4KYK^ /_ "/MS_V#W_\ 0TKZ4H ****
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MO_//KFKWVCQK_P ^&@_^!DO_ ,;H Z6BN:^T>-?^?#0?_ R7_P"-T?:/&O\
MSX:#_P"!DO\ \;H Z6BN:^T>-?\ GPT'_P #)?\ XW1]H\:_\^&@_P#@9+_\
M;H Z6BN:^T>-?^?#0?\ P,E_^-T?:/&O_/AH/_@9+_\ &Z .EHKFOM'C7_GP
MT'_P,E_^-T?:/&O_ #X:#_X&2_\ QN@#I:*YK[1XU_Y\-!_\#)?_ (W1]H\:
M_P#/AH/_ (&2_P#QN@#I:*YK[1XU_P"?#0?_  ,E_P#C='VCQK_SX:#_ .!D
MO_QN@#I:*YK[1XT'_+AH/_@9+_\ &ZJW>N>*-+ELGU#3M)^S3W45LY@NI&==
M[A<@% ._K0!U]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M45GZ]J3:/X?U#4UC$C6EN\P0G ;:I./TH T**Y:&^\9S01RC3M# =0V#>2\
M],_NZD^T>-?^?#0?_ R7_P"-T =+17-?:/&O_/AH/_@9+_\ &Z/M'C7_ )\-
M!_\  R7_ .-T =+17-?:/&O_ #X:#_X&2_\ QNC[1XU_Y\-!_P# R7_XW0!T
MM%<U]H\:_P#/AH/_ (&2_P#QNC[1XU_Y\-!_\#)?_C= '2T5S7VCQK_SX:#_
M .!DO_QNC[1XU_Y\-!_\#)?_ (W0!TM%<U]H\:_\^&@_^!DO_P ;H^T>-?\
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M'C7_ )\-!_\  R7_ .-T =+17-?:/&O_ #X:#_X&2_\ QNC[1XU_Y\-!_P#
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MY\-!_P# R7_XW0!TM%<U]H\:_P#/AH/_ (&2_P#QNC[1XU_Y\-!_\#)?_C=
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MHH **** "BBB@ HHHH *\7_:'_Y VB?]?$G_ *"*]HKQ?]H?_D#:)_U\2?\
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M 5S/Q#_Y)UXA_P"O"7_T$UTU<S\0_P#DG7B'_KPE_P#030!\W?"C_DI^A?\
M75__ $6U?6PZU\D_"C_DI^A?]=7_ /1;5];#K0 M%%% !1110 4444 %%%%
M!1110 4444 %%%% !7B_[0__ "!M$_Z^)/\ T$5[17B_[0__ "!M$_Z^)/\
MT$4 <G\ ?^1]N?\ L'O_ .AI7TI7S7\ ?^1]N?\ L'O_ .AI7TI0 4444 %%
M%% !VKFQ_P E&'_8(/\ Z.KI.U<V/^2C#_L$'_T=0!TG:BCM10 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1VHH[4 <W_ ,U&7_L$'_T<*Z3M7-_\U&7_
M +!!_P#1PKI.U !1110 4444 %%%% !1110 4444 %%%% !VKFO&?_(/TW_L
M+6?_ *.6NE[5S7C/_D'Z;_V%K/\ ]'+0!TM%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5@>-_\ D1-?_P"O";_T UOU@>-_^1$U_P#Z\)O_
M $ T :UE_P >%M_UR7^56:K67_'A;?\ 7)?Y59H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#"\:_\B-KW_8/G_\ 0#6I8?\
M(/M?^N2?RK+\:_\ (C:]_P!@^?\ ] -:EA_R#[7_ *Y)_*@"S1110 4444 %
M%%% !1110 4444 %%%% !2&EI#0!SGA+[NL_]A>Y_F*Z2N;\)?=UG_L+W/\
M,5TE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$/_ ))UXA_Z\)?_
M $$UTU<S\0_^2=>(?^O"7_T$T ?-WPH_Y*?H7_75_P#T6U?6PZU\D_"C_DI^
MA?\ 75__ $6U?6PZT +1110 4444 %%%% !1110 4444 %%%% !1110 5XO^
MT/\ \@;1/^OB3_T$5[17B_[0_P#R!M$_Z^)/_010!R?P!_Y'VY_[![_^AI7T
MI7S7\ ?^1]N?^P>__H:5]*4 %%%% !1110 =JYL?\E&'_8(/_HZND[5S8_Y*
M,/\ L$'_ -'4 =)VHH[44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4=J
M*.U '-_\U&7_ +!!_P#1PKI.U<W_ ,U&7_L$'_T<*Z3M0 4444 %%%% !111
M0 4444 %%%% !1110 =JYKQG_P @_3?^PM9_^CEKI>U<UXS_ .0?IO\ V%K/
M_P!'+0!TM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@>-_
M^1$U_P#Z\)O_ $ UOU@>-_\ D1-?_P"O";_T T :UE_QX6W_ %R7^56:K67_
M !X6W_7)?Y59H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH PO&O\
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M-M%;W1)W1Q2^8HYX^; _E5;6=6;35AAMX/M-]<;A;V^[;OQC)+<X49&3@]:
M/!/^$Z^,/_/E?_\ @I'_ ,11_P )U\8?^?*__P#!2/\ XBO<-/O_ !-+>1IJ
M&C6,%L<[Y8KXR,O''R^6,\X[U/I^MB]EU19$6".PNS;M(S9# (C;O;[^/PH
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MKJ=]J&G7!U&:*6>WO)K8R11&-7V.5!"Y..GK0!XA_P )U\8?^?*__P#!2/\
MXBC_ (3KXP_\^5__ ."D?_$5]'#D4M 'SA_PG7QA_P"?*_\ _!2/_B*/^$Z^
M,/\ SY7_ /X*1_\ $5]'T4 ?.'_"=?&'_GRO_P#P4C_XBC_A.OC#_P ^5_\
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MQA_Y\K__ ,%(_P#B*^CZ* /G#_A.OC#_ ,^5_P#^"D?_ !%'_"=?&'_GRO\
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M (3KXP_\^5__ ."D?_$5]&;QD &C?N!QC@XH ^<_^$Z^,/\ SY7_ /X*1_\
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M_P""D?\ Q%?0MQ/.HB\B)'W2*K;WVX7/S$<') [=ZG+]?Y8H ^<_^$Z^,/\
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M_"=?&'_GRO\ _P %(_\ B*/^$Z^,/_/E?_\ @I'_ ,17T?10!\X?\)U\8?\
MGRO_ /P4C_XBC_A.OC#_ ,^5_P#^"D?_ !%?1]% 'SA_PG7QA_Y\K_\ \%(_
M^(H_X3KXP_\ /E?_ /@I'_Q%?1]% 'SA_P )U\8?^?*__P#!2/\ XBC_ (3K
MXP_\^5__ ."D?_$5]'T4 ?.'_"=?&'_GRO\ _P %(_\ B*/^$Z^,/_/E?_\
M@I'_ ,17T?10!\X?\)U\8?\ GRO_ /P4C_XBC_A.OC#_ ,^5_P#^"D?_ !%?
M1]% 'SA_PG7QA_Y\K_\ \%(_^(H_X3KXP_\ /E?_ /@I'_Q%?1]% 'SA_P )
MU\8?^?*__P#!2/\ XBC_ (3KXP_\^5__ ."D?_$5]'T4 ?.'_"=?&'_GRO\
M_P %(_\ B*/^$Z^,/_/E?_\ @I'_ ,17T?10!\X?\)U\8?\ GRO_ /P4C_XB
MC_A.OC#_ ,^5_P#^"D?_ !%?1]% 'SA_PG7QA_Y\K_\ \%(_^(H_X3KXP_\
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M=:^2?A1_R4_0O^NK_P#HMJ^MAUH 6BBB@ HHHH **** "BBB@ HHHH ****
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MZ%_UU?\ ]%M7UL.M?)/PI(_X6?H?M*^?^_;5];#GGUH 6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KB?BOHUSKGP_U"UM%W31@7 0*6+[#NV@#DDXXK
MMJ8^=PZXQSB@#XKT'5[C0-=L=3A(2:UEWCY<MCH1@\=,C\:^K_"_CC0?%48.
MFZ@CR< P2?+(#@$C!Y8#/49%>8?$?X.W5Q?WVNZ 3.TSB22RV88D]=I'&,X^
M7'XUXT+;4K"Y=#%<P7$3M&VQ&#CGGD?C0!]N45\1_P!K:KM)_M*[/;)F;C\<
MT@UC4<<ZE=Y[_OV_QH ^W:*^(_[8U#_H)W?_ '_;_&C^V-0_Z"=W_P!_V_QH
M ^W**^(_[8U#_H)W?_?]O\:/[8U#_H)W?_?]O\: /MRJFH6-OJ%K);W,8DC<
M9QW!'(8'L0<$$="*^+O[8U#_ *"=W_W_ &_QI/[7U#_H)W?_ '_;_&@#ZZM/
M"=A8WD=YY^H74B',:W=Y).BMZA6) (]>M;R ;@0. /ES7Q/_ &OJ'_03N_\
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M?VQJ'_03N_\ O^W^- 'VY17Q'_;&H?\ 03N_^_[?XT?VQJ'_ $$[O_O^W^-
M'VY17Q'_ &QJ'_03N_\ O^W^-']L:A_T$[O_ +_M_C0!]N45\1_VQJ'_ $$[
MO_O^W^-']L:A_P!!.[_[_M_C0!]N45\1_P!L:A_T$[O_ +_M_C1_;&H?]!.[
M_P"_[?XT ?;E%?$?]L:A_P!!.[_[_M_C1_;&H?\ 03N_^_[?XT ?;E%?$?\
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M#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC4/\
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M/[8U#_H)W?\ W_;_ !H ^W**^(_[8U#_ *"=W_W_ &_QH_MC4/\ H)W?_?\
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M_P"W^-']L:A_T$[O_O\ M_C0!]N45\1_VQJ'_03N_P#O^W^-']L:A_T$[O\
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M_P!_V_QI?[8U#_H)W?\ W_;_ !H ^W**^(_[8U#_ *"=W_W_ &_QH_MC4/\
MH)W?_?\ ;_&@#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[
M<HKXC_MC4/\ H)W?_?\ ;_&C^V-0_P"@G=_]_P!O\: /MRBOB/\ MC4/^@G=
M_P#?]O\ &C^V-0_Z"=W_ -_V_P : /MRBOB/^V-0_P"@G=_]_P!O\:/[8U#_
M *"=W_W_ &_QH ^W**^(_P"V-0_Z"=W_ -_V_P :/[8U#_H)W?\ W_;_ !H
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M4/\ H)W?_?\ ;_&@#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\
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M]O\ &@#[<HKXC_MC4/\ H)W?_?\ ;_&C^V-0_P"@G=_]_P!O\: /MRBOB/\
MMC4/^@G=_P#?]O\ &C^V-0_Z"=W_ -_V_P : /MRBOB/^V-0_P"@G=_]_P!O
M\:/[8U#_ *"=W_W_ &_QH ^W**^(_P"V-0_Z"=W_ -_V_P :/[8U#_H)W?\
MW_;_ !H ^W**^(_[8U#_ *"=W_W_ &_QH_MC4/\ H)W?_?\ ;_&@#[<HKXC_
M +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC4/\ H)W?_?\
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M $+>E?\ @(G^%'_""^$_^A;TK_P$3_"N@HH Y_\ X07PG_T+>E?^ B?X4?\
M""^$_P#H6]*_\!$_PKH** .?_P"$%\)_]"WI7_@(G^%'_""^$_\ H6]*_P#
M1/\ "N@HH Y__A!?"?\ T+>E?^ B?X4?\(+X3_Z%O2O_  $3_"N@HH Y_P#X
M07PG_P!"WI7_ (")_A1_P@OA/_H6]*_\!$_PKH** .?_ .$%\)_]"WI7_@(G
M^%'_  @OA/\ Z%O2O_ 1/\*Z"B@#G_\ A!?"?_0MZ5_X")_A1_P@OA/_ *%O
M2O\ P$3_  KH** .?_X07PG_ -"WI7_@(G^%'_""^$_^A;TK_P !$_PKH**
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M (")_A1_P@OA/_H6]*_\!$_PKH** .?_ .$%\)_]"WI7_@(G^%'_  @OA/\
MZ%O2O_ 1/\*Z"B@#G_\ A!?"?_0MZ5_X")_A1_P@OA/_ *%O2O\ P$3_  KH
M** .?_X07PG_ -"WI7_@(G^%'_""^$_^A;TK_P !$_PKH** .?\ ^$%\)_\
M0MZ5_P" B?X4?\(+X3_Z%O2O_ 1/\*Z"B@#G_P#A!?"?_0MZ5_X")_A1_P (
M+X3_ .A;TK_P$3_"N@HH Y__ (07PG_T+>E?^ B?X4?\(+X3_P"A;TK_ ,!$
M_P *Z"B@#G_^$%\)_P#0MZ5_X")_A1_P@OA/_H6]*_\  1/\*Z"B@#G_ /A!
M?"?_ $+>E?\ @(G^%'_""^$_^A;TK_P$3_"N@HH Y_\ X07PG_T+>E?^ B?X
M4?\ ""^$_P#H6]*_\!$_PKH** .?_P"$%\)_]"WI7_@(G^%'_""^$_\ H6]*
M_P# 1/\ "N@HH Y__A!?"?\ T+>E?^ B?X4?\(+X3_Z%O2O_  $3_"N@HH Y
M_P#X07PG_P!"WI7_ (")_A1_P@OA/_H6]*_\!$_PKH** .?_ .$%\)_]"WI7
M_@(G^%'_  @OA/\ Z%O2O_ 1/\*Z"B@#G_\ A!?"?_0MZ5_X")_A1_P@OA/_
M *%O2O\ P$3_  KH** .?_X07PG_ -"WI7_@(G^%'_""^$_^A;TK_P !$_PK
MH** .?\ ^$%\)_\ 0MZ5_P" B?X4?\(+X3_Z%O2O_ 1/\*Z"B@#G_P#A!?"?
M_0MZ5_X")_A1_P (+X3_ .A;TK_P$3_"N@HH Y__ (07PG_T+>E?^ B?X4?\
M(+X3_P"A;TK_ ,!$_P *Z"B@#G_^$%\)_P#0MZ5_X")_A1_P@OA/_H6]*_\
M 1/\*Z"B@#G_ /A!?"?_ $+>E?\ @(G^%'_""^$_^A;TK_P$3_"N@HH Y_\
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M$%\)_P#0MZ5_X")_A1_P@OA/_H6]*_\  1/\*Z"B@#G_ /A!?"?_ $+>E?\
M@(G^%'_""^$_^A;TK_P$3_"N@HH Y_\ X07PG_T+>E?^ B?X4?\ ""^$_P#H
M6]*_\!$_PKH** .?_P"$%\)_]"WI7_@(G^%'_""^$_\ H6]*_P# 1/\ "N@H
MH Y__A!?"?\ T+>E?^ B?X4?\(+X3_Z%O2O_  $3_"N@HH Y_P#X07PG_P!"
MWI7_ (")_A1_P@OA/_H6]*_\!$_PKH** .?_ .$%\)_]"WI7_@(G^%'_  @O
MA/\ Z%O2O_ 1/\*Z"B@#G_\ A!?"?_0MZ5_X")_A1_P@OA/_ *%O2O\ P$3_
M  KH** .?_X07PG_ -"WI7_@(G^%'_""^$_^A;TK_P !$_PKH** .?\ ^$%\
M)_\ 0MZ5_P" B?X4?\(+X3_Z%O2O_ 1/\*Z"B@#G_P#A!?"?_0MZ5_X")_A1
M_P (+X3_ .A;TK_P$3_"N@HH Y__ (07PG_T+>E?^ B?X4?\(+X3_P"A;TK_
M ,!$_P *Z"B@#G_^$%\)_P#0MZ5_X")_A1_P@OA/_H6]*_\  1/\*Z"B@#G_
M /A!?"?_ $+>E?\ @(G^%'_""^$_^A;TK_P$3_"N@HH Y_\ X07PG_T+>E?^
M B?X4?\ ""^$_P#H6]*_\!$_PKH** .?_P"$%\)_]"WI7_@(G^%'_""^$_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>gu3c32wcjg3v000004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gu3c32wcjg3v000004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" J?"#0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$8!!''%6?C<YD^%UI(0 7NX6P.@RC=* .R\#^)Y/%OA*UUJ:V6V>=I%,2,6
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M^P=<L(;2\=V1)(V*+D8PA5B3NSGO5SXH?$;5?!%WIL6F6MG.EQ&\CM.K'&"
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MC6"W@U;5?"8_L5XP[3P12)E6'RD,21@DCM7JGAWQ)IWB;18]5T^;?"<JX/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KQ/]HK_D':!_UVF_DM>V5YE\8/!FM>,;32XM'BBD:VDD:022A,
M!@N,9^AH I:UG_AFN':<'^S+;I_OI4?P 0CP??GY1F^(XZGY$ZUNZEX5U6Y^
M#,?AF*.(ZD+.&'89 %W*RD\_@:3X2^%-5\(^&[JQU>.*.>6[,JB.0.-I51U'
MN#0!Y?IN3^T<ZL5 ;4Y\ ]SM>NG_ &A1C1]#!SS<2#<.W I]A\._$5O\96\2
M200?V6;V6</YX+;&5@#MZYR16W\7/!VL^,;'3H-(BAE>WE=I!)(% ! H \G^
M(F3X*\!K@8&FM\N.^4_^O7OGAVUTH_#_ $V QVG]F-9*)E&/*.5^?/;DDY_&
MO#OBOIMSH^@^"]+O57[3!I\D<@4[L,"G0CK6['X(^)">$[32M)U:"ZT6[LPQ
MB*I&4$G+)R,GKU]Z ,'X//(GB_6_L^Y632[@Q%#DYW+CIZ=JU/@0L4_C'6)[
M[#WZP[D:0_.&+'?C/.3SFO2/AM\/5\$6=TT]PES>W)7=*L878H_A!Z\YY^@K
MG?$GPOUBP\1R^)? ]ZEI>NS.;>7'WFX<@MD8/)YSR3B@!_Q\@L#X0MII(XOM
M@NU$9X$FS:V['MG;G\*P]3FO9_V:+=[^2;S@\:AI,[M@FP@^FW&/:K47PS\7
M^++^UE\=:K$T%F<Q(@0NZM]X J !T'4'VKN?B!X8N]9\ OH&BPQ^8HB6&)GP
MJJA&!D^PH Y_X$V=L? TESY"F=[IT>0J,D*!M!/?&3CZUG?M!+M\-:.57;LN
MV)..>$-=C\*_#6I>%/!YTW58XTN?M+R;4<,-I"XY'TJ;XE>#_P#A,O"LEG"$
M^VPGS;=G)P&[C@]QQSTS0 GPXD2+X8Z)(^0B6NXY'09/-<@OQ%\0>,_$]QH_
M@F"U@AMV+M?70R'4#J5Y(!/ (R>1D"K7PZ\/^.=%O(]-UZ6)M"2U>-(%D1BK
M'&!P,XQGO7/2?#/QOX5\075UX+O8(X+K>.0H,2;R53Y\YP,<T 4+J#7(OCIH
M"^)9[.XOCY15K12$"9?'4#G.:/V@\KKNB[5R%M'^[V^?%=%:?#'Q%;^,M%\1
M7^I'4[P7!DOY'8(J( -H4>N2V<<=*E^+G@+7_&.JZ=<:-#!(D%NT<A>94(;=
MG'/;% '2>+QCX.ZAO' TT$;?]T<UR/[/&Y=!U@'G_24/H!\M>@^(M%O-1^'=
MUHULJ&\ELA JEL*6P!U_"N=^$/@_6/!^F:E;ZQ'%%)<3*Z".4/D 8YQ0!YQ>
M8'[22N5RO]I1=?7:O-?1P!QG@-CD=LUX_P"/?AOKEYXQ@\3>%##%=Y#2@N 4
ME7H_S9!R,# ';WKO_!4/B"#PW''XEE6;4@[[W4J<C/'*X'2@#?N/^/:3_</\
MJ^=O@/''/XOUB*5%>*33V5P1D,#(@(KZ'E4R0.B@\J1R<'->1?"CX?Z_X3\1
MWUYJMO#%;36QB1DE!.=ZD<?04 <;>WK>!=4\:>$7E==+O;:1K0RJ0@=ER-JC
M/!)VY_V:WO@@9H_"?BUX&99U4% G)5PCXQ^-=1\6?AS=>,4L[S2HX?[0M_W3
M^8Y7?%UX.<#!)/XT_P"$/@[5_!]GJD&KQQQF>5&BV.&R #_C0!Q'P&2*X\5Z
MQ->1I_:*QY627_6%B3O(SS]:Z/X_06A\,6-P?*%\MUL1V(\P(5;<%[XSMS^%
M)X@^%VL:;XDF\2>"+Y8+J7):W<@X+??*ELCGKSGDFJ</PR\8>+]3MI_'&IQM
M;6K91(PA9E/++E1P,@=>: -K3)KR;]GFX;4#,\QTNX7][]XJ-P4<]L 8K$_9
MWXL=>7:,F6')]L/7KUQI=A/HKZ7+ 'L7A^SO"6('EXVXSG/3WKQ?0_A_\1/"
M&L3QZ)=PIITMPC2LKQ_O4!]&!(X)[T 9W[064\4Z6N05^P]^O^L:JOQ:N&G\
M?Z-9SN'M4MX#LDY50Q&[CWP,_2NR^+7@+7?%VOV%WI44,D$5MY;M),J$-N)[
M^Q%=)XY^'5GXPT*)/EM]7MHQY%PIY.!RK>H/Z4 =I;0V\-K##:JBVZ*HC2/[
M@4#Y<>V,5\]?'26^D\>64+&1[80(((7SY9=B<XSQV7/X5J:?X9^,.DV$%G8:
MC'#!%Q$AGB?@\]6!)'MGZ5Z-XW\"P>-=&MHYY?(U6T7=!<\D(Q W9 Z@D#WX
M% 'G$\OQ@FT=]*_L.!+!K<VY2**)=J;=I"_-QQTKIO@OX=\2>'(-4M=:MY+:
MW=HW@B:0,-QW;B "<$_+GZ5C+H/QIM%6V@U>%X(#Y<;EHLN@X!.5)Y'KS7I'
M@?0M2\/:&UIJNH&_NGG:1I3GC('')[8/M0!U%?)?A3PFGC+QY?:2]T]F09I?
M-1 QX;IC/3FOK2O%_A[\//$7AOQ[=:QJ,,"6<B2A728,WS-D9% ''>%Y6^'O
MQ672=3M(YD^UF))GB5IL."L;*<_*#N!(]":Z_P#:"DNHM%TA(7F6U>61IE7[
MC$!=H/YMCZFM#XK_  [U?Q5J6GZEHOD+- I64;A&[=PV[VX'K75W/AEO%7@.
MWT?Q-$L=V8AO,,A(21>%8'O^- 'DWAF[^*FG^'+*+0=%MAIC1AXBL47SJPR&
M.6R2>IR*I:-X?\;>%X_$.K7EG=:=%+83.[I(F#)U7A6/<G'UKHH?"'Q9\/1#
M3M$UJ&;3XL&)OD7KU&'!( ^OTKL?!'A3Q!9_VG=>+-2^W3:DBH\!^9(B,YP/
MN\@CH.U '&_L]P68M-:D58OM8=%# _.$ZG\,@5A_'<$^/M/"YXLHV & "?,?
MFM"/X8^-_"&O7<G@^\C$$J>7'<R.F]ER#M96&,\=<5R7CO2-13QO86,^I2:S
MK4L4?VI1@D2DG]VJKT &TX]\]Z /=/'_ ,0+3P5I=MFW^TW]P 8+8\ @=68]
M@/;)SCBN*UV;XCZEX#U#4]0N=*BTR>U>:2V,9\Y(CGH0,9QT.:ZOXE^ 6\<:
M7:&U>*WO[4DQR2ACN7:?DX.!DXY/I7*67@/XBZ[9?V3XFUK[/I$:HICA,9>1
M1QM!4<#'KG- '1_ _/\ PK:W  _X^)<GUYKS+X=6=M=_&BZCN(HYD6XNI%5A
MGYE8D$>A!KV+X:>'K_POX/33-32-+I)Y'(1PP(8\'([UQO@CX=^(M$^)T^N7
MT$"6#/<%66<,?G)V\#GN* ,?]H;;#?:$L0"AHY2R] >5KU?P_::2?A[86K16
MW]FO8J)ER/+P5^?)Z<DMG\:K?$#P/!XYT1;0SBWN89!)#-Y8..Q![XYZ ]0*
M\ZTSP!\28["3PV^M6]KH)62+D1N"C$]L;OFR>_&: ,7X%!!\1KWRT55^QS<K
MT/[Q.E+XI_Y./@_["%G_ .@QUTWPI^&_B'PAXJGO]3AA2W:U>(,DP;)+*1QU
M' -/UOX>>(M0^+]OXD@@@.G)=V\I<S -M3;GC\#0!F?M%?\ 'YX=_P"N=Q_.
M.O0+Q5'P7E79Q_8.[('&?(K!^+O@;7?&4^EMI$,,HMED$GF2A<;MN,?E78W&
MCW<OPX;1=BF[_LH6NW=P7\K:1GTS0!Y/\"'>+1_%4D1(811,&'&,+)R/>J?P
M)-O>>--2O+QQ+?& R1R3'YR[-\Q'N03GZUV_PB\$ZQX0@UA=:AAC%V8A&$D#
M A=V<_\ ?0KG-8^%WBC2/&DFM>#9XT#L[HSLB- 6SE ",$<G''2@ _:'4AM!
M.P\^?]/X*]:\'$'P3H//_,/@_P#18KYU^)FFZW;/I(U_6FU#7)E;S+="N(%!
M&T  8R26Y[X]J^C/#$4MKX2T6"=&BECLH4D5EP58(!@^^: +U\!]@NL#DPMD
MCJ>#7@?[/G/BG5<-G;9 <#&/G7BOH)XTF1HW7<&4JW..#7A;?#7QMX9\3ZA<
M>#;BWM[6X9A$RR)Q&3G80^3QTS[4 6?VAQML_#^ $7S)\\=.$KN=.!_X4S '
M"X&AY('?]S6#\4O!7B#QAI>@Q6$44MS:JYN3+($&XA!_,&NNL='O8?APNB2(
MGVU=,-MLW\;_ "]H&?3- 'D_P!=A-XC9%*M]GBV\_P"_BN*\(R>+)O%]U>:/
M:?;]:B#2RO=(K.F3@M\Y&&R<'OR:]<^$'@77?!]WJTNLPPQK<QQK%LF#YVEL
M]/K2^*_AMJ\?B*7Q/X)U 6>HRDR30,>)78\G)X Y)P01GIB@#B/$^B_%3QC'
M:QZSHH;[.S-'Y?E)R<9SAO88KW?PI'J$/A72X]69VU!;9!<%VW,7QSD]S7EB
M>%/BQK$GV76]>2WLLB0NA3.1V^0!N?K7LHRJJI&2 !0!A^.M=_X1WP;J.HI*
MD<Z1%8"XR#(?NC\Z^=?ACXPTKP9JUYJ6I+>S33P^6J6Z*5()!))+#G@5[#\5
M_#WB;Q796FEZ+"OV0-YL[/*BAR#P,$9R/ZUO^&O VC:#H-EI\^G6,\T28DE:
M$,9'[GYLG\* /G;Q/XLM+OX@+XIT%;F*3S8YMMS$HVNH X 8Y! '7%>X_$+3
MX/&?PMEN+!&NRL2W=IY9VAL=3@X_A+<&J_Q-^'$?B7085T.QMX+Z"4,BQ*D2
MNIX;<<=JU?AYH^MZ;X0_L/Q)!&3"#%$R3!@\1!&WY>F.GXT >26GCA(/@5<Z
M1NACO$E:S2,MDRQM\SG'; <C\*]6^%VF)X?^&]D9Y'421F[F+IM:/(R1CVQ7
MF%G\%==7QC'+=:?;'1!>[F07 )\C?]WKG[OXU] M!%);26S(#&R;-N>JXQ_*
M@#R>'XB^)/&OB.XTKP1;VMM;VY+M?7G(=<8!*XX!/3OTSBN;\G78?CYHL?B&
MXMIK[",#:#$>W:V,@@<]:T/^%9^-_"NLW-QX,O[>.&ZR6P5!1=Q*I\^<]N:T
M[#X9^(;+QWHWB*[U(:E<">22_F8A=J[0$"K^+9QQ0!S?[0W_ "-&D_\ 7D?_
M $,UU_QJ_P"256'_ %\P?^@-5?XM_#_Q!XOURPNM(@@DB@M_+?S)@A!W$]_K
M70?$GPMJOB;P)::3ID<3W<<L3LKR!1A5(//U- &9\-=<LO#OP4M=4U!RMO"T
MY.T9)/F, H]R>/QJCH/BKQ_X[6;4?#\>F:9IT9$06Z!?>W.<$ G(&,C&.>":
MV_#W@.X_X5&WA36HHEN664C:^Y4<L61N#S@X.*X_1_ 7Q.T&231]*UF&UTAI
MB3.JIDY !;:03V]: #X/QW"_$?Q2E^T4EZH?SGC&$+^=SM]L]*YW48K:X_:&
MEBOQ$;;^T%#^;C:1M'7/X5Z1X ^'NH>#/%NHW,LS7-E-:HHN))!N>4D,YQUQ
MG.,UR?BCX3>(]?\ B'?ZG;BW@LKBX#BX:4-M  ^;;U[=* .U^-,5J_PZNY)O
M*^TI)&;=GQN#%P&V^^TD?3-<7X-;_C'GQ.I(X>;@=OE2GZK\/?B1XHNH]/UW
M5X)]-AE9X[EA'D8! 8(H!Y]/>O0+KP8;'X6W7A;2@))VM3&K2;4\QSW8@ ?_
M *A0!R/[._\ R ];_P"OF/\ ]!-<K\)?^2S7OTNO_0J]&^$/@_6/!^EZE!K$
M<4<D\JN@CE#Y &.U8?@'X=^(O#_Q&N=:U""W2RD$P5DF#'YCD<4 <K\2@3\<
M+3)X,MIE6^J\UT7[0^$TS0<=IIN2?9:L>-?AWXBUOXH6^O64%NUA') S.TP5
MOD(W<?A76_$[P8_C/PS]GMDC_M"V;S+=G.![CTR<#DT :/@$?\6\\/C:,?88
MLC'^R*\6T\MX$^.SQ/\ /;S3F,2R?NU"R\E_3 )(_"O0_AIHGCO1KHVOB2=/
M[*@M?*MHDDC;:P*X^Z,],]37,_M :*C-INM+.JR!?LS1NP&0"6!4=3RQSZ4
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MM%U*P>YG(QO8=,#L!DX[\UQ'@[X=^(-&^*D^OWL$*6,DEPPV3 G#YV_*/J*
M/8D3RP=B*,]>*<<K\W4]_P"M*K9;V]#3STH ^;?@J-OQ4OSMQ_HL^!Z#>M=7
M^T,"_A_15P<?:F)P?]BL^_\ AMXNT#QG>:IX.DM[>"<-Y<AD&45B#LP^<\CK
M71?$CP;XC\6>$= M;=8IM2MMKW9>54^;8 Q!Z'YLT ;/@<D_"/3LC.;!B3@<
M\-7F?[/A/_"2ZPQR,V@Z\_QBO7?#&C7VE?#RRT>Y2-;V*T,3JK@C><\9_&N*
M^$OP_P#$'A'6]0NM6A@BBG@"(8Y0V3N!Z#VH \NTF3Q1)\2;Z?2;;[=K4<LD
M@%TH9@ <;OFQR./SKH_%6D?%/QA:06^K:*KQ0/YD?EB-3NQC'WO0UWGC#X;7
M]QXB;Q+X4O\ ['JV"\D;'B5^W)Z9'4'C@<5@'PM\7M9_T#6-<6VLI>7EC:/*
M$<K]P!NH'0T >G>"+?4;3P;I=OK"RC4(H0LPD(+ Y.,D9'3'>IO%.K1^'_#6
MHZM+,L300L8V=20'(PHP/5B*U[2)H+."%WWO'&JL_P#>(&,UP7Q7T/Q'XFT:
M'2-#1/(E?=<EY44,!R%Y&>H!R/2@#Q'X?>,-/\,>*+K7=6^V3R.C!5MXU.2_
M)SEAC':F>.?%EAKGC*'Q!HZW4,B>6[K<1J-KIC:>&.0<<U[_ .#_  %I>@>&
M[>QN["SNKQ5W7$S0AMSGTW9[8'X5G_$;X>6OB+PRT.DV5M!J$,@DB6-4B5ST
M*LP'3!)^H% $_B74XM:^#M_J4$JS)<Z:S-(H*Y;&&X/N#7'_ +/.T:7KQ"Y(
MN(EX'3Y36KX?\*^*[?X8ZQX7U.VB,ODNECB92I##[G'. <G)]:N?"'P=K'A#
M3]3BU:"..6XE1HPD@8$ $4 ><ZI@?M(1H% QJ<! QU^5>:T_VAL_VKH/1?W,
MHSCON7]*V;_X=^(I_C)_PDT<$!TT7D4N\S#=M55!X^H-7/BYX$UWQC?Z5-H\
M,$J6\3K(9)0O)(Q]>AH Z#Q$,?!J[WJ,+HV<#_KD*XW]GIC_ &;KOR[29H>"
M?9J]"U;1KV]^&USHL21M?/IWV=49QM\S9C&?3-<W\(?!FL^#[/5DUF**-[F2
M-HMDH?(4'/3ZB@#SWX:_\EVN_P#KK>?S:M7]HKG4- QS^ZG_ )I5OQ/\*/$%
MIXL?Q!X.GCCDEG\U8]^QH3@$G+9# MDX]_2L[Q5\+?'6OP6%]=:@NI:CL87*
MR2I&D/3:%P #WS^% 'H>K>,K/P5\-M)OKB(SSO8PK;V__/1_+'!/8>O]:YRW
MU'XD>*/#ESK%M+H]EIES$[QV\REF\O'8A3G(SUP?:NC\2> &\3^ =*T>61(-
M0LXX0L[981L% <8!YS@BN*T?P+\39M/30+[6TL=$6/R\1;"Q0$?*,#<,COF@
M#1_9^5?^$9U,J!D7HR2/^F:UR/P5_P"2JWQ[?9I__0UKU#X8>$;[P;8ZK9WP
M AEO&:V8R DQ !5)QW.*YCX:?#OQ%X:\=7.K:I!!':/!+&A2<,=S,I' ]A0!
M[17A7[1(R_A\!]NX7 /'_7.O=!T%>6?&+P1KGC!])_L6&&0VPE\WS)0F-VW&
M,_0T <?\2[#R/ ?@K7;=9UO;:V@031GB,>6&'/;YL<UFW7B"'XF_$CP[;^7?
M/I\2QI)%)CAQ]]^"< _+S[5Z_JOA"36/A;#X:G)CNDL8D C<?ZV-00,G(QN7
M'TKDOA3\,]5\+:Y<ZKK2"&01>3 D<RNK!OO$XY[+0!R/Q!&/CQ:G?@-<V(P>
M_P!RG_'AK^3QII]JK3/:"V0PQ'/E[RS;L=L\+G\*Z?Q?\._$6K_%:#7[."!M
M.6>V=F:< X3;N^4\]C7;^/? ]KXWT=+=IFM[RV8R6MP,D1DXR"!U!P/?B@#S
M.23XP2:.VFIH=NEFT'D+$D42A$*[<+\W'%'A'0?&'A7P1XNCO8;NR/V4/:*C
M@_O,'<R!2><;?RJZ- ^,M@PL[/68IK6+*1.S1!F4# /*YYXZY->A>!_#NIZ!
MH$UIK.HO?W4\[3-(<Y7<JY49/3(/3B@#P'X<MXVM5OKGPEI\4[,1'-.Z(S =
M=N6(XXS^%;&K>'/BCKGB*UUF]TAXKNVV)'+;M&A4!B<C#>YKJ]0^&7BGPOJE
MS>> -4^SV]R_S6DA7]VO7J^00" !W]ZM:!X7^)%]K^GWWB?6@EM8S+*(HV4B
M7GD'9CC '7(H YO]H4$ZMH/'(MY,^GWAQ7MFC?/X8T\XV@6<>T#TV"N/^*G@
M*;QIIEN^G",:E:-E"[8\Q#U7T'.#DCMCO3OA]IWC?3EN[;Q5=)+;"!$M%5D.
MW&01E0.V.M 'F_P#8MXZU'=MS]@?./\ KHE1ZZ W[2<(/(_M.V!XS_"E=7\*
MOA_X@\+>*;R^U6&WCAEMFB!24,2V]2.![ TS4_AUXAN_C*GB5((#I8O(9O,\
M\!MJJH/R]>QH N_'U5_X0JS9AG;J"A6ZD?(]8-S//9_LTVIMY9(7E8QL5/5&
MF8,/H17=?%CPMJ?BSPO;V.E11O<1WBS8=MHVA6&<_B*?X;\&NGPLB\*Z]M65
MH98Y=C*Q3<[$,I.1D B@#%^!45E'X%DD@2-;B2Y82D8WD#[H;\VQ7">)]O\
MPT/;#& +^T.,?[*5I:5\/OB3X3N[J'P_?6\-I/*-\H:/$@' .U@2, GI7.P:
M7.GQMLK>"^EUAX;Z&2:YX8L1M,AXX 4[ACL!0!].&.)N716;U(S3U7#9/7I7
MDOCKPAXTU?QS:ZCHMR\6FHD0D47909!RWRYYXKUD=CZX[T 24444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6Z"$LB&(NR[F#-Z]/QH Z.\\:3:%"DWB33)+*UDE55NH'$D<:L<+YA."&]0
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MQ<Q>'[!KZ&SDVW$[/L1\?>6(\[VZC!P/>I?']_<:;X%UF\M) DT=L=C;<]2
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M&!G!QG!]:IG7=9G!FL?#5S+;./D:>=(6_%&PR_C7'_#!<?"/4<@AM]W@>G%
M&IH/C_5O%>F6<^B:+#+/(7%V9KDK#;$$[5W!22Q&#]W'(YKH?#OBRTUZ^O[%
M;:ZL[RP8)-!<JJMSGD8)R..ON*PO@[;QI\--*ECCC1Y/,,CJH!=A(PR<=3@
M<^E4;?(_:"O#CEM%'S'']]: .EU'QO:6_B,^&["TN+W5S'NVHN(HR1D>8_\
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M=R#]W!"A9O0%CT12>-S<5YS\4=1U6Y\/Z:M_HC64/]J6Y\S[3')D_-@8'U-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME!T?@9Y*UG>/K+Q1XJT6W6#2A#:QWT4J0;@T[J,_,XX";?0%LY[8KU*C'&*
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MCNHY9&*JP;@L2.1[4 5;;P]J^L^-;;Q!K:00V=E#BRLDF,G[PGF1LJ-K8VC
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MHPQ)V[#\K8)Z[AQV[5T6DW%_JVCM)K.F+9/,6"VV_>P3H-W& ?;FMO '0"C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@!",_A2!0.YIU% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!Y&*** $Q2T44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 F!C%+110 4444 %%%% !1110 A&:39TY/'ZTZB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M& 0.OXUUQ9@<X.._M0!)17&^(_B;X>\*:H-.U66=;@Q"4".(L-I)'7\*Q_\
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M@K_GXO?_  &- 'I5%>:?\+T\%[=PN+PC_KV->BVMPEW:0W,63',@D7/H1D4
M345@>*_%^E^#;"&]U9I5AFE\E?*CWG=@GI^!KDS\<_!8.#<7F?3[,: /2Z*\
MU_X7IX*_Y^+W_P !C1_PO3P5_P _%[_X#&@#TJBO-1\<?!A88N+SG@#[.:]"
MLKI+ZSANHL^5,BR)NZX(!% %BBL3Q1XJTSPAI::CJKRK;O*(@8TW'<02./P-
M<A_PO3P5_P _%[_X#&@#TJBO-?\ A>G@K_GXO?\ P&-'_"]/!7_/Q>_^ QH
M]*HKS4?'+P:3\L]X<#D?9SFO0=/O8]1L+>]AW>3<1++'N&#M89&1^- %FBJ.
MLZM:Z%H]UJEZ66VMDWR%%R<>PK@_^%Z>"O\ GXO?_ 8T >E45YK_ ,+T\%?\
M_%[_ . QH_X7IX*_Y^+W_P !C0!Z517FO_"\O!C$!;B\)]#;D5V7AWQ%9>*-
M(35--,IMI&9%,B;6R#@\4 ;%%9^K:M;Z+I=UJ5V7^S6L9DEVKE@!Z#O7"_\
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M"3D_A0!W=%%<7XD^)_AWPMK+:5J<MPMRL8D/EPEE"GIS0!VE%>:?\+T\%?\
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M_P# 8T?\+T\%?\_%[_X#&@#TJBO-?^%Z>"O^?B]_\!C1_P +S\%_\_%[_P"
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MQUP* 'T5R?BCXAZ%X.NK>VUB2X22=#)'Y41<%0<=:P?^%Z>"O^?B]_\  8T
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MSK!&%#'U.*O[2<9;./:G44 <]<>!?"UU<RW%QH&GRS2L7DD>!268G))-1_\
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MU3_X5]X0_P"A;TS_ ,!EKI:* .:_X5]X0_Z%O3/_  &6C_A7WA#_ *%O3/\
MP&6NEHH P+7P/X7LKJ*ZM=!T^&XB8/')' H96'0@UN;2,X;K[4^B@#'U3PKH
M.MW*7&J:39WDR+L5YH@Q ].:HCX>>#P,#PWIF!_T[+7344 <U_PK[PA_T+>F
M?^ RT?\ "OO"'_0MZ9_X#+72T4 <_;>!O"UG=17-MH&G13Q.'CD2!058<@@^
MM=!110!D:KX6T/7+A9]5TNUO)478K31ABHZXYJC_ ,*]\(9)_P"$;TSGK_HZ
MUTM% '-?\*^\(?\ 0MZ9_P" RT?\*]\(?]"WIG_@,M=+10!SL'@/PK:SQ3P:
M!IT<L3B1'6W4%6!R"#71444 9VK:%I>NQQQ:K8P7D<;;D29 P!QC/-9?_"O?
M!^<_\(WIF<8YMUKI:* .:_X5]X0_Z%O3/_ 9:/\ A7OA#_H6],_\!EKI:* .
M9_X5YX0&<>'-, /7_1EKHXHTAB2*-0J(H55 P !T%/HH H:KHNFZY;I;ZG90
M7<*-O5)XPP#=,X/?DUD?\*]\(9)_X1S3"3_T[K7344 <U_PK[PA_T+>F?^ R
MT?\ "OO"'_0MZ9_X#+72T4 <S_PKSP?C'_".:;^%NM=%;P1VUO'!"BI%&H1%
M48"@< 5)10!2U31].UJU%MJ=E!=P*X<1S(&4,,C.#WY-8_\ PK[PA_T+>F?^
M RUTM% '-?\ "OO"'_0MZ9_X#+1_PK[PA_T+>F?^ RUTM% ',_\ "O/!^2?^
M$;TS)_Z=EKH;>VAM+>.WMXEBAB4(B*,!0.@%2T4 07EG;:A9RVEY!'/;RKMD
MBD7*L/0BL'_A7WA#_H6],_\  9:Z6B@#FO\ A7WA#_H6],_\!EH_X5]X0_Z%
MO3/_  &6NEHH YG_ (5YX/)!/AO3./\ IV6MG3M)L-'LEL]-M8;2W4Y$<*!5
M!/7BKM% %:[L;>_M9K6[B2>WF7:\;KE67T([UA_\*^\(?]"WIG_@,M=+10!S
M7_"OO"'_ $+>F?\ @,M'_"OO"'_0MZ9_X#+72T4 <U_PKWP>?^9;TS_P&6MC
M3=)L-'M!::;:0VENI+"*% J@GKP*NT4 075G!>6<EI<1K+!*I22-QD,IZ@U@
M#X>^#P,#PWIG_@.M=-10!S7_  K[PA_T+>F?^ RT?\*^\(?]"WIG_@,M=+10
M!S7_  K[PA_T+>F?^ RUL:;I%AH]F+33;2&T@#%O+A0*N3WP*NT4 -VXS@G)
MKG3\/_"3.SOX>TYF8[F9K=22:Z2B@#FO^%?>$/\ H6],_P# 9:/^%?>$/^A;
MTS_P&6NEHH YK_A7WA#_ *%O3/\ P&6M'2O#NCZ%YW]E:=;6?G8W^1&%W8Z9
MQ]:U** &[?4YKGI/ /A.65Y9/#VFN[L69FMU))-='10!S7_"OO"'_0MZ9_X#
M+1_PK[PA_P!"WIG_ (#+72T4 <U_PK[PA_T+>F?^ RUH:3X:T;0I)7TK3;:R
M,P D\B,+NQTSBM6B@!NP>I]:YZ7P#X3FF>:7P]IKRNQ9G:W4DD]2:Z.B@#FO
M^%?>$/\ H6],_P# 9:/^%?>$/^A;TS_P&6NEHH YK_A7WA#_ *%O3/\ P&6K
M^E^&=$T22232]+M;-Y0%<P1!=P'8XK6HH ;M/ )R,<\=:YZ;P#X2N)I)IO#V
MFR22.79FMU)+'J3[UT=% '-?\*^\(?\ 0MZ9_P" RT?\*^\(?]"WIG_@,M=+
M10!S7_"OO"'_ $+>F?\ @,M:&E>&M$T.:272]+M+.21=KM!$%+#K@XK5HH *
MP]1\&^&]6O)+O4-$L;FXD #22PAF..G-;E% '-?\*]\(?]"WIG_@,M'_  K[
MPA_T+>F?^ RUTM% '-?\*^\(?]"WIG_@,M6;#P=X<TN]CO+#1+&VN8\[)8H0
MK+D8.#]#6Y10 5B:AX/\/:M>M>:CH]G=7+  RRQ!F('3FMNB@#FO^%>^#QT\
M-Z9_X#+1_P *^\(?]"WIG_@,M=+10!S7_"O?"'_0MZ9_X#+4]CX+\-Z9>17=
MCHEC;W$/^KEC@4,O8X-;U% !6+J7A+0-8O#=ZCI%E=7!789)H0S%1T&36U10
M!S0^'O@\#CPWIG_@,M'_  K[PA_T+>F?^ RUTM% '-'X>^#R,'PWIF#_ -.R
MU-:>"?#-A>1WEGHEC!<Q-N26.$!E/M6_10 5F:MX>TC73$=4TZVO##GR_/B#
M[,]<9]<"M.B@#F1\//!X_P"9;TS_ ,!UI?\ A7WA#_H6],_\!EKI:* .:_X5
M]X0_Z%O3/_ 9:!\/O"*E2OAW3E*_=(@48KI:* $ P,5GZMH&DZZL2ZKIUM>"
M$DQB>,-MSC.,_05HT4 <U_PK[PA_T+>F?^ RT?\ "OO"'_0MZ9_X#+72T4 <
MU_PK[PA_T+>F?^ RT@^'G@\'(\-Z8#G.1;K7344 ,"!0 GRJ!@ "L_5/#^DZ
MW'$FJZ?;WJQ$E!/&&"D]2,UIT4 <U_PK[PA_T+>F?^ RT?\ "OO"'_0MZ9_X
M#+72T4 <U_PK[PA_T+>F?^ RT?\ "O?!^<_\(WIF?^O9:Z6B@!BQ[%55X4#&
M .U5=0TJRU:S:TU&VBNK=R"T4J J2#D<>U7:* .:_P"%?>$/^A;TS_P&6C_A
M7WA#_H6],_\  9:Z6B@#FO\ A7WA#_H6],_\!EI#\//!YZ^&],_\!EKIJ* *
MUG8VVGV<=I9PI!;Q#:D4:[54>@%,U#2[/5;%K*_MX[BU?&^*1=RM@Y&?Q%7*
M* .:_P"%>^$/^A;TS_P&6C_A7WA#_H6],_\  9:Z6B@#FO\ A7WA#_H6],_\
M!EH_X5[X0Q_R+FF?^ RUTM% %:SL+;3K.*TLH4M[>(82.-<*H]A1>Z?:ZE9R
MV=]!'<6\HP\<B[E;OR*LT4 <U_PKWPAC_D6],_\  9:/^%?>$/\ H6],_P#
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MWIG_ (#+1_PKWP@1C_A&],_\!EKI:* ,/3O!WAS2+Q+O3M%L;6X0$+)%"%8
M^XK<Z444 9.J^&=#UR=)M4TJTO)8UV(\\08J,YP,U0_X5]X0_P"A;TS_ ,!E
MKI:* .:_X5]X0_Z%O3/_  &6C_A7WA#_ *%O3/\ P&6NEHH YR#P%X3MIXYX
M/#VG1RQN'1TMU!5@<@CWKH2IYP<>G'2G44 9.J>&-$UN6.75-+M;QXUVHT\0
M8J/09JA_PK[PA_T+>F?^ RUTM% '-?\ "OO"'_0MZ9_X#+1_PK[PA_T+>F?^
M RUTM% '.0^ O"=O.D\/A[38Y8V#HZVZ@JPZ$5T.T>IX.:=10!DZKX9T7798
MI-5TVVO6B!$9GC#;0>N,U0_X5]X0_P"A;TS_ ,!EKI:* .:_X5]X0_Z%O3/_
M  &6C_A7WA#_ *%O3/\ P&6NEHH YR+P%X4AFCFB\/Z<DD;!E9;=001T(KH@
M,'K2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$TT:?]EA>V PT<B[PQSG+;L[CGG)YS0!PUY)IMK9:7<-J-K)>WFLV]U=8F7
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M$45PA^9;A"T3@^N.>.HP15&VTK5+V]@N-<N+5TM6\V"&T1E7S,$;V+$G(!(
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ML%FC[8KN)WR[8^;@]5QP>VXT 6]'LKA[VYUK4(S%<W"A(X&.YK>+^[GU) )
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M/^_J4?\ #0^D?] *\_[^I0![-FC->,_\-#Z1_P! *\_[^I1_PT/I'_0"O/\
MOZE 'LV:,UXS_P -#Z1_T KS_OZE'_#0^D?] *\_[^I0![-FC->,_P##0^D?
M] *\_P"_J4?\-#Z1_P! *\_[^I0![-FC->,_\-#Z1_T KS_OZE'_  T/I'_0
M"O/^_J4 >S9HS7C/_#0^D?\ 0"O/^_J4?\-#Z1_T KS_ +^I0![-FC->,_\
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M![-FC->,_P##0^D?] *\_P"_J4?\-#Z1_P! *\_[^I0![-FC->,_\-#Z1_T
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ME 'LV:,UXS_PT/I'_0"O/^_J4?\ #0^D?] *\_[^I0![-FC->,_\-#Z1_P!
M*\_[^I1_PT/I'_0"O/\ OZE 'LV:,UXS_P -#Z1_T KS_OZE'_#0^D?] *\_
M[^I0![-FC->,_P##0^D?] *\_P"_J4?\-#Z1_P! *\_[^I0![-FC->,_\-#Z
M1_T KS_OZE'_  T/I'_0"O/^_J4 >S9HS7C/_#0^D?\ 0"O/^_J4?\-#Z1_T
M KS_ +^I0![-FC->,_\ #0^D?] *\_[^I1_PT/I'_0"O/^_J4 >S9HS7C/\
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M^I0![-FC->,_\-#Z1_T KS_OZE'_  T/I'_0"O/^_J4 >S9HS7C/_#0^D?\
M0"O/^_J4?\-#Z1_T KS_ +^I0![-FC->,_\ #0^D?] *\_[^I1_PT/I'_0"O
M/^_J4 >S9HS7C/\ PT/I'_0"O/\ OZE'_#0^D?\ 0"O/^_J4 >S9HS7C/_#0
M^D?] *\_[^I1_P -#Z1_T KS_OZE 'LV:,UXS_PT/I'_ $ KS_OZE'_#0^D?
M] *\_P"_J4 >S9HS7C/_  T/I'_0"O/^_J4?\-#Z1_T KS_OZE 'LV:,UXS_
M ,-#Z1_T KS_ +^I1_PT/I'_ $ KS_OZE 'LV:,UXS_PT/I'_0"O/^_J4?\
M#0^D?] *\_[^I0![-FC->,_\-#Z1_P! *\_[^I1_PT/I'_0"O/\ OZE 'LV:
M,UXS_P -#Z1_T KS_OZE'_#0^D?] *\_[^I0![-FC->,_P##0^D?] *\_P"_
MJ4?\-#Z1_P! *\_[^I0![-FC->,_\-#Z1_T KS_OZE'_  T/I'_0"O/^_J4
M>S9HS7C/_#0^D?\ 0"O/^_J4?\-#Z1_T KS_ +^I0![-FC->,_\ #0^D?] *
M\_[^I1_PT/I'_0"O/^_J4 >S9HS7C/\ PT/I'_0"O/\ OZE'_#0^D?\ 0"O/
M^_J4 >S9HS7C/_#0^D?] *\_[^I1_P -#Z1_T KS_OZE 'LV:,UXS_PT/I'_
M $ KS_OZE'_#0^D?] *\_P"_J4 >S9HS7C/_  T/I'_0"O/^_J4?\-#Z1_T
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M.L7_ $,S_P#@$/\ XNO<:* /#O\ AG6+_H9G_P# (?\ Q='_  SK%_T,S_\
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M / (?_%T?\,ZQ?\ 0S/_ . 0_P#BZ]QHH \._P"&=8O^AF?_ , A_P#%T?\
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M *&9_P#P"'_Q='_#.L7_ $,S_P#@$/\ XNO<:* /#O\ AG6+_H9G_P# (?\
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MX9UB_P"AF?\ \ A_\71_PSK%_P!#,_\ X!#_ .+KW&B@#P[_ (9UB_Z&9_\
MP"'_ ,71_P ,ZQ?]#,__ (!#_P"+KW&B@#P[_AG6+_H9G_\  (?_ !='_#.L
M7_0S/_X!#_XNO<:* /#O^&=8O^AF?_P"'_Q='_#.L7_0S/\ ^ 0_^+KW&B@#
MP[_AG6+_ *&9_P#P"'_Q='_#.L7_ $,S_P#@$/\ XNO<:* /#O\ AG6+_H9G
M_P# (?\ Q='_  SK%_T,S_\ @$/_ (NO<:* /#O^&=8O^AF?_P  A_\ %T?\
M,ZQ?]#,__@$/_BZ]QHH \._X9UB_Z&9__ (?_%T?\,ZQ?]#,_P#X!#_XNO<:
M* /#O^&=8O\ H9G_ / (?_%T?\,ZQ?\ 0S/_ . 0_P#BZ]QHH \._P"&=8O^
MAF?_ , A_P#%T?\ #.L7_0S/_P" 0_\ BZ]QHH \._X9UB_Z&9__  "'_P 7
M1_PSK%_T,S_^ 0_^+KW&B@#P[_AG6+_H9G_\ A_\71_PSK%_T,S_ /@$/_BZ
M]QHH \._X9UB_P"AF?\ \ A_\71_PSK%_P!#,_\ X!#_ .+KW&B@#P[_ (9U
MB_Z&9_\ P"'_ ,71_P ,ZQ?]#,__ (!#_P"+KW&B@#P[_AG6+_H9G_\  (?_
M !='_#.L7_0S/_X!#_XNO<:* /#O^&=8O^AF?_P"'_Q='_#.L7_0S/\ ^ 0_
M^+KW&B@#P[_AG6+_ *&9_P#P"'_Q='_#.L7_ $,S_P#@$/\ XNO<:* /#O\
MAG6+_H9G_P# (?\ Q='_  SK%_T,S_\ @$/_ (NO<:* /#O^&=8O^AF?_P
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M$/\ XNO<:* /#O\ AG6+_H9G_P# (?\ Q='_  SK%_T,S_\ @$/_ (NO<:*
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MQ?\ 0S/_ . 0_P#BZ]QHH \._P"&=8O^AF?_ , A_P#%T?\ #.L7_0S/_P"
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MS_\ @$/_ (NO<:* /#O^&=8O^AF?_P  A_\ %T?\,ZQ?]#,__@$/_BZ]QHH
M\._X9UB_Z&9__ (?_%T?\,ZQ?]#,_P#X!#_XNO<:* /#O^&=8O\ H9G_ / (
M?_%T?\,ZQ?\ 0S/_ . 0_P#BZ]QHH \._P"&=8O^AF?_ , A_P#%T?\ #.L7
M_0S/_P" 0_\ BZ]QHH \._X9UB_Z&9__  "'_P 71_PSK%_T,S_^ 0_^+KW&
MB@#P[_AG6+_H9G_\ A_\71_PSK%_T,S_ /@$/_BZ]QHH \._X9UB_P"AF?\
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M_BZ]QHH \._X9UB_Z&9__ (?_%T?\,ZQ?]#,_P#X!#_XNO<:* /#O^&=8O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YCXAJ/\ A7?B$_\ 3C*?_':Z>N9^(?\
MR3KQ#_UX2_\ H)H ^;OA1_R4[0AV\U__ $6U?6PZU\D_"C_DI^A?]=7_ /1;
M5];#K0 M%%% !1110 4444 %%%% !1110 4444 %%%% !7B_[0__ "!M$_Z^
M)/\ T$5[17B_[0__ "!M$_Z^)/\ T$4 <G\ ?^1]N?\ L'O_ .AI7TI7S7\
M?^1]N?\ L'O_ .AI7TI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %<S\0_^2=>(?\ KPE_]!-=-7,_$/\ Y)UXA_Z\)?\ T$T ?-WPH_Y*
M?H7_ %U?_P!%M7UL.M?)/PH_Y*?H7_75_P#T6U?6PZT +1110 4444 %%%%
M!1110 4444 %%%% !1110 5XO^T/_P @;1/^OB3_ -!%>T5XO^T/_P @;1/^
MOB3_ -!% ')_ '_D?;G_ +![_P#H:5]*5\U_ '_D?;G_ +![_P#H:5]*4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$/_DG7B'_ *\)
M?_03735S/Q#_ .2=>(?^O"7_ -!- 'S=\*/^2GZ%_P!=7_\ 1;5];#K7R3\*
M/^2GZ%_UU?\ ]%M7UL.M "T444 %%%% !1110 4444 %%%% !1110 4444 %
M>+_M#_\ (&T3_KXD_P#017M%>+_M#_\ (&T3_KXD_P#010!R?P!_Y'VY_P"P
M>_\ Z&E?2E?-?P!_Y'VY_P"P>_\ Z&E?2E !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5S/Q#_Y)UXA_P"O"7_T$UTU<S\0_P#DG7B'_KPE
M_P#030!\W?"C_DI^A?\ 75__ $6U?6PZU\D_"C_DI^A?]=7_ /1;5];#K0 M
M%%% !1110 4444 %%%% !1110 4444 %%%% !7B_[0__ "!M$_Z^)/\ T$5[
M17B_[0__ "!M$_Z^)/\ T$4 <G\ ?^1]N?\ L'O_ .AI7TI7S7\ ?^1]N?\
ML'O_ .AI7TI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
MS\0_^2=>(?\ KPE_]!-=-7,_$/\ Y)UXA_Z\)?\ T$T ?-WPH_Y*?H7_ %U?
M_P!%M7UL.M?)/PH_Y*?H7_75_P#T6U?6PZT +1110 4444 %%%% !1110 44
M44 %%%% !1110 5XO^T/_P @;1/^OB3_ -!%>T5XO^T/_P @;1/^OB3_ -!%
M ')_ '_D?;G_ +![_P#H:5]*5\U_ '_D?;G_ +![_P#H:5]*4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7,_$/_DG7B'_ *\)?_03735S
M/Q#_ .2=>(?^O"7_ -!- 'S=\*/^2GZ%_P!=7_\ 1;5];#K7R3\*/^2GZ%_U
MU?\ ]%M7UL.M "T444 %%%% !1110 4444 %%%% !1110 4444 %>+_M#_\
M(&T3_KXD_P#017M%>+_M#_\ (&T3_KXD_P#010!R?P!_Y'VY_P"P>_\ Z&E?
M2E?-?P!_Y'VY_P"P>_\ Z&E?2E !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5S/Q#_Y)UXA_P"O"7_T$UTU<S\0_P#DG7B'_KPE_P#030!\
MW?"C_DI^A?\ 75__ $6U?6PZU\D_"C_DI^A?]=7_ /1;5];#K0 M%%% !111
M0 4444 %%%% !1110 4444 %%%% !7B_[0__ "!M$_Z^)/\ T$5[17B_[0__
M "!M$_Z^)/\ T$4 <G\ ?^1]N?\ L'O_ .AI7TI7S7\ ?^1]N?\ L'O_ .AI
M7TI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<S\0_^2=>
M(?\ KPE_]!-=-7,_$/\ Y)UXA_Z\)?\ T$T ?-WPH_Y*?H7_ %U?_P!%M7UL
M.M?)/PH_Y*?H7_75_P#T6U?6PZT +1110 4444 %%%% !1110 4444 %%%%
M!1110 5XO^T/_P @;1/^OB3_ -!%>T5XO^T/_P @;1/^OB3_ -!% ')_ '_D
M?;G_ +![_P#H:5]*5\U_ '_D?;G_ +![_P#H:5]*4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 444FX9Q0 M%-WBE# ]* %HHZ#)IN\>A- #J*;O&.<CC.*"P S0
MZBDW C(R:-PH 6BDW#&>U&X>M "T4W>,GKQ1O&<<_6@!U%-WC)&#D4N[V- "
MT4W>*4L!0 M%-+ #U^E&X4 .HI-P_"DWC_&@!U%)GKQ2!@0#@\_I0 ZBDW"D
MW 4 .HIN\9_G07 &<'K0 ZBD!R.A%+0 4444 %%(6 Q[TA<#K0 ZBDW"C<,X
M[T +12;ADCTHW#..XH 6BDW #)I-XX/.#0 ZBDW MBEH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIQZYKZ$A^:-&R3E02<]>* )Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MI,CUH 6BDW#UZ49'K0 M%)D>M&X8SF@!:*3(SC-&1CK0 M%)N&<9HR/6@!:*
M3(]:,C.,T +12%U R3Q1D>M "T4F11D9ZT +129'K1N'K[4 +12;AZT9&,YH
M 6BDR/6EH **3(SC-&10 M%)D$]:6@!FPYZ\#I2[25P<$TNX#O064$ GD]*
M #%# E<#&?>@L!CGK1N'KTH ;LRI'KZ&@(0,9Z>M.W#&<]:,C.,T -"GKGG&
M/:@IZ8YZDT_-)D9ZT -V?+C@^N11L&:<&4]#0&!Z&@!IC!SD 9ZXH*'G! )[
MX[4[<O'/7I1D8SF@!H3:>,<]<T!,'@T[(]:-P]: &[&W$DY]*-G0\9'>G9&,
MYHR/6@!-IP!VH"8X/K2[AC.>*-P]:  # Q^5!&?SH) ZGK1D'\* &E<]3VI2
MAY&>#3J3(]: &F,&@1X.<#)Y)-/S29'K0 W9CI2>4,< #'(QZT_(]:,CUZT
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$/\ Y)UX
MA_Z\)?\ T$UTU<S\0_\ DG7B'_KPE_\ 030!\W?"C_DI^A?]=7_]%M7UL.M?
M)/PH_P"2GZ%_UU?_ -%M7UL.M "T444 %%%% !1110 4444 %%%% !1110 4
M444 %>+_ +0__(&T3_KXD_\ 017M%>+_ +0__(&T3_KXD_\ 010!R?P!_P"1
M]N?^P>__ *&E?2E?-?P!_P"1]N?^P>__ *&E?2E !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R
M7Q%\22>%O!]YJ,((FXCA;:"%<]"0>H]JZVOGOX]>)$OM5M= MB7:S!DE*/D%
MFQA&7U  /7^*@"EX:^,WB6?Q/I\&K7B3V4LZQR110(K-NX&"!Q@D5]&=>3PU
M?,GQ \'#P]X2\,:G'IR6<[P"*Z0$[S.1NR1] U>X?#37U\0^"=/N'FBENHD\
MFX$8(V,O !R3SMVG\: .1^,/CG7?"5]I<6D7:P">.1I=T0;=@CID>]1_";XF
MZAXGU.XTK6YXY+EE\VWD2'86 ^\" ,#&.I]:POVB,?VEH1/_ #QE_FM<4=-N
MO"FD>%O&6F$9FW,YD)(\U)&P"HQ\NT+WZYH ^C/'FK7FA^"M2U33Y%CN;>,-
M&[("!\P'0_6N'^#_ ([\0^+M4U.+6;J*>."%&CVPJF"203P*V_'6K0:[\&-2
MU*T9O*N;5'0D<C+KG([5P?[/ _XG>M#G'V:/&?\ >- %3QE\5_%VB^,]5TVT
MU")+6WN&CB7[*C8 [$XKUOX<^+QXP\+17LI47D+&*Y55(4..A'U&#QP,XKYX
M\<0I<?%K5+>0D)+J.P[1SRP!KK?!ES-\-_BM<Z!=D+8WDGDK@EL!N8SG@#J-
MQQZT =C\8/&VO>#Y]*71[F. 7*R&3?"KYQMQC(]ZU?#7BC6-0^#T_B"ZGC;4
MTM;F42B-0-R%]O'3C KB/VA\M=>'CDX$<YXYR<IWKHO!O_)N]UG_ )\KW^<E
M &/\*/B+XE\5>,7T[6+M9;<6CR?+;JGS J!R![FO;MI&0.GOWKYJ^ I/_"PY
M1_TXR_\ H25],"@#Y^\4_$_Q7IGQ!N]&M;Z%+.*Z6-4,"9"G&><9[U[]@,",
MX]LX-?*'CO\ Y*_JG_807_V6OK+N* /-_BUXVO?!^DV(TUO*O;F4^7(R*ZA5
M R"#W.1S7*?##XIZWX@\7)I6M7(N!<1OY(CB1-CJ"Q)(ZC -<C\1-6;QG\3H
M[:PB:Z2)TM$C1]RRX))8=,9SC_@-.^)FBCP-\0+6[TBVAM8&$<]LD9)"[,9S
MSG!8>O(H ^F]H+9)((]\5Y[\7?%6K>%- L;S1[A(9I;KRW9HPP9=I/ /TKM=
M$U&'5]$M-0@ECECGB5M\?W2>^/QS7F/[0?\ R*>E_P#7]_[(U '0?";Q-JWB
MOPO-J&K3I-<)=-$&6-5 4*I[?6O0*\I^ '_(A7?_ &$'_P#0$KU:@!A #$[N
M2>YKPSXH?$GQ-X9\9R:=I-[%#;"*-PC0JQ&5YZCUKW4U\O?''/\ PLR< ?>M
MX@3_ ,!H [?X3?$W6/$OB:;2=:E$[21%X6CB5 I7ELXQG/%>UGI7RS>6D7@;
MXD:%?N/(L)$M[M%M\M^[*J&&/=E8XSWKZ%\6:K#I7A#5+ZX=UB2V;)1<L"WR
M@C\2* /#_$WQC\2VWB;4H=*N5BL8IS''%);HS#;\IY(Y^8$_C7?_  =\8ZUX
MPM-7?6IQ(UO)$L>V)4^\&)^[UZ5X?8:(TW@#7=?N(T?R[B*"*1F.]7)RQ_$,
M*]5_9WQ_9^OXZ>;#C\GH L?%SQ_XA\(>(;&TTF[C@@FM?,<-"KG=N89Y'H!6
M=I>K_&;6--M=1LOLLUK<IYD;D0+\IZ<&LK]H0_\ %6::3T&GY^OSMQ7?>!O'
M?A;3O NBVUWK5G!/#;*C1,_*GTH O^ W\?/>W0\8I&L/E@PE/+^]GG[G/3UK
MS7Q=\4?%^G>.-2T?3+R)8HKOR85:!#GVR1_.O<])U[2]=ADFTN^BNXT;8SQG
M(4XSBOEWQO,L/Q:U*29@$74@<GC:,CG]* /3?-^.7:.TQVXMO\:Z R?$Q? J
MLR0GQ(;S!4>3M\C'_?/7\:W?^%D>#&!4>(['>.#\_2NCT^]MM1L8KRSF2>"4
M;DE3HP]: /#=<\0_&#P[I+ZEJK6T%K&55I D#8).T<#GJ15'PUXW^*?BXW']
MC7%M/]F \W,<*[=V<<-C/0UZ3\:O^27ZC_UUA_\ 1BUQ?[.O7Q!_VP_]GH Z
M;1+WXBV6GZ[?>*E@2*VT^22T9!$?WJ@D'"?3O7.?"SXC>)O%7B_^SM5O(IK8
M6[R;%@13D$>@]Z]9\5?\B?K?_7A/_P"BVKY\^!/_ "4C_MRE_FM '1_$WXF>
M*?#7C:YTS3+N)+6*.-E5H$8Y903R1GO7:_"CQRWC30IA>R)_:5F^)@BE<J?N
ML>V3@]/2O'?C9S\3[Y> /)A([<[!5K3O,^%OQ'LI'+?V9>PQL2?G)B<#.<8&
MX'.* /5?B[XJU;PIX?L;S1[A(9I+KRW9HPX9=A/ /TJ;X3^)M6\5^&)M0U:=
M)ITNFC#+&J@*%4]OK7._M LK>$]**$%?MW4<Y_=M5OX!L$^']Z[?=6_D)_[X
M2@#I?&?Q$T;P=%+'/*)=4,6^&T7)W>F3T7UY["O-;7XG?$+QD\4/AG1XK=UW
M,\JH&C; '!9_E!]LYKB;GS/B1\572*X=X;V[(B:4A&6!<D+TXP@/K7U%96ME
MI%C%;P".&"-0@/"YP .3W- 'ED?C?XB^'YM/M/$7A^":.XF59+I?FVJ6"\[/
ME&"1UZU[ H._KGCG-5FNK%TVM/;L@[,ZGI5J-@PR".>>.AH ?7(>-/'FD^![
M6)KP233RG*6T1R[#/+<]!77G@9KY8\87K>._BW]BCO)1;R7:6-NTB#$2\*PQ
MW&_<>O>@#M+'QW\2_&T)NO#&EP6UM 2CO\F)&/3!D],'I^-3:;\;[JPU9M*\
M6:2UI-"5BDEC!RK?Q.P]._R]>U>Q:9IMII&FP6%E D-O"H5408%>4_'KPY:S
M^'8M>18X[JWE6*1@OS2*QP!GV)]* /5[2X@O+5+JUD66&90RNK9##VKPKXB?
M$[Q5X=\;WVEZ=?116L.S8AMT8C* GDCWKK?@9K_]J>#I-/DEEDGT^7;\ZC"1
MM]Q0?P->1?&+'_"TM8S@C$6<_P#7): /0X[CXW2*LBK:LC*"C8MQG/MFO2_"
M)UX^';5O$I4:L2PF*[0,;CM^[QTQ6;:_$7P=#:0K-XAL0RQJ#E^G'2NBTW5+
M+6+&.\T^Z2XMG)*2IR#SB@"XX!SW %>6?$CXLOX4OFT;3H/,U#9F:1U^6#<N
M5([,1D'T]:]2. ?O?,W2OD_Q?%<^&?BG<3ZE$)]E\+I4+E@\9?>%R?4$#IQ0
M!Z#I_B+XOQV$.MRZ='<Z>J>8T!AC5Y%_W1\X^F,UZ%?7WBZ^\ I>:7;VT'B*
M9(Y$A'W44D$J?,XW!<YSWIWAKXB^'/$\:+8WJ17.T_Z+-A7 &,D>W.*ZP9R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5S/Q#_ .2=>(?^O"7_ -!-=-7,_$/_ ))UXA_Z\)?_ $$T ?-W
MPH_Y*?H7_75__1;5];#K7R3\*/\ DI^A?]=7_P#1;5];#K0 M%%% !1110 4
M444 %%%% !1110 4444 %%%% !7B_P"T/_R!M$_Z^)/_ $$5[17B_P"T/_R!
MM$_Z^)/_ $$4 <G\ ?\ D?;G_L'O_P"AI7TI7S7\ ?\ D?;G_L'O_P"AI7TI
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M="6$T6$1>@![ 5S_ .SZDL5EKPEB9"TL) (QV;- '/\ [01_XJ[2_P#KP_\
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MOH*YGBL[66>=XTAB4N[.P  ]R>!7RO\ #GQ9+X'U>\O7TBXO?.@\G8C;-IW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME% #<'U%-V=#M'J?6I** &;6'3%"KM) '&*?10 SDC&W\Z382 .@[C'6I**
M&;">O;I1MR<\C!_.GT4 -P2/2@KGJ?RIU% #-G(()_$T;..I]\&GT4 -VD#&
M:4<"EHH :ZEEP,?C3<-P .QZ]JDHH C*$YSCIQ2\[0=O/I3Z* &,N[)P,XP,
MT;>AQS]:?10!& V02#QQP:=R#TZ]Z=10 S# GOGWI IX!W'^E244 ,"X  &*
M51C_ #UIU% !4>P@_7J:DHH ;CCE1FD(;M@4^B@!BKL!P/P%# E#@<GL:?10
M S8<\8Q3ATYI:* &G.>E-56"@8'7UZ"I** (RA(VXP/Y4!""#SD#'M4E% #-
MF1@].U!4G@YX[^M/HH 802,#(YH*\_+@9.3QUI]% #"N5QMP/2DPVW'ZDU)1
M0 #I36&1TS3J* &88]@!Z4 $CD8[]:?10!%L90Q ^;KQ2[/3 S4E% #"IP..
MG2FA>-NWY3^E2T4 ,"X/0>O%!7.&P?I3Z* &;<G/?'%)L.>U244 1["PY&W)
MYQWI2G/W00>M/HH CV'.0.>V>PI=G4G.?8T^B@!H4CH?SI"I/?BGT4 ,*9YY
M/?!/%!!/)49'0T^B@!FT[>?O8P6]:-I)R2>GK3Z* &!3UR>?6EP1SUIU% #.
M<9 .?3O1M/'7ZYI]% $>#@?*3]>U#+GJN>W7BI** &,K$8X]O:@*?ESVI]%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5S/Q#_ .2=>(?^O"7_ -!-=-7,_$/_ ))UXA_Z\)?_
M $$T ?-WPH_Y*?H7_75__1;5];#K7R3\*/\ DI^A?]=7_P#1;5];#K0 M%%%
M !1110 4444 %%%% !1110 4444 %%%% !7B_P"T/_R!M$_Z^)/_ $$5[17B
M_P"T/_R!M$_Z^)/_ $$4 <G\ ?\ D?;G_L'O_P"AI7TI7S7\ ?\ D?;G_L'O
M_P"AI7TI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M,D8*N3CCUI]-?ITS]: /-_BSXXO_  =I5DFEY6]NY25E9%90BCY@0><_,,<>
MM<Y\+_BGKGB/Q3_96MLDBW$1,'DQ*NUE&XDXYQ@&N*^(FJ_\)G\4([;3TEN8
M8FCMHTB?>LA!.XJ!TZ_I2_$71QX!^(EO>:-;):VQ$=Q;1)(QR5P&SSG!8'(S
MT- 'U#VKPKXE_$WQ/X;\<7>DZ7<0);)%&P#0J2"5!ZGWKV32M2CU/1[6]BE2
M03QJVZ/IDCG'XYKYI^-A ^*%[G;AH8N3V(C% '6S^-_BKH=K#JVJ:9"^F#:S
M,(X\,I'?:20/?'%=Y\._B/#XZBN(GA6UU"W&YX@=RLF>'4_EP<5NO/9VW@E9
M+]XUM5L5WF4#;]P=<U\\?!F&\D^(]C-;1R>2B2-<%"=NPH0-WMN(_'% &PWQ
M5\=W7B*31["6UDF:Z>&"(P+EL' Y/'ZUJ77Q*^(?A&16\4Z1'-'.N(D(1%!S
MUW(3^1^M<-X58+\7K$G"YU5L<\??/6O9/C/K6F6W@JYTZ>2-[VYVFW0*&((<
M$M[#&1GWQ0!TG@CQM8^-]*EN[5&ADA;RY8I2-V< Y&#]W)(!]C7EFK_%;Q/:
M?$>ZT2"XMQ8IJ0MU3[.-VTR!>OTJW^SWIMS'#J^ID+]DF9(5)/)9<D\?1A7
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M6QDB-NDP>96+9).<X8<<"NF\6>*)+;X4-K,D9::[L8\K"Q78TR@9'?@MG\*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5S/Q#_ .2=>(?^O"7_ -!-=-7,_$/_ ))UXA_Z
M\)?_ $$T ?-WPH_Y*?H7_75__1;5];#K7R3\*/\ DI^A?]=7_P#1;5];#K0
MM%%% !1110 4444 %%%% !1110 4444 %%%% !7B_P"T/_R!M$_Z^)/_ $$5
M[17B_P"T/_R!M$_Z^)/_ $$4 <G\ ?\ D?;G_L'O_P"AI7TI7S7\ ?\ D?;G
M_L'O_P"AI7TI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5;4]4T>?4I4P;<!P$1CU)!!R?3\: /:/@OX)NO#FD3:IJ<)BO[[!6/=S''U
M(Z GK^->I"0'GH,XKQ?_ (:#M,D+X;N_;]^,G]*]2UG6H-&\.W&L3*1%#!YA
M&,G)Z# Z\F@#P;XWZ\=:\70Z-8O+-'9J%=$8,K2-S\H!Y/('KQBO<O!WAZU\
M.>%[/3K<#Y4#2-LVEW(&21Z_X5\^?#/1;CQE\1FU.7]W%!<'4)O+P K[MRJ
M<DC=@8ZXKZ@# #YCT[T *<J.#D^] 8GTZ^M>3_&GQQ?>&8=-L])OGM+R8M)(
M?+!!CP0.2#SNKL_ 9U6;PC87.M7%Q-J$R^;+YZ*I3/\ #@ <8 /KS0!T]8'B
MKQ3I_A+1I=0U"7[HQ%$/ORMZ"M^OCSQGXCU/Q-XHN+C4GD:.*0QI$G"H@)&%
M'K[T :NBZ/J_Q3\=R7DL,A@DF\VXE9SMABS]P-USCY1^%?3[6ZPZ9]EB *)"
M8T7KT7 _&O#/#WQ>T'PMI,6FZ9X9NTC3[\AG7=*>[-\O4^WX5Z1X"^(L/CJX
MOHX-,ELQ:!&)D<-OW9Z8 Z;?UH \/^%EK<:;\7].L[R+R;F&2:.:/ ^5Q&X(
MR..M>_\ Q&+?\*[U\ #_ (\GQS7D_P 0_ VM^'O%[>+="CFO(&N&NI$0',+9
M+-NVX^0\_AQ5?Q5\1=5^(>EP^'M&T2X2>0B2<(2QD  R% _AY.<Y[4 2?L_6
M=R-=U2_\D&W6U$+2#'^L+J<?D":[GXJ_$.V\/:9+I%E.6U:ZC*YB;'V<'^(G
ML?0?RJG8Z1?_  L^$.HW4*0MK#*KS.,L%9F"C'/.T,?RKPG3=0MI/$*ZEX@A
MNM2A+F26-7VF5O0G'3Z8H ],^"7@B>YU0>)]0@D2"+=]D9F(,CG@M[KM+=>^
M,5[\JAB01]#7B\7Q]TR!%BC\,W,<* *BK,H  Z #;Q7J?A37D\3^'++68[=K
M=;I6;RV.2N&*\G\* +.O(/\ A']3.!_QZ2]O]@U\W_!#_DI-K_U[R_\ H-?2
M6O?\B[J?_7I+_P"@&OFWX)?+\2K4$'_CWE[?[- 'U#SGMBD+'V]N:XSXG^))
M?"_@NYO;>ZE@O)76*V94#8<\\Y'3 -8_PAU#Q%XAT.ZU37]0N9PTOEVX>-%0
MJ ,NN%!/.1UQQ0!Z6&SGC%&2>F*0@JO)SQ@FN0\=>)=6\+V=G>Z7IAU"W$A-
MX K$I$HR3D=.AY- '/:G\$?"MY9W'V,7,%[*"T<KREMK=>GI7G_@#QIKF@^/
M8M U6_GO+$3_ & PE]X1@=BE<XP-P'X5NZC\>KNZMVAT707BO'8('G?>HSG@
M 8.[IBJ7PT^'6M7'BW^W_$EK+ ()C,XN4*/-,3N! XQ@D&@#V?4O"F@:Q=F[
MU/1[.[GV!-\T(9B!T&3]:YOXJZ3+/\+;ZRTRU#"%8F2), )&C GKCHHKA?BU
MX[\3^'?&BVFE:E)!:_9$<1B-#\Q+9/()["O5["(^(/ MI%>RN3J.G*LSC ;,
MD8R1Q@'F@#RO]G;)?Q =O $&<C'/SUI_M!L#X8THG@?;",^GR&N,MK/Q#\&_
M%\E]-:3WFCL/*\Y01'*&^[ST#\'K_6G:W=>(?C/XAM4T[3)+/38&\HO)EEC.
M,L7/W<XS@8SVH P-3T74;?X5:'?26K+9F^N'#AAT=8PIZYY*-^5>W?!-O^+8
M6(7^&68<_P"^:O>(OA_:ZMX!B\-6TIMX[<(8",E0Z@]<\X))[UY/X3\5ZU\)
MWO='US1;B6&5B\(W$$D'!*D\%/H* (?CN#)\0[5< [K"( 'UWOBO>?"%I<Z=
MX2T>RO(O)N8;.*.6/CY6"@$<<5X?X;\+:S\2?'0\2ZO8M'I#2+,1)N"2(. B
M<Y[=CP3[U]%@'=D_E0 RY_X])O\ <;^5?'7@ZRU/4O%=G::/>BTOYF;R)]Q7
M8 ISR >U?8MS_P >LW^XW\J^4/A.I7XI:/D'[\N>./\ 5/0!WQ^#'BC6M32;
MQ/XF6XC$9C\U'>60#J!\P'')KU%]$L?#O@.^TS3X5BMX;.4 #J?D/)/<GUKH
M0'/7 ^E9_B#Y?#.J9!_X])?_ $ T ?.'P4&?B/ "1_QZS=>G2M*4_P#"O_CJ
MI0^597,W^HM. 8I/NH0<#@X)^E9_P1!/Q(MR1C_1I>H]JZSX_:3<(VD:S#'&
MJQEH7<'#ECAE/'H%/TH PVS\0_CF(9OWMA;7&!!=\@1Q8WJ!SP2&('OS5#XX
M;1\17"_=%I#C\C74?L_Z5/)/K&MSQB17(A61^6W_ 'FQWZ,.:Y?XX GXBRD!
MB!:PC.,^M 'T9X;_ .17TG_KRA_] %:E9?AK_D5M)X(_T*'K_N"M,T ?*/QB
M_P"2I:QSC_4_^BEKUZV^"?@N6RA8V]W^\4,<7+8R1DXKR/XP!C\4M68*VT^5
MA@.#^Z6N^MOC_9PVT41\.W654*2)QS@=>E 'JV@:#IWAS1(M-TY9%LX"S()&
M+,"22>3[DU\Q^.<?\+=U''?45[>ZU]">!?&\7CG3[J]AL9+002B+9*^XG@$G
MC%?/7Q!E:W^*>KSF&0B.^$AQ_$!@X% 'UFWS<$=^]?/?Q]UJWO-:TW28FS/9
M1O)*PP5&_&!QSGY>01W%:-]\;=8UU/[/\+^';@:A.K ;OWK !3\R@ <CKSFL
M3P[\+_%'BO7_ .U/$PFMH992]R9E"32,,9PN!@$=\=J /5/A%8W-A\-M/CNX
MEC=]\J@8Y1F+*>/4$5QG[1'_ ![^'_\ >G_DE>S6EC#86<%G:1B.W@01QJ#G
M:H& .:\8_:(.8?#XP?O3]NG"4 ==\$O^286/_7:;_P!#->AUYY\$P1\,;$$?
M\MIO_0S7H= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5S/Q#_Y)UXA_P"O"7_T$UTU<S\0_P#DG7B'_KPE_P#030!\W?"C_DI^A?\
M75__ $6U?6PZU\D_"C_DI^A?]=7_ /1;5];#K0 M%%% !1110 4444 %%%%
M!1110 4444 %%%% !7B_[0__ "!M$_Z^)/\ T$5[17B_[0__ "!M$_Z^)/\
MT$4 <G\ ?^1]N?\ L'O_ .AI7TI7S7\ ?^1]N?\ L'O_ .AI7TI0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,<;B!@''/-1O"LF28T
M/J2.M3T4 1H !@=CS4E%% %<P1 $^4I8GLHY-*88N\2G/'*YJ>B@!B @GV&*
M<<X.*6B@"N(D5MPC4-W.*D*@D]\]0:DHH A2-$;Y(E [$"FF&(G<8P3G.=O6
MK%% $90%=C LIZYI@AB)_P!2GH1M%3T4 0>1%T,*'/\ LCI4RC"@>E+10!')
M&K?,R!L= 1FFB"+_ )Y)_P!\BIJ* (C!$1CRD_[YHP&4@KG'&".M2T4 0+#&
M&.U K$?PC%/)/]WV(J2B@#SSQ-\,(O%'BZ#6KW59FMXFC*V31!HPJXRG7HQ!
M)X[UWR1B,JBJ%11A0.V/2I:* "HO)CS_ *J/_OFI:* (O(C_ .>4?_?-'EA/
MN(%SP=HQ4M% $03()/)_G]::(@KY54!'/"U/10!$ZJZ'>N0>QY_2@01X_P!4
MG_?-2T4 0F"+J8DX]%IR)M( &%'( XQ4E%  >1BH!%&IRD8!7N%J>B@#B/'?
M@#_A-X[.*35I[.*W)8QI&'5V/ )R1T&?SKIM"TBWT'1+33+5%2*WC"#:NW<>
M[8]SD_C6C10 C9V\=:C=3M.,$G@YZ>]2T4 5V@CQQ&@/?Y1Q4B@D9Z'MZ>U2
M44 0M&C$-)&K-C'3-*%(&T#  Q4M% $!0,FUDW#W&:54"M@(BCN0.]344 1$
M%CSG'3!Z$4C1*1RH([%AFIJ* &1KL7'&/88I]%% !4 AC4Y6-0P.<A:GHH 1
M?NBFN,G'8C%/HH B2.-6W+&JD<<+BD,<94*ZAE'3(SS4U% $,<:)G8N,')P,
M9I&1)#EHP?JM3T4 -087&,>U*PR.:6B@"'R8R<E$)/4E:7R(_P#GE'_WS4M%
M $058P=J!<'^$=:00QGDQJ2>22*FHH B\I%((15QW48-*N0>.YYS4E% !4)C
M5N70-CCD9Q4U% #4540*H 'H*=110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<S\0_P#DG7B'_KPE_P#03735S/Q#_P"2=>(?^O"7
M_P!!- 'S=\*/^2GZ%_UU?_T6U?6PZU\D_"C_ )*?H7_75_\ T6U?6PZT +11
M10 4444 %%%% !1110 4444 %%%% !1110 5XO\ M#_\@;1/^OB3_P!!%>T5
MXO\ M#_\@;1/^OB3_P!!% ')_ '_ )'VY_[![_\ H:5]*5\U_ '_ )'VY_[!
M[_\ H:5]*4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!Y;XOUGXFVGB>[B\/:9%/I**ODR&-22=HW=6!ZYK@M9^*WQ)\/W@LM4AL[:
MYV!RC6Z]#T/#>U?1NT5\R_'=?^+B@9_Y<HOYM0!U,'BCXRW5I!<V^D6\D,T:
MR1NL*8((!_O4SXF^*O%VD>'/#$DE[/INIW$<IO$@(49&W'0^_P"M>N^$\?\
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M-AX<U.[L_FN8+666)<;LL%)''?GM7F?PT\>^,/$?BEK'7+81V8MGD#BT,?S
MK@9/U/Y5T6A>-]4OO!NM:EJ6E"RU+3$D:2W=&520F]>#R 1CK6%\.?BKJGC+
MQ,VEWUC9PQK;O-OM]VX$$ #DGCF@#TC6-=T[0+'[;JMY':P A=[YP2>, #)/
MY5#X>\2V'B>UFN],E:6WBG,&\K@.0 21[<CKCI7@?Q;\0>(]6D6RU;1?L>GV
MU[(+2X$;J9\9'4\'(YXJ3X;>+?%^DZ''9:+X;-_I[799[CR9&*D[0?NG' H
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MBOR2QJ=H5^PPW/<=: */P&?4K2_U:PFMYHK9XQ<'?$5/F9 QD]1@FN'TR?\
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MN4'7K\O6O9EW8R<?2O&_V>B!H&LY_P"?I/\ T&O91TH R_$W_(J:Q_UXS?\
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MG@5])3V\%U \%Q#'-"XPT<BAE8>X/6HK+3+#38VCL+&VM48Y98(E0$],G H
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MW/[F%59NNQ0,X]:L444 12QQ3?+(BNH/*L,BEAB2)2L:*BYZ*,"I" >HS10
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7,_$/\ Y)UXA_Z\)?\ T$UTU<S\0_\ DG7B'_KPE_\
M030!\W?"C_DI^A?]=7_]%M7UL.M?)/PH_P"2GZ%_UU?_ -%M7UL.M "T444
M%%%% !1110 4444 %%%% !1110 4444 %>+_ +0__(&T3_KXD_\ 017M%>+_
M +0__(&T3_KXD_\ 010!R?P!_P"1]N?^P>__ *&E?2E?-?P!_P"1]N?^P>__
M *&E?2E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S/Q#_
M .2=>(?^O"7_ -!-=-7,_$/_ ))UXA_Z\)?_ $$T ?-WPH_Y*?H7_75__1;5
M];#K7R3\*/\ DI^A?]=7_P#1;5];#K0 M%%% !1110 4444 %%%% !1110 4
M444 %%%% !7B_P"T/_R!M$_Z^)/_ $$5[17B_P"T/_R!M$_Z^)/_ $$4 <G\
M ?\ D?;G_L'O_P"AI7TI7S7\ ?\ D?;G_L'O_P"AI7TI0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %<S\0_P#DG7B'_KPE_P#03735S/Q#
M_P"2=>(?^O"7_P!!- 'S=\*/^2GZ%_UU?_T6U?6PZU\D_"C_ )*?H7_75_\
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M]))TQZU@^"G(\"Z"6P!_9\&/KL%:<VIV,-\EE+>VR73@,D+2J'(/3"YR>AH
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MHK/;6M,2^^POJ-HEV6""!IUW[B 0-N<YY'%6RSJHRPR3V'6@"6HF=$#-(P0
M]6.!4-W?6^GP^=>7,,$60"\KA%';J:Y+XFS17/POUJ>&:.6"2!2KJP8'YUY!
M% ';1G<@(((/0CTIU8&@WMO:>%]"26>&)IK6!(ED8+O.Q>%SU/M6ZK9[Y_"@
M!U%(>G%5K:^MKQ/,M;J&>+)7?$X< CJ,CO0!:HJE<ZK8VD\4%Q>V\4TQQ&DD
MJJS=N 3S5AI0J%MPQCJ> />@![<8.>!U'K2 DL#P!Z=ZYK61:ZRFEW$?B464
M$=TKHUO<+MNB#_J\Y^;/H,UF>/O'$/AO1C)IMY927YN$A:,RJ7C#=6*]>W>@
M#NZ@6:-P6C=74'!VG.#4-GJ=GJ2EK&]M[E5."T,JN ?0X-<!\))X[7PIJTT\
ML<4::M<[Y&8!5&%ZGL* /2QTI:KP7,5Q DT,@:)QN5DY##KGBI"Y SZ],B@"
M2BN \<^/E\/1Z?#87EE)<SZA';7'[Q2T"$Y8E>W3'/3-=?'J%KJ-E+)97<%Q
M&%9=\,BNN<=,@T 64FCD7?$ZNF>JG(S4XZ5YE\';J&R^&<<]S-%#$EQ-OD=@
M%7YNYKT:.82Q*\1!1AE2#P0>XH GHJ)I-J,[,J(HR68X '?\*C@O(KJW2XMI
MXIX6SB2-MRGZ$4 6:*9DY[8%037]O;21)<7$,33.(XE=PI=CV&>I^E %JBJG
MV^W:[-I]IB%T$W^1O!<+_>V]<?XU.&+*"#R?:@"2BJ=YJ-KIT FO;N&VCSCS
M)G5%SZ9/&:G2031)+%(K1NH964Y# ]"#Z4 2T55MKZVO%,EK=0SQY*[XG#@$
M=1D=Z9<ZK8VD\4%Q>V\,TQQ&DDJJS<XX!/- %VBHFE"INW#&.O0#WS45I>17
ML(GMIX9X3D"2)PRG'N* +5%53J%J+S[']I@%UMW^3Y@W[?[VWKCWJ1IA'&TL
MKA(U4L68@  #DT 3451?5;%;-;LWUJMNY 29IE"-]&S@U:WXZN,^AH DHKA/
M%'CZ#2]<T#3[&^L9$N[PQWCB96,*#&<\_+G/4^E=A9W]OJ%O]HL[F&XA.0)(
M7#+^8[T 6Z*I2ZG9P7L5E->VT=S* 4A>55=NW"YR:M"3G\<4 /HIA8CT('6H
M9[R"T@::ZGC@B3[TLK!5'XGB@"S15.SU&SOHVEM+V"Y16VLT,BN%..A([]_Q
MI9=0MH+F"VFN(8YYL^7$T@#/C^Z#R?PH MT55CU"UENYK6.YADN80#)"L@+I
MGID=1GWIT]W%;0M/<2QPPH,O)(VU5'N3Q0!8HJE)J5I&(&>Z@1;@@0LTBCS2
M>0%Y^;.>U658G/S9P<=* )**@EF6WB>2>541!EG8@!1ZD]A4=G?VVHVWG65W
M!<Q9VF2&0.N?3(XS0!8.2>HX.:<O2L#Q%8+>S:47UV72S!=K(%CE"?:B/^69
MY&0?2M:ZO;>RB5[B>*WC9MHDE<*,GH.>YH M452_M2Q%[]B-[;F[)X@\U?,]
M?NYSTIUUJ%M8Q>==W,-O"#M,DL@1<^F3WH MT5P?A+Q]#KFKZ]!>7]E!%;7P
MMK-#*@,BXQE>?FR?YUWE !1110 4444 %<S\0_\ DG7B'_KPE_\ 03735S/Q
M#_Y)UXA_Z\)?_030!\W?"C_DI^A?]=7_ /1;5];#K7R3\*/^2GZ%_P!=7_\
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M2KHB>&V&3)"X&[/M\HZ\5+\-'?4K+4_$;O<XU>\:6*.X^]'$I(0#VVXQV]*
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M)1_XMSKRCEC:MC/X5U,<T4T22Q2*\;@%64Y# ]"#W%<I\2B?^%<Z\>"HM&X
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MS7,$9MY)&8$RE'4;N!QG/2NU\'^';&WT#2;UU:XNWLH6\^X.XCY00 .@ Z#
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M2VMQ%/&(@N^)PXR'7(R.] #O!WA2U_X1'3WU3;?W=Q:)YD[Y!V$90 9^4JI
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M2XOOB7X*M;:Y%O)(TP$NW) P,_F,C\:I^*K+PQ9>.?!T>A6EC#.-44W#6D0
M/(&UF48W CH3D5;^)-\FD_$CP7>LDTB1-,6CB&6.=HS]!G)H ['6/ ^E:AX?
MGT^TA6TG,;B"X5F+1N<X8D$%L'L37$7&NS^(/@%J<]T7-S!&;>21F&92CJ-W
M3C/I7H6L>)M)TG0KC5I+J&6WCB=X_*F7]\5!)5#G!:O,X]*GTO\ 9ZU1;P$-
M=@W04J0R!W4A2".HQ0!V7@[PK:'PGI[ZGMOKJYM$\R9\CY"H*A1G"X7 R,'B
MJ'A>XFT+XD:OX6$CW%G-"+^VRQVVPS@ISDG.1SGM6SX(\065]X,TV9W%O)!9
MJ)H[AU5XE48W,,\*<9!]"*P?#Z'7?B[K'B2U;_0;*T&GANHF?.=R$<$#'//<
M4 6=+>/QUXOU&YEN)&TK1KG[-#9[2@>8#YW<Y^8 YP.!P*E\;::OAZT_X2K2
M)!97&G &:)%_=3Q$C<K(,#/3!'ZU7\+QVO@WQAJ^D7LDB+K-V;VSN90 DK,/
MFC!!X8'. <9Q5SXB7\%UH[^&+<27&J:JHC2WB +(@(S(V> H]_7B@#%^)5U%
MJ/\ P@5] 28;G5K>5,C!VM@C^=6_C7&Y\$6R1R%&;48%#8^Z?FYJG\1;)=-@
M^'U@DC2+:ZK;0AV'+!0HR?RJ_P#&=@?!]D <G^T[?I_P*@#?@\#:4=(DMKN(
M2WERBFZO4)6224#!<'/RG/.!Q[5C?"Z<ZUX*DM[^..=;*^EM4,HWEE3!!;/5
MOF/->@9&.M><_!@_\4KJ?_87N/\ V6@"K\,["UFU_P 9F2V@;R=8819B'R8)
MZ>GX5ZC7FGPWE2T\0^.([EA"_P#:CS;9?E/E\_/S_#[]*]*5E=0RL&5AD$'(
M(H 6BBB@ HHHH *YGXA_\DZ\0_\ 7A+_ .@FNFKF?B'_ ,DZ\0_]>$O_ *":
M /F[X4?\E/T+_KJ__HMJ^MAUKY)^%'_)3]"_ZZO_ .BVKZV'6@!:*** "BBB
M@ HHHH **** "BBB@ HHHH **** "O%_VA_^0-HG_7Q)_P"@BO:*\7_:'_Y
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M&"*YSPII=YI6GW.@:C$MQ:PNQM9=A*/"Q)"MDGY@<C'H!ZUUE% '._\ "&:
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M/(1G'/S <=#76*",\ 4ZB@!&^Z:SK_2-.U-6^UVL4A9-F\KA@/9AR/P-:5%
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M&&#6K10!!)&DD#1R@%64@CMCO532M'T_0;!+#3;=;>TCR4B4D@$G)ZG-:5%
M&+J'AS2-4E$MW8JTJL6!C9HRV<?>VD;NG>M&W@BMHO+@BBBC'\$:;1^E6:*
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ML-'L-,C\NRM5C!'+Y+.W?!8Y)'XUIT4 94FB:?)K":O+;(U]%'Y<<I))13U
M!.!VYQFG:OI&GZ]IS6&I6XGM9"I,1)&2IR.GN*TZ* ,0^&-'\S36^QJQTPDV
MC,S$Q$XZ'//3OFM.6WAN(FCEC21&^\K*"#Z<&K%% &!;^$M%LYS<0V0,O_36
M1Y%_[Y8D?D*N7^D6&JP[+RS67(X8Y5QWP&&"/P-:=% &/I?A[2M#5C864<#N
MQ9G.7;)P#\S9..!WKF] TN^O/B9KGB"^LY+>")!9VB3+G> 1^]0GH#CMZUWE
M% !4)17!# '/!R/SR*FHH P&\(:&UY]J-C^^W;L"1@G_ 'QG;CVQ6G]EA>T^
MSM;P^3C!C:,%,#H .F*N44 85AX6T32Y6EM;")')W?,S,%).<J"2%Y)Z8JUI
M6C6&A60L],MDMX-[.4!)&3U/)[FM.B@#(U#0=.U/<;NSA9F(9G4%'XZ?,I!_
M6FGPYI)\/OH8L8AII7:UMR 1G/)SGMUS6S10!5@@BM;2*VA4)%&@2)1_" ,
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M&X8H ]?W'J,\],\4NXCJ>E<N-%UF>V%Z^N3Q:BPR(_*!BC!'*&/.UB.FZH_
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M_>*.4Z5O^%]-AT?PW;7;ZA=NCV<;/]JN2R1C;GY<\+UH Z3=D?>QWZTA=LY
M; /85Q&C2:MXS@?5+FYN=.T>8AK"WM9=DSK_ 'W=>Q'\/^%6;/5-6T7Q/'H>
MM21W-I? FPOP0K?*.8W!Y+>A&<YH ZX]<X'OCK0K$8!X'K3R@8=3[>U<;=WM
MYH_Q+LX)9I6TO5;5E!GG^2.=,G"+ZD;>/>@#L"7"YXSUQ1DLO4@^U<EX_P!3
MOK72;:PTMF^W:C=);((Y?+D5.69E^@7'XU)XEU6_TJWL-$T55N-7O/W4#3R
MB-57F63NP R>G)% '5;\*#R<G\J;O)8 'MG&*Y6[T/7;:QDOM/UFXEU;:&:.
M=R8)/51'T3/8CI^-/TR^B\;Z!#<M->Z;/"[QW,%O=;'CD4E64E2<C()'M@T
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MZ]N37H=K";>SAMR=WE1A!CN ,5A^&_"R^'+W69UN6G_M2\:Z8,N-A.>/<<T
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M\7WO@[Q%.+RX@@^TP7HVC?'D !@!UY_GG-=1?:1J)O)+NPUJ>T:0C<DJ>?&
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MOHA-:W";)$(Z]\_48S6/H'AV^T<10W&MW%]:VZE+>)X]A53T#G)WX& ,],4
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M3]-UV>#3HP$$4L(EE"8Q@2$Y'MQQ0 W2/ ^G:5X7U+1$>:\AOI)))FN6&7+
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MJDMSKFIW2QQN%V%AQO\ +YPF!M[]2?6N\LH#:V\4!DDE\M0OF2/N9L#J3W-
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ME<)/%$XA4;U/7Y4!Q7<5@V.CZA%>K=ZEK,UX\9/EI&GDQX/]Y03N/OVK>[4
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M=V]* -6BH]QPQ+ #V'2N8G\;V3:D=-TJVN]5NP&#_94'EQ%<?>=B!_%VST-
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MF.,=CSDT9;.?TH ?13"6S@8YZ<TF3CYL GT- $E%,.<9!S3Z "BBB@ HHHH
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M/B3S\.M>!X_T1N?2L_1_$=EX>^&?AN2X;][<VMO;6L?3S9&4!1GL.Y/8 ]:
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M#_,5Z90!C>*?^13UD;@/]!GSGO\ (:XKX=>+?#VG_#[1[:\UK3X9XH#NA>=
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M6:=;=#)=G)(9,J5"#[O3.5-;NB>)-1NO$NJ>&-9%O!>P0B6W>U0X>,\;\MD
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MOEGCU2<LAZ@';C(_"@# ^+$OB#1_!MQIUT&U.PN&0+J!0"2)_,!Q(% 7;V!
M':O6],3.CV0)_P"6$>?^^17$?&=U'PRU*+< 6>$*-V"?WBY_*NXTG_D#V/\
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MAFB@)Z^7MY&3DXSCGBK^A^%K;2+R[OYI9;W4[MLS74X&[;V1<<*H]!BNAHH
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MQTOAWQ#>:<VCW&M*M@5V-=1(1=.,="?NCTR #^.:Z'3=*M-&T^WT_3[=(;6
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M/4\8S^==Q9VK6MC;PL=S11*AV\ X&*MT4 <KX5\+W'AW4_$-U)<1RC5+UKI
MBD; <\'U/-.U'PIOU]=?TF?[%J@CV2@#]U=#L)1WQSR.?>NHHH Y*+PG/?ZU
M;ZOX@N([J>T!$%I$"+:-CT<*>2V,]<XSQBG^)/"T^NZWX<OHYXXTTJ[-Q(K
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MW]O<V*DF,:DKL\0)SL5EQE1VW9-=A10!GZ;9WEG9F.[OWO9BQ8R21JN,]@%
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M(V;'S(P&XG@_>)%=Q10!PL7@:]7QYIGB6;4VN9+:WDAF,PPTFX$ @+A% !'
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MUV^B_L^-PQBL@R&Y'I*3V]EP.373QVT*6PMTMXTMU7RQ$% 0+TQCIC':K-%
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MA9N7MKA!)&Q4@D'V-6ZX3X91:PGA#19+F_MYK%[)3%"EL5=.F,ON.[OV%6?
M'B>_\2QZX;_R<V.IR6L9B0J"BXQGGKS0!V5%<;XD\3ZAI7COPQHUL(?LNI&4
M3[URWR@$8.>*WM5O]0M88TTZP6[NI"0HDD\N,8Y.YL$CVX/- &I7)^+_ !1<
M>';_ $"W@@CF74M06UD+[OD!QR,=^>]9FNZYXL\)1QZI>_8M3TH'9=+%$8'M
M\D8?.6W*.0>G451^)<\5SJ'@.X@=9(IM7A=''1E.T@C\* /3%Z9SFJ]_>Q:=
M83WMPVV"WC:61L9PJC)/Y"IV.WN *Y+QW%J\_AK5#97UO#;I83>?#);%VD&T
MYPVX8R..AH DT#7=8\1Q66JVMO:6VD7'(6<EIG7^\-IVC/H>>*ZNO/\ X7P:
MM'X.T::;4()-/-K^[MTM=LBG)Y+[SG'TK7U3Q1<_V]_PC^C6JW.H;=UQ,Y(C
MM%(X9N/F/(PO&?44 =317&W'B35/"]W:Q>(A#<Z?.2K:G;QF-8G.-JO'DX!Y
M^;=^%1?$+Q;J/A>+19+%$?[7J"6\J&/>SH>H7D88]J .WHKGK2XU^26:\O3:
M6ELD3;;-5,CDXR&+\8]"N#TZUR?@;QGXE\;Z"&MX[.WN(Y&2XO'C.U.<KMBS
M\V1P?F&,]Z /3:*\^N?'VJ:?K8T"YTJT?5G\KR%2[.R969@6)V?+C:"1S][K
M4^JZ]XH\-H-7U--,FT@A3<(C,CVNYU48;!\P#/7"Y]* .ZHK(U#4KX6D#Z18
MK>R3C<C/)Y<:K@');!/.>!CGVKEM:\0>*?"/D:AJ L]5TAW$=Q+#$;=K7+ !
MSRVY>W;DB@#NKNXBM;62XGE6**,;F=C@*!W)]*KZ9J,&K:=!J%HY>VN$$D3$
M$$J>AQVKDOB*NI7W@G5;FRU*UCTQM/9GC:V+M(""<AMPVY&.QH^&D&KIX4T:
M>ZO[>:QDL4\B!+4H\?3&7W'=QGL* .[HHKF-9\4S0:Y#H.CV9O-2D7?*2=L=
MLG]]SCZ8'?U% '3T5QEYXBU7PHT#^(#%>Z;*V)=0MH3$+;/3>F6^7_:S^'%7
M_&FNW.A>"]0U>P\LS0Q!XC(NY>2!R,\]: .DHK@M%U[Q3XDLK/5;#[#!8M;*
MPBGC;S+J4??'_3)20<'YN,'':M;PAXL?Q-#>I<6@L+^QG,-S:>9YC)Z$G ZX
M/Y4 0>"_%=SXH?7$N((X1I^H26B>7G+!>YS76@\5XWX/NKZQT'Q_>:7)&MU;
M:K<3+OB,@;;DE<9')QBO4- UB/7="L=3@#+'=1"0!UP1ZY&>.: -6BN4\+>(
M[GQ'KFNE&VZ;87'V2)'@VNTB@;VW;CD;@P'%=43@9H 6BN<NKCQ'?W4D=BMO
MI=LCE4N+J,S/*0<']V"-H[@[CD8X%9OAOQ9JEUK=]X;UVU@M-7M8A)%)&Q*7
M2$GYU7' &!QF@#H[S6+*SU2TTZ6<"[O"1#%W;:"Q/L  >?PK07/>O']=L_$0
M^+?AF.36;)K][6?RIA8D+& K$Y7S/FS]17J^FI=164<=[-'-<J,221Q[%8^H
M&3CC'>@">>58+>25@Y5%+$(I9B!Z <DURUSXONQ:R7EAX;U2\M8Q\[%/)DSW
M C?#-VZ"NL;.W@UG7>L:=IT,TMY?0PQP#]YN<9'OCK0!#HWB"QU^"66PE8F&
M3RI4D4HZ,.H93R#QWK8KSCPI%+JGQ&USQ)9HR:-);+:QR.I7SI%(W,%[C@\]
M:ZW5&U[^T=*_LH6GV(S'[<9L[O+XQL]^M $VO:[IWAZP%YJ4VR-G$:*H+.[$
M\!5'+'V%9$GC%=/>-M9TV?3+6=E2"ZF8,A)Z;]O^K[??Q6-<_9]?^,L-C=Q-
M_P 26P-S$5?Y9'<J 2N.P8UV>MZ7:ZUHMYIUXK&"XB*-M.",CJ/>@"[ECC'*
MGO7-'Q@EY=W=KH6GSZM+9OY=R8G6-$. <!VPK'GD Y%<?HGBEH?@;/J7DEWL
MH&M"#)R^"$#9QQUS^%=QX*TJUTCP?I=O;!MKP+*S.<LS.-Q)/?DT 6=%\0V6
MOQ3O8RMOMW\N:&1"DD3>C*W(]O6M/YR>0,=\$UY[J[0:'\9-'DABD:36[26"
M8!\*I3:P;&.>A'XUZ(!E<<@]\4 <OXE\9#P_K>DZ3'ITU[=:GO$*I(J %<<$
MMP.M$WB]M+>-O$&ESZ7!*ZQ)<-*LL>\G@,4)"#GJV!7/>-N/BQX$]-UP<>IV
MBM[XA7=G!X#U=+R5(S/;211!ADM(RD* .YR10!+XT\8VW@[0H]4N8)+B-I5C
MVPL <D$@\_2M;1M7@US1[/4K1U>"YC$F4<-MXY4X[@\'WKR?Q3;7=I\'?"5G
M>PE;A+ZU65)#D@X?K[UVOAGR]"\2ZUX>W3K"TGVZR67!7RW ,@3&/^6A?B@#
MLL@ G<?PYS7'0?$73[OXAMX1MXFEE56)NHY%:,%4W,..A!!!]Q6[K^K1:)H=
MU?SEBL2?( H)9CP !D9YQ7FVGZ8VE_%3PC%(C1W%QI]S<W2MC/G2;W<?0,Q
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MK]E\TMA/LN[;M]]W.<Y_2M*J5C%=1VD2WLZ2W"_?>./8K?1<G'YU=H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9^(?\ R3KQ
M#_UX2_\ H)KIJYGXA_\ ).O$/_7A+_Z": /F[X4?\E/T+_KJ_P#Z+:OK8=:^
M2?A1_P E/T+_ *ZO_P"BVKZV'6@!:*** "BBB@ HHHH **** "BBB@ HHHH
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M?\,:CIGQ#\3:Y/Y7V/4A#Y 5LM\JX.X=J ,NP&/CWJSG(_XDR<DG'WDKH/B
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M>?I0!B?$,>*/^%>ZPUX-*2V,(+^4TAD W#@$\9K.\4C.D_"[@_\ 'W:>_P#
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M-%V3;EW1W,8_@89&#G&&[>AH =X\P/A]XA)&1_9TW3@_</%<CK/VQOV>G_M
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M%OG,NHW$IGNY,AMTAZ\X' [4 8'BV'6/%'A>\TB;PA<*9X\19OH %<<J>'Z
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M%>9NN 3P![GC\ZUATXKE_%GA2;7+[2M5L;M;?4M+D9[<RQ[XVW#D,,CT'.:
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M KQ?]H?_ ) VB?\ 7Q)_Z"*]HKQ?]H?_ ) VB?\ 7Q)_Z"* .3^ /_(^W/\
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M:>?$J^(3&3J @^S*_F''EYSC;TSFMFBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "JM_ ;FRG@7 :6,H">V01FK5% '+_#_PY<>$O"5KHMS-
M'/)"TC&6/(4[G+8YY[UU%%% !1110 4444 %%%% !1110 UL]L?C63JN@:?K
M%[IMW>PL\VG3>?;D.1M?CGCKTK8HH B&?XNH/&*EHHH **** "BBB@ HHHH
M**** $;[IZ?C61<Z!87>O6FN3Q'[?:(T<+^80%5@0>!P>":V*,#TH .U%%%
M!1110 4444 %%%% !1110 4444 %-?(7BG44 <QXKTC6M<L&TNQN;.WL+E/*
MNY)%9I=C'#!!C'*G'-:FDZ9;Z-I5KIEFFV&VC$:!B2<#W-:=%  .E%%% !11
M10 54NOM9MI?LAA^TA2(_.SLS[XYQ5NB@#D?#OABZL=;O]=U:>&?5KT>6Q@4
MK'%"#\J+D#/0<GFNL3T   '2G44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5QWCGPI<>*H](2VGB@^PZA'=,9 3N50<@
M8[\UV-% "*2R@D8]J6BB@ HHHH **** &,Q#8QQCKGI7*:_X7N]6\9>'=9AG
MC2#3&E,T; Y?< ./RKKJ* (\D8 &1_(5)110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,_$
M/_DG7B'_ *\)?_03735S/Q#_ .2=>(?^O"7_ -!- 'S=\*/^2GZ%_P!=7_\
M1;5];#K7R3\*/^2GZ%_UU?\ ]%M7UL.M "T444 %%%% !1110 4444 %%%%
M!1110 4444 %>+_M#_\ (&T3_KXD_P#017M%>+_M#_\ (&T3_KXD_P#010!R
M?P!_Y'VY_P"P>_\ Z&E?2E?-?P!_Y'VY_P"P>_\ Z&E?2E !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5S/Q#_Y)UXA_P"O"7_T$UTU<S\0
M_P#DG7B'_KPE_P#030!\W?"C_DI^A?\ 75__ $6U?6PZU\D_"C_DI^A?]=7_
M /1;5];#K0 M%%% !1110 4444 %%%% !1110 4444 %%%% !7B_[0__ "!M
M$_Z^)/\ T$5[17B_[0__ "!M$_Z^)/\ T$4 <G\ ?^1]N?\ L'O_ .AI7TI7
MS7\ ?^1]N?\ L'O_ .AI7TI0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %<S\0_^2=>(?\ KPE_]!-=-7,_$/\ Y)UXA_Z\)?\ T$T ?-WP
MH_Y*?H7_ %U?_P!%M7UL.M?)/PH_Y*?H7_75_P#T6U?6PZT +1110 4444 %
M%%% !1110 4444 %%%% !1110 5XO^T/_P @;1/^OB3_ -!%>T5XO^T/_P @
M;1/^OB3_ -!% ')_ '_D?;G_ +![_P#H:5]*5\U_ '_D?;G_ +![_P#H:5]*
M4 %%%% !1110 4444 4[NZ@LHA)=310Q$XW22!%!],GN?Z4Z"\@O81+:S1S1
MM]UXV#*?;(KP?XQZA>^)/&]AX3TQDE\I<A5D(S*>JMVR !CCC/O4_P #-8GL
M=9U+PS?$0D@R)#*2'653AD [8&21CM0![=?ZA::3IT]_?R^3;0KYDCL"VP?A
MFJ6@^*=#\3PS3:->K=1PG9(5C9=I/./F K,^(Y'_  K?Q ,YQ:-7"_L\?\@/
M6O\ KY3_ -!H ]$TOQQX9UK5VTK3M32>^3<6B$3@C;P>2N.*Z.OF[X2?\EEO
M/]VZ_P#0J^D: "BL3Q)XFT[PGI;ZGJDLB6JNJ'8FXY/3CTKF6^,G@X:='?#4
M7*O(8Q"(\R C/)7KCWH ]!HKG_#OB_1?%4+-I.H)+(J[I(3Q)&"2!E>W2HI_
M&NEVOBR#PU,TW]HS#<JB/*\@M][Z T =+17*Z?X_T+5/$TN@V=P\UY$#O94_
M=\=?F]1577OBCX6\/7GV2ZU#S+@,5=+=?,,9'4-CH: .THKGO#?C/0_%D DT
MB_CE?;O:%CB1!DCE>HZ56\5>/=&\'26L>K23(UT&:,1Q%_NXSGTZB@#JJ*X"
M^^,/@^P>!6U!YC-$)%6"/>0#V..C>U=9I.NZ=KEHMUI=Y%>09VF2)@0I]#[^
MU &G17+>*?'^@>$)(8M5NV2:496*--SD>N/3M1X<\>^'_%9":5J :<[LP2C;
M)@8R=OIR.: .II",C'/X5SWBGQCI7@^TMY]5DD6.9_+0I'N.0,U4UWXB>'O#
MUS:6U_=.9KM0Z1QIN95.,%AVSG]#0!/J'CCPUIFN+HEWJ:0Z@SH@@,3DEGQM
M&0N.<COWKI1TKYN\?9;X_P!M@8 NK$Y_[]U[%8?$CP_>^)6\.B:X@U,,4\NY
MA*?,/X?J>U '845D^(/$%EX9T>;5=1=UM8BH?8FYOF( P/QI?#WB"S\2Z4FI
M6"3BVD)"&:,H6'J!W'O[&@#5HI#TXKD/$'Q+\,^&[D6M_J&;C<4>*!=[QG /
MS#MUH ["BL'PSXMTOQ;8R7>E3[TC?8Z,,,A[9';-9LOQ*\/0^*_^$:>6?^TO
M-6$*(3MW$ ]?QH ["JFIW]KI>G3WU[*(;6!#)+(03M4=3QS63XH\7Z9X.L(+
MW5I)A%-+Y*^5$7);!;I]%-9'B;6K7Q'\(]7U33F9K6ZL)3'O3:V!D'CZ@T ;
MGA_Q3HGBF.:31KY;H0$+(51EVD\C[P'I6Y7SY\&_$NE^&/#>OZAJLYAA6>%0
MJ_,SL0W '<_T!KU?PW\0_#OBR1K?3;W_ $@$CR91LD( SD*>H]_:@#K**Y3Q
M5\0-$\&SVD.L23HUTK-'Y41?A< Y_,50U;XL>%=&FBANKZ0O+"LP\J/=M##(
M#>AP0<>] '=45QLOQ-\*P:%'J[:K&89@3'$/]:V,9 7KD9&12^&OB3X=\5ZD
M=/T^[<704N(Y4V%QWQZD=Z +J^./#+>(/[!74T.I^88OL_E/G<.<9VX_6NA'
MWL!N/2O'(;?P/_PN<RK?:M_;_P!N8^48U\CS-IR,XSC'O6=\4?BK%/$-)\.7
M]U;W,4\D%Z?+V@J,J0"??/3% 'NR],9SCVI'XP2> >GK7DW@+XI:%%X0M[.[
MN+M[S3K$RW1,1;@, 2#_ !?>%<)XH^)TNJ?$*SN+;4[L>'[>Z@E6$)L("A?,
MR!R<D-P30!])J26!R![4^L'PSXGT[Q7IS:CIA=K99&CW.A0[@ 3Q^(KG]5^,
M'A#2-2FL9[Z626$[9/L\6]5/<9]1T/O0!WU%9FE:YIVO67VO2[R.YA!P7C((
M!QG!]^:Q?$GQ%\.^%9Q;ZC??Z23@V\0WR 8SD@4 :?B'Q7H?A=+=]:OUM!.6
M$19&;=C&?N@^HK0L+ZUU&TAO+1_,AG0/&X4C<",@\UX)\:/$6F^*/#WAW4=+
MN!- TMPI!&&0@1_*P['_ !KV3P)SX!\/GN=/A_\ 0!0!T-%%<9KGQ.\.>'/$
M/]BZG<3177RY(B)0;N02U '9T5P3_&#P:-4.GC4V+[@OGJF8N>^_ICWKH=1\
M4:9IWAI_$$ER)-.C19#+ -^Y6( ( Z\D4 ;E%<==_$GP]9>&+/Q!<7;+:7A/
MD*$_>/@D'Y>O:MF'Q#ITOAR'7GNT@T^:)91-*=@"GIG/3K0!L45Y[#\9O!TV
MH"T%_*N9#'YK18C!]=W3'O7;6^H6U[8+>VDPN+=T\Q'A.[>/;US0!<I&SBN2
MT'XBZ#XCU:72[.XECO(R08IXBA.#@@9ZD8.:CU[XE:!X=UI=(OGN7O&1658(
M"^[=T ]Z +^N>-/#_ARYCM=7U);2:6/>BE&)89QG@>U;B2K*BR*QVL,CW'K7
MD'Q6B\%7NKZ=/XGN]6M;@V8>*.VB'"%C][(.&SGBO6HY88;!'+8@2('>_&%
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M $_7]H&#%#@GKU:@#WVBN2\2_$/P]X4F6'4K[_2>,V\*[W (R"1U XZ^]/\
M#/Q \.^*V\G3=0!N<DBWD^60@ $D+Z<]: .JHKGO%/B[3?"%A#>ZJ\J0RS>2
MIC3<2V"?Y U@S_&+P?;6%K=&_DD%P2!&D6Z1,''S+_#GM0!W]%8F@>*-+\46
M7VK2;R.9 !O4'YHR1T8=C4?B?Q=I'A#3EO-6NC&KMM1$7<['V'>@#?HKB?#_
M ,4O#/B754TW3[N073J642Q% V.H!]?:KWBCQ[H/@^2"/5KMEEF&5BB3>^/4
M@=!0!U%%<QX;\=^'_%0(TR_#3*&)@D&V3 QEMOIR.:Z,.V?4'I^5 $E%8WB'
MQ!;^&]'DU6^2=K6,@.88BY0'N0.@]_>H_#/BK3/%6F?;]+G\Z$/L8$8=#Z,.
MW'/TH W:*X34OBSX8TK7IM&N9[K[9%-Y+!8"P#<=_3FNIU;6;+0M,FU'4+CR
MK>%"[$]_0?4] /6@"QJ6H6FE:=/?W\HAM8%WRR$$A1]!S6?H7BC1/$\,D^D7
MJW<<3;781L,'\0*Y^_\ $OA[QA\.=5OY+BZ31BK13R)'MD&,$[0<^HKG/ >L
M>"O"?@[5]3TF_P!1ET^*Y3[0US$-X8X P !D'- 'K)P2"2./:LK7O$VC>&;:
M*XUJ]6UBE?8C%&;)QG'R@^E?/]]\4);SXF6FJ2ZE=MX?M;S?%"%VE8\#.5'+
M<]CFNA^,?B*P\3_#[1=3TPRM;2Z@R(73:V55@>/PH ]LTK4[+6-.AU#3YA-:
MSC='(%(##IT(![5<KR3PK\0O#WA#X>>'K74[M_/DMRRQ0KO<+O;D@=!U_*O1
M/#_B32_$MB+O2KM+F(@%L'YHR1D*P['VH UZ**XOQQX^T[PE;O:W4TL5Y<V\
MC6K1Q;_F P"?3DB@#L"=K')SG]!6)KOC#0/"\L$>M:DEK)."8P8V;< >?N@U
MX?\ #?XGQZ?J^K7OBC4;NX>[6-4.PN-PSG@8 XQ5S]H)BVJZ%A06,$I(ZC[R
MT >^6MQ!=01SP-NCE4.C;2,@\@U/7G!^*'ACPU8Z=IM_>R&X6RA+^3'O"$J.
M">Q[_0BNVTW6;'6+07>G7D-U;%B@EB;()'49]10!HT5RWB?Q_H7A&6WAU2X<
M33C*Q1)O;;_>(]*?X;\=Z!XLW)I=\K3[2WV>3Y9  0-VWKCD<T =-4=Q-';V
M\DTS;8T4LQQG ')IRYQS5?4O*.EW8N&983"_F%>H7:<X]\4 9.@>,_#OB>XE
MAT;44NY85W.%C==H/&?F KH*\B^$,'@V#5-2/A>\U2><VZ>:+U H"[N,8 YS
M6]9_%_PC=W4UN;^2%HE9BTT>Q3M/(!/4^@H [^BN'T/XK^%?$%X+.TOC%.Y"
MQK<IY?F,3C:N>IKIM6UJPT*P-[J5Y';V^=H>1@ 3@G ]^#0!I4C<*:X#2/C#
MX3UK4K>PM;R5)[APJ>?$54GLN?4]![FH/B5\1[/PO8WVDPW,\.MR6XDMF$65
M7)XR3QV- 'H7W>K!B>G%2]J\"^%/Q(M;-KFTU^]NI[_4[U?);87&YN/HHR>U
M>K7_ (XTG3?%=IX:GED&H785H@(R5(;('S?\!- '3T5QLGQ*\-Q^(9]$6]>6
M\@21I/+3<JA%+-R.X"GBK'A3Q]HGC)[I-)EG<VNTR>9$4^]G&/7H: .JHKC]
M7^)&@Z)XFCT"\DG6^D:-5"Q$KE\8Y_&NDO;^WTVRFO;R=(;6!2TDCG  '?-
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MW.H2@&7RQ-Y7[OKC);IM]Z /1**JV%];ZE9PW=G<1W%M*NY)8SE6'J#5KM0
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MB3P1I5_KD^J6NFSW >W,<.V1CL;!((/RD9YH ]$TO5+36=/AO["836TH+1R
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M+^PN(/#T6THEQ]TQJ?F167!8E@W.>,U+^T-$$NO#\8)5(X9L!?3*4 =CX?\
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MASZ?<6M[X#^&=1LIKS7KJ*6""XMUCB66,J)5)#!U/I@?K6/\2=+U?PI\3/\
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M4]$O[N_T^VN9[:RE\J65 60[2>/3IFNGK/U.U>^TRZM%<(;F!X@Q&=I8$9H
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MXH>)M/CT#P\VGQP 0W&R,,J;G^^P0#@9KW_Q%H;ZMX)O=%CD_>R6ODA]N<D
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M<_HOQXFL]+M[?5]'FO;^,;7EB<('QP#MQU/>N\^(^E7/BWX;2?8U<S&..\6
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M\P^1+\2OB'9WNBZ))IUC$8HYB(@4A8$MN;: !G&*^GJ ,+QCJTNA>$]3U*!
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MX7^&/AVX^'UG!<6-M-=WEGO%ZT"F1#(NX8/^SNP/I7,?M%?Z_P ._P"[<?\
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MWS:9:8$D\1(4+D;WR<CU"G'.1ZT 8?A6UU/XI>-;$:H\1M+"%(Y@K"/,2\@
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MM[9,E8HT  R<G]<FKM-S@\YIU 'R]X>T2P\0?&^\TS48?-M'O[N1H\\,5+L
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MAUKY)^%'_)3]"_ZZO_Z+:OK8=: %HHHH **** "BBB@ HHHH **** "BBB@
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MU)10!76V0-DHA]/D YIQC1CEHU)'3*YJ:B@")@2!VQZ4QX4D(W1@XYY6K%%
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M9P" >O(K5CZ=<CL?6@!JKE<$ <\@#C_.*:L:;PYC0-G.<<_G4]% !4;HK\,
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M72M/'Y/FO*J1!=QDWX 'KGICWKYN>3X3_P#")_9%FN#K(MP/M4<<HWR^N&X
M)XZ<9JWX:U_Q#XC^%NN>&[ RW=Y9A2.C,;=L@QC/)/!]^<"@#V&;XC>$H+]K
M&37[87 ?RROS'YLXQG&/QS74*^Y%93N5AD,#QBOFCX>'X=W5D-/\46NS4%E.
MRYDE=(RN">2" N,8YZDU](60MX[*WCM&!MTB3RMIW9CQ\N#W&* ,O5?&?A_0
M]0CL-3U..UNI,;$D1N<].0,?K6I>:A;6.F3:A<3JEK#&97EZ@*!G/Y5Y/\>M
M"-[H%GK$7G226DIC(095$;JS>F"%'IS57Q#XIF?]GRRG:2"WN;R-;01#_EK&
MK%& #>JC)(Z9H ]+T?QMX=\0WC6>DZK'<W*)O,:JP.T$9/(]Q5C7/%6B>'5A
M.KZE#:";.P/DEOP&:\-T&PN/ /Q,\.1S(;*&]LHX[J9VS'(2"6 8\?>"=/;U
MK4\>6@\:?&O3- 6TW16BQK=!G \R+/F,01R/E8C\* .A^+6B^'==ET>37/$B
MZ3Y22-"/LYD\X';D\'C''YU+\488(?@>D-M-Y]ND=HL<N,>8H*8;'N.:Y7]H
M:)(KGPXB# 6*<#GL/+XKH_B)_P D L_^O:R_]DH YSPQ_P FW:]_UUE_FE;7
M[//_ "+6K?\ 7VO_ * *QO#'_)M^O_\ 767^:5L_L\_\BSJW_7X/_0!0!ZSJ
M?_(*O/\ KB_\C7SU\"+RTT[6-=O+RY2"&*QW/(YP H8<^]?0NI?\@J\_ZXO_
M .@FOF#X1>%K;Q3XEFMK\E[""$O/!O91+SA1E2.C8;\* /HC1O&GA_7Y&CTS
M5K>Y=<9495CG.,!@,]#TK<:01HTDCA449+'@ ?6OFWXL>$[7P1K>EZEH8^S0
MS#Y8EE?<K(<D[B>^X=/2N@^+'CF_;P=H5K S6KZM:I=7#1<+M('R<\@9(_#@
MT >E0_$;PC=:@MC'K]N;AG\L)A@-WUQC\:Z9)UFC21&5D89#(V0<^A[BOFVR
MD^%"^%$M;R:X.LF [[N*.7.\]P#\O'3IBNM^!'B>YNX;WPY<N\JVJ>=#O;/E
M)D#;Z]3^% 'J>M>)M)\.012ZO?+:QRL55W1B,CZ XZ]ZMV&I6FJV,%[I]RL]
MM,H9)$.01_2L/X@:#_PD?@G4M-2%9K@QF2!2VT"0=#FN!^!_B:!/"6I6%P85
M&FEK@(I_>-&02[8[@=,B@#TG_A,M &O'0_[40ZGO"?9PC%@2 ><#'?KFM.]U
M"VTZV-Q=W,4$8_BE; XY/Z UXE\'=-?5?'&M^)IFN6B5G%O,ZG;)O)R"3U(4
M+QVS69XNO9_'OQB@\-RSO'8VUR8/)=OER@)<_+CE@I ],T >QV'Q!\*ZI>"U
ML=<MI9R"0K%D''N0!6CK/B+2_#MLEUJU\MM [B-9&!(W8)QP/8UYIX_^%7AV
MQ\&ZA?Z-9"SO+6/SO-,LCY5>2N"<9([TWX:R6/Q'\%-H_B*"2_73)UVO)*1D
M%6V\@@G R.2>M &+X=^+%W=?$=I]<UE8-"B$T<852L;C)V,RC.3[U[E9ZE:7
M^GQ7UK<K):S()(Y1T*]<\U\R^!?#6E:Q\5[C1;ZV\W3XWN D.]EQM)V\@YXQ
MZUZ#\8=9/A'PMIOAG0UDM89T*EHVSB%, ID\Y)8=^@- '<)\2/"4M\;)=>MC
M/YGE;1NQOSC&<8KIXY5EC62*19(V&0ZD$$>QKYMT8?"Q/"UO9:N\W]K"-O,N
MX8Y0%8Y(P,[<@$=1@XJ7P#X_O-+\)>)-*#27'V2U,]J96R(QN"$<<_Q@CTQ0
M![?J_CKPUHDP@U'6K:"1AD*,N1SCG:#CD5X?\69H+GXKZ;/!,LD<D5LP93E2
M-QQS5CX/>!M-\50ZCJFN1"[5)!$J&5PV\X8L2#SG-<_XX\/Q^&OB7#I]NY-K
MYL+VZ;F81H6X3+$].?SH ^K!T%>6_&#1/#VKOI)UWQ&-'\L2^5F R>9G;GIT
MQ@?G7J8Z5X1^T8,OX?Y_AG_FE 'JMOJ>D^'/!MA<7&H(NG06T*)=,I 8;0%.
M ,C/'YU7_P"%A^$_[+_M(:]:FU\SRB_/WO3;C/XXKC_'WS_L^VI/4VEETX_N
M5S?PB^''A[Q+X3N=2U:W>XF:=H4&\J(PH!R-N,D[N^>@H ]HTCQ#I?B"V6XT
MC4(;N)L\H<'@X/!Y'Y5K5\V_"WSM"^,]QHEI<-]E,MS;R;E!,BQABN>.#E0>
M*^CS( I8G@#.: ,?7/%FA^'-IU74H+;<=H#$DYQGH,D<4[1_%&BZ_$9=+U*"
MY 8JP0X(QC/!P<<CG%<!X[M/AO:Z]-J/BJ3S[^Y,:F!)'+Q@)Q\J$'! SDUY
M[X=O=#LOC1I3^#9I!IEX5BE25"<;B=RC=SC@4 ?2C.8T+LP55R69CP *Y.3X
MG^#%DDB/B" ,K;" K\'/8XKC?CKXJN]+TVTT6REDB:]!DG=2.8QQM]1DX_#B
MKGA'X.^&X] M)-6MFU"\D F,AE957(!"@ CCZ\T >ESZA:VMB]]+=1K:HF]I
MF;Y OKFN?M/B5X/OKV&TM]=@>>4[47:P!/U(P*\K^,.KSWGBC3?!=CFTL5,2
MM&I"QN7QMX'89Z=.*] T'X1>%=&MK1Y;#[7>P$,TTDC$._J5SMQ^':@#NIKB
M*WC:6658XQU9FP!^)KFH_B1X1EOULDUZW,Y?RPN&'S9QUQCK[UY=\:?$%]J/
MB>P\)6L\D%NS1^:5(*NSD;2<<X&>GTKK[WX-^&6T"6*WLEBU+[-M6Z:60J),
M?>V[L8SS0!Z1',DL:O'*KHPR'7D'Z5D:?XLT359[V&QU2"5[(D7'4>5CCDD
M5Y9\"O$]U+)?>&[J661($\^ NW$:@X*^N,D8[#%<;X:L9-?\=:[X82?[-!J=
MS)Y\RD[MB2,Q4=N0<<T ?0NE^+-$UN*XGTW4HIX[4A9FR55,],[L>E5K'QWX
M8U/5!IEIK5O+>%F3RQD%F'4 D8KP_P")7A^+X=:3#H6F75S+;:K)]HG>4X.8
MP0!D8!!WY(/<#%=QX?\ A%HLG@BUF:)/[=FM?.BOTDD7RY&&Y&P&_AR/RH X
MSX'X'Q)O@K 9M)LX_P"NB5[UK/B+2O#]M]HU;4(;5..7//)P.!S^E>!? L%/
MB->*S9(L91TY/SI7I?Q"M/ 2ZA#J7B^8.Z6PCBMA*=^W>?G"J0QY)![<4 =5
MH_C+P_X@=TTK5[>Y="%902IR<] <$].U3:[XFTGPU!%/K%\EK'*Q5"X)W$#.
M!BOG#5K[PK8^-M"U#P')-"%E"RI(C80Y !7?DG(+9^@KT']H4 >']&.,DW3<
MG_=H [RY^(OA2TM+2ZEURW6"Z4M$V"VX#O@#(_&MVQU.SU2U6ZLKJ.>%@&#1
MMD8(R/IQSBO(/#'PK\-ZE\,(]1GAE^WW-JTXN!(<QGT5?NXX[CO69^SY?W1U
M#5M/#_Z-Y*SE-H^_N SGZ<4 >TZWXBTSPY:"ZU>^BM87?:C-R3^ YJKHWC3P
M]XANY+32M6BN+E%WE%!!(]L@9KPI(IOBW\59;:\NIH;"#<4C/.Q$."HQQDD]
M?\*]MT+P'X:\-7K7>E::L-R5V%R[,0.^-Q./PH U-9\0:7X?M5N-5OH[6)FV
M*SYY/L!5?1?%N@^(<C2=6AN2IP54D,>/0X-?.NL^*+'Q3\3#=>)+F==%M)BO
MV?:S@(.-HV="3GGVIOBO4O!EI+8ZCX EN[2^@EW2*H<*!C.[+=><#'0@T ?4
MNXXW9_ "L%?&OAUM9_L;^U474=YC\A@RMN],D8_7FI/"FMGQ%X5T_5,,C7,0
M8AB,Y'!Z>I!KQ?XTZ8VB^-M+\2V\3NLFQF#K^[WQD%5R/89_"@#W/5];T_P]
M8&]U:\2VMMX3S&!/)Z#@&H=#\3Z1XE@FFT:_2\2)@',:D8)^H%>8_%J]NM=L
MO"V@V<L/GZHZR36P(ZD*4//*C)?GVJ/X;Y\-?%'Q#X<)%E82EY;2WDZR8;Y-
MI/S'Y,GKTH ].O?%.AV6M0:1<ZA%'J$^!';\EB3P!QT)QWKS?QMX>\+W_P 2
MH+[4/%(LM15[<BQ-N6+8(V_-GO6)X1M8O&/QOU?6OLQ^SV4N_P":3F.10%0X
M'7E3Q^=9OQ,X^-]GQ_':C/XB@#JOB=\5?L=K'9^%M7@^U&22*[98SNBQ@<$X
MP0<],UU_P\\::?X@T&PL_P"U/M>L16JR74; [@1@,22,'DBO,?C=X1T3P[#I
M][I=GY%Q>W$IN&\QFW]#T)(')/2O1?A;X2T73/#.EZS9VACO[NR3SY?,8[\X
M)X)P.0.@H \M^&LD,/QMOY9I51$>[)9CA0,MGFO;=+\>^&-8NFL]/URVFN%7
M<5.5XR!_$ .]> >$M!M?$?Q>O=,O7E%J]Q<O*L;E?, 8Y4D=CT-7?B]X4TWP
M3KNDW&A*]OYZ-)L+;@C(5P1G)YST/'% 'TJ&88)'7GBN(\??$"Q\,:5J%K;Z
MA$FNQPK);P.A;=D\>W3/>NKT.>6\\/Z;<SOOFFM8I)&P!EB@)/YUP?Q:\(:'
M<^%=6U^6SW:G! HCG\QN,, .,X[GM0!D?"CXBI>V]U;>)-;+:G=WP%K%(6/#
M 85>, 9R,5Q_Q?)_X7!9J>28[8K@9/WC6O\  WPEHNLZ?=:OJ%IYU]9WRF"7
MS&7;A58< X///-8_QEC,_P 6+: NRAX(%#+PRY8\@T >VW7C[PS9:S_9-SK-
MO'>[@GE$'[QZ G&!U]:Z"*9)HDDBE61''RLIR#]#7B?Q3^&V@Z!X%?5;%)EO
MH)(Q+,\A<W!8A26SGGDGC'-:GP]\3W&G?!6ZU2XWS#3FDCA50 0HVX'3L3WH
M [W6O&OA_P .W4=KJVJP6UPR[MA!8_H#C\:T=*UG3M:MDN=.O8[F%QN5D;M[
MCJ/QKYC\*:AX5O\ 5M2U3Q[<S7<DY!1 )"VXG.[*$<8XQ5NS\4Z3X5^)<%]X
M2N+M]$N-B36[#:.205^;MT(/7KS0!]15B0>*=&N=<N-&@U&)]0MP6E@PV5 Z
MDDC%; 9L<@<5\UZL]Q)\;=9TZTE6&34Y&L_/R?W8=5RPP>ORT >^:7XKT36=
M0N;#3]1BN;JV&94C!^4 X)Z8(SZ$UFWGQ&\*6.H36-SKMLD\)VNH#'!^H&/U
MKS/Q1X:MOA#X?N;S0[Z^EOM3460D<KB)?OL1@=2%(&/6N8\)2?#>+0"GBH2W
M&J32M(9$2;]V#C )4X)X)S[T ?2\%S'<0"6WG2:-OXXV#*/Q%4]9\0:7X>LU
MN]5ODM868(#)GD^P'->&_"#Q1'IWCNY\.6EQ<W6DW;2?9?,(&-N6#D8XRH/
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M0ZM;-8 .?.+8^[UX/.>#QBO-_"OPU\.7WPVMM8U"WFO+Z2R:82RSO\GRG:H
M.,#MQ7"_!WPK8>+=:O;?5VFFM+6(3+;ARJ,Y^7)QWQ0![WI/CSPUKE^+'3M7
M@GNBI81 ,"0,>H&>M;5[?VVFVDMW>3K#;QKEG<X %?-_C73;7P3\6M-B\/1_
M8TC$,@&2_P S$@GYL]JTOC;XEFO/%</ALW4EII]ML,YQE69L-NP.3A3T]N*
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MQ0!1U+6K#1K1[K4KR&WA12VYVZ@>@ZG\*S-*\<^&M;N/L^FZU;SR#DJ25//
MQN SS7B5JS?%/XO-#?RNVFVQ<BTD)PL:'!4;<8))Z]>E;WQ1^&^A>'_"?]KZ
M';_89[.5&=A-(68$A0 2W!R0<^U 'JOB+Q/I/AFW235;V.U,P?R-X)WLH'H/
M<?G7S7X5D\-^)O$VIWOCB],$<RM,&C9E!E+C(X!XP37K'AB#3_B9\.K.[\0V
MS7=UIIEA$C2E=[A5.[Y2.V!SZ5YQ\'O"^C^*O$&H6>LV?VB&*U\Q%\QEVMO4
M9RI'K0!]+6*6XTZW6V^:W$2B,GNN./TKYT^+,4E[\7DL%N)(EG^SQY4GY=V
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M'<%FB5PI]@1UI&TC3GLXK-]/MGM8SE(6A4HOT7&!0!Y=^T(0?".EX/2_!/\
MWPU=1\+HPWPNT8'.&@<'_OMJZR[TZPU!!'>65O<HIR%FB#@'\13X;:&V@2"U
MA2"&,?(D:!57V % 'SC<^']/^'7CVY_M[0FU+P[.K"W<_O/*0D$-V!;@*02.
MIYK2O/%OPWEMQ'HO@?[?>,P BE@$:[>^2"QX^E>]W-G;W5NT-Q;QS0M]Z.1
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M,ZJ=Q5E(V';_ '>Q^HJ[<_''2WT.:WL;.^_MQX-JJ]NOEF?;C&-V<9]J]?V
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ME>\6_A_1[.9)[72;*"13D/%;JK+],"K5Y86E_ +:\M8KB$D'RYHPZY'?!XH
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M%% !1110 5XO^T/_ ,@;1/\ KXD_]!%>T5XO^T/_ ,@;1/\ KXD_]!% ')_
M'_D?;G_L'O\ ^AI7TI7S7\ ?^1]N?^P>_P#Z&E?2E !1110 4444 %%(>G7%
M1\E]O) ZX/2@"6BH]PW<$D#K[&DW#AB3ZCGK0!+149)ZCN/RK@OBCHWB;6]#
MLX/#$T\5U'<EY#%<^22FT]3D<9QQ0!Z#17&Z5>7_ (0^&D5UKB3W%Y86S/<*
M91([X)/WLG/!%5OAYX[F\=1ZI<"T6W@M9PD(W$L5()&[W^G% '=T5\__ !IU
MK5]/\=Z?#8:C>P1M:1DI!<,BY+MDD XS7O*L2H5C[ B@">BF*Q)ZYIQZ'- "
MT5'EL#^=(201U^M $M%1 DY&2!UYH!.WG&[V/% $M%1;NASGGGF@-N;G[P'K
M0!+140+8Y(';-'0X8XXZYH EHJ($^N2>ASTI%8L3RP)Z9H FHJ+<=P ))-&\
MYQC!(Z$T 2T5'R "3\H]_P!:\XO?BEL^)%OX0M; Y-UY$\\A[$ @IC\>M 'I
M=%1_-D98C/H*9+*$C9SGY 20.,T 3T5YMX%^)[>-_$U[96]@+>SAM1*CNQ\P
MMD#![8Y^M>BL>0"V!T/- $E%19Z@D\G&1ZTY6)/7- #Z*0\#-1,_*Y)Y(P!0
M!-4$UM;SN&FAC<@8^= :>3SG)!%)N/.2./;I0 Y<9P.@]J?4708'8\]J,\G#
M9'3DT 2T5$6VL<=3UYH+!C@Y [<XH EHKY[^$>NZM>_$V^MKO4KZ>W6WF(BE
MG=QD.H& 3VS7OZD_@/O9ZT 2T4P$D@@?+CO3Z "BHRQ/0]* 6/?(QVH DHKC
MOB1XDG\+^#+N]LR?M+D6\3@@[';.&.?3%>??"#1?$FJ2Z=XHN?$=U-IRM*C6
M<T\KEL J,Y.WKS0![E117GGQ'^)+>!4@MH['[3>7$9DB9FP@PP!R.O0GI0!Z
M'16=;W3W>B0W;862:V61@I/RY7/%>)? [6M4U+Q;J"7FIWES$+,N%N+AG .]
M>@)ZT >_45$"5!9CW[9- 8D\9]<CH10!+141+CG;GCUQ4@Z<T +136.WYLG'
MI3"1AL;C]#0!+142.",J2<<49Q\Q.,?E0 I&6.!@CN:ACM;=')BMTC=1C<$
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MO@E*/CGC(.:F^#]_>WOP]L[B^GFGG>67<\TA=^&.!D^U 'H-%1 XZ-[\U+0
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MD=3FEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF
M?B'_ ,DZ\0_]>$O_ *":Z:N9^(?_ "3KQ#_UX2_^@F@#YN^%'_)3]"_ZZO\
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M8:E974BKN=;>X5RH]?E/3-> ZJZZ?^T0ES>%;>U^VI+YTV$&W:!NR>W'7VH
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M!*JD%BQ0AMH [G;@>YH \GT+2O$OQBDN]2U#6Y].M+>7_1T1-T>YOO*,,,8
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M[Q'7VK?C\&>)_'/AF+Q1K/BEH=T3SP6\41*JF,]=PQG'O6C^T$6&AZ+\N/\
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MG,8&\W>O*M@KGIG)] #7G_A+P#X*U_P_!>7OBQ;2[.1+#(\<;(1Z;L'&,<T
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M;X@OHKR1&(M[L-G)&,(#CG(Y'I@]:X?P5X'\&^)- BN]3\4+87R,R36\CI&
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M'Q(U%I[F4PK:3N1(Y^4!UYKV?P=JNG7_ (:TRWM+ZUN)X;*$2Q)*KM&=@'S
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<S\0_P#DG7B'_KPE_P#03735S/Q#_P"2=>(?^O"7_P!!- 'S
M=\*/^2GZ%_UU?_T6U?6PZU\D_"C_ )*?H7_75_\ T6U?6PZT +1110 4444
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M^@)H;Z="=-C;<MO@[,[MWKG.:W** /.M(^#'A'2;[[4+:>Y9>B7#AD!R#D
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MIFJ1LT#D,"C89&'0@^O7\ZVZ* .0\)?#O1_!US<W6FM=&:Y01R>=*&& <\8
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MK=@;O[5() PED#)\YR>,"NQP=PZ\<T^B@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P DZ\0_]>$O_H)H
M ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:OK8=: %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\
M:'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#
M2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\
M(^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P D
MZ\0_]>$O_H)H ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:
MOK8=: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q
M)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\
M(^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P DZ\0_]>$O_H)H
M ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:OK8=: %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\
M:'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#
M2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\
M(^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P D
MZ\0_]>$O_H)H ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:
MOK8=: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q
M)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\
M(^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P DZ\0_]>$O_H)H
M ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:OK8=: %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\
M:'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#
M2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\
M(^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P D
MZ\0_]>$O_H)H ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:
MOK8=: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q
M)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\
M(^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P DZ\0_]>$O_H)H
M ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:OK8=: %HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\
M:'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#
M2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH *\7_ &A_^0-HG_7Q)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\
M(^W/_8/?_P!#2OI2OFOX _\ (^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YGXA_P#).O$/_7A+_P"@FNFKF?B'_P D
MZ\0_]>$O_H)H ^;OA1_R4_0O^NK_ /HMJ^MAUKY)^%'_ "4_0O\ KJ__ *+:
MOK8=: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\7_ &A_^0-HG_7Q
M)_Z"*]HKQ?\ :'_Y VB?]?$G_H(H Y/X _\ (^W/_8/?_P!#2OI2OFOX _\
M(^W/_8/?_P!#2OI2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BDW#.*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M /0TKZ4KYK^ /_(^W/\ V#W_ /0TKZ4H **** "BBB@ HHHH **** "BBB@
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ML-B/('H,=O7O6YXG\6Z?8_%VWTB;PMIMQ=/<6Z#4)#^\&[;@].HS^E 'L:G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ*,91#@X96P!U(&">E9/B_X>_$/Q!?P:O?6$-W=W,(\Q;=U7R<=%8$@9^F:
M/H+021X9TL@9/V.+C_@ J34]2MM(T^>_OIA#;0+N=ST [?CV_&DT:*2#0]/M
MYEVRQ6T:.I[$* :K^)-!A\0^'+_29L[+J,C[V/F'*Y/ID"@#SK2O'_BCQ9)/
M_P (7X>L8]-MV*M)>D@.Y).1@@#J"1UYK!^%:W@^,FOC4;>WM[Q8)?-AMO\
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MDR2R*"$,ZY^9/D)SP.AP.:ZOXF>'IO%'@JYM;6W>XNXF66VC1PN7''4]L$T
M>:_%'6/^$UUKPQX?LY8$2Z6&9B<L\$DN,!L'H%(-=7\99)M'^&,=K:'R8GGB
MMY1&@ *;6./8945@_"#X?:SHOBFYU/7=.DM?)BVVK-*K9)X(P">U>OZYH=KK
M^B76E79807*;'*GD>X- 'S[X!UWQMH/AM8_#OA47MG-(SO=?9Y6:1LD'D-CC
M&.!VJYX.TOQDGQ3M];NM N=/AN9BMSLMBL2H1D@9Z D"M2#0?BAX!B;2_#HB
MU+3=SO$<*?+!)XPY&">IQD9-=7X(M/'USKS:MXHN%@MO*:'["K  MP0^T97U
M[YH \Q\(VMOJ?QROK&\A62VEOKMGB8G:S(SLN1WP0#CI7LGC+P/9>)?#,^E6
M<<5E*S++&\4:IN=<X# #D<FN"\'>"_$NG_&2ZUN\TR2'3GN;IUF,B%<.&VG
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M !%*NGV-DY$MLI"_:593V3(."!UQUKU=.AY)- #J*** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(?\ R3KQ#_UX2_\ H)H ^;OA1_R4_0O^NK_^BVKZV'6ODGX4?\E/T+_KJ_\
MZ+:OK8=: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\7_:'_Y VB?]
M?$G_ *"*]HKQ?]H?_D#:)_U\2?\ H(H Y/X _P#(^W/_ &#W_P#0TKZ4KYK^
M /\ R/MS_P!@]_\ T-*^E* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KF?B'_R3KQ#_P!>$O\ Z":Z:N9^(?\ R3KQ#_UX2_\ H)H ^;OA
M1_R4_0O^NK_^BVKZV'6ODGX4?\E/T+_KJ_\ Z+:OK8=: %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *\7_:'_Y VB?]?$G_ *"*]HKQ?]H?_D#:)_U\
M2?\ H(H Y/X _P#(^W/_ &#W_P#0TKZ4KYK^ /\ R/MS_P!@]_\ T-*^E* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?B'_R3KQ#_P!>
M$O\ Z":Z:N9^(?\ R3KQ#_UX2_\ H)H ^;OA1_R4_0O^NK_^BVKZV'6ODGX4
M?\E/T+_KJ_\ Z+:OK8=: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M\7_:'_Y VB?]?$G_ *"*]HKQ?]H?_D#:)_U\2?\ H(H Y/X _P#(^W/_ &#W
M_P#0TKZ4KYK^ /\ R/MS_P!@]_\ T-*^E* "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KF?B'_R3KQ#_P!>$O\ Z":Z:N9^(?\ R3KQ#_UX
M2_\ H)H ^;OA1_R4_0O^NK_^BVKZV'6ODGX4?\E/T+_KJ_\ Z+:OK8=: %HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *\7_:'_Y VB?]?$G_ *"*]HKQ
M?]H?_D#:)_U\2?\ H(H Y/X _P#(^W/_ &#W_P#0TKZ4KYK^ /\ R/MS_P!@
M]_\ T-*^E* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?
MB'_R3KQ#_P!>$O\ Z":Z:N9^(?\ R3KQ#_UX2_\ H)H ^;OA1_R4_0O^NK_^
MBVKZV'6ODGX4?\E/T+_KJ_\ Z+:OK8=: %HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *\7_:(_Y VA_]?$G_ *"*]HKR+]H#3I[GPI97L83R;.<^=G[V
M' 48H X?X '/CVY]?[/D!_[[2OI6OFGX"R*GQ N!(R@M8/C!XSO3BOI7(SB@
M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N9^(?_).O$/\
MUX2_^@FNER/6N8^(KHOP[\0;F W6,H&3U.TT ?.'PH_Y*?H7_75__1;5];#K
M7R3\*2/^%GZ'[2OG_OVU?6PYY]: %HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *XGXKZ-<ZY\/\ 4+6T7=-&!<! I8OL.[: .23CBNVICYW#KC'.* /B
MO0=7N- UVQU.$A)K67>/ERV.A&#QTR/QKZO\+^.-!\51@Z;J"/)P#!)\L@.
M2,'E@,]1D5YA\1_@[=7%_?:[H!,[3.))++9AB3UVD<8SCY<?C7C0MM2L+ET,
M5S!<1.T;;$8..>>1^- 'VY17Q'_:VJ[2?[2NSVR9FX_'-(-8U''.I7>>_P"_
M;_&@#[=HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC
M4/\ H)W?_?\ ;_&C^V-0_P"@G=_]_P!O\: /MRBOB/\ MC4/^@G=_P#?]O\
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M^(_[8U#_ *"=W_W_ &_QH_MC4/\ H)W?_?\ ;_&@#[<HKXC_ +8U#_H)W?\
MW_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC4/\ H)W?_?\ ;_&C^V-0_P"@
MG=_]_P!O\: /MRBOB/\ MC4/^@G=_P#?]O\ &C^V-0_Z"=W_ -_V_P : /MR
MBOB/^V-0_P"@G=_]_P!O\:/[8U#_ *"=W_W_ &_QH ^W**^(_P"V-0_Z"=W_
M -_V_P :/[8U#_H)W?\ W_;_ !H ^W**^(_[8U#_ *"=W_W_ &_QH_MC4/\
MH)W?_?\ ;_&@#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[
M<HKXC_MC4/\ H)W?_?\ ;_&C^V-0_P"@G=_]_P!O\: /MRBOB/\ MC4/^@G=
M_P#?]O\ &C^V-0_Z"=W_ -_V_P : /MRBOB/^V-0_P"@G=_]_P!O\:/[8U#_
M *"=W_W_ &_QH ^W**^(_P"V-0_Z"=W_ -_V_P :/[8U#_H)W?\ W_;_ !H
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M4/\ H)W?_?\ ;_&@#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\
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M]O\ &@#[<HKXC_MC4/\ H)W?_?\ ;_&C^V-0_P"@G=_]_P!O\: /MRBOB/\
MMC4/^@G=_P#?]O\ &C^V-0_Z"=W_ -_V_P : /MRBOB/^V-0_P"@G=_]_P!O
M\:/[8U#_ *"=W_W_ &_QH ^W**^(_P"V-0_Z"=W_ -_V_P :/[8U#_H)W?\
MW_;_ !H ^W**^(_[8U#_ *"=W_W_ &_QH_MC4/\ H)W?_?\ ;_&@#[<HKXC_
M +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC4/\ H)W?_?\
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M#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC4/\
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M/[8U#_H)W?\ W_;_ !H ^W**^(_[8U#_ *"=W_W_ &_QH_MC4/\ H)W?_?\
M;_&@#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC
M4/\ H)W?_?\ ;_&C^V-0_P"@G=_]_P!O\: /MRBOB/\ MC4/^@G=_P#?]O\
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M^(_[8U#_ *"=W_W_ &_QH_MC4/\ H)W?_?\ ;_&@#[<HKXC_ +8U#_H)W?\
MW_;_ !H_MC4/^@G=_P#?]O\ &@#[<HKXC_MC4/\ H)W?_?\ ;_&C^V-0_P"@
MG=_]_P!O\: /MRBOB/\ MC4/^@G=_P#?]O\ &C^V-0_Z"=W_ -_V_P : /MR
MBOB/^V-0_P"@G=_]_P!O\:/[8U#_ *"=W_W_ &_QH ^W**^(_P"V-0_Z"=W_
M -_V_P :/[8U#_H)W?\ W_;_ !H ^W**^(_[8U#_ *"=W_W_ &_QH_MC4/\
MH)W?_?\ ;_&@#[<HKXC_ +8U#_H)W?\ W_;_ !H_MC4/^@G=_P#?]O\ &@#[
M<HKXC_MC4/\ H)W?_?\ ;_&C^V-0_P"@G=_]_P!O\: /MRBOB/\ MC4/^@G=
M_P#?]O\ &C^V-0_Z"=W_ -_V_P : /MRBOB/^V-0_P"@G=_]_P!O\:/[8U#_
M *"=W_W_ &_QH ^W**^(_P"V-0_Z"=W_ -_V_P :/[8U#_H)W?\ W_;_ !H
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M (")_A1_P@OA/_H6]*_\!$_PKH** .?_ .$%\)_]"WI7_@(G^%'_  @OA/\
MZ%O2O_ 1/\*Z"B@#G_\ A!?"?_0MZ5_X")_A1_P@OA/_ *%O2O\ P$3_  KH
M** .?_X07PG_ -"WI7_@(G^%'_""^$_^A;TK_P !$_PKH** .?\ ^$%\)_\
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M(+X3_P"A;TK_ ,!$_P *Z"B@#G_^$%\)_P#0MZ5_X")_A1_P@OA/_H6]*_\
M 1/\*Z"B@#G_ /A!?"?_ $+>E?\ @(G^%'_""^$_^A;TK_P$3_"N@HH Y_\
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M$%\)_P#0MZ5_X")_A1_P@OA/_H6]*_\  1/\*Z"B@#G_ /A!?"?_ $+>E?\
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M B?X4?\ ""^$_P#H6]*_\!$_PKH** .?_P"$%\)_]"WI7_@(G^%'_""^$_\
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M*_\  1/\*Z"B@#G_ /A!?"?_ $+>E?\ @(G^%'_""^$_^A;TK_P$3_"N@HH
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M* .?_P"$%\)_]"WI7_@(G^%'_""^$_\ H6]*_P# 1/\ "N@HH Y__A!?"?\
MT+>E?^ B?X4?\(+X3_Z%O2O_  $3_"N@HH Y_P#X07PG_P!"WI7_ (")_A1_
MP@OA/_H6]*_\!$_PKH** .?_ .$%\)_]"WI7_@(G^%'_  @OA/\ Z%O2O_ 1
M/\*Z"B@#G_\ A!?"?_0MZ5_X")_A1_P@OA/_ *%O2O\ P$3_  KH** .?_X0
M7PG_ -"WI7_@(G^%'_""^$_^A;TK_P !$_PKH** .?\ ^$%\)_\ 0MZ5_P"
MB?X4?\(+X3_Z%O2O_ 1/\*Z"B@#G_P#A!?"?_0MZ5_X")_A1_P (+X3_ .A;
MTK_P$3_"N@HH Y__ (07PG_T+>E?^ B?X4?\(+X3_P"A;TK_ ,!$_P *Z"B@
M#G_^$%\)_P#0MZ5_X")_A1_P@OA/_H6]*_\  1/\*Z"B@#G_ /A!?"?_ $+>
ME?\ @(G^%'_""^$_^A;TK_P$3_"N@HH Y_\ X07PG_T+>E?^ B?X4?\ ""^$
M_P#H6]*_\!$_PKH** .?_P"$%\)_]"WI7_@(G^%'_""^$_\ H6]*_P# 1/\
M"N@HH Y__A!?"?\ T+>E?^ B?X4?\(+X3_Z%O2O_  $3_"N@HH Y_P#X07PG
M_P!"WI7_ (")_A1_P@OA/_H6]*_\!$_PKH** .?_ .$%\)_]"WI7_@(G^%'_
M  @OA/\ Z%O2O_ 1/\*Z"B@#G_\ A!?"?_0MZ5_X")_A1_P@OA/_ *%O2O\
MP$3_  KH** .?_X07PG_ -"WI7_@(G^%'_""^$_^A;TK_P !$_PKH** .?\
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1%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
